PARADIGM pathway analysis of mRNA expression and copy number data
Colorectal Adenocarcinoma (Primary solid tumor)
23 September 2013  |  analyses__2013_09_23
Maintainer Information
Citation Information
doi:10.7908/C1W957HR
Maintained by Dan DiCara (Broad Institute)
Cite as Broad Institute TCGA Genome Data Analysis Center (2013): PARADIGM pathway analysis of mRNA expression and copy number data. Broad Institute of MIT and Harvard. doi:10.7908/C1W957HR
Overview
Introduction

PAthway Representation and Analysis by Direct Inference on Graphical Models (PARADIGM) predicts the activity of a diverse set of molecular concepts such as genes, complexes, and processes. The predicted activities are called Inferred Pathway Levels (IPLs) and are derived from a probabilistic belief propagation strategy that incorporates multimodal data such as copy number and gene expression estimates with a concept's pathway context.

Summary

There were 48 significant pathways identified in this analysis.

Table 1.  Get Full Table Top 10 out of 131 pathways in order of significance.

Pathway.Name Avg.Num.Perturbations
IL23-mediated signaling events 41
TCGA08_p53 36
Ephrin B reverse signaling 34
Wnt signaling 31
HIF-1-alpha transcription factor network 30
IL4-mediated signaling events 30
Fc-epsilon receptor I signaling in mast cells 26
Endothelins 26
Osteopontin-mediated events 25
Signaling mediated by p38-alpha and p38-beta 25
Results
Summary Table

The following list describes the columns found in Table 2.

  • Pathway.Name = Full pathway name of curated PARADIGM pathway

  • Significance.Ratio = (Ave.Num.Perturbations)/ (Cohort Size) where Cohort Size is 222 . Pathway is significant if Significance.Ratio > 0.05 .

  • Avg.Num.Perturbations = Average number of samples with perturbations across the pathway concepts determined by a background permutation model (>2 standard deviations away from the permuted distribution)

  • Total.Perturbations = Total number of perturbed concepts across all samples (>2 standard deviations away from the permuted distribution)

  • Num.Entities = Number of concepts that belong to the pathway

  • Min.Mean.Truth = Minimum IPL for concepts in the pathway among real samples

  • Max.Mean.Truth = Maximum IPL for concepts in the pathway among real samples

  • Min.Mean.Within = Minimum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Max.Mean.Within = Maximum IPL for concepts in the pathway among null samples using "within permutation" (values are permuted across genes)

  • Min.Mean.Any = Minimum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes)

  • Max.Mean.Any = Maximum IPL for concepts in the pathway among null samples using "any permutation" (values are permuted across samples and genes).

Table 2.  Get Full Table This summary table provides a report of cancer type specific pathway perturbations. Click on the links in the first column to display more detailed results for each pathway. A pathway is defined as significant (red number in Significance.Ratio column) if the Ave.Num.Perturbationsis > 5% of the cohort size ( 222 ).

Pathway.Name Significance.Ratio Avg.Num.Perturbations Total.Perturbations Num.Entities Min.Mean.Truth Max.Mean.Truth Min.Mean.Within Max.Mean.Within Min.Mean.Any Max.Mean.Within.1
IL23-mediated signaling events 0.1847 41 2472 60 -0.6 0.037 1000 -1000 -0.087 -1000
TCGA08_p53 0.1622 36 252 7 -0.083 0.031 1000 -1000 -0.004 -1000
Ephrin B reverse signaling 0.1532 34 1635 48 -0.23 0.052 1000 -1000 -0.026 -1000
Wnt signaling 0.1396 31 218 7 -0.11 0.033 1000 -1000 -0.01 -1000
HIF-1-alpha transcription factor network 0.1351 30 2334 76 -0.27 0.043 1000 -1000 -0.043 -1000
IL4-mediated signaling events 0.1351 30 2784 91 -0.6 0.49 1000 -1000 -0.079 -1000
Fc-epsilon receptor I signaling in mast cells 0.1171 26 2543 97 -0.19 0.039 1000 -1000 -0.058 -1000
Endothelins 0.1171 26 2539 96 -0.22 0.047 1000 -1000 -0.041 -1000
Osteopontin-mediated events 0.1126 25 986 38 -0.16 0.043 1000 -1000 -0.026 -1000
Signaling mediated by p38-alpha and p38-beta 0.1126 25 1122 44 -0.15 0.037 1000 -1000 -0.023 -1000
Syndecan-1-mediated signaling events 0.1081 24 834 34 -0.13 0.046 1000 -1000 -0.034 -1000
EGFR-dependent Endothelin signaling events 0.1036 23 487 21 -0.087 0.054 1000 -1000 -0.042 -1000
Noncanonical Wnt signaling pathway 0.0991 22 581 26 -0.11 0.037 1000 -1000 -0.033 -1000
Calcineurin-regulated NFAT-dependent transcription in lymphocytes 0.0991 22 1513 68 -0.37 0.17 1000 -1000 -0.079 -1000
IL12-mediated signaling events 0.0946 21 1863 87 -0.33 0.039 1000 -1000 -0.042 -1000
Glypican 1 network 0.0946 21 1032 48 -0.12 0.047 1000 -1000 -0.022 -1000
Thromboxane A2 receptor signaling 0.0901 20 2188 105 -0.17 0.054 1000 -1000 -0.043 -1000
TCGA08_retinoblastoma 0.0856 19 156 8 -0.024 0.037 1000 -1000 -0.005 -1000
Glucocorticoid receptor regulatory network 0.0811 18 2070 114 -0.39 0.21 1000 -1000 -0.047 -1000
IL1-mediated signaling events 0.0811 18 1157 62 -0.14 0.063 1000 -1000 -0.032 -1000
FAS signaling pathway (CD95) 0.0811 18 865 47 -0.32 0.059 1000 -1000 -0.037 -1000
Glypican 2 network 0.0811 18 75 4 -0.005 0 1000 -1000 0 -1000
Calcium signaling in the CD4+ TCR pathway 0.0811 18 579 31 -0.19 0.034 1000 -1000 -0.045 -1000
IL27-mediated signaling events 0.0811 18 922 51 -0.19 0.12 1000 -1000 -0.068 -1000
Presenilin action in Notch and Wnt signaling 0.0766 17 1040 61 -0.14 0.095 1000 -1000 -0.039 -1000
FOXA2 and FOXA3 transcription factor networks 0.0766 17 813 46 -0.24 0.055 1000 -1000 -0.085 -1000
BMP receptor signaling 0.0766 17 1449 81 -0.14 0.066 1000 -1000 -0.034 -1000
TCR signaling in naïve CD8+ T cells 0.0766 17 1597 93 -0.082 0.054 1000 -1000 -0.038 -1000
EPHB forward signaling 0.0766 17 1448 85 -0.078 0.11 1000 -1000 -0.055 -1000
FOXM1 transcription factor network 0.0766 17 892 51 -0.25 0.035 1000 -1000 -0.077 -1000
Signaling events mediated by Stem cell factor receptor (c-Kit) 0.0766 17 1355 78 -0.24 0.049 1000 -1000 -0.057 -1000
amb2 Integrin signaling 0.0721 16 1391 82 -0.16 0.046 1000 -1000 -0.028 -1000
Syndecan-2-mediated signaling events 0.0676 15 1052 69 -0.13 0.046 1000 -1000 -0.034 -1000
Arf6 signaling events 0.0676 15 934 62 -0.087 0.088 1000 -1000 -0.013 -1000
IFN-gamma pathway 0.0676 15 1032 68 -0.1 0.047 1000 -1000 -0.043 -1000
Canonical Wnt signaling pathway 0.0676 15 803 51 -0.26 0.1 1000 -1000 -0.037 -1000
Visual signal transduction: Rods 0.0676 15 808 52 -0.16 0.057 1000 -1000 -0.032 -1000
PLK2 and PLK4 events 0.0631 14 44 3 -0.012 0.031 1000 -1000 -0.005 -1000
Signaling events mediated by the Hedgehog family 0.0586 13 705 52 -0.11 0.071 1000 -1000 -0.029 -1000
Cellular roles of Anthrax toxin 0.0586 13 507 39 -0.061 0.033 1000 -1000 -0.018 -1000
Nectin adhesion pathway 0.0586 13 829 63 -0.054 0.069 1000 -1000 -0.038 -1000
Syndecan-3-mediated signaling events 0.0586 13 464 35 -0.13 0.055 1000 -1000 -0.018 -1000
IL6-mediated signaling events 0.0586 13 1046 75 -0.12 0.053 1000 -1000 -0.043 -1000
Caspase cascade in apoptosis 0.0541 12 907 74 -0.12 0.061 1000 -1000 -0.038 -1000
a4b1 and a4b7 Integrin signaling 0.0541 12 61 5 0.004 0.035 1000 -1000 0.019 -1000
S1P1 pathway 0.0541 12 454 36 -0.13 0.037 1000 -1000 -0.035 -1000
BCR signaling pathway 0.0541 12 1263 99 -0.18 0.045 1000 -1000 -0.049 -1000
Syndecan-4-mediated signaling events 0.0541 12 850 67 -0.053 0.056 1000 -1000 -0.036 -1000
Reelin signaling pathway 0.0495 11 653 56 -0.076 0.094 1000 -1000 -0.03 -1000
LPA receptor mediated events 0.0495 11 1149 102 -0.14 0.037 1000 -1000 -0.073 -1000
Stabilization and expansion of the E-cadherin adherens junction 0.0495 11 874 74 -0.087 0.055 1000 -1000 -0.056 -1000
Signaling events mediated by PRL 0.0495 11 378 34 -0.046 0.054 1000 -1000 -0.035 -1000
Ras signaling in the CD4+ TCR pathway 0.0495 11 191 17 -0.027 0.048 1000 -1000 -0.014 -1000
JNK signaling in the CD4+ TCR pathway 0.0450 10 171 17 -0.034 0.037 1000 -1000 -0.026 -1000
Signaling events mediated by PTP1B 0.0450 10 819 76 -0.085 0.062 1000 -1000 -0.027 -1000
Arf6 downstream pathway 0.0450 10 461 43 -0.036 0.043 1000 -1000 -0.026 -1000
E-cadherin signaling in the nascent adherens junction 0.0450 10 779 76 -0.042 0.073 1000 -1000 -0.049 -1000
E-cadherin signaling events 0.0450 10 52 5 0.013 0.039 1000 -1000 0.02 -1000
Sphingosine 1-phosphate (S1P) pathway 0.0405 9 269 28 -0.034 0.048 1000 -1000 -0.015 -1000
Visual signal transduction: Cones 0.0405 9 363 38 -0.003 0.047 1000 -1000 0 -1000
p75(NTR)-mediated signaling 0.0405 9 1130 125 -0.13 0.078 1000 -1000 -0.043 -1000
Ceramide signaling pathway 0.0405 9 728 76 -0.087 0.074 1000 -1000 -0.031 -1000
IL2 signaling events mediated by PI3K 0.0405 9 525 58 -0.069 0.054 1000 -1000 -0.034 -1000
Integrins in angiogenesis 0.0405 9 756 84 -0.16 0.077 1000 -1000 -0.029 -1000
HIV-1 Nef: Negative effector of Fas and TNF-alpha 0.0405 9 409 45 -0.057 0.052 1000 -1000 -0.046 -1000
Regulation of p38-alpha and p38-beta 0.0405 9 494 54 -0.084 0.068 1000 -1000 -0.044 -1000
Nongenotropic Androgen signaling 0.0405 9 504 52 -0.096 0.055 1000 -1000 -0.025 -1000
IL2 signaling events mediated by STAT5 0.0405 9 217 22 -0.081 0.038 1000 -1000 -0.04 -1000
Aurora B signaling 0.0405 9 606 67 -0.14 0.055 1000 -1000 -0.026 -1000
PDGFR-alpha signaling pathway 0.0360 8 383 44 -0.12 0.076 1000 -1000 -0.031 -1000
Signaling mediated by p38-gamma and p38-delta 0.0360 8 130 15 -0.021 0.031 1000 -1000 -0.031 -1000
Class I PI3K signaling events 0.0360 8 601 73 -0.064 0.05 1000 -1000 -0.028 -1000
Plasma membrane estrogen receptor signaling 0.0360 8 744 86 -0.047 0.085 1000 -1000 -0.051 -1000
Regulation of Androgen receptor activity 0.0360 8 607 70 -0.1 0.075 1000 -1000 -0.04 -1000
Regulation of nuclear SMAD2/3 signaling 0.0315 7 969 136 -0.071 0.051 1000 -1000 -0.036 -1000
Hedgehog signaling events mediated by Gli proteins 0.0315 7 497 65 -0.11 0.061 1000 -1000 -0.043 -1000
PLK1 signaling events 0.0315 7 626 85 -0.026 0.07 1000 -1000 -0.032 -1000
mTOR signaling pathway 0.0315 7 408 53 -0.078 0.041 1000 -1000 -0.034 -1000
Paxillin-independent events mediated by a4b1 and a4b7 0.0315 7 268 37 -0.024 0.072 1000 -1000 -0.03 -1000
RXR and RAR heterodimerization with other nuclear receptor 0.0315 7 373 52 -0.071 0.098 1000 -1000 -0.029 -1000
Effects of Botulinum toxin 0.0315 7 197 26 -0.089 0.063 1000 -1000 -0.002 -1000
Regulation of Telomerase 0.0315 7 782 102 -0.19 0.082 1000 -1000 -0.047 -1000
Insulin Pathway 0.0315 7 567 74 -0.16 0.11 1000 -1000 -0.03 -1000
VEGFR1 specific signals 0.0315 7 421 56 -0.005 0.095 1000 -1000 -0.035 -1000
PDGFR-beta signaling pathway 0.0315 7 731 97 -0.052 0.094 1000 -1000 -0.039 -1000
ErbB4 signaling events 0.0270 6 471 69 -0.17 0.06 1000 -1000 -0.036 -1000
Lissencephaly gene (LIS1) in neuronal migration and development 0.0270 6 336 54 -0.076 0.051 1000 -1000 -0.04 -1000
Class I PI3K signaling events mediated by Akt 0.0270 6 413 68 -0.047 0.059 1000 -1000 -0.029 -1000
Signaling events mediated by HDAC Class III 0.0270 6 266 40 -0.061 0.066 1000 -1000 -0.029 -1000
TRAIL signaling pathway 0.0270 6 300 48 -0.018 0.059 1000 -1000 -0.026 -1000
FoxO family signaling 0.0270 6 391 64 -0.076 0.054 1000 -1000 -0.051 -1000
Retinoic acid receptors-mediated signaling 0.0270 6 377 58 -0.097 0.069 1000 -1000 -0.034 -1000
Paxillin-dependent events mediated by a4b1 0.0270 6 224 36 -0.061 0.065 1000 -1000 -0.028 -1000
Arf6 trafficking events 0.0270 6 492 71 -0.045 0.056 1000 -1000 -0.024 -1000
S1P3 pathway 0.0270 6 286 42 -0.029 0.048 1000 -1000 -0.028 -1000
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha 0.0270 6 227 33 -0.039 0.079 1000 -1000 -0.037 -1000
S1P4 pathway 0.0270 6 154 25 -0.015 0.048 1000 -1000 -0.018 -1000
ErbB2/ErbB3 signaling events 0.0225 5 348 65 -0.093 0.053 1000 -1000 -0.061 -1000
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met) 0.0225 5 492 85 -0.18 0.084 1000 -1000 -0.054 -1000
Signaling events regulated by Ret tyrosine kinase 0.0225 5 418 82 -0.023 0.069 1000 -1000 -0.056 -1000
S1P5 pathway 0.0225 5 93 17 -0.013 0.037 1000 -1000 -0.006 -1000
ceramide signaling pathway 0.0225 5 248 49 -0.006 0.052 1000 -1000 -0.037 -1000
HIF-2-alpha transcription factor network 0.0225 5 253 43 -0.047 0.056 1000 -1000 -0.038 -1000
Signaling events mediated by VEGFR1 and VEGFR2 0.0225 5 717 125 -0.036 0.1 1000 -1000 -0.04 -1000
TCGA08_rtk_signaling 0.0225 5 134 26 -0.042 0.075 1000 -1000 -0.01 -1000
E-cadherin signaling in keratinocytes 0.0225 5 256 43 -0.044 0.093 1000 -1000 -0.019 -1000
Class IB PI3K non-lipid kinase events 0.0225 5 15 3 -0.026 0.026 1000 -1000 -0.02 -1000
Coregulation of Androgen receptor activity 0.0180 4 322 76 -0.071 0.059 1000 -1000 -0.025 -1000
BARD1 signaling events 0.0180 4 241 57 -0.039 0.077 1000 -1000 -0.036 -1000
EPO signaling pathway 0.0180 4 240 55 -0.02 0.078 1000 -1000 -0.034 -1000
Role of Calcineurin-dependent NFAT signaling in lymphocytes 0.0180 4 362 83 -0.032 0.073 1000 -1000 -0.023 -1000
IGF1 pathway 0.0180 4 230 57 -0.025 0.089 1000 -1000 -0.033 -1000
Angiopoietin receptor Tie2-mediated signaling 0.0180 4 368 88 -0.16 0.11 1000 -1000 -0.066 -1000
Neurotrophic factor-mediated Trk receptor signaling 0.0180 4 493 120 -0.018 0.097 1000 -1000 -0.041 -1000
LPA4-mediated signaling events 0.0135 3 46 12 -0.023 0.014 1000 -1000 -0.025 -1000
Regulation of cytoplasmic and nuclear SMAD2/3 signaling 0.0135 3 78 23 0 0.042 1000 -1000 -0.019 -1000
Ephrin A reverse signaling 0.0135 3 26 7 0 0.04 1000 -1000 0 -1000
Aurora A signaling 0.0135 3 206 60 -0.024 0.077 1000 -1000 -0.014 -1000
Aurora C signaling 0.0135 3 26 7 0 0.04 1000 -1000 -0.014 -1000
Insulin-mediated glucose transport 0.0135 3 106 32 -0.021 0.056 1000 -1000 -0.021 -1000
Signaling events mediated by HDAC Class I 0.0135 3 314 104 -0.071 0.081 1000 -1000 -0.028 -1000
Atypical NF-kappaB pathway 0.0135 3 94 31 -0.013 0.048 1000 -1000 -0.015 -1000
p38 MAPK signaling pathway 0.0135 3 136 44 0 0.061 1000 -1000 -0.019 -1000
Canonical NF-kappaB pathway 0.0090 2 105 39 -0.036 0.078 1000 -1000 -0.017 -1000
Signaling events mediated by HDAC Class II 0.0090 2 174 75 -0.016 0.071 1000 -1000 -0.019 -1000
Arf1 pathway 0.0090 2 109 54 -0.001 0.079 1000 -1000 -0.017 -1000
Nephrin/Neph1 signaling in the kidney podocyte 0.0045 1 55 34 -0.046 0.096 1000 -1000 -0.031 -1000
Circadian rhythm pathway 0.0045 1 25 22 -0.011 0.074 1000 -1000 -0.036 -1000
Sumoylation by RanBP2 regulates transcriptional repression 0.0045 1 29 27 0 0.056 1000 -1000 -0.029 -1000
Rapid glucocorticoid signaling 0.0000 0 16 20 0 0.043 1000 -1000 -0.002 -1000
Alternative NF-kappaB pathway 0.0000 0 12 13 0 0.095 1000 -1000 0 -1000
Total NA 1440 83507 7203 -13 8.6 131000 -131000 -4.3 -131000
IL23-mediated signaling events

Figure S1.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S1.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCL2 -0.5 0.61 -10000 0 -1.3 66 66
IL23A -0.56 0.62 -10000 0 -1.3 74 74
NF kappa B1 p50/RelA/I kappa B alpha -0.47 0.59 -10000 0 -1.2 70 70
positive regulation of T cell mediated cytotoxicity -0.52 0.65 -10000 0 -1.4 63 63
ITGA3 -0.48 0.56 -10000 0 -1.2 62 62
IL17F -0.3 0.35 -10000 0 -0.74 63 63
IL12B -0.017 0.073 -10000 0 -0.41 3 3
STAT1 (dimer) -0.5 0.62 -10000 0 -1.3 63 63
CD4 -0.43 0.53 -10000 0 -1.2 53 53
IL23 -0.53 0.6 -10000 0 -1.3 74 74
IL23R -0.13 0.37 -10000 0 -1.4 15 15
IL1B -0.55 0.64 -10000 0 -1.4 67 67
T-helper cell lineage commitment 0 0 -10000 0 -10000 0 0
IL24 -0.44 0.53 -10000 0 -1.2 54 54
TYK2 -0.008 0.043 -10000 0 -10000 0 0
STAT4 0.023 0.076 -10000 0 -0.31 9 9
STAT3 0.037 0.006 -10000 0 -10000 0 0
IL18RAP -0.06 0.18 -10000 0 -0.36 50 50
IL12RB1 -0.009 0.045 -10000 0 -0.22 1 1
PIK3CA 0.037 0.005 -10000 0 -10000 0 0
IL12Rbeta1/TYK2 -0.007 0.057 -10000 0 -10000 0 0
IL23R/JAK2 -0.14 0.36 -10000 0 -1.3 15 15
positive regulation of chronic inflammatory response -0.52 0.65 -10000 0 -1.4 63 63
natural killer cell activation 0.009 0.019 0.082 11 -10000 0 11
JAK2 -0.025 0.088 -10000 0 -0.29 12 12
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
NFKB1 0.034 0.007 -10000 0 -10000 0 0
RELA 0.034 0.007 -10000 0 -10000 0 0
positive regulation of dendritic cell antigen processing and presentation -0.5 0.55 -10000 0 -1.2 75 75
ALOX12B -0.44 0.53 -10000 0 -1.2 59 59
CXCL1 -0.54 0.62 -10000 0 -1.3 75 75
T cell proliferation -0.52 0.65 -10000 0 -1.4 63 63
NFKBIA 0.027 0.043 -10000 0 -0.29 3 3
IL17A -0.22 0.28 -10000 0 -0.56 57 57
PI3K -0.46 0.6 -10000 0 -1.3 63 63
IFNG -0.029 0.06 0.13 8 -0.13 37 45
STAT3 (dimer) -0.43 0.57 -10000 0 -1.2 62 62
IL18R1 0.005 0.094 -10000 0 -0.26 19 19
IL23/IL23R/JAK2/TYK2/SOCS3 -0.25 0.33 -10000 0 -0.79 32 32
IL18/IL18R -0.062 0.18 -10000 0 -0.34 53 53
macrophage activation -0.023 0.022 -10000 0 -0.048 52 52
TNF -0.5 0.58 -10000 0 -1.2 67 67
STAT3/STAT4 -0.46 0.6 -10000 0 -1.3 62 62
STAT4 (dimer) -0.5 0.62 -10000 0 -1.3 63 63
IL18 -0.025 0.15 -10000 0 -0.41 27 27
IL19 -0.44 0.53 -10000 0 -1.2 58 58
STAT5A (dimer) -0.49 0.62 -10000 0 -1.3 62 62
STAT1 0.019 0.062 -10000 0 -0.19 18 18
SOCS3 0.013 0.092 -10000 0 -0.31 14 14
CXCL9 -0.6 0.66 -10000 0 -1.3 89 89
MPO -0.44 0.53 -10000 0 -1.2 57 57
positive regulation of humoral immune response -0.52 0.65 -10000 0 -1.4 63 63
IL23/IL23R/JAK2/TYK2 -0.56 0.74 -10000 0 -1.5 63 63
IL6 -0.56 0.64 -10000 0 -1.3 74 74
STAT5A 0.03 0.046 -10000 0 -0.24 5 5
IL2 0.028 0.027 -10000 0 -10000 0 0
positive regulation of tyrosine phosphorylation of STAT protein 0.009 0.019 0.082 11 -10000 0 11
CD3E -0.44 0.53 -10000 0 -1.2 60 60
keratinocyte proliferation -0.52 0.65 -10000 0 -1.4 63 63
NOS2 -0.44 0.53 -10000 0 -1.1 67 67
TCGA08_p53

Figure S2.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S2.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2A -0.032 0.096 -10000 0 -0.34 16 16
TP53 -0.083 0.13 0.26 2 -0.25 70 72
Senescence -0.082 0.13 0.26 2 -0.25 70 72
Apoptosis -0.082 0.13 0.26 2 -0.25 70 72
Activated_Oncogenes 0 0 -10000 0 -10000 0 0
MDM2 0.018 0.067 0.23 17 -10000 0 17
MDM4 0.031 0.051 -10000 0 -0.38 3 3
Ephrin B reverse signaling

Figure S3.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S3.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EFNB2 -0.005 0.12 -10000 0 -0.45 14 14
EPHB2 0.008 0.12 -10000 0 -0.47 12 12
EFNB1 0.014 0.043 -10000 0 -0.34 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.001 0.13 -10000 0 -0.28 24 24
Ephrin B2/EPHB1-2 -0.038 0.13 -10000 0 -0.29 35 35
neuron projection morphogenesis -0.017 0.11 -10000 0 -0.26 26 26
Ephrin B1/EPHB1-2/Tiam1 -0.007 0.13 -10000 0 -0.28 30 30
DNM1 0.034 0.03 -10000 0 -0.18 4 4
cell-cell signaling 0.001 0.005 -10000 0 -10000 0 0
MAP2K4 -0.15 0.24 0.24 1 -0.52 61 62
YES1 -0.22 0.36 -10000 0 -0.76 63 63
Ephrin B1/EPHB1-2/NCK2 -0.002 0.13 -10000 0 -0.28 29 29
PI3K -0.12 0.27 -10000 0 -0.5 68 68
mol:GDP -0.009 0.13 -10000 0 -0.27 30 30
ITGA2B 0.036 0.008 -10000 0 -10000 0 0
endothelial cell proliferation 0.012 0.083 -10000 0 -0.28 14 14
FYN -0.22 0.36 -10000 0 -0.76 65 65
MAP3K7 -0.16 0.25 -10000 0 -0.55 61 61
FGR -0.22 0.35 -10000 0 -0.75 64 64
TIAM1 0.03 0.051 -10000 0 -0.38 3 3
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
RGS3 0.037 0.005 -10000 0 -10000 0 0
cell adhesion -0.12 0.24 -10000 0 -0.48 62 62
LYN -0.21 0.35 -10000 0 -0.75 63 63
Ephrin B1/EPHB1-2/Src Family Kinases -0.2 0.32 -10000 0 -0.68 64 64
Ephrin B1/EPHB1-2 -0.17 0.27 -10000 0 -0.59 60 60
SRC -0.2 0.34 -10000 0 -0.72 62 62
ITGB3 0.035 0.017 -10000 0 -0.19 1 1
EPHB1 -0.063 0.16 -10000 0 -0.25 74 74
EPHB4 0.026 0.065 -10000 0 -0.33 6 6
RAC1 0.034 0.012 -10000 0 -10000 0 0
Ephrin B2/EPHB4 0.012 0.084 -10000 0 -0.29 14 14
alphaIIb/beta3 Integrin 0.052 0.017 -10000 0 -10000 0 0
BLK -0.23 0.36 -10000 0 -0.77 63 63
HCK -0.21 0.34 -10000 0 -0.73 63 63
regulation of stress fiber formation 0.005 0.13 0.28 29 -10000 0 29
MAPK8 -0.14 0.23 -10000 0 -0.48 64 64
Ephrin B1/EPHB1-2/RGS3 -0.004 0.13 -10000 0 -0.28 29 29
endothelial cell migration -0.089 0.23 0.22 14 -0.45 52 66
NCK2 0.038 0 -10000 0 -10000 0 0
PTPN13 -0.18 0.26 -10000 0 -0.42 99 99
regulation of focal adhesion formation 0.005 0.13 0.28 29 -10000 0 29
chemotaxis 0.006 0.13 0.28 29 -10000 0 29
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
Rac1/GTP -0.006 0.12 -10000 0 -0.27 24 24
angiogenesis -0.17 0.27 -10000 0 -0.59 61 61
LCK -0.23 0.36 -10000 0 -0.77 64 64
Wnt signaling

Figure S4.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S4.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Noncanonical Wnts/FZD -0.11 0.2 -9999 0 -0.36 63 63
FZD6 0.023 0.062 -9999 0 -0.4 4 4
WNT6 0.033 0.03 -9999 0 -0.19 4 4
WNT4 -0.033 0.16 -9999 0 -0.36 37 37
FZD3 -0.034 0.16 -9999 0 -0.38 32 32
WNT5A -0.007 0.13 -9999 0 -0.37 23 23
WNT11 -0.057 0.18 -9999 0 -0.33 55 55
HIF-1-alpha transcription factor network

Figure S5.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S5.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PKM2 -0.18 0.42 -10000 0 -0.87 43 43
HDAC7 -0.001 0.006 -10000 0 -10000 0 0
HIF1A/ARNT/Cbp/p300/Src-1 -0.13 0.39 -10000 0 -0.82 28 28
SMAD4 0.023 0.038 -10000 0 -0.47 1 1
ID2 -0.19 0.44 -10000 0 -0.9 44 44
AP1 -0.071 0.16 -10000 0 -0.34 46 46
ABCG2 -0.2 0.44 -10000 0 -0.9 44 44
HIF1A -0.014 0.099 -10000 0 -0.3 7 7
TFF3 -0.19 0.44 -10000 0 -0.89 46 46
GATA2 0.02 0.058 -10000 0 -0.38 3 3
AKT1 -0.013 0.094 -10000 0 -0.27 4 4
response to hypoxia -0.03 0.072 -10000 0 -0.17 4 4
MCL1 -0.18 0.43 -10000 0 -0.88 42 42
NDRG1 -0.19 0.42 -10000 0 -0.89 40 40
SERPINE1 -0.19 0.42 -10000 0 -0.85 45 45
FECH -0.2 0.42 -10000 0 -0.87 45 45
FURIN -0.18 0.42 -10000 0 -0.85 46 46
NCOA2 0.029 0.05 -10000 0 -0.47 2 2
EP300 -0.031 0.13 -10000 0 -0.32 19 19
HMOX1 -0.19 0.43 -10000 0 -0.9 43 43
BHLHE40 -0.2 0.41 -10000 0 -0.85 45 45
BHLHE41 -0.2 0.41 -10000 0 -0.85 45 45
HIF1A/ARNT/SMAD3/SMAD4/SP1 -0.013 0.15 -10000 0 -0.43 2 2
ENG -0.03 0.12 0.32 2 -0.39 2 4
JUN -0.023 0.15 -10000 0 -0.4 26 26
RORA -0.2 0.43 -10000 0 -0.89 44 44
ABCB1 -0.27 0.48 -10000 0 -1.1 48 48
TFRC -0.19 0.43 -10000 0 -0.85 46 46
CXCR4 -0.2 0.45 -10000 0 -0.9 47 47
TF -0.19 0.43 -10000 0 -0.87 43 43
CITED2 -0.18 0.42 -10000 0 -0.86 44 44
HIF1A/ARNT -0.16 0.52 -10000 0 -1 37 37
LDHA -0.004 0.14 -10000 0 -0.84 4 4
ETS1 -0.18 0.43 -10000 0 -0.87 43 43
PGK1 -0.18 0.43 -10000 0 -0.87 44 44
NOS2 -0.2 0.41 -10000 0 -0.85 45 45
ITGB2 -0.2 0.44 -10000 0 -0.92 43 43
ALDOA -0.18 0.42 -10000 0 -0.86 43 43
Cbp/p300/CITED2 -0.19 0.43 -10000 0 -0.92 38 38
FOS -0.062 0.16 -10000 0 -0.31 56 56
HK2 -0.18 0.43 -10000 0 -0.88 42 42
SP1 -0.005 0.069 -10000 0 -0.21 1 1
GCK -0.032 0.2 -10000 0 -1.4 2 2
HK1 -0.18 0.42 -10000 0 -0.87 41 41
NPM1 -0.18 0.43 -10000 0 -0.87 43 43
EGLN1 -0.19 0.42 -10000 0 -0.87 42 42
CREB1 0.043 0.014 -10000 0 -10000 0 0
PGM1 -0.19 0.44 -10000 0 -0.89 45 45
SMAD3 0.03 0.052 -10000 0 -0.37 3 3
EDN1 -0.23 0.44 -10000 0 -1.2 31 31
IGFBP1 -0.2 0.42 -10000 0 -0.87 43 43
VEGFA -0.13 0.32 -10000 0 -0.69 29 29
HIF1A/JAB1 0.009 0.081 -10000 0 -0.23 6 6
CP -0.19 0.43 -10000 0 -0.87 45 45
CXCL12 -0.2 0.44 -10000 0 -0.91 45 45
COPS5 0.031 0.037 -10000 0 -0.47 1 1
SMAD3/SMAD4 0.032 0.053 -10000 0 -0.34 3 3
BNIP3 -0.22 0.45 -10000 0 -0.89 50 50
EGLN3 -0.21 0.45 -10000 0 -0.91 46 46
CA9 -0.23 0.46 -10000 0 -0.94 47 47
TERT -0.18 0.42 -10000 0 -0.85 45 45
ENO1 -0.18 0.42 -10000 0 -0.87 43 43
PFKL -0.18 0.42 -10000 0 -0.88 42 42
NCOA1 0.029 0.069 -10000 0 -0.47 4 4
ADM -0.19 0.44 -10000 0 -0.9 43 43
ARNT -0.013 0.094 -10000 0 -0.47 1 1
HNF4A 0.011 0.07 -10000 0 -0.47 4 4
ADFP -0.2 0.41 -10000 0 -0.85 45 45
SLC2A1 -0.15 0.34 -10000 0 -0.72 32 32
LEP -0.19 0.42 -10000 0 -0.88 42 42
HIF1A/ARNT/Cbp/p300 -0.14 0.39 -10000 0 -0.82 29 29
EPO -0.088 0.28 -10000 0 -0.86 10 10
CREBBP -0.014 0.1 -10000 0 -0.28 10 10
HIF1A/ARNT/Cbp/p300/HDAC7 -0.14 0.38 -10000 0 -0.81 29 29
PFKFB3 -0.18 0.42 -10000 0 -0.85 45 45
NT5E -0.21 0.45 -10000 0 -0.9 46 46
IL4-mediated signaling events

Figure S6.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S6.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.35 0.64 -10000 0 -1.3 51 51
STAT6 (cleaved dimer) -0.44 0.63 -10000 0 -1.4 57 57
IGHG1 -0.11 0.23 -10000 0 -0.47 21 21
IGHG3 -0.41 0.58 -10000 0 -1.3 57 57
AKT1 -0.19 0.36 -10000 0 -0.94 26 26
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHP1 -0.17 0.37 -10000 0 -1.1 21 21
IL4/IL4R/JAK1/IL2R gamma/JAK3/IRS1 -0.22 0.42 -10000 0 -1.1 25 25
THY1 -0.43 0.62 -10000 0 -1.3 56 56
MYB 0.001 0.13 -10000 0 -0.47 15 15
HMGA1 0.035 0.035 -10000 0 -0.47 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3 -0.24 0.4 -10000 0 -0.86 45 45
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHIP -0.22 0.4 -10000 0 -1.1 24 24
SP1 0.024 0.048 -10000 0 -0.18 2 2
INPP5D 0 0 -10000 0 -10000 0 0
SOCS5 0.037 0.034 -10000 0 -10000 0 0
STAT6 (dimer)/ETS1 -0.43 0.64 -10000 0 -1.4 58 58
SOCS1 -0.25 0.38 -10000 0 -0.8 49 49
SOCS3 -0.22 0.39 -10000 0 -1 29 29
FCER2 -0.31 0.48 -10000 0 -1 47 47
PARP14 0.031 0.038 -10000 0 -0.19 6 6
CCL17 -0.45 0.65 -10000 0 -1.4 56 56
GRB2 0.036 0.007 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP -0.15 0.28 -10000 0 -0.75 21 21
T cell proliferation -0.43 0.64 -10000 0 -1.4 55 55
IL4R/JAK1 -0.42 0.62 -10000 0 -1.3 55 55
EGR2 -0.51 0.7 -10000 0 -1.4 66 66
JAK2 -0.025 0.093 -10000 0 -0.3 12 12
JAK3 0.038 0.016 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
JAK1 0.014 0.046 -10000 0 -0.48 1 1
COL1A2 -0.19 0.44 -10000 0 -1.5 18 18
CCL26 -0.48 0.67 -10000 0 -1.4 64 64
IL4R -0.45 0.66 -10000 0 -1.4 55 55
PTPN6 0.038 0.027 -10000 0 -10000 0 0
IL13RA2 -0.53 0.72 -10000 0 -1.5 68 68
IL13RA1 -0.02 0.078 -10000 0 -0.31 5 5
IRF4 -0.095 0.33 -10000 0 -1.2 13 13
ARG1 -0.088 0.34 -10000 0 -1.4 10 10
CBL -0.23 0.38 -10000 0 -0.83 42 42
GTF3A -0.007 0.1 -10000 0 -0.4 11 11
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
IL13RA1/JAK2 -0.023 0.11 -10000 0 -0.3 9 9
IRF4/BCL6 -0.093 0.31 -10000 0 -1.2 13 13
CD40LG 0.024 0.075 -10000 0 -0.3 8 8
MAPK14 -0.24 0.39 -10000 0 -0.88 41 41
mitosis -0.18 0.34 -10000 0 -0.86 26 26
STAT6 -0.52 0.82 -10000 0 -1.7 57 57
SPI1 0.02 0.07 -10000 0 -0.21 15 15
RPS6KB1 -0.16 0.33 -10000 0 -0.82 26 26
STAT6 (dimer) -0.52 0.82 -10000 0 -1.7 57 57
STAT6 (dimer)/PARP14 -0.46 0.7 -10000 0 -1.5 57 57
mast cell activation 0.007 0.016 -10000 0 -10000 0 0
IL4/IL4R/JAK1/IL2R gamma/JAK3/DOK2 -0.24 0.41 -10000 0 -1.1 26 26
FRAP1 -0.19 0.36 -10000 0 -0.94 26 26
LTA -0.43 0.62 -10000 0 -1.3 55 55
FES 0.018 0.078 -10000 0 -0.29 11 11
T-helper 1 cell differentiation 0.49 0.74 1.5 57 -10000 0 57
CCL11 -0.48 0.68 -10000 0 -1.5 61 61
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES -0.21 0.4 -10000 0 -1.1 27 27
IL2RG -0.017 0.15 -10000 0 -0.42 26 26
IL10 -0.42 0.61 -10000 0 -1.3 54 54
IRS1 0.017 0.094 -10000 0 -0.37 11 11
IRS2 -0.006 0.12 -10000 0 -0.43 15 15
IL4 -0.056 0.18 -10000 0 -1.2 2 2
IL5 -0.42 0.61 -10000 0 -1.3 56 56
IL4/IL4R/JAK1/IL13RA1/JAK2 -0.3 0.47 -10000 0 -0.97 52 52
COL1A1 -0.28 0.55 -10000 0 -1.5 31 31
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
IL4/IL4R/JAK1 -0.44 0.65 -10000 0 -1.5 49 49
IL2R gamma/JAK3 0.012 0.12 -10000 0 -0.33 22 22
TFF3 -0.45 0.65 -10000 0 -1.4 57 57
ALOX15 -0.43 0.62 -10000 0 -1.3 58 58
MYBL1 0.027 0.045 -10000 0 -0.26 4 4
T-helper 2 cell differentiation -0.34 0.53 -10000 0 -1.1 52 52
SHC1 0.037 0.006 -10000 0 -10000 0 0
CEBPB 0.015 0.044 -10000 0 -0.48 1 1
IL4/IL4R/JAK1/IL2R gamma/JAK3/FES/IRS2 -0.2 0.4 -10000 0 -1.1 24 24
mol:PI-3-4-5-P3 -0.19 0.36 -10000 0 -0.94 26 26
PI3K -0.2 0.4 -10000 0 -1 26 26
DOK2 0.013 0.062 -10000 0 -0.21 13 13
ETS1 0.03 0.054 -10000 0 -0.31 2 2
IL4/IL4R/JAK1/IL2R gamma/JAK3/SHC/SHIP/GRB2 -0.14 0.27 -10000 0 -0.71 22 22
ITGB3 -0.42 0.61 -10000 0 -1.3 56 56
PIGR -0.48 0.69 -10000 0 -1.5 60 60
IGHE 0.059 0.087 0.17 49 -0.24 2 51
MAPKKK cascade -0.14 0.26 -10000 0 -0.7 22 22
BCL6 0.01 0.1 -10000 0 -0.3 17 17
OPRM1 -0.43 0.62 -10000 0 -1.3 57 57
RETNLB -0.6 0.74 -10000 0 -1.5 83 83
SELP -0.49 0.7 -10000 0 -1.5 61 61
AICDA -0.42 0.6 -10000 0 -1.3 57 57
Fc-epsilon receptor I signaling in mast cells

Figure S7.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S7.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PPAP2A 0.03 0.053 -10000 0 -0.33 4 4
LAT2 -0.074 0.16 -10000 0 -0.38 34 34
AP1 -0.12 0.24 -10000 0 -0.56 36 36
mol:PIP3 -0.11 0.22 0.4 1 -0.52 37 38
IKBKB -0.039 0.13 0.21 13 -0.27 29 42
AKT1 -0.11 0.16 0.34 6 -0.41 28 34
IKBKG -0.05 0.12 0.22 7 -0.28 32 39
MS4A2 -0.057 0.18 -10000 0 -0.35 52 52
mol:Sphingosine-1-phosphate 0 0 -10000 0 -10000 0 0
PIK3CA 0.037 0.005 -10000 0 -10000 0 0
MAP3K1 -0.076 0.18 0.29 2 -0.44 32 34
mol:Ca2+ -0.079 0.16 0.24 4 -0.39 35 39
LYN 0.03 0.015 -10000 0 -10000 0 0
CBLB -0.073 0.16 -10000 0 -0.39 34 34
SHC1 0.037 0.006 -10000 0 -10000 0 0
RasGAP/p62DOK 0.039 0.084 -10000 0 -0.25 11 11
positive regulation of cell migration 0 0 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
PLD2 -0.11 0.17 0.34 6 -0.34 59 65
PTPN13 -0.13 0.21 -10000 0 -0.59 21 21
PTPN11 0.018 0.059 -10000 0 -0.4 3 3
GO:0007205 0 0 -10000 0 -10000 0 0
regulation of mast cell degranulation -0.07 0.14 0.42 2 -0.34 25 27
SYK 0.029 0.053 -10000 0 -0.39 3 3
GRB2 0.036 0.007 -10000 0 -10000 0 0
LAT/PLCgamma1/GRB2/SLP76/GADs -0.08 0.24 -10000 0 -0.52 39 39
LAT -0.075 0.16 -10000 0 -0.39 35 35
PAK2 -0.082 0.2 0.31 2 -0.49 32 34
NFATC2 -0.02 0.046 -10000 0 -10000 0 0
HRAS -0.091 0.22 0.38 1 -0.51 36 37
GAB2 0.037 0.004 -10000 0 -10000 0 0
PLA2G1B 0.023 0.14 -10000 0 -0.83 5 5
Fc epsilon R1 -0.098 0.2 -10000 0 -0.35 75 75
Antigen/IgE/Fc epsilon R1 -0.088 0.19 -10000 0 -0.32 75 75
mol:GDP -0.098 0.23 -10000 0 -0.55 36 36
JUN -0.015 0.15 -10000 0 -0.39 26 26
mol:Ca++ 0 0 -10000 0 -10000 0 0
PIK3R1 0.029 0.06 -10000 0 -0.47 3 3
FOS -0.055 0.16 -10000 0 -0.3 56 56
Antigen/IgE/Fc epsilon R1/LYN/SYK -0.071 0.17 -10000 0 -0.4 34 34
CHUK -0.055 0.12 0.2 5 -0.28 34 39
KLRG1 -0.071 0.15 -10000 0 -0.38 30 30
VAV1 -0.09 0.18 -10000 0 -0.42 40 40
calcium-dependent protein kinase C activity 0 0 -10000 0 -10000 0 0
CBL -0.073 0.16 -10000 0 -0.39 34 34
negative regulation of mast cell degranulation -0.067 0.14 -10000 0 -0.36 28 28
BTK -0.096 0.25 -10000 0 -0.63 30 30
Fc epsilon R1/FcgammaRIIB/SHIP/RasGAP/p62DOK -0.15 0.26 -10000 0 -0.53 56 56
GAB2/PI3K/SHP2 -0.12 0.16 -10000 0 -0.35 52 52
Antigen/IgE/Fc epsilon R1/LYN/SYK/WIP -0.086 0.18 -10000 0 -0.44 34 34
RAF1 0.027 0.15 -10000 0 -0.93 5 5
Fc epsilon R1/FcgammaRIIB/SHIP -0.13 0.23 -10000 0 -0.41 74 74
FCER1G 0.03 0.057 -10000 0 -0.31 5 5
FCER1A -0.12 0.22 -10000 0 -0.38 82 82
Antigen/IgE/Fc epsilon R1/Fyn -0.083 0.2 -10000 0 -0.34 65 65
MAPK3 0.024 0.14 -10000 0 -0.83 5 5
MAPK1 0.017 0.14 -10000 0 -0.85 5 5
NFKB1 0.037 0.006 -10000 0 -10000 0 0
MAPK8 -0.11 0.28 -10000 0 -0.74 26 26
DUSP1 0.004 0.098 -10000 0 -0.24 25 25
NF-kappa-B/RelA -0.016 0.084 0.14 5 -0.18 23 28
actin cytoskeleton reorganization -0.059 0.18 -10000 0 -0.57 11 11
mol:Glucocorticoid Dexamethasone 0 0 -10000 0 -10000 0 0
PI3K -0.071 0.2 -10000 0 -0.47 34 34
FER -0.077 0.16 -10000 0 -0.39 34 34
RELA 0.037 0.006 -10000 0 -10000 0 0
ITK -0.02 0.084 -10000 0 -0.41 7 7
SOS1 0.037 0.003 -10000 0 -10000 0 0
PLCG1 -0.045 0.24 0.37 2 -0.51 33 35
cytokine secretion -0.019 0.054 -10000 0 -0.15 1 1
SPHK1 -0.099 0.19 -10000 0 -0.44 39 39
PTK2 -0.063 0.19 -10000 0 -0.64 9 9
NTAL/PLCgamma1/GRB2/SLP76/GADs -0.083 0.26 0.24 2 -0.53 42 44
EDG1 0 0 -10000 0 -10000 0 0
mol:DAG -0.1 0.22 0.42 1 -0.53 35 36
MAP2K2 0.02 0.14 -10000 0 -0.84 5 5
MAP2K1 0.017 0.14 -10000 0 -0.87 5 5
MAP2K7 0.031 0.046 -10000 0 -0.24 5 5
KLRG1/SHP2 -0.058 0.14 -10000 0 -0.35 29 29
MAP2K4 -0.19 0.42 -10000 0 -0.91 53 53
Fc epsilon R1/FcgammaRIIB -0.14 0.25 -10000 0 -0.43 74 74
mol:Choline -0.11 0.17 0.34 6 -0.33 59 65
SHC/Grb2/SOS1 -0.03 0.18 -10000 0 -0.41 26 26
FYN 0.011 0.098 -10000 0 -0.32 15 15
DOK1 0.034 0.038 -10000 0 -0.33 2 2
PXN -0.058 0.18 0.39 1 -0.58 9 10
HCLS1 -0.08 0.18 -10000 0 -0.42 35 35
PRKCB -0.075 0.16 0.23 5 -0.38 35 40
FCGR2B -0.082 0.19 -10000 0 -0.35 66 66
IGHE -0.003 0.007 -10000 0 -10000 0 0
KLRG1/SHIP -0.068 0.14 -10000 0 -0.37 28 28
LCP2 -0.022 0.15 -10000 0 -0.36 32 32
PLA2G4A -0.15 0.19 -10000 0 -0.42 58 58
RASA1 0.026 0.07 -10000 0 -0.41 5 5
mol:Phosphatidic acid -0.11 0.17 0.34 6 -0.33 59 65
IKK complex -0.025 0.1 0.22 9 -0.22 22 31
WIPF1 0.018 0.093 -10000 0 -0.38 10 10
Endothelins

Figure S8.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S8.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 -0.016 0.18 0.28 21 -0.38 16 37
PTK2B 0.028 0.016 -10000 0 -10000 0 0
mol:Ca2+ -0.059 0.24 -10000 0 -0.62 21 21
EDN1 -0.028 0.22 0.24 22 -0.44 36 58
EDN3 -0.09 0.19 -10000 0 -0.39 55 55
EDN2 -0.087 0.19 -10000 0 -0.33 72 72
HRAS/GDP -0.064 0.21 0.32 4 -0.44 30 34
ETA receptor/Endothelin-1/Gq/GTP/PLC beta -0.05 0.16 0.26 1 -0.34 33 34
ADCY4 -0.035 0.15 0.28 1 -0.38 16 17
ADCY5 -0.02 0.14 0.28 1 -0.35 11 12
ADCY6 -0.019 0.14 0.28 1 -0.35 11 12
ADCY7 -0.022 0.14 -10000 0 -0.36 11 11
ADCY1 -0.019 0.13 -10000 0 -0.36 10 10
ADCY2 -0.02 0.14 0.28 1 -0.35 11 12
ADCY3 -0.031 0.15 0.28 1 -0.36 16 17
ADCY8 -0.028 0.13 -10000 0 -0.34 12 12
ADCY9 -0.024 0.14 -10000 0 -0.36 11 11
arachidonic acid secretion -0.16 0.26 0.31 1 -0.57 48 49
ETB receptor/Endothelin-1/Gq/GTP -0.047 0.14 -10000 0 -0.33 31 31
GNAO1 0.037 0.005 -10000 0 -10000 0 0
HRAS 0.033 0.038 -10000 0 -0.33 2 2
ETA receptor/Endothelin-1/G12/GTP 0.047 0.2 0.38 29 -0.35 16 45
ETA receptor/Endothelin-1/Gs/GTP 0.027 0.18 0.35 26 -0.32 18 44
mol:GTP -0.002 0.007 -10000 0 -10000 0 0
COL3A1 -0.028 0.22 0.28 16 -0.55 16 32
EDNRB -0.013 0.12 -10000 0 -0.39 16 16
response to oxidative stress 0 0 -10000 0 -10000 0 0
CYSLTR2 -0.004 0.17 0.35 9 -0.44 6 15
CYSLTR1 -0.023 0.2 0.28 19 -0.5 14 33
SLC9A1 -0.005 0.14 0.2 22 -0.36 11 33
mol:GDP -0.076 0.21 0.32 4 -0.43 34 38
SLC9A3 -0.097 0.32 -10000 0 -0.7 38 38
RAF1 -0.098 0.21 0.31 2 -0.5 32 34
JUN -0.11 0.36 -10000 0 -1 23 23
JAK2 -0.022 0.19 0.28 24 -0.4 20 44
mol:IP3 -0.058 0.17 0.28 2 -0.36 37 39
ETA receptor/Endothelin-1 0.03 0.25 0.43 33 -0.38 31 64
PLCB1 -0.038 0.16 -10000 0 -0.4 32 32
PLCB2 0.032 0.019 -10000 0 -0.19 1 1
ETA receptor/Endothelin-3 -0.056 0.16 -10000 0 -0.34 42 42
FOS -0.18 0.36 -10000 0 -0.94 36 36
Gai/GDP 0 0.18 -10000 0 -0.84 8 8
CRK 0.03 0.015 -10000 0 -10000 0 0
mol:Ca ++ -0.075 0.21 0.33 3 -0.45 34 37
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
PRKCB1 -0.056 0.17 0.24 3 -0.34 39 42
GNAQ -0.002 0.008 -10000 0 -10000 0 0
GNAZ 0.024 0.061 -10000 0 -0.26 8 8
GNAL 0.025 0.033 -10000 0 -0.19 4 4
Gs family/GDP -0.067 0.19 0.31 3 -0.41 30 33
ETA receptor/Endothelin-1/Gq/GTP -0.033 0.15 0.21 12 -0.32 26 38
MAPK14 -0.062 0.15 -10000 0 -0.37 26 26
TRPC6 -0.064 0.26 -10000 0 -0.65 21 21
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
GNAI3 0.034 0.035 -10000 0 -0.47 1 1
GNAI1 -0.005 0.13 -10000 0 -0.38 21 21
ETB receptor/Endothelin-1/Gq/GTP/PLC beta -0.064 0.16 -10000 0 -0.35 34 34
ETB receptor/Endothelin-2 -0.055 0.16 -10000 0 -0.38 33 33
ETB receptor/Endothelin-3 -0.069 0.16 -10000 0 -0.37 40 40
ETB receptor/Endothelin-1 -0.03 0.18 -10000 0 -0.37 37 37
MAPK3 -0.16 0.32 -10000 0 -0.76 38 38
MAPK1 -0.16 0.32 0.34 1 -0.75 40 41
Rac1/GDP -0.067 0.2 0.29 3 -0.42 31 34
cAMP biosynthetic process -0.012 0.14 0.36 2 -0.36 12 14
MAPK8 -0.058 0.23 -10000 0 -0.57 22 22
SRC 0.013 0.061 -10000 0 -0.47 3 3
ETB receptor/Endothelin-1/Gi/GTP -0.031 0.14 -10000 0 -0.35 23 23
p130Cas/CRK/Src/PYK2 -0.063 0.24 0.36 6 -0.5 30 36
mol:K + 0 0 -10000 0 -10000 0 0
G12/GDP -0.067 0.2 0.29 3 -0.43 30 33
COL1A2 -0.027 0.27 0.38 10 -0.64 22 32
EntrezGene:2778 0 0 -10000 0 -10000 0 0
ETA receptor/Endothelin-2 -0.036 0.18 -10000 0 -0.34 42 42
mol:DAG -0.058 0.17 0.28 2 -0.36 37 39
MAP2K2 -0.12 0.25 0.33 1 -0.57 39 40
MAP2K1 -0.13 0.26 0.33 1 -0.6 38 39
EDNRA 0.039 0.13 0.25 4 -0.33 8 12
positive regulation of muscle contraction 0.001 0.16 0.26 24 -0.36 12 36
Gq family/GDP -0.07 0.19 -10000 0 -0.41 33 33
HRAS/GTP -0.076 0.19 0.3 3 -0.43 31 34
PRKCH -0.064 0.18 0.29 1 -0.38 35 36
RAC1 0.034 0.012 -10000 0 -10000 0 0
PRKCA -0.057 0.17 0.25 3 -0.37 32 35
PRKCB -0.057 0.17 0.24 3 -0.34 39 42
PRKCE -0.058 0.17 0.26 2 -0.37 32 34
PRKCD -0.055 0.17 0.26 2 -0.37 29 31
PRKCG -0.064 0.18 0.26 2 -0.38 32 34
regulation of vascular smooth muscle contraction -0.22 0.43 -10000 0 -1.1 36 36
PRKCQ -0.076 0.18 0.26 2 -0.37 41 43
PLA2G4A -0.18 0.29 0.31 1 -0.63 48 49
GNA14 -0.022 0.14 -10000 0 -0.36 29 29
GNA15 0.018 0.066 -10000 0 -0.25 10 10
GNA12 0.034 0.011 -10000 0 -10000 0 0
GNA11 0.025 0.054 -10000 0 -0.38 3 3
Rac1/GTP 0.047 0.2 0.38 29 -0.33 19 48
MMP1 -0.22 0.38 0.42 1 -0.87 52 53
Osteopontin-mediated events

Figure S9.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S9.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer -0.078 0.14 -10000 0 -0.26 61 61
NF kappa B1 p50/RelA/I kappa B alpha -0.08 0.15 0.33 2 -0.42 14 16
alphaV/beta3 Integrin/Osteopontin/Src -0.11 0.18 -10000 0 -0.34 66 66
AP1 -0.13 0.18 -10000 0 -0.44 30 30
ILK -0.086 0.13 -10000 0 -0.34 12 12
bone resorption -0.088 0.13 -10000 0 -0.34 14 14
PTK2B 0.028 0.016 -10000 0 -10000 0 0
PYK2/p130Cas -0.04 0.15 -10000 0 -0.31 15 15
ITGAV 0.023 0.08 -10000 0 -0.39 7 7
mol:GTP 0 0 -10000 0 -10000 0 0
CD44/Rho Family GTPase/ROCK2 0.028 0.098 -10000 0 -0.34 14 14
alphaV/beta3 Integrin/Osteopontin -0.08 0.16 -10000 0 -0.29 65 65
MAP3K1 -0.088 0.13 -10000 0 -0.27 63 63
JUN -0.015 0.15 -10000 0 -0.39 26 26
MAPK3 -0.098 0.13 -10000 0 -0.3 28 28
MAPK1 -0.092 0.13 -10000 0 -0.38 13 13
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
NFKB1 0.037 0.006 -10000 0 -10000 0 0
MAPK8 -0.089 0.12 0.2 2 -0.32 16 18
ITGB3 0.034 0.024 -10000 0 -0.2 1 1
NFKBIA -0.098 0.14 0.34 1 -0.39 21 22
FOS -0.055 0.16 -10000 0 -0.3 56 56
CD44 0.032 0.049 -10000 0 -0.47 2 2
CHUK 0.031 0.049 -10000 0 -0.47 2 2
PLAU -0.15 0.31 -10000 0 -1.1 17 17
NF kappa B1 p50/RelA -0.077 0.16 -10000 0 -0.42 18 18
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
RELA 0.037 0.006 -10000 0 -10000 0 0
alphaV beta3 Integrin 0.043 0.062 -10000 0 -0.33 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
SYK -0.089 0.14 -10000 0 -0.27 64 64
VAV3 -0.14 0.15 -10000 0 -0.29 96 96
MAP3K14 -0.09 0.13 -10000 0 -0.27 63 63
ROCK2 0.008 0.12 -10000 0 -0.45 13 13
SPP1 -0.16 0.21 -10000 0 -0.34 112 112
RAC1 0.034 0.012 -10000 0 -10000 0 0
Rac1/GTP -0.12 0.14 -10000 0 -0.32 42 42
MMP2 -0.14 0.16 -10000 0 -0.44 25 25
Signaling mediated by p38-alpha and p38-beta

Figure S10.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S10.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTGS2 -0.15 0.37 -10000 0 -1.1 29 29
MKNK1 0.037 0.005 -10000 0 -10000 0 0
MAPK14 -0.032 0.12 -10000 0 -0.31 27 27
ATF2/c-Jun -0.079 0.2 -10000 0 -0.6 21 21
MAPK11 -0.031 0.12 -10000 0 -0.32 26 26
MITF -0.05 0.15 -10000 0 -0.36 33 33
MAPKAPK5 -0.04 0.13 -10000 0 -0.35 29 29
KRT8 -0.043 0.14 -10000 0 -0.36 30 30
MAPKAPK3 0.037 0.004 -10000 0 -10000 0 0
MAPKAPK2 0.037 0.006 -10000 0 -10000 0 0
p38alpha-beta/CK2 -0.047 0.17 -10000 0 -0.44 28 28
CEBPB -0.026 0.099 -10000 0 -0.33 17 17
SLC9A1 -0.043 0.14 -10000 0 -0.38 28 28
mol:GDP 0 0 -10000 0 -10000 0 0
ATF2 -0.046 0.14 -10000 0 -0.33 37 37
p38alpha-beta/MNK1 -0.02 0.15 -10000 0 -0.36 27 27
JUN -0.08 0.19 -10000 0 -0.6 21 21
PPARGC1A -0.08 0.17 -10000 0 -0.38 48 48
USF1 -0.06 0.15 -10000 0 -0.37 34 34
RAB5/GDP/GDI1 -0.021 0.11 -10000 0 -0.26 28 28
NOS2 -0.046 0.13 -10000 0 -0.36 29 29
DDIT3 -0.045 0.14 -10000 0 -0.35 31 31
RAB5A 0.037 0.006 -10000 0 -10000 0 0
HSPB1 -0.032 0.13 0.28 8 -0.29 30 38
p38alpha-beta/HBP1 -0.025 0.15 -10000 0 -0.36 29 29
CREB1 -0.044 0.14 -10000 0 -0.38 28 28
RAB5/GDP 0.027 0.004 -10000 0 -10000 0 0
EIF4E -0.043 0.12 -10000 0 -0.33 24 24
RPS6KA4 -0.038 0.13 -10000 0 -0.35 28 28
PLA2G4A -0.15 0.17 -10000 0 -0.36 65 65
GDI1 -0.039 0.13 -10000 0 -0.35 29 29
TP53 -0.088 0.16 -10000 0 -0.46 27 27
RPS6KA5 -0.05 0.14 -10000 0 -0.36 32 32
ESR1 -0.043 0.14 -10000 0 -0.36 30 30
HBP1 0.031 0.049 -10000 0 -0.47 2 2
MEF2C -0.059 0.15 -10000 0 -0.35 39 39
MEF2A -0.037 0.13 -10000 0 -0.36 26 26
EIF4EBP1 -0.054 0.15 -10000 0 -0.4 29 29
KRT19 -0.053 0.14 -10000 0 -0.34 37 37
ELK4 -0.043 0.13 -10000 0 -0.35 31 31
ATF6 -0.039 0.13 -10000 0 -0.35 29 29
ATF1 -0.044 0.14 -10000 0 -0.38 28 28
p38alpha-beta/MAPKAPK2 -0.019 0.15 -10000 0 -0.38 24 24
p38alpha-beta/MAPKAPK3 -0.019 0.15 -10000 0 -0.38 24 24
Syndecan-1-mediated signaling events

Figure S11.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S11.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.035 0.017 -10000 0 -0.19 1 1
CCL5 -0.034 0.16 -10000 0 -0.34 40 40
SDCBP 0.032 0.02 -10000 0 -0.19 1 1
FGFR/FGF2/Syndecan-1 -0.078 0.17 0.25 5 -0.35 37 42
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
RP11-540L11.1 0 0 -10000 0 -10000 0 0
Syndecan-1/Laminin-5 -0.08 0.14 -10000 0 -0.37 24 24
Syndecan-1/Syntenin -0.065 0.16 0.34 1 -0.35 30 31
MAPK3 -0.075 0.16 0.32 1 -0.38 20 21
HGF/MET 0.046 0.049 -10000 0 -0.38 2 2
TGFB1/TGF beta receptor Type II 0.035 0.017 -10000 0 -0.19 1 1
BSG 0.037 0.006 -10000 0 -10000 0 0
keratinocyte migration -0.079 0.13 -10000 0 -0.37 24 24
Syndecan-1/RANTES -0.096 0.2 0.34 1 -0.38 45 46
Syndecan-1/CD147 -0.062 0.18 0.35 1 -0.35 28 29
Syndecan-1/Syntenin/PIP2 -0.063 0.16 0.32 1 -0.33 30 31
LAMA5 0.011 0.057 -10000 0 -0.28 6 6
positive regulation of cell-cell adhesion -0.062 0.15 0.32 1 -0.33 30 31
MMP7 -0.11 0.21 -10000 0 -0.38 78 78
HGF 0.034 0.023 -10000 0 -0.19 2 2
Syndecan-1/CASK -0.085 0.16 -10000 0 -0.33 38 38
Syndecan-1/HGF/MET -0.059 0.18 0.35 1 -0.36 30 31
regulation of cell adhesion -0.074 0.16 0.34 3 -0.38 18 21
HPSE -0.012 0.13 -10000 0 -0.3 31 31
positive regulation of cell migration -0.078 0.17 0.25 5 -0.35 37 42
SDC1 -0.073 0.17 -10000 0 -0.35 37 37
Syndecan-1/Collagen -0.078 0.17 0.25 5 -0.35 37 42
PPIB 0.03 0.044 -10000 0 -0.26 4 4
MET 0.029 0.054 -10000 0 -0.33 4 4
PRKACA 0.037 0.006 -10000 0 -10000 0 0
MMP9 -0.009 0.1 -10000 0 -0.31 18 18
MAPK1 -0.071 0.16 0.32 1 -0.38 18 19
homophilic cell adhesion -0.078 0.17 0.25 5 -0.34 38 43
MMP1 -0.13 0.21 -10000 0 -0.33 94 94
EGFR-dependent Endothelin signaling events

Figure S12.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S12.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HRAS 0.034 0.038 -9999 0 -0.33 2 2
EGFR 0.018 0.086 -9999 0 -0.4 8 8
EGF/EGFR -0.075 0.15 -9999 0 -0.29 56 56
EGF/EGFR dimer/SHC/GRB2/SOS1 -0.002 0.13 -9999 0 -0.25 33 33
mol:GTP 0 0 -9999 0 -10000 0 0
EDNRA 0.011 0.089 -9999 0 -0.24 20 20
response to oxidative stress 0 0 -9999 0 -10000 0 0
EGF -0.087 0.18 -9999 0 -0.3 78 78
EGF/EGFR dimer/SHC -0.028 0.13 -9999 0 -0.29 34 34
mol:GDP -0.006 0.13 -9999 0 -0.25 33 33
mol:Ca2+ 0 0 -9999 0 -10000 0 0
EDN1 -0.059 0.18 -9999 0 -0.34 54 54
GRB2/SOS1 0.054 0.011 -9999 0 -10000 0 0
HRAS/GTP -0.019 0.11 -9999 0 -0.23 34 34
SHC1 0.037 0.006 -9999 0 -10000 0 0
HRAS/GDP -0.008 0.12 -9999 0 -0.24 34 34
FRAP1 -0.061 0.081 -9999 0 -0.24 33 33
EGF/EGFR dimer -0.049 0.14 -9999 0 -0.34 34 34
SOS1 0.038 0.003 -9999 0 -10000 0 0
GRB2 0.036 0.007 -9999 0 -10000 0 0
ETA receptor/Endothelin-1 -0.04 0.14 -9999 0 -0.34 34 34
Noncanonical Wnt signaling pathway

Figure S13.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S13.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC2 0.02 0.019 -10000 0 -10000 0 0
GNB1/GNG2 -0.087 0.2 -10000 0 -0.45 33 33
mol:DAG -0.079 0.16 -10000 0 -0.45 25 25
PLCG1 -0.082 0.16 -10000 0 -0.45 26 26
YES1 -0.1 0.19 -10000 0 -0.46 33 33
FZD3 -0.034 0.16 -10000 0 -0.38 32 32
FZD6 0.023 0.062 -10000 0 -0.4 4 4
G protein -0.026 0.22 0.28 10 -0.47 25 35
MAP3K7 -0.073 0.13 -10000 0 -0.41 21 21
mol:Ca2+ -0.077 0.15 -10000 0 -0.43 25 25
mol:IP3 -0.079 0.16 -10000 0 -0.45 25 25
NLK -0.004 0.1 -10000 0 -0.74 4 4
GNB1 0.035 0.009 -10000 0 -10000 0 0
CAMK2A -0.076 0.14 -10000 0 -0.41 24 24
MAP3K7IP1 0 0 -10000 0 -10000 0 0
Noncanonical Wnts/FZD -0.11 0.2 -10000 0 -0.36 63 63
CSNK1A1 0.037 0.005 -10000 0 -10000 0 0
GNAS -0.081 0.18 -10000 0 -0.47 29 29
GO:0007205 -0.081 0.16 -10000 0 -0.44 25 25
WNT6 0.033 0.03 -10000 0 -0.19 4 4
WNT4 -0.033 0.16 -10000 0 -0.36 37 37
NFAT1/CK1 alpha -0.074 0.17 -10000 0 -0.47 25 25
GNG2 0.034 0.011 -10000 0 -10000 0 0
WNT5A -0.007 0.13 -10000 0 -0.37 23 23
WNT11 -0.057 0.18 -10000 0 -0.33 55 55
CDC42 -0.096 0.18 -10000 0 -0.44 33 33
Calcineurin-regulated NFAT-dependent transcription in lymphocytes

Figure S14.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S14.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FOXP3 0.032 0.033 -10000 0 -0.2 2 2
NFATC2 -0.046 0.17 -10000 0 -0.53 15 15
NFATC3 -0.049 0.11 -10000 0 -0.33 12 12
CD40LG -0.31 0.4 -10000 0 -0.87 51 51
ITCH 0.005 0.061 -10000 0 -10000 0 0
CBLB 0.016 0.08 -10000 0 -0.5 2 2
CD4-positive CD25-positive alpha-beta regulatory T cell lineage commitment -0.24 0.36 -10000 0 -0.97 32 32
JUNB 0.021 0.069 -10000 0 -0.23 13 13
CaM/Ca2+/Calcineurin A alpha-beta B1 0.024 0.082 -10000 0 -0.26 14 14
T cell anergy 0.013 0.11 -10000 0 -0.37 12 12
TLE4 -0.04 0.15 -10000 0 -0.58 10 10
Jun/NFAT1-c-4/p21SNFT -0.22 0.33 -10000 0 -0.86 32 32
AP-1/NFAT1-c-4 -0.36 0.44 -10000 0 -1 51 51
IKZF1 -0.035 0.13 -10000 0 -0.51 7 7
T-helper 2 cell differentiation -0.082 0.2 -10000 0 -0.72 8 8
AP-1/NFAT1 -0.096 0.19 -10000 0 -0.47 28 28
CALM1 0.029 0.054 -10000 0 -0.16 13 13
EGR2 -0.24 0.5 -10000 0 -1.4 32 32
EGR3 -0.22 0.46 -10000 0 -1.2 31 31
NFAT1/FOXP3 -0.022 0.13 -10000 0 -0.41 11 11
EGR1 -0.05 0.16 -10000 0 -0.3 55 55
JUN -0.05 0.15 -10000 0 -0.45 23 23
EGR4 0.001 0.002 -10000 0 -10000 0 0
mol:Ca2+ -0.001 0.043 -10000 0 -0.16 13 13
GBP3 -0.071 0.22 -10000 0 -0.68 21 21
FOSL1 0.031 0.037 -10000 0 -0.19 6 6
NFAT1-c-4/MAF/IRF4 -0.17 0.34 -10000 0 -0.9 29 29
DGKA -0.036 0.14 -10000 0 -0.44 12 12
CREM 0.033 0.038 -10000 0 -0.33 2 2
NFAT1-c-4/PPARG -0.19 0.34 -10000 0 -0.87 31 31
CTLA4 0.001 0.14 -10000 0 -0.42 8 8
NFAT1-c-4 (dimer)/EGR1 -0.2 0.35 -10000 0 -0.88 34 34
NFAT1-c-4 (dimer)/EGR4 -0.17 0.32 -10000 0 -0.88 28 28
FOS -0.088 0.16 -10000 0 -0.32 56 56
IFNG -0.32 0.53 -10000 0 -1.2 52 52
T cell activation -0.1 0.22 -10000 0 -0.72 8 8
MAF 0.006 0.11 -10000 0 -0.33 18 18
T-helper 2 cell lineage commitment 0 0 -10000 0 -10000 0 0
activation-induced cell death of T cells 0.17 0.3 0.76 36 -10000 0 36
TNF -0.18 0.32 -10000 0 -0.82 33 33
FASLG -0.35 0.62 -10000 0 -1.5 45 45
TBX21 -0.073 0.17 -10000 0 -0.33 52 52
BATF3 0 0 -10000 0 -10000 0 0
PRKCQ -0.019 0.14 -10000 0 -0.36 25 25
PTPN1 -0.034 0.14 -10000 0 -0.59 6 6
NFAT1-c-4/ICER1 -0.17 0.33 -10000 0 -0.89 28 28
GATA3 0.033 0.052 -10000 0 -0.38 3 3
T-helper 1 cell differentiation -0.31 0.5 -10000 0 -1.1 52 52
IL2RA -0.25 0.37 -10000 0 -0.93 36 36
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
CASP3 -0.033 0.13 -10000 0 -0.45 11 11
E2F1 0.02 0.052 -10000 0 -0.47 2 2
PPARG -0.018 0.16 -10000 0 -0.44 25 25
SLC3A2 -0.032 0.13 -10000 0 -0.54 6 6
IRF4 0.01 0.1 -10000 0 -0.33 16 16
PTGS2 -0.34 0.42 -10000 0 -0.87 63 63
CSF2 -0.34 0.42 -10000 0 -0.87 64 64
JunB/Fra1/NFAT1-c-4 -0.16 0.32 -10000 0 -0.86 28 28
IL4 -0.085 0.21 -10000 0 -0.76 8 8
IL5 -0.31 0.39 -10000 0 -0.86 52 52
IL2 -0.1 0.23 -10000 0 -0.75 7 7
IL3 -0.037 0.14 -10000 0 -0.81 6 6
RNF128 -0.005 0.14 -10000 0 -0.56 13 13
NFATC1 -0.17 0.3 -10000 0 -0.76 36 36
CDK4 0.091 0.18 0.58 11 -10000 0 11
PTPRK -0.037 0.14 -10000 0 -0.59 8 8
IL8 -0.37 0.44 -10000 0 -0.91 64 64
POU2F1 0.034 0.064 -10000 0 -0.35 5 5
IL12-mediated signaling events

Figure S15.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S15.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IL12/IL12R/TYK2/JAK2/SOCS1 -0.019 0.12 -10000 0 -0.36 12 12
TBX21 -0.24 0.51 -10000 0 -1.3 34 34
B2M 0.018 0.083 -10000 0 -0.33 10 10
TYK2 0.016 0.04 -10000 0 -10000 0 0
IL12RB1 0.015 0.042 -10000 0 -0.21 1 1
GADD45B -0.16 0.39 -10000 0 -0.99 30 30
IL12RB2 0 0.084 -10000 0 -0.26 14 14
GADD45G -0.17 0.4 -10000 0 -0.97 33 33
natural killer cell activation -0.006 0.02 -10000 0 -10000 0 0
RELB 0.034 0.035 -10000 0 -0.47 1 1
RELA 0.037 0.006 -10000 0 -10000 0 0
IL18 -0.02 0.15 -10000 0 -0.41 27 27
IL2RA -0.033 0.16 -10000 0 -0.34 40 40
IFNG -0.098 0.19 -10000 0 -0.31 83 83
STAT3 (dimer) -0.15 0.34 -10000 0 -0.74 42 42
HLA-DRB5 -0.039 0.17 -10000 0 -0.42 33 33
FASLG -0.21 0.47 -10000 0 -1.3 27 27
NF kappa B2 p52/RelB -0.17 0.41 -10000 0 -0.87 43 43
CD4 0.03 0.019 -10000 0 -10000 0 0
SOCS1 0.029 0.061 -10000 0 -0.4 4 4
EntrezGene:6955 -0.002 0.008 -10000 0 -10000 0 0
CD3D -0.005 0.12 -10000 0 -0.37 19 19
CD3E 0.03 0.025 -10000 0 -0.2 1 1
CD3G -0.027 0.15 -10000 0 -0.35 33 33
IL12Rbeta2/JAK2 0.003 0.1 -10000 0 -0.35 10 10
CCL3 -0.2 0.44 -10000 0 -1.1 35 35
CCL4 -0.2 0.45 -10000 0 -1.1 31 31
HLA-A 0.005 0.12 -10000 0 -0.37 17 17
IL18/IL18R -0.037 0.19 -10000 0 -0.34 52 52
NOS2 -0.18 0.4 -10000 0 -0.85 43 43
IL12/IL12R/TYK2/JAK2/SPHK2 -0.022 0.12 -10000 0 -0.37 11 11
IL1R1 -0.19 0.41 -10000 0 -1 31 31
IL4 0.039 0.044 -10000 0 -0.32 2 2
JAK2 0 0.084 -10000 0 -0.27 13 13
EntrezGene:6957 -0.002 0.008 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.062 0.24 -10000 0 -0.72 19 19
RAB7A -0.13 0.32 -10000 0 -0.84 24 24
lysosomal transport -0.12 0.3 -10000 0 -0.78 25 25
FOS -0.33 0.57 -10000 0 -1.3 54 54
STAT4 (dimer) -0.15 0.38 -10000 0 -0.87 36 36
STAT5A (dimer) -0.21 0.43 -10000 0 -0.9 48 48
GZMA -0.18 0.4 -10000 0 -0.86 43 43
GZMB -0.26 0.53 -10000 0 -1.3 42 42
HLX 0.036 0.016 -10000 0 -0.19 1 1
LCK -0.22 0.46 -10000 0 -0.95 47 47
TCR/CD3/MHC II/CD4 -0.1 0.25 -10000 0 -0.57 36 36
IL2/IL2R -0.006 0.17 -10000 0 -0.35 36 36
MAPK14 -0.18 0.41 -10000 0 -0.91 39 39
CCR5 -0.2 0.46 -10000 0 -1.2 30 30
IL1B -0.071 0.18 -10000 0 -0.4 46 46
STAT6 -0.043 0.16 -10000 0 -0.66 7 7
STAT4 0.023 0.076 -10000 0 -0.31 9 9
STAT3 0.037 0.006 -10000 0 -10000 0 0
STAT1 0.019 0.062 -10000 0 -0.19 18 18
NFKB1 0.037 0.006 -10000 0 -10000 0 0
NFKB2 0.035 0.017 -10000 0 -0.19 1 1
IL12B 0.01 0.066 -10000 0 -0.34 4 4
CD8A 0.001 0.004 -10000 0 -10000 0 0
CD8B 0.018 0.09 -10000 0 -0.34 11 11
T-helper 1 cell differentiation 0 0 -10000 0 -10000 0 0
natural killer cell mediated cytotoxicity 0.019 0.12 0.36 12 -10000 0 12
IL2RB 0.018 0.087 -10000 0 -0.38 9 9
proteasomal ubiquitin-dependent protein catabolic process -0.13 0.34 -10000 0 -0.78 36 36
IL2RG -0.019 0.16 -10000 0 -0.43 26 26
IL12 -0.011 0.11 -10000 0 -0.34 15 15
STAT5A 0.03 0.046 -10000 0 -0.24 5 5
CD247 -0.016 0.14 -10000 0 -0.35 27 27
IL2 0.037 0.006 -10000 0 -10000 0 0
SPHK2 0.024 0.078 -10000 0 -0.42 6 6
FRAP1 0 0 -10000 0 -10000 0 0
IL12A -0.026 0.13 -10000 0 -0.32 27 27
IL12/IL12R/TYK2/JAK2 -0.22 0.52 -10000 0 -1.1 43 43
MAP2K3 -0.2 0.43 -10000 0 -0.92 43 43
RIPK2 0.025 0.06 -10000 0 -0.47 3 3
MAP2K6 -0.18 0.42 -10000 0 -0.91 40 40
regulation of dendritic cell antigen processing and presentation 0 0 -10000 0 -10000 0 0
HLA-DRA -0.027 0.15 -10000 0 -0.36 31 31
IL18RAP -0.054 0.18 -10000 0 -0.36 50 50
IL12Rbeta1/TYK2 0.026 0.055 -10000 0 -10000 0 0
EOMES 0.001 0.18 -10000 0 -1.1 4 4
STAT1 (dimer) -0.2 0.39 -10000 0 -0.85 44 44
T cell proliferation -0.12 0.28 -10000 0 -0.61 39 39
T-helper 1 cell lineage commitment 0 0 -10000 0 -10000 0 0
IL18R1 0.01 0.095 -10000 0 -0.27 19 19
CD8-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA -0.12 0.32 -10000 0 -0.68 39 39
ATF2 -0.16 0.37 -10000 0 -0.84 37 37
Glypican 1 network

Figure S16.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S16.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GPC1/FGF2 dimer/FGFR1 dimer 0.019 0.12 -10000 0 -0.32 18 18
fibroblast growth factor receptor signaling pathway 0.018 0.12 -10000 0 -0.32 18 18
LAMA1 0.028 0.016 -10000 0 -10000 0 0
PRNP 0.014 0.085 -10000 0 -0.43 7 7
GPC1/SLIT2 -0.031 0.16 -10000 0 -0.37 31 31
SMAD2 -0.002 0.067 -10000 0 -0.26 12 12
GPC1/PrPc/Cu2+ 0.017 0.075 -10000 0 -0.28 10 10
GPC1/Laminin alpha1 0.023 0.076 -10000 0 -0.33 7 7
TDGF1 -0.06 0.2 -10000 0 -0.45 43 43
CRIPTO/GPC1 -0.041 0.16 -10000 0 -0.34 47 47
APP/GPC1 0.018 0.098 -10000 0 -0.34 12 12
mol:NO 0 0 -10000 0 -10000 0 0
YES1 -0.054 0.13 -10000 0 -0.29 48 48
FLT1 0.011 0.072 -10000 0 -0.26 11 11
GPC1/TGFB/TGFBR1/TGFBR2 0.047 0.087 -10000 0 -0.29 11 11
SERPINC1 0.03 0.046 -10000 0 -0.24 5 5
FYN -0.063 0.14 -10000 0 -0.3 53 53
FGR -0.055 0.13 -10000 0 -0.3 47 47
positive regulation of MAPKKK cascade -0.044 0.2 0.27 7 -0.38 43 50
SLIT2 -0.052 0.17 -10000 0 -0.33 52 52
GPC1/NRG 0.02 0.085 -10000 0 -0.33 9 9
NRG1 0.024 0.052 -10000 0 -0.38 3 3
GPC1/VEGF165 homodimer/VEGFR1 homodimer 0.033 0.077 -10000 0 -0.34 5 5
LYN -0.048 0.12 -10000 0 -0.29 43 43
mol:Spermine -0.006 0.065 -10000 0 -0.34 7 7
cell growth 0.018 0.12 -10000 0 -0.32 18 18
BMP signaling pathway -0.012 0.098 0.32 15 -10000 0 15
SRC -0.049 0.12 -10000 0 -0.3 37 37
TGFBR1 0.029 0.061 -10000 0 -0.4 4 4
mol:Cu2+ 0 0 -10000 0 -10000 0 0
PLA2G2A -0.12 0.22 -10000 0 -0.39 80 80
GPC1 0.012 0.098 -10000 0 -0.32 15 15
TGFBR1 (dimer) 0.029 0.061 -10000 0 -0.4 4 4
VEGFA 0.037 0.006 -10000 0 -10000 0 0
BLK -0.064 0.14 -10000 0 -0.3 51 51
HCK -0.062 0.13 -10000 0 -0.31 45 45
FGF2 0.001 0.11 -10000 0 -0.28 24 24
FGFR1 0.024 0.058 -10000 0 -0.28 6 6
VEGFR1 homodimer 0.011 0.072 -10000 0 -0.26 11 11
TGFBR2 0.033 0.049 -10000 0 -0.47 2 2
cell death 0.018 0.097 -10000 0 -0.34 12 12
ATIII/GPC1 0.03 0.08 -10000 0 -0.34 7 7
PLA2G2A/GPC1 -0.091 0.18 -10000 0 -0.35 65 65
LCK -0.08 0.15 -10000 0 -0.31 60 60
neuron differentiation 0.02 0.084 -10000 0 -0.33 9 9
PrPc/Cu2+ 0.011 0.061 -10000 0 -0.34 6 6
APP 0.018 0.083 -10000 0 -0.33 10 10
TGFBR2 (dimer) 0.033 0.049 -10000 0 -0.47 2 2
Thromboxane A2 receptor signaling

Figure S17.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S17.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGM2 -0.012 0.11 -10000 0 -0.37 17 17
GNB1/GNG2 -0.064 0.079 -10000 0 -0.18 55 55
AKT1 -0.063 0.13 0.28 2 -0.35 14 16
EGF -0.087 0.18 -10000 0 -0.3 78 78
mol:TXA2 0 0.001 -10000 0 -10000 0 0
FGR -0.023 0.074 0.32 2 -0.24 2 4
mol:Ca2+ -0.081 0.16 0.29 2 -0.31 41 43
LYN -0.018 0.069 0.32 2 -0.24 2 4
RhoA/GTP -0.033 0.068 -10000 0 -0.14 9 9
mol:PGI2 0 0 -10000 0 -10000 0 0
SYK -0.095 0.18 0.31 2 -0.35 53 55
GNG2 0.034 0.011 -10000 0 -10000 0 0
ARRB2 0.028 0.037 -10000 0 -0.47 1 1
TP alpha/Gq family/GDP/G beta5/gamma2 -0.048 0.15 -10000 0 -0.44 21 21
G beta5/gamma2 -0.078 0.11 -10000 0 -0.25 43 43
PRKCH -0.1 0.18 0.28 1 -0.37 54 55
DNM1 0.033 0.031 -10000 0 -0.19 4 4
TXA2/TP beta/beta Arrestin3 0.017 0.042 -10000 0 -0.52 1 1
mol:GTP 0 0.001 -10000 0 -10000 0 0
PTGDR -0.055 0.16 -10000 0 -0.28 61 61
G12 family/GTP -0.086 0.15 -10000 0 -0.31 47 47
ADRBK1 0.037 0.004 -10000 0 -10000 0 0
ADRBK2 0.031 0.041 -10000 0 -0.28 3 3
RhoA/GTP/ROCK1 0.039 0.021 -10000 0 -10000 0 0
mol:GDP 0.054 0.13 0.34 16 -0.33 1 17
mol:NADP 0.03 0.051 -10000 0 -0.38 3 3
RAB11A 0.032 0.039 -10000 0 -0.33 2 2
PRKG1 0.036 0.007 -10000 0 -10000 0 0
mol:IP3 -0.11 0.2 0.33 1 -0.39 44 45
cell morphogenesis 0.038 0.021 -10000 0 -10000 0 0
PLCB2 -0.16 0.26 -10000 0 -0.54 45 45
mol:cGMP 0 0.001 -10000 0 -10000 0 0
BLK -0.028 0.079 0.32 2 -0.25 5 7
mol:PDG2 0 0 -10000 0 -10000 0 0
HCK -0.026 0.075 -10000 0 -0.31 8 8
RHOA 0.037 0.005 -10000 0 -10000 0 0
PTGIR 0.035 0.016 -10000 0 -0.19 1 1
PRKCB1 -0.1 0.19 0.3 1 -0.38 57 58
GNAQ 0 0 -10000 0 -10000 0 0
mol:L-citrulline 0.03 0.051 -10000 0 -0.38 3 3
TXA2/TXA2-R family -0.15 0.26 -10000 0 -0.53 57 57
LCK -0.041 0.093 0.32 2 -0.28 10 12
TXA2/TP beta/beta Arrestin3/RAB11/GDP -0.004 0.08 -10000 0 -0.28 1 1
TXA2-R family/G12 family/GDP/G beta/gamma -0.001 0.12 -10000 0 -0.45 12 12
TXA2/TP beta/beta Arrestin2/RAB11/GDP -0.007 0.078 -10000 0 -0.23 3 3
MAPK14 -0.06 0.12 0.24 3 -0.24 32 35
TGM2/GTP -0.13 0.2 -10000 0 -0.48 24 24
MAPK11 -0.062 0.12 0.24 3 -0.24 32 35
ARHGEF1 -0.041 0.1 0.19 6 -0.2 14 20
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
JNK cascade -0.11 0.2 0.33 1 -0.39 56 57
RAB11/GDP 0.032 0.038 -10000 0 -0.32 2 2
ICAM1 -0.076 0.15 0.27 1 -0.29 52 53
cAMP biosynthetic process -0.1 0.18 0.31 2 -0.38 33 35
Gq family/GTP/EBP50 -0.006 0.073 -10000 0 -0.21 22 22
actin cytoskeleton reorganization 0.038 0.021 -10000 0 -10000 0 0
SRC -0.016 0.051 -10000 0 -0.24 1 1
GNB5 -0.002 0.12 -10000 0 -0.36 20 20
GNB1 0.035 0.009 -10000 0 -10000 0 0
EGF/EGFR -0.028 0.12 0.41 2 -0.27 19 21
VCAM1 -0.08 0.16 0.25 2 -0.31 54 56
TP beta/Gq family/GDP/G beta5/gamma2 -0.048 0.15 -10000 0 -0.44 21 21
platelet activation -0.08 0.16 0.31 3 -0.31 41 44
PGI2/IP 0.026 0.011 -10000 0 -0.12 1 1
PRKACA -0.015 0.076 -10000 0 -0.24 17 17
Gq family/GDP/G beta5/gamma2 -0.043 0.14 -10000 0 -0.39 22 22
TXA2/TP beta/beta Arrestin2 -0.014 0.072 -10000 0 -0.36 3 3
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TBXA2R -0.023 0.066 -10000 0 -0.22 16 16
mol:DAG -0.12 0.22 0.32 1 -0.43 57 58
EGFR 0.018 0.086 -10000 0 -0.4 8 8
TXA2/TP alpha -0.14 0.25 0.38 1 -0.51 37 38
Gq family/GTP -0.017 0.077 -10000 0 -0.23 23 23
YES1 -0.019 0.069 0.38 1 -0.24 2 3
GNAI2/GTP -0.016 0.078 -10000 0 -0.24 4 4
PGD2/DP -0.037 0.11 -10000 0 -0.19 62 62
SLC9A3R1 0.028 0.062 -10000 0 -0.4 4 4
FYN -0.031 0.086 0.32 2 -0.33 5 7
mol:NO 0.03 0.051 -10000 0 -0.38 3 3
GNA15 0.024 0.064 -10000 0 -0.24 10 10
PGK/cGMP 0.043 0.036 -10000 0 -0.29 2 2
RhoA/GDP 0.037 0.005 -10000 0 -10000 0 0
TP alpha/TGM2/GDP/G beta/gamma -0.007 0.083 -10000 0 -0.3 4 4
NOS3 0.03 0.051 -10000 0 -0.38 3 3
RAC1 0.034 0.012 -10000 0 -10000 0 0
PRKCA -0.093 0.18 0.38 1 -0.36 52 53
PRKCB -0.096 0.18 0.3 1 -0.36 56 57
PRKCE -0.097 0.18 0.31 1 -0.36 55 56
PRKCD -0.1 0.19 -10000 0 -0.39 55 55
PRKCG -0.11 0.2 0.34 1 -0.39 55 56
muscle contraction -0.14 0.24 0.36 1 -0.49 57 58
PRKCZ -0.093 0.18 0.29 2 -0.34 56 58
ARR3 0.038 0.003 -10000 0 -10000 0 0
TXA2/TP beta -0.003 0.083 -10000 0 -0.3 1 1
PRKCQ -0.11 0.19 0.36 1 -0.37 58 59
MAPKKK cascade -0.13 0.23 0.34 1 -0.46 55 56
SELE -0.1 0.19 0.25 2 -0.38 57 59
TP beta/GNAI2/GDP/G beta/gamma 0.009 0.096 0.27 1 -0.27 2 3
ROCK1 0.029 0.016 -10000 0 -10000 0 0
GNA14 -0.016 0.14 -10000 0 -0.35 29 29
chemotaxis -0.17 0.29 -10000 0 -0.62 55 55
GNA12 0.034 0.011 -10000 0 -10000 0 0
GNA13 0.036 0.009 -10000 0 -10000 0 0
GNA11 0.031 0.051 -10000 0 -0.38 3 3
Rac1/GTP 0.024 0.008 -10000 0 -10000 0 0
TCGA08_retinoblastoma

Figure S18.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S18.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDKN2B 0.007 0.083 -10000 0 -0.25 16 16
CDKN2C 0.037 0.054 -10000 0 -0.35 3 3
CDKN2A -0.024 0.14 -10000 0 -0.29 42 42
CCND2 0.004 0.07 0.18 19 -10000 0 19
RB1 0.004 0.074 0.18 5 -0.2 13 18
CDK4 0.014 0.07 0.21 19 -10000 0 19
CDK6 0.011 0.071 0.21 18 -0.15 1 19
G1/S progression -0.003 0.076 0.2 15 -0.18 5 20
Glucocorticoid receptor regulatory network

Figure S19.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S19.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PCK2 0.062 0.11 -10000 0 -0.74 2 2
SMARCC2 0.037 0.004 -10000 0 -10000 0 0
SMARCC1 0.037 0.004 -10000 0 -10000 0 0
TBX21 -0.15 0.25 0.34 1 -0.74 26 27
SUMO2 0.032 0.018 -10000 0 -10000 0 0
STAT1 (dimer) 0.01 0.095 -10000 0 -0.24 25 25
FKBP4 0.034 0.035 -10000 0 -0.47 1 1
FKBP5 0.028 0.063 -10000 0 -0.36 5 5
GR alpha/HSP90/FKBP51/HSP90 0.11 0.1 0.31 14 -0.23 1 15
PRL -0.05 0.1 -10000 0 -10000 0 0
cortisol/GR alpha (dimer)/TIF2 0.17 0.22 0.52 43 -10000 0 43
RELA -0.08 0.12 -10000 0 -0.27 31 31
FGG 0.14 0.2 0.45 40 -0.51 2 42
GR beta/TIF2 0.096 0.11 0.3 24 -0.34 1 25
IFNG -0.34 0.44 -10000 0 -1.1 49 49
apoptosis -0.014 0.23 0.6 3 -0.59 14 17
CREB1 0.042 0.041 -10000 0 -0.38 2 2
histone acetylation -0.073 0.12 -10000 0 -0.34 21 21
BGLAP -0.066 0.12 -10000 0 -10000 0 0
GR/PKAc 0.099 0.15 0.32 17 -0.26 13 30
NF kappa B1 p50/RelA -0.15 0.22 -10000 0 -0.45 52 52
SMARCD1 0.037 0.004 -10000 0 -10000 0 0
MDM2 0.079 0.089 0.23 39 -10000 0 39
GATA3 0.037 0.056 -10000 0 -0.46 2 2
AKT1 0.027 0.033 0.23 2 -0.18 3 5
CSF2 -0.24 0.44 -10000 0 -1.3 30 30
GSK3B 0.031 0.038 -10000 0 -0.47 1 1
NR1I3 -0.002 0.21 0.59 5 -0.64 3 8
CSN2 0.12 0.16 0.37 36 -10000 0 36
BRG1/BAF155/BAF170/BAF60A 0.09 0.035 -10000 0 -0.26 1 1
NFATC1 0.008 0.073 -10000 0 -0.4 2 2
POU2F1 0.033 0.065 -10000 0 -0.36 5 5
CDKN1A -0.098 0.28 -10000 0 -1.7 5 5
response to stress 0 0 -10000 0 -10000 0 0
response to UV -0.001 0.008 -10000 0 -10000 0 0
SFN 0.021 0.07 -10000 0 -0.28 9 9
GR alpha/HSP90/FKBP51/HSP90/14-3-3 0.11 0.11 0.34 7 -0.27 1 8
prolactin receptor activity 0 0 -10000 0 -10000 0 0
EGR1 -0.073 0.32 0.58 4 -0.77 30 34
JUN -0.16 0.19 -10000 0 -0.49 37 37
IL4 -0.064 0.14 -10000 0 -0.65 5 5
CDK5R1 0.035 0.009 -10000 0 -10000 0 0
PRKACA 0.037 0.006 -10000 0 -10000 0 0
cortisol/GR alpha (monomer)/AP-1 -0.067 0.17 0.21 32 -0.34 36 68
GR alpha/HSP90/FKBP51/HSP90/PP5C 0.12 0.1 0.33 10 -10000 0 10
cortisol/GR alpha (monomer) 0.21 0.26 0.6 50 -10000 0 50
NCOA2 0.028 0.05 -10000 0 -0.47 2 2
response to hypoxia 0 0 -10000 0 -10000 0 0
FOS -0.093 0.17 -10000 0 -0.36 50 50
AP-1/NFAT1-c-4 -0.24 0.26 -10000 0 -0.6 50 50
AFP -0.19 0.38 -10000 0 -1.5 14 14
SUV420H1 0.037 0.005 -10000 0 -10000 0 0
IRF1 0.085 0.21 0.41 17 -0.7 8 25
TP53 -0.042 0.19 -10000 0 -0.49 31 31
PPP5C 0.036 0.016 -10000 0 -0.19 1 1
KRT17 -0.2 0.27 -10000 0 -0.78 22 22
KRT14 -0.074 0.14 -10000 0 -0.73 1 1
TBP 0.043 0.016 -10000 0 -10000 0 0
CREBBP 0.039 0.045 0.28 1 -0.43 1 2
HDAC1 0.033 0.012 -10000 0 -10000 0 0
HDAC2 0.045 0.047 0.28 1 -0.47 1 2
AP-1 -0.24 0.26 -10000 0 -0.6 50 50
MAPK14 0.035 0.009 -10000 0 -10000 0 0
MAPK10 0.011 0.097 -10000 0 -0.34 13 13
MAPK11 0.029 0.024 -10000 0 -0.19 1 1
KRT5 -0.2 0.27 -10000 0 -0.76 26 26
interleukin-1 receptor activity 0.011 0.029 0.23 1 -10000 0 1
NCOA1 0.029 0.07 -10000 0 -0.4 5 5
STAT1 0.01 0.095 -10000 0 -0.24 25 25
CGA -0.076 0.16 -10000 0 -1.1 2 2
NF kappa B1 p50/RelA/Cbp/cortisol/GR alpha (monomer)/HDAC2 0.088 0.2 0.51 29 -0.39 1 30
MAPK3 0.022 0.073 -10000 0 -0.38 6 6
MAPK1 0.034 0.012 -10000 0 -10000 0 0
ICAM1 -0.22 0.28 -10000 0 -0.71 36 36
NFKB1 -0.08 0.12 -10000 0 -0.27 29 29
MAPK8 -0.11 0.15 -10000 0 -0.38 32 32
MAPK9 0.033 0.036 -10000 0 -0.48 1 1
cortisol/GR alpha (dimer) -0.021 0.23 0.61 3 -0.62 14 17
BAX -0.071 0.19 -10000 0 -2.1 1 1
POMC -0.11 0.23 -10000 0 -1.7 3 3
EP300 0.025 0.1 0.37 1 -0.44 8 9
cortisol/GR alpha (dimer)/p53 0.1 0.24 0.53 32 -0.63 1 33
proteasomal ubiquitin-dependent protein catabolic process 0.05 0.089 0.28 15 -10000 0 15
SGK1 0.033 0.1 0.29 5 -0.26 10 15
IL13 -0.15 0.19 -10000 0 -0.67 8 8
IL6 -0.36 0.49 -10000 0 -1.1 58 58
PRKACG 0.037 0.006 -10000 0 -10000 0 0
IL5 -0.13 0.16 -10000 0 -0.8 1 1
IL2 -0.19 0.24 -10000 0 -0.69 23 23
CDK5 0.035 0.008 -10000 0 -10000 0 0
PRKACB -0.025 0.16 -10000 0 -0.39 31 31
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
IL8 -0.39 0.5 -10000 0 -1.1 59 59
CDK5R1/CDK5 0.049 0.017 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/PKAc -0.11 0.21 -10000 0 -0.41 44 44
cortisol/GR alpha (dimer)/Hsp90/FKBP52/HSP90 0.17 0.21 0.51 42 -10000 0 42
SMARCA4 0.033 0.041 -10000 0 -0.28 3 3
chromatin remodeling 0.13 0.14 0.34 43 -10000 0 43
NF kappa B1 p50/RelA/Cbp -0.097 0.19 -10000 0 -0.43 32 32
JUN (dimer) -0.16 0.19 -10000 0 -0.48 37 37
YWHAH 0.033 0.036 -10000 0 -0.47 1 1
VIPR1 -0.13 0.24 -10000 0 -0.64 29 29
NR3C1 0.13 0.16 0.39 40 -10000 0 40
NR4A1 0.016 0.084 -10000 0 -0.45 3 3
TIF2/SUV420H1 0.043 0.042 -10000 0 -0.34 2 2
MAPKKK cascade -0.014 0.23 0.6 3 -0.59 14 17
cortisol/GR alpha (dimer)/Src-1 0.2 0.23 0.53 49 -10000 0 49
PBX1 0.024 0.093 -10000 0 -0.46 7 7
POU1F1 0.041 0.036 -10000 0 -0.46 1 1
SELE -0.37 0.48 -10000 0 -1.1 57 57
cortisol/GR alpha/BRG1/BAF155/BAF170/BAF60A 0.13 0.14 0.34 42 -10000 0 42
cortisol/GR alpha (monomer)/Hsp90/FKBP52/HSP90 0.17 0.21 0.51 42 -10000 0 42
mol:cortisol 0.12 0.16 0.35 53 -10000 0 53
MMP1 -0.35 0.52 -10000 0 -1.2 54 54
IL1-mediated signaling events

Figure S20.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S20.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
UBC13/UEV1A 0.026 0.025 -10000 0 -0.34 1 1
PRKCZ 0 0 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
ERC1 0.035 0.017 -10000 0 -0.19 1 1
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4 -0.03 0.09 -10000 0 -0.25 8 8
IRAK/TOLLIP 0.04 0.031 0.18 1 -0.34 1 2
IKBKB 0.032 0.013 -10000 0 -10000 0 0
IKBKG 0.036 0.016 -10000 0 -0.19 1 1
IL1 alpha/IL1R2 -0.11 0.18 -10000 0 -0.35 66 66
IL1A -0.079 0.18 -10000 0 -0.31 73 73
IL1B -0.12 0.18 -10000 0 -0.38 63 63
IRAK/TRAF6/p62/Atypical PKCs 0.063 0.049 -10000 0 -0.26 3 3
IL1R2 -0.067 0.18 -10000 0 -0.34 60 60
IL1R1 0.019 0.076 -10000 0 -0.25 14 14
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP -0.019 0.086 -10000 0 -0.36 1 1
TOLLIP 0.037 0.005 -10000 0 -10000 0 0
TICAM2 0 0 -10000 0 -10000 0 0
MAP3K3 0.036 0.009 -10000 0 -10000 0 0
TAK1/TAB1/TAB2 0.024 0.008 -10000 0 -10000 0 0
IKK complex/ELKS 0.029 0.08 -10000 0 -0.38 3 3
JUN -0.04 0.079 0.32 1 -0.23 26 27
MAP3K7 0.036 0.008 -10000 0 -10000 0 0
IL1 beta fragment/IL1R1/IL1RAP/PI3K -0.058 0.18 -10000 0 -0.3 61 61
IL1 alpha/IL1R1/IL1RAP/MYD88 -0.003 0.14 -10000 0 -0.27 34 34
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4 0.01 0.14 -10000 0 -0.26 34 34
IL1 beta fragment/IL1R1/IL1RAP -0.08 0.17 -10000 0 -0.32 64 64
NFKB1 0.037 0.006 -10000 0 -10000 0 0
MAPK8 -0.017 0.05 0.34 1 -0.22 9 10
IRAK1 0.017 0.028 -10000 0 -0.37 1 1
IL1RN/IL1R1 -0.015 0.14 -10000 0 -0.33 27 27
IRAK4 0.037 0.004 -10000 0 -10000 0 0
PRKCI 0.03 0.053 -10000 0 -0.33 4 4
TRAF6 0.037 0.005 -10000 0 -10000 0 0
PI3K 0.048 0.047 -10000 0 -0.34 3 3
IL1 beta fragment/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.036 0.1 -10000 0 -0.31 11 11
CHUK 0.031 0.049 -10000 0 -0.47 2 2
IL1 beta fragment/IL1R1/IL1RAP/MYD88s -0.08 0.17 -10000 0 -0.32 64 64
IL1 beta/IL1R2 -0.14 0.21 -10000 0 -0.38 79 79
IRAK/TRAF6/TAK1/TAB1/TAB2 0.048 0.031 -10000 0 -0.3 1 1
NF kappa B1 p50/RelA -0.063 0.16 -10000 0 -0.37 23 23
IRAK3 -0.004 0.12 -10000 0 -0.29 27 27
IL1 beta fragment/IL1R1/IL1RAP/TICAM2/IRAK4 -0.064 0.17 -10000 0 -0.29 64 64
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/TOLLIP -0.013 0.098 -10000 0 -0.34 3 3
IL1 alpha/IL1R1/IL1RAP -0.022 0.14 -10000 0 -0.28 38 38
RELA 0.037 0.006 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
SQSTM1 0.036 0.016 -10000 0 -0.19 1 1
MYD88 0.037 0.004 -10000 0 -10000 0 0
IRAK/TRAF6/MEKK3 0.057 0.036 -10000 0 -0.32 1 1
IL1RAP 0.033 0.031 -10000 0 -0.19 4 4
UBE2N 0.035 0.035 -10000 0 -0.47 1 1
IRAK/TRAF6 -0.072 0.14 -10000 0 -0.35 22 22
CASP1 -0.083 0.2 -10000 0 -0.36 65 65
IL1RN/IL1R2 -0.076 0.19 -10000 0 -0.36 56 56
IL1 beta fragment/IL1R1/IL1RAP/MYD88 -0.065 0.18 -10000 0 -0.3 64 64
TMEM189-UBE2V1 0 0 -10000 0 -10000 0 0
IL1 alpha/IL1R1/IL1RAP/MYD88/IRAK4/IRAK/TOLLIP 0 0.093 -10000 0 -0.35 6 6
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
IL1RN -0.039 0.16 -10000 0 -0.3 49 49
TRAF6/TAK1/TAB1/TAB2 0.05 0.025 -10000 0 -0.23 1 1
MAP2K6 0.006 0.059 0.35 1 -0.23 10 11
FAS signaling pathway (CD95)

Figure S21.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S21.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPTAN1 0.003 0.066 0.22 9 -0.24 5 14
RFC1 0.002 0.065 0.22 8 -0.25 4 12
PRKDC 0.015 0.082 0.23 19 -0.25 4 23
RIPK1 0.04 0.008 -10000 0 -10000 0 0
CASP7 -0.037 0.15 -10000 0 -0.63 11 11
FASLG/FAS/FADD/FAF1 0.004 0.14 0.21 31 -0.29 21 52
MAP2K4 -0.11 0.19 0.26 1 -0.43 39 40
mol:ceramide -0.073 0.16 -10000 0 -0.43 25 25
GSN -0.003 0.074 0.22 9 -0.26 6 15
FASLG/FAS/FADD/FAF1/Caspase 8 -0.012 0.14 -10000 0 -0.39 15 15
FAS -0.045 0.16 -10000 0 -0.39 35 35
BID -0.025 0.047 0.27 2 -0.33 3 5
MAP3K1 -0.05 0.14 -10000 0 -0.46 11 11
MAP3K7 0.034 0.008 -10000 0 -10000 0 0
RB1 0.031 0.11 0.26 29 -0.25 2 31
CFLAR 0.04 0.006 -10000 0 -10000 0 0
HGF/MET -0.062 0.16 -10000 0 -0.29 61 61
ARHGDIB -0.003 0.082 0.29 7 -0.25 8 15
FADD 0.024 0.026 -10000 0 -10000 0 0
actin filament polymerization 0.003 0.074 0.26 6 -0.22 9 15
NFKB1 -0.054 0.15 -10000 0 -0.65 7 7
MAPK8 -0.15 0.24 -10000 0 -0.51 57 57
DFFA 0.003 0.065 0.22 8 -0.25 4 12
DNA fragmentation during apoptosis 0.001 0.064 0.22 7 -0.25 4 11
FAS/FADD/MET 0.009 0.12 -10000 0 -0.3 23 23
CFLAR/RIP1 0.059 0.013 -10000 0 -10000 0 0
FAIM3 0.031 0.053 -10000 0 -0.33 4 4
FAF1 0.022 0.028 -10000 0 -10000 0 0
PARP1 0 0.063 0.22 7 -0.24 5 12
DFFB 0.001 0.064 0.22 7 -0.25 4 11
CHUK -0.053 0.14 -10000 0 -0.6 7 7
FASLG -0.038 0.14 -10000 0 -0.3 38 38
FAS/FADD -0.018 0.13 -10000 0 -0.34 25 25
HGF 0.034 0.023 -10000 0 -0.19 2 2
LMNA -0.004 0.073 0.23 3 -0.27 7 10
CASP6 -0.001 0.075 0.22 8 -0.28 7 15
CASP10 0.015 0.062 -10000 0 -0.29 6 6
CASP3 0.003 0.074 0.26 9 -0.25 7 16
PTPN13 -0.15 0.22 -10000 0 -0.36 99 99
CASP8 -0.028 0.055 0.35 2 -0.36 3 5
IL6 -0.32 0.56 -10000 0 -1.3 52 52
MET 0.029 0.054 -10000 0 -0.33 4 4
ICAD/CAD -0.004 0.054 0.19 6 -0.25 3 9
FASLG/FAS/FADD/FAF1/Caspase 10 -0.074 0.16 -10000 0 -0.44 25 25
activation of caspase activity by cytochrome c -0.025 0.047 0.27 2 -0.33 3 5
PAK2 0.003 0.069 0.22 10 -0.26 4 14
BCL2 0.001 0.093 -10000 0 -0.29 16 16
Glypican 2 network

Figure S22.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S22.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MDK -0.005 0.12 -9999 0 -0.32 25 25
GPC2 0 0 -9999 0 -10000 0 0
GPC2/Midkine -0.002 0.089 -9999 0 -0.22 25 25
neuron projection morphogenesis -0.002 0.088 -9999 0 -0.22 25 25
Calcium signaling in the CD4+ TCR pathway

Figure S23.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S23.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC1 -0.023 0.051 -9999 0 -0.16 10 10
NFATC2 -0.007 0.028 -9999 0 -10000 0 0
NFATC3 -0.019 0.05 -9999 0 -0.24 2 2
CD40LG -0.15 0.26 -9999 0 -0.55 45 45
PTGS2 -0.18 0.29 -9999 0 -0.57 60 60
JUNB 0.021 0.069 -9999 0 -0.23 13 13
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.004 0.035 -9999 0 -0.093 3 3
CaM/Ca2+ -0.004 0.035 -9999 0 -0.093 3 3
CALM1 0.014 0.032 -9999 0 -10000 0 0
JUN -0.033 0.15 -9999 0 -0.43 23 23
mol:Ca2+ -0.011 0.014 -9999 0 -10000 0 0
Calcineurin A alpha-beta B1/FKBP12/FK506 0.013 0.025 -9999 0 -0.28 1 1
FOSL1 0.031 0.037 -9999 0 -0.19 6 6
CREM 0.033 0.038 -9999 0 -0.33 2 2
Jun/NFAT1-c-4/p21SNFT -0.069 0.14 -9999 0 -0.38 21 21
FOS -0.07 0.16 -9999 0 -0.31 56 56
IFNG -0.19 0.3 -9999 0 -0.59 61 61
AP-1/NFAT1-c-4 -0.17 0.31 -9999 0 -0.62 48 48
FASLG -0.16 0.28 -9999 0 -0.59 48 48
NFAT1-c-4/ICER1 -0.025 0.083 -9999 0 -0.3 2 2
IL2RA -0.17 0.29 -9999 0 -0.59 52 52
FKBP12/FK506 0.02 0.027 -9999 0 -0.34 1 1
CSF2 -0.18 0.29 -9999 0 -0.59 55 55
JunB/Fra1/NFAT1-c-4 0.004 0.12 -9999 0 -0.35 2 2
IL4 -0.15 0.26 -9999 0 -0.52 48 48
IL2 -0.002 0.14 -9999 0 -0.92 5 5
IL3 0.01 0.13 -9999 0 -0.76 6 6
FKBP1A 0.027 0.037 -9999 0 -0.47 1 1
BATF3 0 0 -9999 0 -10000 0 0
mol:FK506 0 0 -9999 0 -10000 0 0
POU2F1 0.034 0.064 -9999 0 -0.35 5 5
IL27-mediated signaling events

Figure S24.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S24.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.043 0.019 -10000 0 -10000 0 0
CD4-positive alpha-beta T cell lineage commitment 0 0 -10000 0 -10000 0 0
cytokine production during immune response 0.12 0.21 0.6 23 -10000 0 23
IL27/IL27R/JAK1 -0.14 0.33 -10000 0 -1.1 16 16
TBX21 -0.19 0.24 -10000 0 -0.57 45 45
IL12B 0.021 0.057 -10000 0 -0.3 5 5
IL12A -0.024 0.084 -10000 0 -0.22 27 27
IL6ST 0.018 0.029 -10000 0 -10000 0 0
IL27RA/JAK1 -0.097 0.34 -10000 0 -1.3 15 15
IL27 -0.1 0.2 -10000 0 -0.42 57 57
TYK2 0.016 0.032 -10000 0 -10000 0 0
T-helper cell lineage commitment -0.014 0.16 0.98 2 -10000 0 2
T-helper 2 cell differentiation 0.12 0.21 0.6 23 -10000 0 23
T cell proliferation during immune response 0.12 0.21 0.6 23 -10000 0 23
MAPKKK cascade -0.12 0.21 -10000 0 -0.6 23 23
STAT3 0.037 0.006 -10000 0 -10000 0 0
STAT2 0.034 0.038 -10000 0 -0.33 2 2
STAT1 0.018 0.063 -10000 0 -0.19 18 18
IL12RB1 0.034 0.016 -10000 0 -0.19 1 1
positive regulation of tyrosine phosphorylation of STAT protein 0 0 -10000 0 -10000 0 0
IL12RB2 -0.18 0.22 -10000 0 -0.56 36 36
IL27/IL27R/JAK2/TYK2 -0.13 0.21 -10000 0 -0.6 23 23
positive regulation of T cell mediated cytotoxicity -0.12 0.21 -10000 0 -0.6 23 23
STAT1 (dimer) -0.19 0.34 0.52 1 -0.92 25 26
JAK2 0.001 0.078 -10000 0 -0.26 13 13
JAK1 0.033 0.035 -10000 0 -0.47 1 1
STAT2 (dimer) -0.12 0.21 -10000 0 -0.59 22 22
T cell proliferation -0.17 0.22 -10000 0 -0.54 38 38
IL12/IL12R/TYK2/JAK2 -0.059 0.2 -10000 0 -0.85 8 8
IL17A -0.014 0.16 0.98 2 -10000 0 2
mast cell activation 0.12 0.21 0.6 23 -10000 0 23
IFNG -0.033 0.055 -10000 0 -0.13 42 42
T cell differentiation -0.01 0.01 -10000 0 -0.023 65 65
STAT3 (dimer) -0.11 0.21 -10000 0 -0.58 22 22
STAT5A (dimer) -0.11 0.21 -10000 0 -0.59 22 22
STAT4 (dimer) -0.12 0.22 -10000 0 -0.6 23 23
STAT4 0.023 0.076 -10000 0 -0.31 9 9
T cell activation 0.001 0.034 0.12 15 -10000 0 15
IL27R/JAK2/TYK2 -0.097 0.32 -10000 0 -1.2 16 16
GATA3 0.019 0.16 0.67 2 -1.4 2 4
IL18 -0.03 0.1 -10000 0 -0.34 21 21
positive regulation of mast cell cytokine production -0.11 0.2 -10000 0 -0.56 22 22
IL27/EBI3 -0.064 0.15 -10000 0 -0.35 44 44
IL27RA -0.11 0.35 -10000 0 -1.4 15 15
IL6 -0.11 0.2 -10000 0 -0.46 46 46
STAT5A 0.03 0.046 -10000 0 -0.24 5 5
monocyte differentiation -0.002 0.003 -10000 0 -10000 0 0
IL2 0.034 0.12 0.46 15 -10000 0 15
IL1B -0.053 0.12 -10000 0 -0.33 32 32
EBI3 0.019 0.027 -10000 0 -10000 0 0
TNF 0 0.041 -10000 0 -0.17 9 9
Presenilin action in Notch and Wnt signaling

Figure S25.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S25.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Delta 1/NOTCH/NOTCH(cleaved) 0.001 0.18 -10000 0 -0.48 25 25
HDAC1 0.035 0.012 -10000 0 -10000 0 0
AES 0.034 0.035 -10000 0 -0.47 1 1
FBXW11 0.037 0.004 -10000 0 -10000 0 0
DTX1 0.037 0.004 -10000 0 -10000 0 0
LRP6/FZD1 0.05 0.02 -10000 0 -10000 0 0
TLE1 0.006 0.12 -10000 0 -0.47 13 13
AP1 -0.12 0.17 -10000 0 -0.32 73 73
NCSTN 0.037 0.006 -10000 0 -10000 0 0
ADAM10 0.026 0.063 -10000 0 -0.36 5 5
Beta Catenin/TCF1/CtBP/CBP/TLE1/AES/SMAD4 0.015 0.13 -10000 0 -0.56 7 7
NICD/RBPSUH 0 0.18 -10000 0 -0.46 25 25
WIF1 -0.017 0.096 -10000 0 -0.19 52 52
NOTCH1 -0.025 0.18 -10000 0 -0.49 25 25
PSENEN 0.033 0.038 -10000 0 -0.33 2 2
KREMEN2 -0.062 0.17 -10000 0 -0.29 65 65
DKK1 -0.087 0.18 -10000 0 -0.3 79 79
beta catenin/beta TrCP1 0.068 0.1 0.31 5 -0.3 3 8
APH1B 0.022 0.07 -10000 0 -0.28 9 9
APH1A 0.008 0.098 -10000 0 -0.27 20 20
AXIN1 -0.026 0.11 -10000 0 -0.62 4 4
CtBP/CBP/TCF1/TLE1/AES 0.01 0.081 0.21 1 -0.35 2 3
PSEN1 0.034 0.011 -10000 0 -10000 0 0
FOS -0.055 0.16 -10000 0 -0.3 56 56
JUN -0.015 0.15 -10000 0 -0.39 26 26
MAP3K7 0.036 0.008 -10000 0 -10000 0 0
CTNNB1 0.053 0.1 0.31 5 -0.32 3 8
MAPK3 0.025 0.072 -10000 0 -0.38 6 6
DKK2/LRP6/Kremen 2 -0.043 0.15 -10000 0 -0.29 45 45
HNF1A 0.032 0.048 -10000 0 -0.46 2 2
CTBP1 0.036 0.008 -10000 0 -10000 0 0
MYC -0.036 0.31 -10000 0 -1.4 10 10
NKD1 -0.14 0.21 -10000 0 -0.33 100 100
FZD1 0.036 0.009 -10000 0 -10000 0 0
NOTCH1 precursor/Deltex homolog 1 0.001 0.18 -10000 0 -0.46 25 25
apoptosis -0.12 0.17 -10000 0 -0.32 73 73
Delta 1/NOTCHprecursor -0.002 0.18 -10000 0 -0.47 25 25
DLL1 0.033 0.038 -10000 0 -0.33 2 2
PPARD 0.035 0.059 -10000 0 -0.74 1 1
Gamma Secretase 0.055 0.098 -10000 0 -0.26 10 10
APC -0.054 0.14 -10000 0 -0.45 20 20
DVL1 0.004 0.1 -10000 0 -0.58 5 5
CSNK2A1 0.029 0.016 -10000 0 -10000 0 0
MAP3K7IP1 -0.001 0.004 -10000 0 -10000 0 0
DKK1/LRP6/Kremen 2 -0.083 0.17 -10000 0 -0.32 56 56
LRP6 0.035 0.017 -10000 0 -0.19 1 1
CSNK1A1 0.037 0.005 -10000 0 -10000 0 0
NLK 0.018 0.012 -10000 0 -10000 0 0
CCND1 0.012 0.19 -10000 0 -1.2 4 4
WNT1 0.037 0.004 -10000 0 -10000 0 0
Axin1/APC/beta catenin 0.008 0.15 0.43 3 -0.43 10 13
DKK2 -0.025 0.14 -10000 0 -0.28 41 41
NOTCH1 precursor/DVL1 -0.02 0.2 -10000 0 -0.57 18 18
GSK3B 0.034 0.035 -10000 0 -0.47 1 1
FRAT1 0.031 0.049 -10000 0 -0.47 2 2
NOTCH/Deltex homolog 1 0.005 0.18 -10000 0 -0.47 25 25
PPP2R5D 0.095 0.11 0.28 48 -10000 0 48
MAPK1 0.035 0.01 -10000 0 -10000 0 0
WNT1/LRP6/FZD1 0.045 0.081 -10000 0 -10000 0 0
RBPJ 0.037 0.006 -10000 0 -10000 0 0
CREBBP 0.035 0.036 -10000 0 -0.47 1 1
FOXA2 and FOXA3 transcription factor networks

Figure S26.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S26.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ACADVL -0.11 0.38 -10000 0 -0.95 25 25
PCK1 -0.24 0.54 -10000 0 -1.3 38 38
HNF4A -0.084 0.44 0.59 7 -1.2 21 28
KCNJ11 -0.088 0.38 -10000 0 -1 18 18
AKT1 -0.035 0.22 -10000 0 -0.56 16 16
response to starvation -0.005 0.029 -10000 0 -0.2 1 1
DLK1 -0.096 0.41 -10000 0 -1.1 21 21
NKX2-1 0.055 0.21 0.51 8 -10000 0 8
ACADM -0.11 0.39 0.59 1 -1 22 23
TAT -0.064 0.24 -10000 0 -0.66 15 15
CEBPB 0.016 0.04 -10000 0 -0.46 1 1
CEBPA 0.012 0.092 -10000 0 -0.37 10 10
TTR -0.2 0.48 0.59 2 -1.2 34 36
PKLR -0.12 0.4 -10000 0 -1.1 22 22
APOA1 -0.12 0.56 -10000 0 -1.4 27 27
CPT1C -0.12 0.39 -10000 0 -1 24 24
ALAS1 -0.025 0.19 -10000 0 -0.74 2 2
TFRC -0.1 0.38 -10000 0 -0.95 24 24
FOXF1 0.003 0.12 -10000 0 -0.43 14 14
NF1 0.041 0.011 -10000 0 -10000 0 0
HNF1A (dimer) 0.027 0.076 -10000 0 -0.29 7 7
CPT1A -0.11 0.38 -10000 0 -0.99 24 24
HMGCS1 -0.12 0.38 -10000 0 -1 23 23
NR3C1 0.023 0.091 -10000 0 -0.37 9 9
CPT1B -0.11 0.37 -10000 0 -1 21 21
chromatin remodeling 0 0 -10000 0 -10000 0 0
SP1 0.033 0.044 -10000 0 -0.21 4 4
GCK -0.096 0.39 0.59 2 -1 22 24
CREB1 -0.007 0.095 -10000 0 -0.23 24 24
IGFBP1 -0.055 0.25 -10000 0 -1.2 5 5
PDX1 -0.033 0.28 -10000 0 -1.3 6 6
UCP2 -0.12 0.39 -10000 0 -0.97 26 26
ALDOB -0.19 0.49 -10000 0 -1.1 43 43
AFP -0.14 0.27 -10000 0 -0.87 19 19
BDH1 -0.12 0.41 -10000 0 -1.1 24 24
HADH -0.098 0.4 -10000 0 -1.1 18 18
F2 -0.079 0.48 -10000 0 -1.4 14 14
HNF1A 0.027 0.076 -10000 0 -0.29 7 7
G6PC 0.004 0.2 -10000 0 -1.2 3 3
SLC2A2 -0.054 0.32 -10000 0 -1.2 8 8
INS 0.03 0.025 0.23 1 -10000 0 1
FOXA1 -0.13 0.23 -10000 0 -0.45 66 66
FOXA3 -0.037 0.17 -10000 0 -0.4 26 26
FOXA2 -0.091 0.43 -10000 0 -1.1 21 21
ABCC8 -0.094 0.38 -10000 0 -0.98 20 20
ALB -0.11 0.19 -10000 0 -0.59 17 17
BMP receptor signaling

Figure S27.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S27.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BMP7/BMPR2/BMPR1A-1B/FS -0.04 0.12 -9999 0 -0.26 39 39
SMAD6-7/SMURF1 0.047 0.046 -9999 0 -0.29 1 1
NOG 0.031 0.049 -9999 0 -0.47 2 2
SMAD9 -0.08 0.21 -9999 0 -0.52 34 34
SMAD4 0.023 0.038 -9999 0 -0.47 1 1
SMAD5 -0.042 0.13 -9999 0 -0.43 13 13
BMP7/USAG1 -0.14 0.2 -9999 0 -0.42 63 63
SMAD5/SKI -0.036 0.14 -9999 0 -0.41 15 15
SMAD1 -0.002 0.11 -9999 0 -0.46 7 7
BMP2 -0.018 0.14 -9999 0 -0.44 21 21
SMAD1/SMAD1/SMAD4 0.011 0.1 -9999 0 -0.49 3 3
BMPR1A 0.031 0.049 -9999 0 -0.47 2 2
BMPR1B 0.033 0.027 -9999 0 -0.19 3 3
BMPR1A-1B/BAMBI -0.01 0.13 -9999 0 -0.29 33 33
AHSG 0.014 0.11 -9999 0 -0.47 10 10
CER1 0.033 0.038 -9999 0 -0.33 2 2
BMP2-4/CER1 -0.031 0.14 -9999 0 -0.3 38 38
BMP2-4/BMPR2/BMPR1A-1B/RGM/ENDOFIN/GADD34/PP1CA -0.043 0.15 -9999 0 -0.39 20 20
BMP2-4 (homodimer) -0.043 0.15 -9999 0 -0.35 37 37
RGMB -0.008 0.11 -9999 0 -0.24 34 34
BMP6/BMPR2/BMPR1A-1B 0.064 0.081 -9999 0 -0.26 8 8
RGMA 0.018 0.087 -9999 0 -0.38 9 9
SMURF1 0.036 0.008 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/XIAP -0.056 0.14 -9999 0 -0.34 27 27
BMP2-4/USAG1 -0.12 0.18 -9999 0 -0.35 70 70
SMAD6/SMURF1/SMAD5 -0.037 0.14 -9999 0 -0.4 15 15
SOSTDC1 -0.14 0.22 -9999 0 -0.37 89 89
BMP7/BMPR2/BMPR1A-1B -0.041 0.12 -9999 0 -0.26 37 37
SKI 0.035 0.009 -9999 0 -10000 0 0
BMP6 (homodimer) 0.014 0.092 -9999 0 -0.31 14 14
HFE2 0.024 0.078 -9999 0 -0.42 6 6
ZFYVE16 0.037 0.006 -9999 0 -10000 0 0
MAP3K7 0.036 0.008 -9999 0 -10000 0 0
BMP2-4/CHRD -0.026 0.14 -9999 0 -0.3 36 36
SMAD5/SMAD5/SMAD4 -0.037 0.14 -9999 0 -0.4 15 15
MAPK1 0.035 0.01 -9999 0 -10000 0 0
TAK1/TAB family -0.034 0.13 -9999 0 -0.34 18 18
BMP7 (homodimer) -0.097 0.18 -9999 0 -0.34 67 67
NUP214 0.035 0.022 -9999 0 -0.19 2 2
BMP6/FETUA 0.019 0.11 -9999 0 -0.36 15 15
SMAD1/SKI 0.014 0.11 -9999 0 -0.43 7 7
SMAD6 0.032 0.028 -9999 0 -0.19 3 3
CTDSP2 0.03 0.053 -9999 0 -0.33 4 4
BMP2-4/FETUA -0.041 0.15 -9999 0 -0.32 43 43
MAP3K7IP1 0 0 -9999 0 -10000 0 0
GREM1 -0.052 0.18 -9999 0 -0.38 45 45
BMPR2 (homodimer) 0.037 0.003 -9999 0 -10000 0 0
GADD34/PP1CA 0.066 0.036 -9999 0 -10000 0 0
BMPR1A-1B (homodimer) 0.046 0.045 -9999 0 -0.34 2 2
CHRDL1 0.024 0.069 -9999 0 -0.28 9 9
ENDOFIN/SMAD1 0.014 0.11 -9999 0 -0.44 7 7
SMAD6-7/SMURF1/SMAD1 0.027 0.12 -9999 0 -0.45 5 5
SMAD6/SMURF1 0.036 0.008 -9999 0 -10000 0 0
BAMBI -0.064 0.18 -9999 0 -0.34 58 58
SMURF2 0.024 0.063 -9999 0 -0.25 9 9
BMP2-4/CHRDL1 -0.034 0.14 -9999 0 -0.31 38 38
BMP2-4/GREM1 -0.08 0.16 -9999 0 -0.31 62 62
SMAD7 0.024 0.038 -9999 0 -0.47 1 1
SMAD8A/SMAD8A/SMAD4 -0.076 0.21 -9999 0 -0.49 37 37
SMAD1/SMAD6 0.012 0.11 -9999 0 -0.44 7 7
TAK1/SMAD6 0.051 0.015 -9999 0 -10000 0 0
BMP7 -0.097 0.18 -9999 0 -0.34 67 67
BMP6 0.014 0.092 -9999 0 -0.31 14 14
MAP3K7IP2 0 0 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM/SMAD7/SMURF1 -0.06 0.15 -9999 0 -0.4 24 24
PPM1A 0.034 0.012 -9999 0 -10000 0 0
SMAD1/SMURF2 0.009 0.12 -9999 0 -0.43 8 8
SMAD7/SMURF1 0.035 0.037 -9999 0 -0.34 1 1
CTDSPL 0.017 0.093 -9999 0 -0.38 10 10
PPP1CA 0.033 0.031 -9999 0 -0.19 4 4
XIAP 0 0 -9999 0 -10000 0 0
CTDSP1 0.038 0.003 -9999 0 -10000 0 0
PPP1R15A 0.034 0.027 -9999 0 -0.19 3 3
BMP2-4/BMPR2/BMPR1A-1B/RGM/FS -0.06 0.15 -9999 0 -0.37 26 26
CHRD 0.037 0.004 -9999 0 -10000 0 0
BMPR2 0.038 0.003 -9999 0 -10000 0 0
BMP2-4/BMPR2/BMPR1A-1B/RGM -0.056 0.14 -9999 0 -0.38 23 23
BMP4 -0.045 0.17 -9999 0 -0.36 43 43
FST 0.019 0.092 -9999 0 -0.41 9 9
BMP2-4/NOG -0.029 0.14 -9999 0 -0.3 38 38
BMP7/BMPR2/BMPR1A-1B/SMAD6/SMURF1 -0.035 0.12 -9999 0 -0.25 36 36
TCR signaling in naïve CD8+ T cells

Figure S28.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S28.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GRB2/SOS1/SHC -0.022 0.19 0.3 5 -0.52 19 24
FYN -0.067 0.23 -10000 0 -0.65 22 22
LAT/GRAP2/SLP76 -0.049 0.21 -10000 0 -0.51 27 27
IKBKB 0.032 0.013 -10000 0 -10000 0 0
AKT1 -0.058 0.16 0.24 2 -0.41 29 31
B2M 0.016 0.084 -10000 0 -0.33 10 10
IKBKG -0.013 0.055 0.16 2 -0.14 16 18
MAP3K8 0.009 0.1 -10000 0 -0.3 18 18
mol:Ca2+ -0.014 0.021 0.088 3 -0.068 3 6
integrin-mediated signaling pathway 0.038 0.046 -10000 0 -0.28 3 3
LAT/GRAP2/SLP76/VAV1/PI3K Class IA -0.082 0.23 0.3 1 -0.6 28 29
TRPV6 0.042 0.25 1.2 10 -10000 0 10
CD28 0.003 0.12 -10000 0 -0.33 20 20
SHC1 -0.058 0.22 0.3 5 -0.61 22 27
receptor internalization -0.065 0.25 -10000 0 -0.65 26 26
PRF1 -0.069 0.25 -10000 0 -0.84 15 15
KRAS 0.033 0.038 -10000 0 -0.33 2 2
GRB2 0.036 0.007 -10000 0 -10000 0 0
COT/AKT1 -0.042 0.14 0.23 2 -0.33 32 34
LAT -0.062 0.22 0.3 1 -0.62 22 23
EntrezGene:6955 -0.001 0.003 -10000 0 -10000 0 0
CD3D 0.001 0.12 -10000 0 -0.37 19 19
CD3E 0.035 0.018 -10000 0 -0.19 1 1
CD3G -0.022 0.15 -10000 0 -0.34 33 33
RASGRP2 0 0.035 -10000 0 -0.16 7 7
RASGRP1 -0.033 0.17 0.34 1 -0.43 23 24
HLA-A 0.004 0.12 -10000 0 -0.38 17 17
RASSF5 0.024 0.068 -10000 0 -0.29 8 8
RAP1A/GTP/RAPL 0.038 0.047 -10000 0 -0.29 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
mol:GDP 0.014 0.07 0.22 5 -0.13 12 17
PDK1/CARD11/BCL10/MALT1/TRAF6 -0.039 0.076 -10000 0 -0.2 27 27
PRKCA 0.001 0.12 0.17 11 -0.26 21 32
GRAP2 0.021 0.079 -10000 0 -0.39 7 7
mol:IP3 -0.054 0.14 -10000 0 -0.41 23 23
EntrezGene:6957 -0.001 0.004 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8 -0.055 0.21 -10000 0 -0.59 22 22
ORAI1 -0.041 0.21 -10000 0 -0.96 10 10
CSK -0.058 0.22 0.27 1 -0.62 21 22
B7 family/CD28 -0.066 0.26 -10000 0 -0.62 27 27
CHUK 0.031 0.049 -10000 0 -0.47 2 2
TCR/CD3/MHC I/CD8/LCK/ZAP-70 -0.07 0.25 -10000 0 -0.7 23 23
PTPN6 -0.067 0.22 -10000 0 -0.62 22 22
VAV1 -0.074 0.24 0.32 1 -0.64 25 26
Monovalent TCR/CD3 -0.042 0.19 -10000 0 -0.5 25 25
CBL 0.037 0.006 -10000 0 -10000 0 0
LCK -0.072 0.24 -10000 0 -0.65 25 25
PAG1 -0.052 0.22 0.25 1 -0.59 23 24
RAP1A 0.036 0.009 -10000 0 -10000 0 0
TCR/CD3/MHC I/CD8/LCK -0.072 0.26 -10000 0 -0.71 23 23
CD80 0.028 0.043 -10000 0 -0.19 8 8
CD86 -0.042 0.17 -10000 0 -0.36 42 42
PDK1/CARD11/BCL10/MALT1 -0.035 0.098 0.13 1 -0.24 27 28
HRAS 0.034 0.038 -10000 0 -0.33 2 2
GO:0035030 -0.078 0.2 -10000 0 -0.5 28 28
CD8A -0.001 0.004 -10000 0 -10000 0 0
CD8B 0.017 0.091 -10000 0 -0.35 11 11
PTPRC -0.023 0.15 -10000 0 -0.36 32 32
PDK1/PKC theta -0.062 0.2 0.31 2 -0.5 26 28
CSK/PAG1 -0.047 0.21 0.26 2 -0.58 21 23
SOS1 0.038 0.003 -10000 0 -10000 0 0
peptide-MHC class I 0.012 0.12 -10000 0 -0.37 15 15
GRAP2/SLP76 -0.054 0.24 -10000 0 -0.6 26 26
STIM1 -0.005 0.11 1.2 1 -0.94 1 2
RAS family/GTP 0.01 0.084 0.23 3 -0.18 10 13
TCR/CD3/MHC I/CD8/LCK/ZAP-70/CBL/ubiquitin -0.072 0.27 -10000 0 -0.68 27 27
mol:DAG -0.057 0.12 -10000 0 -0.35 25 25
RAP1A/GDP 0.012 0.035 0.14 3 -0.064 6 9
PLCG1 0.02 0.019 -10000 0 -10000 0 0
CD247 -0.012 0.14 -10000 0 -0.35 27 27
cytotoxic T cell degranulation -0.066 0.24 -10000 0 -0.76 17 17
RAP1A/GTP 0.001 0.014 -10000 0 -0.061 7 7
mol:PI-3-4-5-P3 -0.065 0.19 0.29 1 -0.48 28 29
LAT/GRAP2/SLP76/VAV1/PLCgamma1 -0.067 0.18 -10000 0 -0.53 23 23
NRAS 0.021 0.076 -10000 0 -0.31 9 9
ZAP70 0.032 0.051 -10000 0 -0.38 3 3
GRB2/SOS1 0.054 0.011 -10000 0 -10000 0 0
LAT/GRAP2/SLP76/VAV1 -0.059 0.21 0.3 1 -0.51 28 29
MALT1 0.023 0.038 -10000 0 -0.47 1 1
TRAF6 0.037 0.005 -10000 0 -10000 0 0
CD8 heterodimer 0.012 0.065 -10000 0 -0.24 11 11
CARD11 -0.007 0.093 -10000 0 -0.2 36 36
PRKCB -0.043 0.084 -10000 0 -0.25 25 25
PRKCE 0.002 0.12 0.17 12 -0.26 21 33
PRKCQ -0.071 0.22 0.31 1 -0.58 26 27
LCP2 -0.021 0.15 -10000 0 -0.36 32 32
BCL10 0.034 0.035 -10000 0 -0.47 1 1
regulation of survival gene product expression -0.047 0.14 0.23 2 -0.35 29 31
IKK complex 0.024 0.076 0.15 28 -0.11 8 36
RAS family/GDP -0.005 0.015 -10000 0 -0.056 5 5
MAP3K14 -0.033 0.11 0.19 2 -0.27 26 28
PDPK1 -0.05 0.15 0.24 3 -0.38 28 31
TCR/CD3/MHC I/CD8/Fyn -0.067 0.24 -10000 0 -0.66 23 23
EPHB forward signaling

Figure S29.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S29.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Ephrin A5/EPHB2 0.022 0.085 -10000 0 -0.29 14 14
cell-cell adhesion 0.055 0.11 0.28 32 -10000 0 32
Ephrin B/EPHB2/RasGAP 0.013 0.13 -10000 0 -0.28 27 27
ITSN1 0.036 0.008 -10000 0 -10000 0 0
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
SHC1 0.037 0.006 -10000 0 -10000 0 0
Ephrin B1/EPHB3 -0.004 0.13 -10000 0 -0.3 31 31
Ephrin B1/EPHB1 -0.023 0.11 -10000 0 -0.3 21 21
HRAS/GDP -0.037 0.13 -10000 0 -0.36 17 17
Ephrin B/EPHB1/GRB7 -0.014 0.12 -10000 0 -0.27 28 28
Endophilin/SYNJ1 0.026 0.12 -10000 0 -0.25 23 23
KRAS 0.033 0.038 -10000 0 -0.33 2 2
Ephrin B/EPHB1/Src -0.01 0.11 -10000 0 -0.29 19 19
endothelial cell migration 0.027 0.092 -10000 0 -0.26 16 16
GRB2 0.036 0.007 -10000 0 -10000 0 0
GRB7 0.03 0.049 -10000 0 -0.47 2 2
PAK1 0.03 0.13 0.36 1 -0.26 20 21
HRAS 0.034 0.038 -10000 0 -0.33 2 2
RRAS 0.028 0.13 -10000 0 -0.25 26 26
DNM1 0.033 0.031 -10000 0 -0.19 4 4
cell-cell signaling 0 0 -10000 0 -10000 0 0
CRK -0.008 0.12 0.36 1 -0.26 27 28
lamellipodium assembly -0.055 0.11 -10000 0 -0.28 32 32
Ephrin B/EPHB1/Src/p52 SHC/GRB2 -0.011 0.11 -10000 0 -0.42 7 7
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
EPHB2 0.006 0.12 -10000 0 -0.47 12 12
EPHB3 -0.039 0.18 -10000 0 -0.44 34 34
EPHB1 -0.066 0.16 -10000 0 -0.26 75 75
EPHB4 0.026 0.065 -10000 0 -0.33 6 6
mol:GDP -0.014 0.13 0.28 7 -0.38 16 23
Ephrin B/EPHB2 0.008 0.11 -10000 0 -0.26 25 25
Ephrin B/EPHB3 -0.008 0.12 -10000 0 -0.26 36 36
JNK cascade -0.053 0.13 0.34 4 -0.3 35 39
Ephrin B/EPHB1 -0.018 0.12 -10000 0 -0.27 27 27
RAP1/GDP -0.009 0.15 0.29 8 -0.35 16 24
EFNB2 -0.005 0.12 -10000 0 -0.45 14 14
EFNB3 0.03 0.015 -10000 0 -10000 0 0
EFNB1 0.031 0.053 -10000 0 -0.33 4 4
Ephrin B2/EPHB1-2 -0.041 0.13 -10000 0 -0.29 35 35
RAP1B 0.035 0.035 -10000 0 -0.47 1 1
RAP1A 0.036 0.009 -10000 0 -10000 0 0
CDC42/GTP -0.045 0.14 -10000 0 -0.34 26 26
Rap1/GTP -0.048 0.12 -10000 0 -0.38 12 12
axon guidance 0.022 0.085 -10000 0 -0.29 14 14
MAPK3 -0.006 0.11 -10000 0 -0.38 9 9
MAPK1 0 0.1 -10000 0 -0.38 7 7
Rac1/GDP -0.025 0.13 0.26 4 -0.37 15 19
actin cytoskeleton reorganization -0.059 0.1 -10000 0 -0.33 14 14
CDC42/GDP -0.014 0.15 0.3 10 -0.36 16 26
PI3K 0.032 0.095 -10000 0 -0.26 16 16
EFNA5 0.031 0.051 -10000 0 -0.38 3 3
Ephrin B2/EPHB4 0.012 0.083 -10000 0 -0.29 14 14
Ephrin B/EPHB2/Intersectin/N-WASP -0.014 0.11 -10000 0 -0.41 8 8
CDC42 0.034 0.018 -10000 0 -0.19 1 1
RAS family/GTP -0.056 0.12 -10000 0 -0.37 14 14
PTK2 0.11 0.22 0.59 37 -10000 0 37
MAP4K4 -0.054 0.13 0.34 4 -0.3 35 39
SRC 0.013 0.06 -10000 0 -0.47 3 3
KALRN 0.037 0.006 -10000 0 -10000 0 0
Intersectin/N-WASP 0.049 0.031 -10000 0 -0.34 1 1
neuron projection morphogenesis -0.019 0.16 0.42 9 -0.37 10 19
MAP2K1 -0.009 0.1 -10000 0 -0.4 7 7
WASL 0.034 0.035 -10000 0 -0.47 1 1
Ephrin B1/EPHB1-2/NCK1 -0.021 0.15 -10000 0 -0.3 33 33
cell migration 0.019 0.15 0.29 11 -0.45 7 18
NRAS 0.021 0.076 -10000 0 -0.31 9 9
SYNJ1 0.026 0.13 -10000 0 -0.25 23 23
PXN 0.037 0.004 -10000 0 -10000 0 0
TF 0.007 0.13 0.2 2 -0.43 3 5
HRAS/GTP -0.039 0.13 -10000 0 -0.29 33 33
Ephrin B1/EPHB1-2 -0.026 0.13 -10000 0 -0.3 30 30
cell adhesion mediated by integrin -0.015 0.12 0.26 14 -0.2 47 61
RAC1 0.034 0.012 -10000 0 -10000 0 0
mol:GTP -0.037 0.14 -10000 0 -0.3 35 35
RAC1-CDC42/GTP -0.078 0.14 -10000 0 -0.38 25 25
RASA1 0.026 0.07 -10000 0 -0.41 5 5
RAC1-CDC42/GDP -0.017 0.14 0.26 5 -0.35 15 20
ruffle organization -0.015 0.17 0.39 13 -0.41 10 23
NCK1 0.028 0.069 -10000 0 -0.47 4 4
receptor internalization 0.008 0.12 0.2 2 -0.43 2 4
Ephrin B/EPHB2/KALRN 0.018 0.12 -10000 0 -0.26 25 25
ROCK1 -0.026 0.11 -10000 0 -0.28 31 31
RAS family/GDP -0.06 0.1 -10000 0 -0.36 12 12
Rac1/GTP -0.054 0.12 -10000 0 -0.29 32 32
Ephrin B/EPHB1/Src/Paxillin -0.018 0.11 -10000 0 -0.29 20 20
FOXM1 transcription factor network

Figure S30.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S30.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NFATC3 -0.098 0.42 -9999 0 -1.2 18 18
PLK1 0.022 0.17 -9999 0 -1.2 4 4
BIRC5 -0.016 0.27 -9999 0 -1.2 10 10
HSPA1B -0.099 0.42 -9999 0 -1.1 20 20
MAP2K1 0.025 0.05 -9999 0 -10000 0 0
BRCA2 -0.069 0.45 -9999 0 -1.2 19 19
FOXM1 -0.16 0.59 -9999 0 -1.6 20 20
XRCC1 -0.095 0.42 -9999 0 -1.1 19 19
FOXM1B/p19 -0.15 0.46 -9999 0 -1.2 22 22
Cyclin D1/CDK4 -0.093 0.4 -9999 0 -0.99 23 23
CDC2 -0.11 0.44 -9999 0 -1.2 20 20
TGFA -0.12 0.4 -9999 0 -0.96 26 26
SKP2 -0.1 0.43 -9999 0 -1.2 20 20
CCNE1 0.029 0.056 -9999 0 -0.3 5 5
CKS1B -0.094 0.42 -9999 0 -1.1 18 18
RB1 -0.037 0.24 -9999 0 -0.96 8 8
FOXM1C/SP1 -0.12 0.49 -9999 0 -1.3 21 21
AURKB -0.16 0.43 -9999 0 -0.95 45 45
CENPF -0.1 0.44 -9999 0 -1.2 20 20
CDK4 0.03 0.029 -9999 0 -10000 0 0
MYC -0.1 0.38 -9999 0 -0.96 21 21
CHEK2 0.023 0.062 -9999 0 -0.52 1 1
ONECUT1 -0.11 0.42 -9999 0 -1 23 23
CDKN2A -0.033 0.14 -9999 0 -0.3 43 43
LAMA4 -0.1 0.42 -9999 0 -1.2 18 18
FOXM1B/HNF6 -0.14 0.49 -9999 0 -1.3 23 23
FOS -0.22 0.56 -9999 0 -1.2 46 46
SP1 0.034 0.021 -9999 0 -0.19 1 1
CDC25B -0.12 0.51 -9999 0 -1.2 29 29
response to radiation 0.003 0.027 -9999 0 -10000 0 0
CENPB -0.074 0.43 -9999 0 -1.1 17 17
CENPA -0.1 0.43 -9999 0 -1.2 18 18
NEK2 -0.1 0.43 -9999 0 -1.2 19 19
HIST1H2BA -0.099 0.42 -9999 0 -1.1 19 19
CCNA2 0.021 0.091 -9999 0 -0.47 7 7
EP300 0.017 0.091 -9999 0 -0.43 8 8
CCNB1/CDK1 -0.14 0.51 -9999 0 -1.5 19 19
CCNB2 -0.11 0.44 -9999 0 -1.2 20 20
CCNB1 -0.11 0.46 -9999 0 -1.3 19 19
ETV5 -0.13 0.46 -9999 0 -1.2 21 21
ESR1 -0.11 0.44 -9999 0 -1.2 20 20
CCND1 -0.11 0.4 -9999 0 -1 23 23
GSK3A 0.027 0.045 -9999 0 -10000 0 0
Cyclin A-E1/CDK1-2 0.035 0.1 -9999 0 -0.29 12 12
CDK2 0.022 0.072 -9999 0 -0.26 11 11
G2/M transition of mitotic cell cycle 0.003 0.033 -9999 0 -10000 0 0
FOXM1B/Cbp/p300 -0.11 0.46 -9999 0 -1.2 20 20
GAS1 -0.25 0.59 -9999 0 -1.2 51 51
MMP2 -0.12 0.45 -9999 0 -1.2 21 21
RB1/FOXM1C -0.12 0.4 -9999 0 -1 23 23
CREBBP 0.034 0.035 -9999 0 -0.47 1 1
Signaling events mediated by Stem cell factor receptor (c-Kit)

Figure S31.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S31.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K1 -0.052 0.14 -10000 0 -0.41 22 22
CRKL -0.054 0.15 -10000 0 -0.43 23 23
HRAS -0.034 0.15 -10000 0 -0.39 24 24
mol:PIP3 -0.038 0.15 -10000 0 -0.39 25 25
SPRED1 0.016 0.096 -10000 0 -0.47 8 8
SPRED2 0.033 0.049 -10000 0 -0.47 2 2
GAB1 -0.054 0.15 -10000 0 -0.43 25 25
FOXO3 -0.069 0.19 0.34 1 -0.47 28 29
AKT1 -0.071 0.2 -10000 0 -0.5 28 28
BAD -0.067 0.19 -10000 0 -0.47 27 27
megakaryocyte differentiation -0.097 0.17 -10000 0 -0.46 28 28
GSK3B -0.065 0.19 0.38 1 -0.47 26 27
RAF1 -0.032 0.12 -10000 0 -0.32 23 23
SHC1 0.037 0.006 -10000 0 -10000 0 0
STAT3 -0.05 0.15 -10000 0 -0.44 22 22
STAT1 -0.13 0.36 -10000 0 -1 26 26
HRAS/SPRED1 -0.026 0.14 -10000 0 -0.34 25 25
cell proliferation -0.049 0.15 -10000 0 -0.42 24 24
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
TEC 0.037 0.004 -10000 0 -10000 0 0
RPS6KB1 -0.051 0.17 -10000 0 -0.44 28 28
HRAS/SPRED2 -0.02 0.14 -10000 0 -0.33 25 25
LYN/TEC/p62DOK -0.012 0.16 -10000 0 -0.41 21 21
MAPK3 -0.021 0.096 -10000 0 -0.29 11 11
STAP1 -0.062 0.15 -10000 0 -0.43 26 26
GRAP2 0.021 0.079 -10000 0 -0.39 7 7
JAK2 -0.098 0.29 -10000 0 -0.82 26 26
STAT1 (dimer) -0.12 0.35 -10000 0 -1 26 26
mol:Gleevec 0.002 0.007 -10000 0 -10000 0 0
GRB2/SOCS1/VAV1 -0.027 0.19 -10000 0 -0.47 24 24
actin filament polymerization -0.048 0.15 -10000 0 -0.42 25 25
LYN 0.032 0.013 -10000 0 -10000 0 0
STAP1/STAT5A (dimer) -0.082 0.21 -10000 0 -0.6 26 26
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
CBL/CRKL/GRB2 -0.025 0.15 -10000 0 -0.4 22 22
PI3K -0.024 0.17 -10000 0 -0.41 26 26
PTEN 0.031 0.049 -10000 0 -0.47 2 2
SCF/KIT/EPO/EPOR -0.12 0.44 -10000 0 -1.3 22 22
MAPK8 -0.05 0.15 -10000 0 -0.43 24 24
STAT3 (dimer) -0.049 0.15 -10000 0 -0.43 22 22
positive regulation of transcription -0.016 0.081 -10000 0 -0.23 11 11
mol:GDP -0.034 0.16 -10000 0 -0.42 23 23
PIK3C2B -0.052 0.16 -10000 0 -0.42 27 27
CBL/CRKL -0.039 0.15 -10000 0 -0.41 23 23
FER -0.056 0.15 -10000 0 -0.44 25 25
SH2B3 -0.052 0.15 -10000 0 -0.43 25 25
PDPK1 -0.035 0.14 0.26 1 -0.37 23 24
SNAI2 -0.06 0.16 -10000 0 -0.44 26 26
positive regulation of cell proliferation -0.086 0.26 -10000 0 -0.72 26 26
KITLG 0.009 0.087 -10000 0 -0.28 14 14
cell motility -0.086 0.26 -10000 0 -0.72 26 26
PTPN6 0.039 0.012 -10000 0 -10000 0 0
EPOR -0.008 0.15 -10000 0 -0.9 2 2
STAT5A (dimer) -0.068 0.22 -10000 0 -0.61 25 25
SOCS1 0.029 0.061 -10000 0 -0.4 4 4
cell migration 0.049 0.15 0.43 23 -10000 0 23
SOS1 0.038 0.003 -10000 0 -10000 0 0
EPO 0.027 0.031 -10000 0 -0.19 2 2
VAV1 0 0.13 -10000 0 -0.41 18 18
GRB10 -0.061 0.15 -10000 0 -0.41 26 26
PTPN11 0.033 0.051 -10000 0 -0.37 3 3
SCF/KIT -0.05 0.16 -10000 0 -0.45 25 25
GO:0007205 0.003 0.008 -10000 0 -10000 0 0
MAP2K1 -0.026 0.098 -10000 0 -0.29 10 10
CBL 0.037 0.006 -10000 0 -10000 0 0
KIT -0.13 0.44 -10000 0 -1.4 23 23
MAP2K2 -0.026 0.097 -10000 0 -0.29 9 9
SHC/Grb2/SOS1 -0.006 0.17 -10000 0 -0.43 21 21
STAT5A -0.072 0.22 -10000 0 -0.63 25 25
GRB2 0.036 0.007 -10000 0 -10000 0 0
response to radiation -0.059 0.16 -10000 0 -0.44 25 25
SHC/GRAP2 0.04 0.062 -10000 0 -0.34 5 5
PTPRO -0.099 0.18 -10000 0 -0.46 29 29
SH2B2 -0.05 0.15 -10000 0 -0.43 25 25
DOK1 0.034 0.038 -10000 0 -0.33 2 2
MATK -0.05 0.15 -10000 0 -0.44 23 23
CREBBP 0.018 0.067 -10000 0 -0.47 1 1
BCL2 -0.24 0.47 -10000 0 -1.4 25 25
amb2 Integrin signaling

Figure S32.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S32.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaM/beta2 Integrin/proMMP-2 -0.027 0.14 -10000 0 -0.34 28 28
alphaM/beta2 Integrin/GPIbA -0.019 0.12 -10000 0 -0.3 23 23
alphaM/beta2 Integrin/proMMP-9 -0.029 0.12 -10000 0 -0.33 23 23
PLAUR 0.016 0.09 -10000 0 -0.33 12 12
HMGB1 0.009 0.049 -10000 0 -0.33 2 2
alphaM/beta2 Integrin/Talin -0.012 0.12 -10000 0 -0.3 23 23
AGER 0.011 0.044 -10000 0 -10000 0 0
RAP1A 0.036 0.009 -10000 0 -10000 0 0
SELPLG 0.016 0.091 -10000 0 -0.32 13 13
mol:LDL 0 0 -10000 0 -10000 0 0
alphaM/beta2 Integrin/RAGE/HMGB1 -0.021 0.14 -10000 0 -0.33 19 19
mol:GTP 0 0 -10000 0 -10000 0 0
MMP9 -0.009 0.1 -10000 0 -0.31 18 18
CYR61 -0.006 0.12 -10000 0 -0.29 28 28
TLN1 0.037 0.006 -10000 0 -10000 0 0
Rap1/GTP -0.007 0.13 -10000 0 -0.4 12 12
RHOA 0.037 0.005 -10000 0 -10000 0 0
P-selectin oligomer -0.051 0.18 -10000 0 -0.36 47 47
MYH2 -0.032 0.14 -10000 0 -0.52 11 11
MST1R 0.03 0.06 -10000 0 -0.47 3 3
leukocyte activation during inflammatory response -0.018 0.13 -10000 0 -0.28 28 28
APOB 0.006 0.12 -10000 0 -0.45 14 14
mol:GDP 0 0 -10000 0 -10000 0 0
complement component iC3b receptor activity 0 0 -10000 0 -10000 0 0
MMP2 0.007 0.1 -10000 0 -0.29 20 20
JAM3 0.028 0.043 -10000 0 -0.19 8 8
GP1BA 0.028 0.026 -10000 0 -0.19 2 2
alphaM/beta2 Integrin/CTGF -0.016 0.13 -10000 0 -0.31 22 22
alphaM/beta2 Integrin -0.028 0.13 -10000 0 -0.42 13 13
JAM3 homodimer 0.028 0.043 -10000 0 -0.19 8 8
ICAM2 0.015 0.09 -10000 0 -0.33 12 12
ICAM1 0.01 0.089 -10000 0 -0.24 20 20
phagocytosis triggered by activation of immune response cell surface activating receptor -0.028 0.13 -10000 0 -0.42 13 13
cell adhesion -0.02 0.12 -10000 0 -0.3 23 23
NFKB1 -0.062 0.21 0.4 3 -0.39 43 46
THY1 0.017 0.089 -10000 0 -0.34 11 11
RhoA/GDP 0.027 0.004 -10000 0 -10000 0 0
Lipoprotein(a) 0.027 0.081 -10000 0 -0.29 13 13
alphaM/beta2 Integrin/LRP/tPA -0.009 0.14 -10000 0 -0.3 25 25
IL6 -0.16 0.32 -10000 0 -0.66 53 53
ITGB2 -0.036 0.13 -10000 0 -0.33 29 29
elevation of cytosolic calcium ion concentration -0.032 0.17 -10000 0 -0.36 33 33
alphaM/beta2 Integrin/JAM2/JAM3 -0.025 0.16 -10000 0 -0.35 30 30
JAM2 -0.01 0.13 -10000 0 -0.36 24 24
alphaM/beta2 Integrin/ICAM1 0.008 0.15 -10000 0 -0.3 32 32
alphaM/beta2 Integrin/uPA/Plg -0.024 0.16 -10000 0 -0.34 31 31
RhoA/GTP -0.024 0.14 -10000 0 -0.5 11 11
positive regulation of phagocytosis -0.039 0.13 -10000 0 -0.44 15 15
Ron/MSP 0.034 0.073 -10000 0 -0.34 5 5
alphaM/beta2 Integrin/uPAR/uPA -0.031 0.17 -10000 0 -0.36 33 33
alphaM/beta2 Integrin/uPAR -0.023 0.13 -10000 0 -0.3 30 30
PLAU -0.012 0.14 -10000 0 -0.34 27 27
PLAT 0.012 0.093 -10000 0 -0.38 10 10
actin filament polymerization -0.031 0.13 -10000 0 -0.51 10 10
MST1 0.018 0.073 -10000 0 -0.22 16 16
alphaM/beta2 Integrin/lipoprotein(a) -0.014 0.13 -10000 0 -0.29 28 28
TNF -0.067 0.2 0.3 2 -0.52 15 17
RAP1B 0.035 0.035 -10000 0 -0.47 1 1
alphaM/beta2 Integrin/uPA -0.04 0.16 -10000 0 -0.36 34 34
fibrinolysis -0.025 0.16 -10000 0 -0.34 31 31
HCK -0.01 0.11 -10000 0 -0.35 17 17
dendritic cell antigen processing and presentation -0.028 0.13 -10000 0 -0.42 13 13
VTN 0.036 0.008 -10000 0 -10000 0 0
alphaM/beta2 Integrin/CYR61 -0.039 0.15 -10000 0 -0.33 33 33
LPA 0.036 0.008 -10000 0 -10000 0 0
LRP1 0.037 0.004 -10000 0 -10000 0 0
cell migration -0.037 0.13 -10000 0 -0.32 27 27
FN1 -0.014 0.13 -10000 0 -0.28 35 35
alphaM/beta2 Integrin/Thy1 -0.024 0.15 -10000 0 -0.35 25 25
MPO 0.023 0.052 -10000 0 -0.19 12 12
KNG1 0.004 0.11 -10000 0 -0.29 22 22
RAP1/GDP 0.046 0.026 -10000 0 -0.29 1 1
ROCK1 -0.023 0.13 -10000 0 -0.55 8 8
ELA2 0 0 -10000 0 -10000 0 0
PLG 0.033 0.035 -10000 0 -0.47 1 1
CTGF 0.03 0.038 -10000 0 -0.19 6 6
alphaM/beta2 Integrin/Hck -0.027 0.13 -10000 0 -0.35 23 23
ITGAM -0.009 0.094 -10000 0 -0.29 14 14
alphaM/beta2 Integrin/P-Selectin/PSGL1 -0.056 0.18 -10000 0 -0.34 47 47
HP 0.032 0.049 -10000 0 -0.47 2 2
leukocyte adhesion -0.028 0.18 -10000 0 -0.48 18 18
SELP -0.051 0.18 -10000 0 -0.36 47 47
Syndecan-2-mediated signaling events

Figure S33.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S33.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Syndecan-2/Fibronectin -0.01 0.11 -10000 0 -0.36 16 16
EPHB2 0.006 0.12 -10000 0 -0.47 12 12
Syndecan-2/TACI 0.009 0.069 -10000 0 -0.26 11 11
LAMA1 0.028 0.016 -10000 0 -10000 0 0
Syndecan-2/alpha2 ITGB1 0.025 0.11 -10000 0 -0.25 20 20
HRAS 0.034 0.038 -10000 0 -0.33 2 2
Syndecan-2/CASK -0.006 0.063 -10000 0 -0.27 11 11
ITGA5 0.028 0.045 -10000 0 -0.19 9 9
BAX -0.011 0.086 -10000 0 -0.95 1 1
EPB41 0.029 0.044 -10000 0 -0.26 4 4
positive regulation of cell-cell adhesion 0.012 0.064 -10000 0 -0.24 11 11
LAMA3 0.005 0.089 -10000 0 -0.28 16 16
EZR 0 0 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
CAV2 -0.009 0.13 -10000 0 -0.31 28 28
Syndecan-2/MMP2 0.001 0.099 -10000 0 -0.31 16 16
RP11-540L11.1 0 0 -10000 0 -10000 0 0
alpha2 ITGB1 0.035 0.082 -10000 0 -0.34 9 9
dendrite morphogenesis -0.002 0.092 -10000 0 -0.27 21 21
Syndecan-2/GM-CSF -0.036 0.12 -10000 0 -0.28 33 33
determination of left/right symmetry -0.006 0.075 -10000 0 -0.32 11 11
Syndecan-2/PKC delta 0.014 0.071 -10000 0 -0.27 11 11
GNB2L1 0.035 0.035 -10000 0 -0.47 1 1
MAPK3 -0.024 0.13 0.2 23 -0.27 33 56
MAPK1 -0.018 0.12 0.2 22 -0.27 27 49
Syndecan-2/RACK1 0.027 0.076 -10000 0 -0.26 11 11
NF1 0.036 0.008 -10000 0 -10000 0 0
FGFR/FGF/Syndecan-2 -0.006 0.075 -10000 0 -0.32 11 11
ITGA2 0.013 0.1 -10000 0 -0.4 12 12
MAPK8 -0.006 0.069 -10000 0 -0.29 11 11
Syndecan-2/alpha2/beta1 Integrin 0.041 0.099 -10000 0 -0.24 16 16
Syndecan-2/Kininogen -0.002 0.093 -10000 0 -0.28 18 18
ITGB1 0.036 0.016 -10000 0 -0.19 1 1
SRC 0.008 0.065 -10000 0 -0.25 8 8
Syndecan-2/CASK/Protein 4.1 0.01 0.067 -10000 0 -0.24 12 12
extracellular matrix organization 0.014 0.07 -10000 0 -0.27 11 11
actin cytoskeleton reorganization -0.01 0.11 -10000 0 -0.35 16 16
Syndecan-2/Caveolin-2/Ras 0.005 0.11 -10000 0 -0.33 16 16
Syndecan-2/Laminin alpha3 -0.006 0.082 -10000 0 -0.28 15 15
Syndecan-2/RasGAP 0.038 0.084 -10000 0 -0.25 13 13
alpha5/beta1 Integrin 0.046 0.039 -10000 0 -10000 0 0
PRKCD 0.037 0.005 -10000 0 -10000 0 0
Syndecan-2 dimer -0.002 0.093 -10000 0 -0.27 21 21
GO:0007205 0.002 0.011 -10000 0 -10000 0 0
DNA mediated transformation 0 0 -10000 0 -10000 0 0
Syndecan-2/RasGAP/Src 0.01 0.061 -10000 0 -0.24 8 8
RHOA 0.037 0.005 -10000 0 -10000 0 0
SDCBP 0.032 0.02 -10000 0 -0.19 1 1
TNFRSF13B 0.03 0.015 -10000 0 -10000 0 0
RASA1 0.026 0.07 -10000 0 -0.41 5 5
alpha2/beta1 Integrin 0.035 0.082 -10000 0 -0.34 9 9
Syndecan-2/Synbindin 0.014 0.07 -10000 0 -0.27 11 11
TGFB1 0.035 0.017 -10000 0 -0.19 1 1
CASP3 0.024 0.09 0.2 26 -0.25 11 37
FN1 -0.014 0.13 -10000 0 -0.28 35 35
Syndecan-2/IL8 -0.07 0.15 -10000 0 -0.31 49 49
SDC2 -0.006 0.076 -10000 0 -0.32 11 11
KNG1 0.004 0.11 -10000 0 -0.29 22 22
Syndecan-2/Neurofibromin 0.013 0.071 -10000 0 -0.27 11 11
TRAPPC4 0.037 0.006 -10000 0 -10000 0 0
CSF2 -0.066 0.18 -10000 0 -0.31 63 63
Syndecan-2/TGFB1 0.014 0.071 -10000 0 -0.27 11 11
Syndecan-2/Syntenin/PI-4-5-P2 0.013 0.064 -10000 0 -0.24 11 11
Syndecan-2/Ezrin 0.013 0.064 -10000 0 -0.24 11 11
PRKACA 0.03 0.092 0.2 31 -0.25 11 42
angiogenesis -0.07 0.15 -10000 0 -0.31 49 49
MMP2 0.007 0.1 -10000 0 -0.29 20 20
IL8 -0.13 0.21 -10000 0 -0.35 94 94
calcineurin-NFAT signaling pathway 0.009 0.069 -10000 0 -0.26 11 11
Arf6 signaling events

Figure S34.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S34.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CENTA1/KIF3B 0.017 0.023 -10000 0 -0.28 1 1
ARNO/beta Arrestin1-2 0.001 0.086 -10000 0 -0.23 20 20
EGFR 0.018 0.086 -10000 0 -0.4 8 8
EPHA2 0.014 0.083 -10000 0 -0.26 15 15
USP6 0.03 0.015 -10000 0 -10000 0 0
IQSEC1 0.036 0.016 -10000 0 -0.19 1 1
EGFR/EGFR/EGF/EGF -0.049 0.14 -10000 0 -0.34 34 34
ARRB2 0.01 0.047 -10000 0 -0.36 3 3
mol:GTP 0.005 0.021 0.12 5 -10000 0 5
ARRB1 0.02 0.091 -10000 0 -0.43 8 8
FBXO8 0.036 0.008 -10000 0 -10000 0 0
TSHR 0.031 0.036 -10000 0 -0.47 1 1
EGF -0.087 0.18 -10000 0 -0.3 78 78
somatostatin receptor activity 0 0 0.001 12 -0.001 15 27
ARAP2 0 0 0 13 0 12 25
mol:GDP 0.004 0.074 0.17 6 -0.23 9 15
mol:PI-3-4-5-P3 0 0 0 12 0 16 28
ITGA2B 0.036 0.008 -10000 0 -10000 0 0
ARF6 0.029 0.05 -10000 0 -0.47 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.049 0.098 -10000 0 -0.28 12 12
ADAP1 0 0 0 9 0 4 13
KIF13B 0.026 0.038 -10000 0 -0.47 1 1
HGF/MET 0.046 0.049 -10000 0 -0.38 2 2
PXN 0.037 0.004 -10000 0 -10000 0 0
ARF6/GTP 0.001 0.1 0.22 9 -0.21 17 26
EGFR/EGFR/EGF/EGF/ARFGEP100 -0.028 0.13 -10000 0 -0.29 34 34
ADRB2 0.002 0.12 -10000 0 -0.38 18 18
receptor agonist activity 0 0 0 12 0 13 25
actin filament binding 0 0 0 12 0 15 27
SRC 0.013 0.06 -10000 0 -0.47 3 3
ITGB3 0.035 0.017 -10000 0 -0.19 1 1
GNAQ 0 0 0.001 13 -0.001 10 23
EFA6/PI-4-5-P2 0 0.001 0.001 16 -0.001 7 23
ARF6/GDP -0.022 0.11 0.18 4 -0.28 25 29
ARF6/GDP/GULP/ACAP1 -0.005 0.12 0.21 2 -0.26 21 23
alphaIIb/beta3 Integrin/paxillin/GIT1 0.088 0.03 -10000 0 -10000 0 0
ACAP1 0 0 0 5 -10000 0 5
ACAP2 0 0 0 13 0 14 27
LHCGR/beta Arrestin2 0.011 0.059 -10000 0 -0.36 3 3
EFNA1 0.023 0.075 -10000 0 -0.33 8 8
HGF 0.034 0.023 -10000 0 -0.19 2 2
CYTH3 0 0 0.001 14 -0.001 12 26
CYTH2 -0.001 0.001 -10000 0 -0.004 18 18
NCK1 0.028 0.069 -10000 0 -0.47 4 4
fibronectin binding 0 0 0 9 0 14 23
endosomal lumen acidification 0 0 0 15 0 11 26
microtubule-based process 0 0 -10000 0 -10000 0 0
GULP1 -0.044 0.17 -10000 0 -0.33 48 48
GNAQ/ARNO 0.001 0.004 0.009 13 -0.006 9 22
mol:Phosphatidic acid 0 0 0 13 0 14 27
PIP3-E 0 0 0 6 0 19 25
MET 0.029 0.054 -10000 0 -0.33 4 4
GNA14 -0.015 0.14 -10000 0 -0.35 29 29
GNA15 0.024 0.064 -10000 0 -0.24 10 10
GIT1 0.035 0.017 -10000 0 -0.19 1 1
mol:PI-4-5-P2 0 0 0.001 13 -0.001 11 24
GNA11 0.031 0.051 -10000 0 -0.38 3 3
LHCGR 0.028 0.059 -10000 0 -0.27 7 7
AGTR1 0.009 0.082 -10000 0 -0.21 24 24
desensitization of G-protein coupled receptor protein signaling pathway 0.011 0.059 -10000 0 -0.36 3 3
IPCEF1/ARNO -0.026 0.095 -10000 0 -0.22 34 34
alphaIIb/beta3 Integrin 0.052 0.017 -10000 0 -10000 0 0
IFN-gamma pathway

Figure S35.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S35.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 -0.008 0.14 -10000 0 -0.25 41 41
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
CRKL 0.03 0.049 -10000 0 -0.47 2 2
STAT1 (dimer)/Cbp/p300 -0.047 0.16 0.32 1 -0.36 24 25
IFN-gammaR/JAK1/JAK1/JAK2/JAK2 0.025 0.084 -10000 0 -0.3 5 5
antigen processing and presentation of peptide antigen via MHC class I -0.068 0.12 -10000 0 -0.29 24 24
CaM/Ca2+ -0.004 0.13 -10000 0 -0.23 40 40
RAP1A 0.036 0.009 -10000 0 -10000 0 0
STAT1 (dimer)/SHP2 -0.049 0.12 -10000 0 -0.25 46 46
AKT1 -0.055 0.11 0.32 3 -0.34 6 9
MAP2K1 -0.06 0.1 0.35 2 -0.26 11 13
MAP3K11 -0.051 0.11 0.35 2 -0.25 24 26
IFNGR1 0.017 0.046 -10000 0 -0.47 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKII -0.008 0.11 -10000 0 -0.4 6 6
Rap1/GTP -0.044 0.094 -10000 0 -0.29 6 6
CRKL/C3G 0.047 0.042 -10000 0 -0.34 2 2
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2 /TC-PTP -0.002 0.14 -10000 0 -0.25 38 38
CEBPB -0.022 0.17 0.44 2 -0.48 12 14
STAT3 0.037 0.006 -10000 0 -10000 0 0
IFN-gamma/IFN-gammaR/JAK1/JAK1/JAK2/JAK2/SOCS1 0.002 0.23 -10000 0 -1.1 6 6
STAT1 -0.059 0.12 0.35 2 -0.26 34 36
CALM1 0.033 0.012 -10000 0 -10000 0 0
IFN-gamma (dimer) -0.1 0.19 -10000 0 -0.32 83 83
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
STAT1 (dimer)/PIAS1 -0.046 0.12 0.35 2 -0.28 15 17
CEBPB/PTGES2/Cbp/p300 -0.017 0.14 -10000 0 -0.36 15 15
mol:Ca2+ -0.012 0.13 -10000 0 -0.24 41 41
MAPK3 -0.053 0.16 -10000 0 -0.88 4 4
STAT1 (dimer) -0.086 0.16 -10000 0 -0.42 23 23
MAPK1 -0.083 0.22 0.4 1 -0.81 14 15
JAK2 0.005 0.08 -10000 0 -0.27 13 13
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
JAK1 0.017 0.047 -10000 0 -0.47 1 1
CAMK2D 0.034 0.035 -10000 0 -0.47 1 1
DAPK1 -0.015 0.14 0.34 3 -0.47 7 10
SMAD7 -0.029 0.067 0.2 2 -0.19 5 7
CBL/CRKL/C3G -0.028 0.12 0.35 2 -0.33 6 8
PI3K -0.004 0.14 -10000 0 -0.27 20 20
IFNG -0.1 0.19 -10000 0 -0.32 83 83
apoptosis -0.023 0.13 0.35 2 -0.4 9 11
CAMK2G 0.036 0.008 -10000 0 -10000 0 0
STAT3 (dimer) 0.037 0.006 -10000 0 -10000 0 0
CAMK2A 0.036 0.016 -10000 0 -0.19 1 1
CAMK2B 0.029 0.035 -10000 0 -0.19 5 5
FRAP1 -0.06 0.098 0.3 3 -0.32 6 9
PRKCD -0.057 0.11 0.33 3 -0.35 6 9
RAP1B 0.035 0.035 -10000 0 -0.47 1 1
negative regulation of cell growth -0.068 0.12 -10000 0 -0.29 24 24
PTPN2 0.029 0.016 -10000 0 -10000 0 0
EP300 0.017 0.091 -10000 0 -0.43 8 8
IRF1 -0.074 0.16 0.39 2 -0.44 20 22
STAT1 (dimer)/PIASy -0.049 0.12 0.39 1 -0.28 15 16
SOCS1 0.005 0.22 -10000 0 -1.2 6 6
mol:GDP -0.029 0.12 0.33 2 -0.32 6 8
CASP1 -0.067 0.12 0.2 2 -0.27 41 43
PTGES2 0.037 0.005 -10000 0 -10000 0 0
IRF9 -0.005 0.091 0.22 4 -0.24 13 17
mol:PI-3-4-5-P3 -0.032 0.12 -10000 0 -0.26 20 20
RAP1/GDP -0.027 0.11 -10000 0 -0.31 5 5
CBL -0.051 0.11 0.35 2 -0.24 35 37
MAP3K1 -0.053 0.11 0.35 2 -0.24 35 37
PIAS1 0.035 0.009 -10000 0 -10000 0 0
PIAS4 0.033 0.038 -10000 0 -0.33 2 2
antigen processing and presentation of peptide antigen via MHC class II -0.068 0.12 -10000 0 -0.29 24 24
PTPN11 -0.055 0.11 -10000 0 -0.24 41 41
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
RAPGEF1 0.036 0.016 -10000 0 -0.19 1 1
Canonical Wnt signaling pathway

Figure S36.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S36.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.05 0.039 0.21 4 -10000 0 4
AES 0.046 0.048 0.18 4 -0.47 1 5
FBXW11 0.037 0.004 -10000 0 -10000 0 0
mol:GTP 0 0.001 -10000 0 -10000 0 0
LRP6/FZD1 0.05 0.02 -10000 0 -10000 0 0
SMAD4 0.023 0.038 -10000 0 -0.47 1 1
DKK2 -0.025 0.14 -10000 0 -0.28 41 41
TLE1 0.019 0.13 0.24 1 -0.46 13 14
MACF1 0.037 0.005 -10000 0 -10000 0 0
CTNNB1 0.041 0.098 0.4 4 -0.29 1 5
WIF1 -0.017 0.096 -10000 0 -0.19 52 52
beta catenin/RanBP3 0.09 0.18 0.41 43 -10000 0 43
KREMEN2 -0.062 0.17 -10000 0 -0.29 65 65
DKK1 -0.087 0.18 -10000 0 -0.3 79 79
beta catenin/beta TrCP1 0.058 0.098 0.39 4 -10000 0 4
FZD1 0.036 0.009 -10000 0 -10000 0 0
AXIN2 -0.26 0.62 0.61 9 -1.5 40 49
AXIN1 0.032 0.049 -10000 0 -0.47 2 2
RAN 0.038 0.004 -10000 0 -10000 0 0
Axin1/APC/GSK3/beta catenin 0.04 0.094 -10000 0 -0.5 5 5
beta catenin/TCF/CtBP/CBP/TLE1/AES/SMAD4 -0.042 0.19 0.4 1 -0.56 13 14
Axin1/APC/GSK3 0.055 0.079 0.24 2 -0.32 2 4
Axin1/APC/GSK3/beta catenin/Macf1 0.026 0.092 -10000 0 -0.36 5 5
HNF1A 0.045 0.05 0.19 2 -0.35 2 4
CTBP1 0.048 0.036 0.21 3 -10000 0 3
MYC 0.012 0.43 0.61 31 -1.6 10 41
RANBP3 0.035 0.034 -10000 0 -0.46 1 1
DKK2/LRP6/Kremen 2 -0.043 0.15 -10000 0 -0.29 45 45
NKD1 -0.14 0.21 -10000 0 -0.33 100 100
TCF4 0.034 0.046 0.19 4 -0.18 2 6
TCF3 0.042 0.067 0.24 1 -0.44 3 4
WNT1/LRP6/FZD1/Axin1 0.083 0.048 -10000 0 -0.26 2 2
Ran/GTP 0.029 0.004 -10000 0 -10000 0 0
CtBP/CBP/TCF/TLE1/AES 0.049 0.23 0.47 38 -0.5 3 41
LEF1 0.017 0.11 0.19 2 -0.3 19 21
DVL1 0.036 0.08 -10000 0 -0.53 2 2
CSNK2A1 0.029 0.016 -10000 0 -10000 0 0
beta catenin/TCF/CtBP/CBP/TLE1/AES -0.031 0.16 0.41 1 -0.65 6 7
DKK1/LRP6/Kremen 2 -0.083 0.17 -10000 0 -0.32 56 56
LRP6 0.035 0.017 -10000 0 -0.19 1 1
CSNK1A1 0.051 0.037 0.2 4 -10000 0 4
NLK 0.031 0.02 -10000 0 -0.19 1 1
CCND1 -0.049 0.18 -10000 0 -1.4 2 2
WNT1 0.037 0.005 -10000 0 -10000 0 0
GSK3A 0.037 0.006 -10000 0 -10000 0 0
GSK3B 0.035 0.035 -10000 0 -0.47 1 1
FRAT1 0.031 0.049 -10000 0 -0.47 2 2
PPP2R5D 0.1 0.11 0.28 48 -10000 0 48
APC 0.023 0.097 0.56 3 -0.25 10 13
WNT1/LRP6/FZD1 0.043 0.04 -10000 0 -0.22 1 1
CREBBP 0.046 0.05 0.2 4 -0.47 1 5
Visual signal transduction: Rods

Figure S37.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S37.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:K + 0.032 0.038 -10000 0 -0.33 2 2
GNAT1/GTP 0.024 0.023 -10000 0 -10000 0 0
Metarhodopsin II/Arrestin 0.041 0.042 -10000 0 -0.29 2 2
PDE6G/GNAT1/GTP 0.044 0.027 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
GNAT1 0.032 0.034 -10000 0 -0.19 5 5
GRK1 0 0 -10000 0 -10000 0 0
CNG Channel -0.046 0.14 -10000 0 -0.28 34 34
mol:Na + -0.03 0.14 -10000 0 -0.36 12 12
mol:ADP 0 0 -10000 0 -10000 0 0
RGS9-1/Gbeta5/R9AP 0.014 0.11 -10000 0 -0.3 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
cGMP/CNG Channel -0.022 0.15 -10000 0 -0.38 12 12
CNGB1 0.037 0.005 -10000 0 -10000 0 0
RDH5 0.022 0.08 -10000 0 -0.36 8 8
SAG 0.024 0.064 -10000 0 -0.24 10 10
mol:Ca2+ -0.061 0.14 0.39 6 -0.36 12 18
Na + (4 Units) -0.034 0.13 -10000 0 -0.35 12 12
RGS9 0.028 0.049 -10000 0 -0.23 6 6
GNB1/GNGT1 -0.1 0.17 -10000 0 -0.34 66 66
GNAT1/GDP 0.024 0.11 -10000 0 -0.26 19 19
GUCY2D 0.029 0.021 -10000 0 -0.19 1 1
GNGT1 -0.16 0.22 -10000 0 -0.37 103 103
GUCY2F 0.017 0.097 -10000 0 -0.44 9 9
GNB5 -0.002 0.12 -10000 0 -0.36 20 20
mol:GMP (4 units) -0.008 0.095 -10000 0 -0.26 22 22
mol:11-cis-retinal 0.022 0.08 -10000 0 -0.36 8 8
mol:cGMP 0.033 0.099 -10000 0 -0.26 17 17
GNB1 0.035 0.009 -10000 0 -10000 0 0
Rhodopsin 0.042 0.063 -10000 0 -0.34 5 5
SLC24A1 0.032 0.039 -10000 0 -0.33 2 2
CNGA1 -0.074 0.19 -10000 0 -0.35 62 62
Metarhodopsin II 0.024 0.003 -10000 0 -10000 0 0
mol:Ca ++ 0 0 -10000 0 -10000 0 0
GC1/GCAP Family 0.051 0.085 -10000 0 -0.27 9 9
RGS9BP 0.007 0.1 -10000 0 -0.29 19 19
Metarhodopsin II/Transducin -0.067 0.12 -10000 0 -0.24 65 65
GCAP Family/Ca ++ 0.049 0.075 -10000 0 -0.27 9 9
PDE6A/B -0.007 0.13 -10000 0 -0.33 23 23
mol:Pi 0.013 0.11 -10000 0 -0.29 20 20
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
Transducin -0.066 0.14 -10000 0 -0.26 67 67
PDE6B 0.023 0.07 -10000 0 -0.28 9 9
PDE6A -0.025 0.15 -10000 0 -0.34 35 35
PDE6G 0.035 0.017 -10000 0 -0.19 1 1
RHO 0.037 0.005 -10000 0 -10000 0 0
PDE6 0.014 0.14 -10000 0 -0.26 41 41
GUCA1A 0.035 0.022 -10000 0 -0.19 2 2
GC2/GCAP Family 0.057 0.11 -10000 0 -0.28 17 17
GUCA1C 0.014 0.1 -10000 0 -0.38 12 12
GUCA1B 0.031 0.044 -10000 0 -0.26 4 4
PLK2 and PLK4 events

Figure S38.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S38.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLK2 -0.009 0.13 -9999 0 -0.32 28 28
PLK4 0.031 0.051 -9999 0 -0.38 3 3
regulation of centriole replication -0.012 0.092 -9999 0 -0.35 13 13
Signaling events mediated by the Hedgehog family

Figure S39.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S39.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB2 0.008 0.16 -10000 0 -0.66 9 9
IHH 0.024 0.1 -10000 0 -0.56 5 5
SHH Np/Cholesterol/GAS1 -0.072 0.14 -10000 0 -0.29 50 50
LRPAP1 0.036 0.007 -10000 0 -10000 0 0
dorsoventral neural tube patterning 0.071 0.14 0.29 50 -10000 0 50
SMO/beta Arrestin2 0.001 0.16 -10000 0 -0.6 8 8
SMO -0.012 0.16 -10000 0 -0.6 9 9
AKT1 -0.016 0.16 -10000 0 -0.59 9 9
ARRB2 0.028 0.037 -10000 0 -0.47 1 1
BOC 0.029 0.05 -10000 0 -0.23 7 7
ADRBK1 0.037 0.004 -10000 0 -10000 0 0
heart looping -0.011 0.15 -10000 0 -0.59 9 9
STIL -0.007 0.13 0.36 1 -0.38 11 12
DHH N/PTCH2 0.054 0.01 -10000 0 -10000 0 0
DHH N/PTCH1 0.033 0.12 -10000 0 -0.45 9 9
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
DHH 0.037 0.004 -10000 0 -10000 0 0
PTHLH -0.006 0.2 -10000 0 -0.91 9 9
determination of left/right symmetry -0.011 0.15 -10000 0 -0.59 9 9
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
skeletal system development -0.005 0.2 -10000 0 -0.9 9 9
IHH N/Hhip -0.014 0.16 -10000 0 -0.4 29 29
DHH N/Hhip -0.003 0.13 -10000 0 -0.34 26 26
mol:Cholesterol 0 0 -10000 0 -10000 0 0
heart development -0.011 0.15 -10000 0 -0.59 9 9
pancreas development -0.036 0.17 -10000 0 -0.38 37 37
HHAT 0 0.12 -10000 0 -0.38 19 19
PI3K 0.048 0.047 -10000 0 -0.34 3 3
EntrezGene:84976 0 0 -10000 0 -10000 0 0
GAS1 -0.11 0.2 -10000 0 -0.32 92 92
somite specification -0.011 0.15 -10000 0 -0.59 9 9
SHH Np/Cholesterol/PTCH1 -0.002 0.12 -10000 0 -0.42 9 9
SHH Np/Cholesterol/PTCH2 0.011 0.078 -10000 0 -0.27 14 14
SHH Np/Cholesterol/Megalin 0.01 0.079 -10000 0 -0.27 14 14
SHH -0.01 0.092 -10000 0 -0.34 14 14
catabolic process 0.015 0.12 -10000 0 -0.44 12 12
SMO/Vitamin D3 -0.012 0.14 -10000 0 -0.52 9 9
SHH Np/Cholesterol/Hhip -0.03 0.13 -10000 0 -0.3 35 35
LRP2 0.035 0.022 -10000 0 -0.19 2 2
receptor-mediated endocytosis -0.017 0.14 -10000 0 -0.52 9 9
SHH Np/Cholesterol/BOC 0.007 0.08 -10000 0 -0.27 14 14
SHH Np/Cholesterol/CDO 0.009 0.079 -10000 0 -0.27 14 14
mesenchymal cell differentiation 0.03 0.13 0.29 35 -10000 0 35
mol:Vitamin D3 0.006 0.13 0.39 1 -0.42 9 10
IHH N/PTCH2 0.045 0.068 -10000 0 -0.34 5 5
CDON 0.035 0.022 -10000 0 -0.19 2 2
IHH N/PTCH1 0.026 0.13 -10000 0 -0.44 12 12
Megalin/LRPAP1 0.052 0.02 -10000 0 -10000 0 0
PTCH2 0.037 0.005 -10000 0 -10000 0 0
SHH Np/Cholesterol -0.002 0.073 -10000 0 -0.26 14 14
PTCH1 0.015 0.13 -10000 0 -0.44 12 12
HHIP -0.036 0.17 -10000 0 -0.39 37 37
Cellular roles of Anthrax toxin

Figure S40.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S40.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ANTXR1 -0.013 0.14 -10000 0 -0.33 30 30
ANTXR2 0.017 0.082 -10000 0 -0.27 14 14
negative regulation of myeloid dendritic cell antigen processing and presentation -0.008 0.019 -10000 0 -0.066 18 18
monocyte activation -0.009 0.12 -10000 0 -0.4 18 18
MAP2K2 0.008 0.081 -10000 0 -0.58 4 4
MAP2K1 -0.01 0.017 -10000 0 -0.096 1 1
MAP2K7 -0.013 0.026 -10000 0 -0.15 3 3
MAP2K6 -0.02 0.053 0.13 1 -0.23 11 12
CYAA -0.035 0.072 -10000 0 -0.25 18 18
MAP2K4 -0.009 0.022 -10000 0 -0.24 1 1
IL1B -0.061 0.093 -10000 0 -0.26 34 34
Channel 0.004 0.096 -10000 0 -0.27 18 18
NLRP1 -0.012 0.029 -10000 0 -0.21 2 2
CALM1 0.033 0.012 -10000 0 -10000 0 0
negative regulation of phagocytosis -0.043 0.14 -10000 0 -0.42 26 26
mol:Ca2+ 0 0 -10000 0 -10000 0 0
regulation of endothelial cell proliferation 0.008 0.019 0.066 18 -10000 0 18
MAPK3 -0.015 0.039 0.13 1 -0.22 5 6
MAPK1 -0.01 0.018 -10000 0 -0.11 2 2
PGR -0.012 0.024 -10000 0 -0.17 2 2
PA/Cellular Receptors 0.002 0.1 -10000 0 -0.3 18 18
apoptosis -0.008 0.019 -10000 0 -0.066 18 18
LOC728358 0 0 -10000 0 -10000 0 0
Lethal toxin (unfolded) 0.006 0.09 -10000 0 -0.26 18 18
macrophage activation -0.012 0.048 0.17 6 -0.25 4 10
TNF 0.025 0.062 -10000 0 -0.25 9 9
VCAM1 -0.008 0.12 -10000 0 -0.4 17 17
platelet activation -0.043 0.14 -10000 0 -0.42 26 26
MAPKKK cascade 0.01 0.028 0.088 8 -0.13 1 9
IL18 -0.046 0.082 -10000 0 -0.26 23 23
negative regulation of macrophage activation -0.008 0.019 -10000 0 -0.066 18 18
LEF -0.008 0.019 -10000 0 -0.066 18 18
CASP1 -0.02 0.041 -10000 0 -0.097 34 34
mol:cAMP -0.044 0.15 -10000 0 -0.43 26 26
necrosis -0.008 0.019 -10000 0 -0.066 18 18
intracellular pH reduction 0 0 -10000 0 -10000 0 0
PAGA 0 0 -10000 0 -10000 0 0
Edema toxin (unfolded) 0.005 0.091 -10000 0 -0.26 18 18
mol:Epigallocatechin-3-gallate (EGCG) 0 0 -10000 0 -10000 0 0
Nectin adhesion pathway

Figure S41.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S41.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.035 0.035 -10000 0 -0.47 1 1
alphaV beta3 Integrin 0.043 0.058 -10000 0 -0.34 4 4
PTK2 -0.021 0.14 -10000 0 -0.4 21 21
positive regulation of JNK cascade 0.004 0.13 -10000 0 -0.31 19 19
CDC42/GDP 0.012 0.19 -10000 0 -0.43 23 23
Rac1/GDP 0.001 0.18 -10000 0 -0.42 23 23
RAP1B 0.035 0.035 -10000 0 -0.47 1 1
RAP1A 0.036 0.009 -10000 0 -10000 0 0
CTNNB1 0.018 0.081 -10000 0 -0.27 13 13
CDC42/GTP 0.011 0.16 -10000 0 -0.38 19 19
nectin-3/I-afadin -0.002 0.13 -10000 0 -0.35 25 25
RAPGEF1 -0.014 0.17 -10000 0 -0.44 24 24
mol:GTP 0 0 -10000 0 -10000 0 0
CRK -0.031 0.19 -10000 0 -0.49 26 26
PDGFB-D/PDGFRB 0.035 0.035 -10000 0 -0.47 1 1
TLN1 -0.017 0.064 -10000 0 -0.26 7 7
Rap1/GTP -0.007 0.13 -10000 0 -0.32 24 24
IQGAP1 0.035 0.01 -10000 0 -10000 0 0
Rap1/GTP/I-afadin 0.056 0.059 -10000 0 -0.26 6 6
nectin-3(dimer)/I-afadin/I-afadin/nectin-3(dimer)/I-afadin/I-afadin -0.002 0.13 -10000 0 -0.35 25 25
PVR 0.037 0.006 -10000 0 -10000 0 0
Necl-5(dimer) 0.037 0.006 -10000 0 -10000 0 0
mol:GDP -0.01 0.22 -10000 0 -0.51 27 27
MLLT4 0.024 0.077 -10000 0 -0.47 5 5
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
PI3K 0.046 0.13 -10000 0 -0.27 28 28
nectin-1(dimer)/I-afadin/I-afadin/nectin-1(dimer)/I-afadin/I-afadin 0.042 0.062 -10000 0 -0.34 5 5
positive regulation of lamellipodium assembly -0.018 0.15 -10000 0 -0.35 23 23
PVRL1 0.036 0.016 -10000 0 -0.19 1 1
PVRL3 -0.022 0.15 -10000 0 -0.38 30 30
PVRL2 0.032 0.041 -10000 0 -0.28 3 3
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
CDH1 0.013 0.11 -10000 0 -0.47 10 10
CLDN1 -0.028 0.16 -10000 0 -0.38 33 33
JAM-A/CLDN1 -0.008 0.16 -10000 0 -0.29 48 48
SRC -0.054 0.2 -10000 0 -0.53 27 27
ITGB3 0.035 0.017 -10000 0 -0.19 1 1
nectin-1(dimer)/I-afadin/I-afadin 0.042 0.062 -10000 0 -0.34 5 5
FARP2 0.003 0.21 -10000 0 -0.5 19 19
RAC1 0.034 0.012 -10000 0 -10000 0 0
CTNNA1 0.037 0.005 -10000 0 -10000 0 0
nectin-3(dimer)/I-afadin/I-afadin/Necl-5(dimer) 0.021 0.12 -10000 0 -0.3 24 24
nectin-1/I-afadin 0.042 0.062 -10000 0 -0.34 5 5
nectin-2/I-afadin 0.04 0.068 -10000 0 -0.34 6 6
RAC1/GTP/IQGAP1/filamentous actin 0.042 0.019 -10000 0 -10000 0 0
nectin-1(dimer)/I-afadin/I-afadin/nectin-3(dimer/I-afadin/I-afadin 0.019 0.12 -10000 0 -0.3 25 25
CDC42/GTP/IQGAP1/filamentous actin 0.043 0.02 -10000 0 -10000 0 0
F11R 0.025 0.077 -10000 0 -0.47 5 5
positive regulation of filopodium formation 0.004 0.13 -10000 0 -0.31 19 19
alphaV/beta3 Integrin/Talin -0.015 0.1 -10000 0 -0.31 6 6
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.04 0.068 -10000 0 -0.34 6 6
nectin-2(dimer)/I-afadin/I-afadin 0.04 0.068 -10000 0 -0.34 6 6
PIP5K1C -0.017 0.07 -10000 0 -0.2 26 26
VAV2 -0.035 0.25 -10000 0 -0.6 22 22
RAP1/GDP 0.018 0.18 0.3 1 -0.39 23 24
ITGAV 0.024 0.079 -10000 0 -0.39 7 7
nectin-3(dimer)/I-afadin/I-afadin/nectin-2(dimer)/I-afadin/I-afadin 0.018 0.12 -10000 0 -0.3 25 25
nectin-3(dimer)/I-afadin/I-afadin -0.002 0.13 -10000 0 -0.35 25 25
Rac1/GTP -0.021 0.19 -10000 0 -0.44 23 23
PTPRM -0.016 0.081 -10000 0 -0.21 28 28
E-cadherin/beta catenin/alpha catenin 0.069 0.12 -10000 0 -0.31 16 16
adherens junction assembly 0 0 -10000 0 -10000 0 0
CDC42 0.034 0.018 -10000 0 -0.19 1 1
Syndecan-3-mediated signaling events

Figure S42.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S42.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN 0.036 0.016 -10000 0 -0.19 1 1
Syndecan-3/Src/Cortactin -0.013 0.15 -10000 0 -0.48 14 14
Syndecan-3/Neurocan -0.003 0.14 -10000 0 -0.46 17 17
POMC 0.023 0.071 -10000 0 -0.27 10 10
EGFR 0.018 0.086 -10000 0 -0.4 8 8
Syndecan-3/EGFR -0.015 0.14 -10000 0 -0.45 18 18
AGRP 0.034 0.027 -10000 0 -0.19 3 3
NCSTN 0.037 0.006 -10000 0 -10000 0 0
PSENEN 0.033 0.038 -10000 0 -0.33 2 2
RP11-540L11.1 0 0 -10000 0 -10000 0 0
APH1B 0.022 0.07 -10000 0 -0.28 9 9
APH1A 0.008 0.098 -10000 0 -0.27 20 20
NCAN 0.037 0.004 -10000 0 -10000 0 0
long-term memory 0.002 0.15 -10000 0 -0.45 18 18
Syndecan-3/IL8 -0.084 0.18 -10000 0 -0.48 24 24
PSEN1 0.034 0.011 -10000 0 -10000 0 0
Src/Cortactin 0.024 0.051 -10000 0 -0.34 3 3
FYN 0.011 0.098 -10000 0 -0.32 15 15
limb bud formation -0.025 0.14 -10000 0 -0.47 17 17
MC4R 0.025 0.018 -10000 0 -10000 0 0
SRC 0.013 0.06 -10000 0 -0.47 3 3
PTN -0.011 0.14 -10000 0 -0.4 23 23
FGFR/FGF/Syndecan-3 -0.026 0.14 -10000 0 -0.48 17 17
neuron projection morphogenesis 0.037 0.18 0.33 3 -0.47 14 17
Syndecan-3/AgRP -0.005 0.14 -10000 0 -0.46 17 17
Syndecan-3/AgRP/MC4R 0.001 0.14 -10000 0 -0.44 17 17
Fyn/Cortactin 0.032 0.078 -10000 0 -0.34 7 7
SDC3 -0.026 0.14 -10000 0 -0.48 17 17
GO:0007205 0 0 -10000 0 -10000 0 0
positive regulation of leukocyte migration -0.082 0.18 -10000 0 -0.47 24 24
IL8 -0.13 0.21 -10000 0 -0.35 94 94
Syndecan-3/Fyn/Cortactin 0.002 0.16 -10000 0 -0.46 18 18
Syndecan-3/CASK -0.027 0.13 -10000 0 -0.44 18 18
alpha-MSH/MC4R 0.027 0.056 -10000 0 -0.32 3 3
Gamma Secretase 0.055 0.098 -10000 0 -0.26 10 10
IL6-mediated signaling events

Figure S43.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S43.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 -0.001 0.28 -10000 0 -0.78 11 11
CRP -0.056 0.25 0.48 1 -0.8 11 12
cell cycle arrest -0.073 0.29 -10000 0 -0.86 15 15
TIMP1 -0.043 0.24 -10000 0 -0.74 13 13
IL6ST 0.034 0.024 -10000 0 -10000 0 0
Rac1/GDP -0.07 0.18 -10000 0 -0.5 19 19
AP1 0.014 0.15 -10000 0 -0.5 5 5
GAB2 0.038 0.008 -10000 0 -10000 0 0
TNFSF11 -0.11 0.41 -10000 0 -1 31 31
HSP90B1 0.027 0.088 -10000 0 -1 1 1
GAB1 0.031 0.054 -10000 0 -0.33 4 4
MAPK14 -0.072 0.19 -10000 0 -0.65 13 13
AKT1 0.032 0.08 -10000 0 -0.45 3 3
FOXO1 0.053 0.11 -10000 0 -0.47 1 1
MAP2K6 -0.068 0.18 -10000 0 -0.47 21 21
mol:GTP 0 0.002 -10000 0 -10000 0 0
MAP2K4 -0.078 0.18 0.32 1 -0.56 16 17
MITF -0.064 0.17 0.25 1 -0.46 20 21
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
TYK2 0.037 0.006 -10000 0 -10000 0 0
A2M -0.026 0.28 -10000 0 -1.3 9 9
CEBPB 0.021 0.041 -10000 0 -0.47 1 1
GRB2/SOS1/GAB family/SHP2 0.019 0.1 -10000 0 -0.43 4 4
STAT3 -0.082 0.32 -10000 0 -0.96 15 15
STAT1 0.019 0.026 -10000 0 -10000 0 0
CEBPD -0.045 0.25 -10000 0 -0.8 10 10
PIK3CA 0.038 0.008 -10000 0 -10000 0 0
PI3K 0.05 0.048 -10000 0 -0.34 3 3
JUN -0.015 0.15 -10000 0 -0.39 26 26
PIAS3/MITF -0.048 0.18 -10000 0 -0.46 18 18
MAPK11 -0.074 0.19 -10000 0 -0.63 15 15
STAT3 (dimer)/FOXO1 -0.021 0.26 0.43 4 -0.66 14 18
GRB2/SOS1/GAB family 0.002 0.18 -10000 0 -0.45 13 13
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/HCK -0.066 0.15 -10000 0 -0.42 19 19
GRB2 0.037 0.009 -10000 0 -10000 0 0
JAK2 0.019 0.075 -10000 0 -0.25 13 13
LBP 0.043 0.23 -10000 0 -0.6 8 8
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
JAK1 0.033 0.037 -10000 0 -0.46 1 1
MYC -0.064 0.33 -10000 0 -0.98 17 17
FGG -0.068 0.27 -10000 0 -0.85 13 13
macrophage differentiation -0.073 0.29 -10000 0 -0.86 15 15
IL6/IL6RA/gp130 (dimer)/JAK2/JAK2/LMO4 -0.047 0.17 -10000 0 -0.28 61 61
JUNB -0.067 0.26 -10000 0 -0.82 13 13
FOS -0.055 0.16 -10000 0 -0.3 56 56
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4 -0.063 0.17 -10000 0 -0.46 19 19
STAT1/PIAS1 -0.033 0.17 -10000 0 -0.46 12 12
GRB2/SOS1/GAB family/SHP2/PI3K 0.041 0.075 -10000 0 -0.39 3 3
STAT3 (dimer) -0.077 0.31 -10000 0 -0.94 15 15
PRKCD -0.064 0.23 0.36 11 -0.61 17 28
IL6R 0.023 0.075 -10000 0 -0.35 7 7
SOCS3 -0.082 0.26 0.37 1 -0.98 12 13
gp130 (dimer)/JAK1/JAK1/LMO4 0.037 0.1 -10000 0 -0.28 14 14
Rac1/GTP -0.071 0.18 -10000 0 -0.52 18 18
HCK -0.01 0.11 -10000 0 -0.35 17 17
MAPKKK cascade 0.043 0.12 -10000 0 -0.53 5 5
bone resorption -0.09 0.38 0.48 1 -0.93 31 32
IRF1 -0.082 0.3 -10000 0 -0.97 14 14
mol:GDP -0.072 0.19 -10000 0 -0.5 21 21
SOS1 0.038 0.007 -10000 0 -10000 0 0
VAV1 -0.073 0.19 -10000 0 -0.51 21 21
IL6/IL6RA/gp130 (dimer)/JAK1/JAK1/LMO4/SOCS3 -0.077 0.21 -10000 0 -0.68 16 16
PTPN11 0.01 0.12 -10000 0 -0.96 3 3
IL6/IL6RA -0.075 0.16 -10000 0 -0.33 54 54
gp130 (dimer)/TYK2/TYK2/LMO4 0.039 0.097 -10000 0 -0.28 12 12
gp130 (dimer)/JAK2/JAK2/LMO4 0.027 0.11 -10000 0 -0.26 21 21
IL6 -0.12 0.2 -10000 0 -0.34 86 86
PIAS3 0.035 0.022 -10000 0 -0.19 2 2
PTPRE 0.023 0.057 -10000 0 -0.29 5 5
PIAS1 0.035 0.009 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
IL6/IL6RA/gp130 (dimer)/TYK2/TYK2/LMO4 -0.057 0.14 -10000 0 -0.31 25 25
LMO4 -0.011 0.13 -10000 0 -0.31 28 28
STAT3 (dimer)/PIAS3 -0.068 0.29 -10000 0 -0.86 15 15
MCL1 0.031 0.13 -10000 0 -1.1 2 2
Caspase cascade in apoptosis

Figure S44.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S44.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TOP1 -0.032 0.14 -10000 0 -0.48 11 11
ACTA1 -0.046 0.14 0.21 1 -0.39 21 22
NUMA1 -0.022 0.15 -10000 0 -0.47 12 12
SPTAN1 -0.045 0.14 -10000 0 -0.39 21 21
LIMK1 -0.056 0.16 0.27 2 -0.4 23 25
BIRC3 -0.006 0.12 -10000 0 -0.29 28 28
BIRC2 0.035 0.017 -10000 0 -0.19 1 1
BAX 0.034 0.027 -10000 0 -0.19 3 3
CASP10 -0.054 0.1 0.21 1 -0.3 27 28
CRMA 0 0 -10000 0 -0.001 1 1
XIAP 0 0 0 1 -0.001 7 8
PTK2 -0.023 0.14 -10000 0 -0.47 11 11
DIABLO 0.037 0.004 -10000 0 -10000 0 0
apoptotic nuclear changes -0.044 0.14 -10000 0 -0.39 21 21
response to UV 0 0 -10000 0 -10000 0 0
CRADD 0.028 0.069 -10000 0 -0.47 4 4
GSN -0.053 0.14 -10000 0 -0.39 22 22
MADD 0.037 0.004 -10000 0 -10000 0 0
TFAP2A 0.019 0.13 -10000 0 -0.7 6 6
BID -0.021 0.067 0.13 1 -0.18 28 29
MAP3K1 -0.006 0.075 -10000 0 -0.54 2 2
TRADD 0.037 0.005 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.032 0.081 -10000 0 -0.32 9 9
mol:Activated DNA 0 0 -10000 0 -10000 0 0
ARHGDIB -0.054 0.15 0.26 3 -0.4 24 27
CASP9 0.035 0.01 -10000 0 -10000 0 0
DNA repair -0.003 0.061 0.26 4 -0.17 4 8
neuron apoptosis -0.041 0.23 -10000 0 -0.72 20 20
mol:NAD 0 0 -10000 0 -10000 0 0
DNA fragmentation during apoptosis -0.036 0.16 -10000 0 -0.47 13 13
APAF1 0.012 0.1 -10000 0 -0.35 14 14
CASP6 -0.018 0.2 -10000 0 -0.86 9 9
TRAF2 0.036 0.016 -10000 0 -0.19 1 1
ICAD/CAD -0.047 0.13 -10000 0 -0.4 18 18
CASP7 0.019 0.085 0.28 9 -0.37 3 12
KRT18 0.012 0.077 -10000 0 -0.55 3 3
apoptosis -0.046 0.15 0.31 1 -0.44 16 17
DFFA -0.044 0.14 -10000 0 -0.39 20 20
DFFB -0.046 0.14 -10000 0 -0.39 20 20
PARP1 0.003 0.062 0.18 4 -0.27 4 8
actin filament polymerization 0.061 0.16 0.4 23 -0.3 1 24
TNF 0.025 0.062 -10000 0 -0.25 9 9
CYCS -0.009 0.063 0.18 1 -0.28 4 5
SATB1 -0.063 0.2 -10000 0 -0.84 9 9
SLK -0.046 0.14 0.22 1 -0.39 20 21
p15 BID/BAX -0.015 0.085 -10000 0 -0.26 9 9
CASP2 0.015 0.075 0.22 6 -0.31 4 10
JNK cascade 0.006 0.075 0.53 2 -10000 0 2
CASP3 -0.046 0.15 0.23 1 -0.4 21 22
LMNB2 0.016 0.13 0.41 2 -0.56 5 7
RIPK1 0.037 0.006 -10000 0 -10000 0 0
CASP4 0.022 0.076 -10000 0 -0.31 9 9
Mammalian IAPs/DIABLO 0.04 0.083 -10000 0 -0.25 11 11
negative regulation of DNA binding 0.019 0.13 -10000 0 -0.69 6 6
stress fiber formation -0.045 0.14 0.22 1 -0.39 20 21
GZMB -0.038 0.12 -10000 0 -0.35 22 22
CASP1 -0.057 0.14 -10000 0 -0.33 41 41
LMNB1 -0.011 0.15 0.4 2 -0.5 8 10
APP -0.042 0.23 -10000 0 -0.74 20 20
TNFRSF1A 0.036 0.008 -10000 0 -10000 0 0
response to stress 0 0 0.001 13 -0.001 2 15
CASP8 0.005 0.041 -10000 0 -0.34 3 3
VIM -0.043 0.15 0.33 1 -0.44 17 18
LMNA 0.021 0.1 0.4 2 -0.43 5 7
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD/PIDD 0.014 0.072 -10000 0 -0.31 5 5
LRDD 0 0 -10000 0 -10000 0 0
SREBF1 -0.044 0.14 -10000 0 -0.39 20 20
APAF-1/Caspase 9 -0.027 0.18 -10000 0 -0.63 16 16
nuclear fragmentation during apoptosis -0.021 0.15 -10000 0 -0.46 12 12
CFL2 -0.063 0.16 0.31 1 -0.4 24 25
GAS2 -0.12 0.16 -10000 0 -0.37 43 43
positive regulation of apoptosis 0.011 0.12 0.41 2 -0.6 4 6
PRF1 0.007 0.083 -10000 0 -0.21 25 25
a4b1 and a4b7 Integrin signaling

Figure S45.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S45.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ITGB1 0.036 0.016 -9999 0 -0.19 1 1
ITGB7 0.004 0.12 -9999 0 -0.47 14 14
ITGA4 0.011 0.11 -9999 0 -0.45 12 12
alpha4/beta7 Integrin 0.009 0.13 -9999 0 -0.35 24 24
alpha4/beta1 Integrin 0.035 0.085 -9999 0 -0.34 10 10
S1P1 pathway

Figure S46.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S46.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.048 0.03 -10000 0 -0.34 1 1
PDGFRB 0.036 0.035 -10000 0 -0.47 1 1
SPHK1 -0.077 0.23 -10000 0 -0.71 24 24
mol:S1P -0.056 0.21 -10000 0 -0.61 24 24
S1P1/S1P/Gi -0.038 0.16 -10000 0 -0.38 30 30
GNAO1 0.031 0.02 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/PLCgamma1 0.014 0.18 0.33 8 -0.39 18 26
PLCG1 -0.007 0.16 0.26 2 -0.39 19 21
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.036 0.035 -10000 0 -0.47 1 1
GNAI2 0.02 0.073 -10000 0 -0.42 5 5
GNAI3 0.031 0.038 -10000 0 -0.47 1 1
GNAI1 -0.008 0.13 -10000 0 -0.38 21 21
mol:GDP 0 0 -10000 0 -10000 0 0
EDG1 -0.002 0.025 -10000 0 -0.28 1 1
S1P1/S1P -0.039 0.16 0.25 1 -0.43 23 24
negative regulation of cAMP metabolic process -0.037 0.16 -10000 0 -0.37 30 30
MAPK3 -0.078 0.22 -10000 0 -0.57 30 30
calcium-dependent phospholipase C activity -0.001 0.004 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
RhoA/GDP 0.027 0.004 -10000 0 -10000 0 0
KDR 0.032 0.038 -10000 0 -0.33 2 2
PLCB2 -0.025 0.15 0.31 3 -0.4 21 24
RAC1 0.034 0.012 -10000 0 -10000 0 0
RhoA/GTP -0.035 0.14 -10000 0 -0.37 23 23
receptor internalization -0.038 0.15 -10000 0 -0.4 23 23
PTGS2 -0.13 0.38 0.52 1 -1 30 31
Rac1/GTP -0.037 0.13 -10000 0 -0.37 22 22
RHOA 0.037 0.005 -10000 0 -10000 0 0
VEGFA 0.036 0.007 -10000 0 -10000 0 0
negative regulation of T cell proliferation -0.037 0.16 -10000 0 -0.37 30 30
GO:0007205 0 0 -10000 0 -10000 0 0
GNAZ 0.021 0.063 -10000 0 -0.26 8 8
MAPK1 -0.065 0.22 0.42 1 -0.56 29 30
S1P1/S1P/PDGFB-D/PDGFRB -0.009 0.17 0.34 4 -0.46 14 18
ABCC1 0.033 0.041 -10000 0 -0.28 3 3
BCR signaling pathway

Figure S47.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S47.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
JUN -0.077 0.16 0.49 1 -0.38 24 25
IKBKB 0.004 0.1 0.29 4 -0.31 4 8
AKT1 -0.028 0.099 0.36 5 -0.25 8 13
IKBKG 0.007 0.084 0.39 1 -0.27 3 4
CALM1 -0.012 0.11 -10000 0 -0.43 9 9
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
MAP3K1 -0.061 0.2 0.47 2 -0.57 18 20
MAP3K7 0.036 0.008 -10000 0 -10000 0 0
mol:Ca2+ -0.012 0.12 0.23 1 -0.42 11 12
DOK1 0.034 0.038 -10000 0 -0.33 2 2
AP-1 -0.059 0.1 0.29 1 -0.25 17 18
LYN 0.032 0.013 -10000 0 -10000 0 0
BLNK 0.005 0.12 -10000 0 -0.43 14 14
SHC1 0.037 0.006 -10000 0 -10000 0 0
BCR complex 0.014 0.1 -10000 0 -0.3 18 18
CD22 -0.05 0.16 -10000 0 -0.59 12 12
CAMK2G -0.012 0.11 0.33 1 -0.38 9 10
CSNK2A1 0.029 0.016 -10000 0 -10000 0 0
INPP5D 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.003 0.091 -10000 0 -0.44 2 2
GO:0007205 -0.013 0.13 0.23 1 -0.42 11 12
SYK 0.031 0.051 -10000 0 -0.38 3 3
ELK1 -0.014 0.12 0.24 2 -0.42 10 12
NFATC1 -0.072 0.17 0.3 2 -0.46 21 23
B-cell antigen/BCR complex 0.014 0.1 -10000 0 -0.3 18 18
PAG1/CSK 0.034 0.064 -10000 0 -0.34 5 5
NFKBIB 0.016 0.05 0.19 2 -0.13 8 10
HRAS -0.005 0.1 0.24 3 -0.39 6 9
NFKBIA 0.018 0.048 0.19 2 -0.13 4 6
NF-kappa-B/RelA/I kappa B beta 0.023 0.044 0.2 2 -10000 0 2
RasGAP/Csk -0.026 0.16 -10000 0 -0.29 43 43
mol:GDP -0.01 0.12 0.22 2 -0.4 11 13
PTEN 0.031 0.049 -10000 0 -0.47 2 2
CD79B 0.004 0.11 -10000 0 -0.3 20 20
NF-kappa-B/RelA/I kappa B alpha 0.024 0.043 0.2 2 -10000 0 2
GRB2 0.036 0.007 -10000 0 -10000 0 0
PI3K/BCAP/CD19 -0.05 0.17 0.48 1 -0.56 14 15
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:IP3 -0.012 0.13 0.24 1 -0.43 11 12
CSK 0.035 0.01 -10000 0 -10000 0 0
FOS -0.05 0.14 0.26 1 -0.38 19 20
CHUK -0.009 0.11 0.39 1 -0.33 14 15
IBTK 0.031 0.044 -10000 0 -0.26 4 4
CARD11/BCL10/MALT1/TAK1 -0.004 0.12 -10000 0 -0.38 9 9
PTPN6 -0.048 0.15 -10000 0 -0.6 10 10
RELA 0.037 0.006 -10000 0 -10000 0 0
BCL2A1 0.005 0.039 -10000 0 -0.12 1 1
VAV2 -0.091 0.21 -10000 0 -0.55 29 29
ubiquitin-dependent protein catabolic process 0.02 0.05 0.19 2 -0.13 6 8
BTK -0.058 0.3 -10000 0 -1.2 15 15
CD19 -0.065 0.17 -10000 0 -0.59 14 14
MAP4K1 0.035 0.017 -10000 0 -0.19 1 1
CD72 -0.025 0.15 -10000 0 -0.33 36 36
PAG1 0.018 0.079 -10000 0 -0.39 7 7
MAPK14 -0.051 0.17 0.44 3 -0.49 17 20
SH3BP5 0.02 0.09 -10000 0 -0.47 7 7
PIK3AP1 -0.029 0.13 -10000 0 -0.42 14 14
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2/CD72 -0.027 0.17 -10000 0 -0.54 15 15
RAF1 -0.005 0.1 0.24 2 -0.37 6 8
RasGAP/p62DOK/SHIP -0.029 0.16 -10000 0 -0.28 43 43
CD79A 0.017 0.078 -10000 0 -0.24 15 15
re-entry into mitotic cell cycle -0.058 0.099 0.28 1 -0.25 16 17
RASA1 0.026 0.07 -10000 0 -0.41 5 5
MAPK3 -0.008 0.098 0.26 2 -0.35 7 9
MAPK1 -0.004 0.087 0.23 1 -0.32 6 7
CD72/SHP1 -0.05 0.18 -10000 0 -0.57 15 15
NFKB1 0.037 0.006 -10000 0 -10000 0 0
MAPK8 -0.051 0.17 0.38 3 -0.47 18 21
actin cytoskeleton organization -0.063 0.19 0.33 2 -0.46 28 30
NF-kappa-B/RelA 0.045 0.086 0.34 2 -0.3 1 3
Calcineurin 0.004 0.12 -10000 0 -0.38 9 9
PI3K -0.06 0.14 -10000 0 -0.43 17 17
B-cell antigen/BCR complex/Btk/LYN/SYK/BLNK/PLCgamma2 -0.01 0.13 0.24 4 -0.46 11 15
SOS1 0.038 0.003 -10000 0 -10000 0 0
Bam32/HPK1 -0.14 0.35 -10000 0 -0.8 45 45
DAPP1 -0.18 0.4 -10000 0 -0.93 45 45
cytokine secretion -0.067 0.16 0.3 2 -0.42 21 23
mol:DAG -0.012 0.13 0.24 1 -0.43 11 12
PLCG2 -0.004 0.12 -10000 0 -0.31 25 25
MAP2K1 -0.006 0.095 0.24 1 -0.35 6 7
B-cell antigen/BCR complex/FcgammaRIIB -0.044 0.16 -10000 0 -0.3 51 51
mol:PI-3-4-5-P3 -0.057 0.097 -10000 0 -0.3 17 17
ETS1 -0.014 0.1 0.31 1 -0.36 9 10
B-cell antigen/BCR complex/LYN/SYK/BLNK 0.038 0.12 -10000 0 -0.28 16 16
B-cell antigen/BCR complex/LYN -0.043 0.17 -10000 0 -0.56 15 15
MALT1 0.023 0.038 -10000 0 -0.47 1 1
TRAF6 0.037 0.005 -10000 0 -10000 0 0
RAC1 -0.07 0.2 0.34 2 -0.5 28 30
B-cell antigen/BCR complex/LYN/SYK -0.005 0.16 -10000 0 -0.56 10 10
CARD11 -0.012 0.13 0.27 1 -0.39 11 12
FCGR2B -0.082 0.19 -10000 0 -0.35 66 66
PPP3CA 0.036 0.016 -10000 0 -0.19 1 1
BCL10 0.034 0.035 -10000 0 -0.47 1 1
IKK complex 0.008 0.053 0.21 4 -0.13 3 7
PTPRC -0.022 0.15 -10000 0 -0.36 32 32
PDPK1 -0.034 0.085 0.29 4 -0.23 10 14
PPP3CB 0.036 0.008 -10000 0 -10000 0 0
PPP3CC 0.018 0.071 -10000 0 -0.41 5 5
POU2F2 0.02 0.035 0.22 2 -10000 0 2
Syndecan-4-mediated signaling events

Figure S48.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S48.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.011 0.11 -10000 0 -0.44 11 11
Syndecan-4/Syndesmos 0.056 0.18 0.36 1 -0.49 14 15
positive regulation of JNK cascade 0.03 0.21 0.35 1 -0.5 19 20
Syndecan-4/ADAM12 0.034 0.2 0.36 1 -0.52 16 17
CCL5 -0.034 0.16 -10000 0 -0.34 40 40
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
DNM2 0.037 0.005 -10000 0 -10000 0 0
ITGA5 0.028 0.045 -10000 0 -0.19 9 9
SDCBP 0.032 0.02 -10000 0 -0.19 1 1
PLG 0.004 0.046 -10000 0 -0.45 1 1
ADAM12 -0.023 0.14 -10000 0 -0.29 39 39
mol:GTP 0 0 -10000 0 -10000 0 0
NUDT16L1 0.037 0.006 -10000 0 -10000 0 0
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
Syndecan-4/PKC alpha -0.023 0.026 -10000 0 -10000 0 0
Syndecan-4/Laminin alpha1 0.033 0.18 -10000 0 -0.48 15 15
Syndecan-4/CXCL12/CXCR4 0.031 0.22 0.37 1 -0.53 19 20
Syndecan-4/Laminin alpha3 0.024 0.18 -10000 0 -0.5 15 15
MDK -0.005 0.12 -10000 0 -0.32 25 25
Syndecan-4/FZD7 0.019 0.21 0.36 1 -0.52 18 19
Syndecan-4/Midkine 0.04 0.2 -10000 0 -0.53 15 15
FZD7 -0.053 0.18 -10000 0 -0.34 51 51
Syndecan-4/FGFR1/FGF 0.04 0.2 0.36 1 -0.53 11 12
THBS1 0.019 0.082 -10000 0 -0.34 9 9
integrin-mediated signaling pathway 0.044 0.19 -10000 0 -0.49 16 16
positive regulation of MAPKKK cascade 0.03 0.21 0.35 1 -0.5 19 20
Syndecan-4/TACI 0.042 0.18 0.36 1 -0.48 15 16
CXCR4 -0.023 0.14 -10000 0 -0.31 38 38
cell adhesion -0.002 0.073 0.19 5 -0.3 9 14
Syndecan-4/Dynamin 0.054 0.19 0.36 1 -0.49 15 16
Syndecan-4/TSP1 0.045 0.2 0.36 1 -0.51 16 17
Syndecan-4/GIPC 0.051 0.19 0.36 1 -0.48 15 16
Syndecan-4/RANTES 0.027 0.2 0.36 1 -0.55 15 16
ITGB1 0.036 0.016 -10000 0 -0.19 1 1
LAMA1 0.028 0.016 -10000 0 -10000 0 0
LAMA3 0.005 0.089 -10000 0 -0.28 16 16
RAC1 0.034 0.012 -10000 0 -10000 0 0
PRKCA 0.016 0.12 0.69 6 -0.41 1 7
Syndecan-4/alpha-Actinin 0.046 0.18 -10000 0 -0.48 15 15
TFPI 0.026 0.056 -10000 0 -0.22 10 10
F2 0.037 0.081 -10000 0 -0.42 5 5
alpha5/beta1 Integrin 0.046 0.039 -10000 0 -10000 0 0
positive regulation of cell adhesion 0.015 0.18 -10000 0 -0.5 14 14
ACTN1 0.034 0.011 -10000 0 -10000 0 0
TNC 0.012 0.088 -10000 0 -0.25 19 19
Syndecan-4/CXCL12 0.037 0.2 0.36 1 -0.52 16 17
FGF6 0.029 0.053 -10000 0 -0.33 4 4
RHOA 0.037 0.005 -10000 0 -10000 0 0
CXCL12 -0.012 0.13 -10000 0 -0.29 32 32
TNFRSF13B 0.03 0.015 -10000 0 -10000 0 0
FGF2 0.001 0.11 -10000 0 -0.28 24 24
FGFR1 0.024 0.058 -10000 0 -0.28 6 6
Syndecan-4/PI-4-5-P2 -0.033 0.14 -10000 0 -0.48 15 15
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.041 0.12 -10000 0 -0.28 35 35
cell migration -0.012 0.015 -10000 0 -10000 0 0
PRKCD 0.008 0.035 -10000 0 -10000 0 0
vasculogenesis 0.045 0.19 0.36 1 -0.49 16 17
SDC4 -0.026 0.14 -10000 0 -0.51 15 15
Syndecan-4/Tenascin C 0.044 0.2 -10000 0 -0.51 16 16
Syndecan-4/PI-4-5-P2/PKC alpha -0.019 0.021 -10000 0 -10000 0 0
Syndecan-4/Syntenin 0.043 0.18 0.36 1 -0.49 13 14
MMP9 -0.009 0.1 -10000 0 -0.31 18 18
Rac1/GTP -0.002 0.075 0.19 4 -0.3 9 13
cytoskeleton organization 0.056 0.18 0.36 1 -0.47 14 15
GIPC1 0.031 0.051 -10000 0 -0.38 3 3
Syndecan-4/TFPI 0.052 0.19 0.36 1 -0.5 15 16
Reelin signaling pathway

Figure S49.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S49.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CDK5R1/CDK5 0.051 0.016 -10000 0 -10000 0 0
VLDLR -0.076 0.19 -10000 0 -0.36 61 61
CRKL 0.03 0.049 -10000 0 -0.47 2 2
LRPAP1 0.036 0.007 -10000 0 -10000 0 0
FYN 0.011 0.098 -10000 0 -0.32 15 15
ITGA3 0.018 0.087 -10000 0 -0.38 9 9
RELN/VLDLR/Fyn -0.026 0.15 -10000 0 -0.3 39 39
MAPK8IP1/MKK7/MAP3K11/JNK1 0.094 0.052 -10000 0 -0.25 1 1
AKT1 -0.028 0.094 -10000 0 -0.23 29 29
MAP2K7 0.031 0.046 -10000 0 -0.24 5 5
RAPGEF1 0.036 0.016 -10000 0 -0.19 1 1
DAB1 0.037 0.006 -10000 0 -10000 0 0
RELN/LRP8/DAB1 0.051 0.068 -10000 0 -0.26 8 8
LRPAP1/LRP8 0.036 0.077 -10000 0 -0.34 8 8
RELN/LRP8/DAB1/Fyn 0.047 0.095 -10000 0 -0.26 15 15
DAB1/alpha3/beta1 Integrin -0.017 0.14 -10000 0 -0.33 6 6
long-term memory 0.045 0.11 -10000 0 -0.26 17 17
DAB1/LIS1 0.01 0.13 -10000 0 -0.24 39 39
DAB1/CRLK/C3G -0.011 0.13 -10000 0 -0.25 37 37
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
DAB1/NCK2 0.027 0.14 -10000 0 -0.24 39 39
ARHGEF2 0.036 0.016 -10000 0 -0.19 1 1
mol:Src family inhibitors PP1 and PP2 0 0 -10000 0 -10000 0 0
GRIN2A 0.037 0.006 -10000 0 -10000 0 0
CDK5R1 0.036 0.008 -10000 0 -10000 0 0
RELN 0.035 0.017 -10000 0 -0.19 1 1
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
RELN/LRP8/Fyn 0.033 0.1 -10000 0 -0.3 15 15
GRIN2A/RELN/LRP8/DAB1/Fyn 0.063 0.1 -10000 0 -0.26 15 15
MAPK8 0.036 0.007 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.006 0.12 -10000 0 -0.26 33 33
ITGB1 0.036 0.016 -10000 0 -0.19 1 1
MAP1B -0.035 0.11 0.32 2 -0.24 41 43
RELN/LRP8 0.051 0.075 -10000 0 -0.29 8 8
GRIN2B/RELN/LRP8/DAB1/Fyn 0.053 0.11 -10000 0 -0.27 17 17
PI3K 0.048 0.047 -10000 0 -0.34 3 3
mol:PP2 0 0 -10000 0 -10000 0 0
alpha3/beta1 Integrin 0.038 0.069 -10000 0 -0.34 6 6
RAP1A -0.055 0.1 0.33 3 -0.34 3 6
PAFAH1B1 0.03 0.015 -10000 0 -10000 0 0
MAPK8IP1 0.035 0.022 -10000 0 -0.19 2 2
CRLK/C3G 0.047 0.042 -10000 0 -0.34 2 2
GRIN2B 0.021 0.067 -10000 0 -0.23 12 12
NCK2 0.038 0 -10000 0 -10000 0 0
neuron differentiation 0.021 0.074 -10000 0 -0.32 3 3
neuron adhesion -0.056 0.12 0.4 4 -0.44 2 6
LRP8 0.015 0.099 -10000 0 -0.39 11 11
GSK3B -0.028 0.094 -10000 0 -0.43 3 3
RELN/VLDLR/DAB1/Fyn -0.009 0.14 -10000 0 -0.26 38 38
MAP3K11 0.037 0.006 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/P13K -0.021 0.1 -10000 0 -0.24 33 33
CDK5 0.036 0.008 -10000 0 -10000 0 0
MAPT 0.018 0.13 0.77 6 -0.43 1 7
neuron migration -0.043 0.12 0.29 4 -0.37 5 9
RELN/LRP8/DAB1/Fyn/MAPK8IP1/MKK7/MAP3K11/JNK1 0.021 0.074 -10000 0 -0.33 3 3
RELN/VLDLR -0.009 0.14 -10000 0 -0.26 41 41
LPA receptor mediated events

Figure S50.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S50.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.031 0.056 -10000 0 -0.21 7 7
NF kappa B1 p50/RelA/I kappa B alpha -0.001 0.092 -10000 0 -0.26 7 7
AP1 -0.065 0.11 -10000 0 -0.23 55 55
mol:PIP3 -0.015 0.067 -10000 0 -0.22 16 16
AKT1 0.021 0.067 0.26 3 -0.35 1 4
PTK2B -0.044 0.095 -10000 0 -0.19 56 56
RHOA 0.016 0.061 0.26 2 -0.3 3 5
PIK3CB 0.034 0.035 -10000 0 -0.47 1 1
mol:Ca2+ -0.019 0.078 0.21 2 -0.24 18 20
MAGI3 0.033 0.035 -10000 0 -0.47 1 1
RELA 0.037 0.006 -10000 0 -10000 0 0
apoptosis 0.005 0.048 -10000 0 -0.22 8 8
HRAS/GDP 0.025 0.027 -10000 0 -0.23 2 2
positive regulation of microtubule depolymerization -0.038 0.089 0.2 2 -0.25 10 12
NF kappa B1 p50/RelA -0.03 0.078 -10000 0 -0.25 13 13
endothelial cell migration -0.006 0.11 -10000 0 -0.56 7 7
ADCY4 -0.027 0.1 -10000 0 -0.32 16 16
ADCY5 -0.009 0.079 -10000 0 -0.3 10 10
ADCY6 -0.009 0.081 -10000 0 -0.3 10 10
ADCY7 -0.011 0.082 -10000 0 -0.3 10 10
ADCY1 -0.012 0.078 -10000 0 -0.3 10 10
ADCY2 -0.01 0.081 -10000 0 -0.3 10 10
ADCY3 -0.018 0.09 -10000 0 -0.29 13 13
ADCY8 -0.012 0.08 -10000 0 -0.28 11 11
ADCY9 -0.013 0.084 -10000 0 -0.31 10 10
GSK3B -0.042 0.093 0.18 2 -0.22 25 27
arachidonic acid secretion -0.012 0.086 -10000 0 -0.29 13 13
GNG2 0.034 0.011 -10000 0 -10000 0 0
TRIP6 -0.017 0.11 -10000 0 -0.41 15 15
GNAO1 0.009 0.052 -10000 0 -0.24 7 7
HRAS 0.034 0.038 -10000 0 -0.33 2 2
NFKBIA -0.026 0.081 0.18 1 -0.27 9 10
GAB1 0.03 0.053 -10000 0 -0.33 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
lamellipodium assembly -0.017 0.26 -10000 0 -0.84 18 18
JUN -0.015 0.15 -10000 0 -0.39 26 26
LPA/LPA2/NHERF2 0.002 0.07 -10000 0 -0.24 13 13
TIAM1 -0.038 0.29 -10000 0 -0.97 19 19
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:IP3 -0.026 0.075 0.21 2 -0.24 18 20
PLCB3 -0.007 0.084 0.19 5 -0.25 17 22
FOS -0.055 0.16 -10000 0 -0.3 56 56
positive regulation of mitosis -0.012 0.086 -10000 0 -0.29 13 13
LPA/LPA1-2-3 -0.006 0.042 -10000 0 -0.2 8 8
mol:Ca ++ 0 0 -10000 0 -10000 0 0
JNK cascade 0 0.001 -10000 0 -10000 0 0
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
stress fiber formation -0.004 0.066 -10000 0 -0.28 3 3
GNAZ 0.002 0.067 -10000 0 -0.29 8 8
EGFR/PI3K-beta/Gab1 -0.006 0.073 -10000 0 -0.23 16 16
positive regulation of dendritic cell cytokine production -0.007 0.042 -10000 0 -0.22 7 7
LPA/LPA2/MAGI-3 0.018 0.032 -10000 0 -0.28 1 1
ARHGEF1 0.033 0.076 0.2 23 -0.2 7 30
GNAI2 0.003 0.069 -10000 0 -0.28 10 10
GNAI3 0.007 0.055 -10000 0 -0.24 8 8
GNAI1 -0.015 0.091 -10000 0 -0.28 20 20
LPA/LPA3 -0.005 0.021 -10000 0 -0.087 10 10
LPA/LPA2 -0.004 0.021 -10000 0 -0.082 11 11
LPA/LPA1 -0.007 0.056 -10000 0 -0.28 7 7
HB-EGF/EGFR -0.018 0.099 -10000 0 -0.32 17 17
HBEGF -0.022 0.089 -10000 0 -0.34 13 13
mol:DAG -0.026 0.075 0.21 2 -0.24 18 20
cAMP biosynthetic process -0.013 0.095 0.29 3 -0.3 12 15
NFKB1 0.037 0.006 -10000 0 -10000 0 0
SRC 0.013 0.06 -10000 0 -0.47 3 3
GNB1 0.035 0.009 -10000 0 -10000 0 0
LYN 0 0.078 0.2 4 -0.25 4 8
GNAQ -0.003 0.017 -10000 0 -0.086 7 7
LPAR2 0 0.001 -10000 0 -10000 0 0
LPAR3 -0.001 0.001 -10000 0 -10000 0 0
LPAR1 -0.005 0.033 -10000 0 -0.097 20 20
IL8 -0.14 0.23 -10000 0 -0.48 62 62
PTK2 0.011 0.043 -10000 0 -0.2 6 6
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
CASP3 0.005 0.048 -10000 0 -0.22 8 8
EGFR 0.017 0.086 -10000 0 -0.4 8 8
PLCG1 -0.001 0.031 -10000 0 -0.13 9 9
PLD2 0.009 0.045 -10000 0 -0.2 7 7
G12/G13 0.032 0.057 -10000 0 -0.22 7 7
PI3K-beta 0.007 0.056 -10000 0 -0.39 1 1
cell migration 0.007 0.091 -10000 0 -0.24 18 18
SLC9A3R2 0.008 0.11 -10000 0 -0.39 14 14
PXN -0.004 0.066 -10000 0 -0.28 3 3
HRAS/GTP -0.013 0.088 -10000 0 -0.3 13 13
RAC1 0.034 0.012 -10000 0 -10000 0 0
MMP9 -0.009 0.1 -10000 0 -0.31 18 18
PRKCE 0.035 0.035 -10000 0 -0.47 1 1
PRKCD -0.019 0.079 0.22 3 -0.24 15 18
Gi(beta/gamma) -0.011 0.089 -10000 0 -0.29 14 14
mol:LPA -0.006 0.033 -10000 0 -0.097 20 20
TRIP6/p130 Cas/FAK1/Paxillin 0.022 0.1 -10000 0 -0.4 4 4
MAPKKK cascade -0.012 0.086 -10000 0 -0.29 13 13
contractile ring contraction involved in cytokinesis 0.015 0.061 0.26 2 -0.3 3 5
mol:GDP 0 0 -10000 0 -10000 0 0
GNA14 -0.016 0.078 -10000 0 -0.23 21 21
GNA15 0.005 0.036 -10000 0 -0.12 10 10
GNA12 0.034 0.011 -10000 0 -10000 0 0
GNA13 0.036 0.009 -10000 0 -10000 0 0
MAPT -0.039 0.091 0.2 2 -0.25 11 13
GNA11 0.007 0.033 -10000 0 -0.14 6 6
Rac1/GTP -0.02 0.27 -10000 0 -0.9 18 18
MMP2 -0.006 0.11 -10000 0 -0.57 7 7
Stabilization and expansion of the E-cadherin adherens junction

Figure S51.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S51.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
adherens junction organization 0.01 0.075 -10000 0 -0.23 17 17
epithelial cell differentiation 0.048 0.087 -10000 0 -0.25 14 14
CYFIP2 0.012 0.11 -10000 0 -0.44 11 11
ENAH -0.039 0.083 0.28 1 -0.35 5 6
EGFR 0.018 0.086 -10000 0 -0.4 8 8
EPHA2 0.014 0.083 -10000 0 -0.26 15 15
MYO6 -0.007 0.075 -10000 0 -0.24 17 17
CTNNB1 0.018 0.081 -10000 0 -0.27 13 13
ABI1/Sra1/Nap1 0.048 0.089 -10000 0 -0.3 11 11
AQP5 -0.005 0.094 -10000 0 -0.49 4 4
CTNND1 0.037 0.006 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.001 0.07 -10000 0 -0.24 14 14
regulation of calcium-dependent cell-cell adhesion -0.034 0.096 -10000 0 -0.24 32 32
EGF -0.087 0.18 -10000 0 -0.3 78 78
NCKAP1 0.025 0.064 -10000 0 -0.24 10 10
AQP3 -0.019 0.11 -10000 0 -0.45 8 8
cortical microtubule organization 0.048 0.087 -10000 0 -0.25 14 14
GO:0000145 -0.024 0.061 0.16 4 -0.23 14 18
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.055 0.091 -10000 0 -0.25 14 14
MLLT4 0.024 0.077 -10000 0 -0.47 5 5
ARF6/GDP -0.051 0.085 -10000 0 -0.36 8 8
ARF6 0.029 0.05 -10000 0 -0.47 2 2
Ephrin A1/EPHA2/NCK1/GIT1 0.049 0.098 -10000 0 -0.28 12 12
mol:Ca2+ 0 0 -10000 0 -10000 0 0
VASP -0.015 0.072 -10000 0 -0.28 6 6
PVRL2 0.032 0.041 -10000 0 -0.28 3 3
ZYX -0.006 0.071 -10000 0 -0.24 16 16
ARF6/GTP 0.047 0.1 -10000 0 -0.27 14 14
CDH1 0.013 0.11 -10000 0 -0.47 10 10
EGFR/EGFR/EGF/EGF -0.035 0.13 -10000 0 -0.26 44 44
RhoA/GDP 0.051 0.086 -10000 0 -0.24 14 14
actin cytoskeleton organization -0.03 0.064 -10000 0 -0.24 13 13
IGF-1R heterotetramer 0.032 0.039 -10000 0 -0.33 2 2
GIT1 0.035 0.017 -10000 0 -0.19 1 1
IGF1R 0.032 0.039 -10000 0 -0.33 2 2
IGF1 0.018 0.078 -10000 0 -0.24 15 15
DIAPH1 0.029 0.18 -10000 0 -0.63 13 13
Wnt receptor signaling pathway -0.048 0.087 0.25 14 -10000 0 14
RHOA 0.037 0.005 -10000 0 -10000 0 0
RhoA/GTP -0.049 0.082 -10000 0 -0.39 6 6
CTNNA1 0.037 0.005 -10000 0 -10000 0 0
VCL -0.031 0.066 -10000 0 -0.24 13 13
EFNA1 0.023 0.075 -10000 0 -0.33 8 8
LPP -0.025 0.062 0.17 4 -0.24 13 17
Ephrin A1/EPHA2 0.02 0.11 -10000 0 -0.29 19 19
SEC6/SEC8 -0.008 0.085 -10000 0 -0.28 16 16
MGAT3 -0.035 0.097 -10000 0 -0.24 32 32
HGF/MET 0.036 0.092 -10000 0 -0.26 15 15
HGF 0.034 0.023 -10000 0 -0.19 2 2
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN 0.009 0.075 -10000 0 -0.23 17 17
actin cable formation -0.018 0.1 0.36 4 -0.29 9 13
KIAA1543 -0.025 0.061 -10000 0 -0.23 13 13
KIFC3 -0.006 0.071 -10000 0 -0.24 15 15
NCK1 0.028 0.069 -10000 0 -0.47 4 4
EXOC3 0.036 0.008 -10000 0 -10000 0 0
ACTN1 -0.002 0.07 -10000 0 -0.24 14 14
NCK1/GIT1 0.044 0.056 -10000 0 -0.34 4 4
mol:GDP 0.048 0.087 -10000 0 -0.25 14 14
EXOC4 0.036 0.008 -10000 0 -10000 0 0
STX4 -0.004 0.069 -10000 0 -0.24 15 15
PIP5K1C -0.001 0.071 -10000 0 -0.24 14 14
LIMA1 0.026 0.072 -10000 0 -0.38 6 6
ABI1 0.037 0.004 -10000 0 -10000 0 0
ROCK1 -0.031 0.091 0.3 3 -0.39 4 7
adherens junction assembly -0.007 0.073 0.27 3 -0.32 1 4
IGF-1R heterotetramer/IGF1 0.026 0.095 -10000 0 -0.24 18 18
nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin 0.04 0.068 -10000 0 -0.34 6 6
MET 0.029 0.054 -10000 0 -0.33 4 4
PLEKHA7 0 0.071 -10000 0 -0.24 14 14
mol:GTP 0.046 0.096 -10000 0 -0.28 12 12
establishment of epithelial cell apical/basal polarity -0.025 0.095 0.33 1 -0.37 6 7
cortical actin cytoskeleton stabilization 0.01 0.075 -10000 0 -0.23 17 17
regulation of cell-cell adhesion -0.03 0.064 -10000 0 -0.24 13 13
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton 0.009 0.075 -10000 0 -0.23 17 17
Signaling events mediated by PRL

Figure S52.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S52.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CCNE1 0.028 0.055 -10000 0 -0.3 5 5
mol:Halofuginone 0.002 0.021 -10000 0 -0.2 2 2
ITGA1 0.022 0.085 -10000 0 -0.43 7 7
CDKN1A 0.038 0.11 -10000 0 -0.37 7 7
PRL-3/alpha Tubulin 0.011 0.1 -10000 0 -0.34 16 16
mol:Ca2+ -0.038 0.13 0.34 11 -0.35 16 27
AGT -0.046 0.16 -10000 0 -0.31 51 51
CCNA2 0.032 0.14 -10000 0 -0.65 3 3
TUBA1B 0.034 0.038 -10000 0 -0.33 2 2
EGR1 -0.04 0.12 -10000 0 -0.32 26 26
CDK2/Cyclin E1 0.047 0.13 -10000 0 -0.39 6 6
MAPK3 -0.02 0.1 -10000 0 -0.35 18 18
PRL-2 /Rab GGTase beta 0.052 0.014 -10000 0 -10000 0 0
MAPK1 -0.011 0.089 -10000 0 -0.34 14 14
PTP4A1 -0.019 0.11 -10000 0 -0.69 3 3
PTP4A3 -0.009 0.13 -10000 0 -0.41 19 19
PTP4A2 0.036 0.008 -10000 0 -10000 0 0
ITGB1 -0.012 0.094 -10000 0 -0.34 15 15
SRC 0.013 0.06 -10000 0 -0.47 3 3
RAC1 0 0.14 -10000 0 -0.45 14 14
Rab GGTase beta/Rab GGTase alpha 0.049 0.019 -10000 0 -10000 0 0
PRL-1/ATF-5 0.051 0.15 0.36 1 -0.61 4 5
RABGGTA 0.034 0.011 -10000 0 -10000 0 0
BCAR1 0.007 0.097 0.36 15 -10000 0 15
RHOC -0.003 0.15 -10000 0 -0.43 18 18
RHOA 0.006 0.14 -10000 0 -0.45 14 14
cell motility -0.005 0.18 0.31 3 -0.43 21 24
PRL-1/alpha Tubulin 0.054 0.15 0.36 2 -0.65 3 5
PRL-3/alpha1 Integrin 0.008 0.11 -10000 0 -0.34 18 18
ROCK1 0.002 0.17 0.31 3 -0.44 20 23
RABGGTB 0.036 0.007 -10000 0 -10000 0 0
CDK2 0.022 0.072 -10000 0 -0.26 11 11
mitosis -0.018 0.11 -10000 0 -0.68 3 3
ATF5 0.03 0.053 -10000 0 -0.33 4 4
Ras signaling in the CD4+ TCR pathway

Figure S53.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S53.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ERK1-2/ELK1 -0.027 0.16 -9999 0 -0.39 16 16
MAP3K8 0.008 0.1 -9999 0 -0.3 18 18
FOS -0.014 0.11 -9999 0 -0.37 8 8
PRKCA 0.025 0.042 -9999 0 -0.34 2 2
PTPN7 0.002 0.071 -9999 0 -0.19 23 23
HRAS 0.033 0.038 -9999 0 -0.33 2 2
PRKCB -0.003 0.006 -9999 0 -0.015 36 36
NRAS 0.021 0.076 -9999 0 -0.31 9 9
RAS family/GTP 0.048 0.062 -9999 0 -0.25 6 6
MAPK3 0.008 0.085 -9999 0 -0.46 5 5
MAP2K1 -0.005 0.066 -9999 0 -0.26 6 6
ELK1 0.023 0.037 -9999 0 -0.2 3 3
BRAF 0.007 0.038 -9999 0 -0.3 2 2
mol:GTP -0.001 0.002 -9999 0 -0.004 36 36
MAPK1 -0.009 0.12 -9999 0 -0.44 14 14
RAF1 0.006 0.042 -9999 0 -0.28 3 3
KRAS 0.033 0.038 -9999 0 -0.33 2 2
JNK signaling in the CD4+ TCR pathway

Figure S54.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S54.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
LAT/GRAP2/SLP76/HPK1 0.031 0.12 -9999 0 -0.29 21 21
MAP4K1 0.035 0.017 -9999 0 -0.19 1 1
MAP3K8 0.009 0.1 -9999 0 -0.3 18 18
PRKCB 0 0 -9999 0 -10000 0 0
DBNL 0.03 0.032 -9999 0 -0.19 4 4
CRKL 0.03 0.049 -9999 0 -0.47 2 2
MAP3K1 -0.016 0.11 -9999 0 -0.44 8 8
JUN -0.034 0.14 -9999 0 -0.64 7 7
MAP3K7 -0.011 0.11 -9999 0 -0.44 7 7
GRAP2 0.021 0.079 -9999 0 -0.39 7 7
CRK 0.03 0.015 -9999 0 -10000 0 0
MAP2K4 -0.033 0.14 -9999 0 -0.44 15 15
LAT 0.025 0.061 -9999 0 -0.26 8 8
LCP2 -0.021 0.15 -9999 0 -0.36 32 32
MAPK8 -0.008 0.13 -9999 0 -0.66 7 7
LAT/GRAP2/SLP76/HPK1/HIP-55/CRK family -0.005 0.11 -9999 0 -0.31 16 16
LAT/GRAP2/SLP76/HPK1/HIP-55 0.037 0.12 -9999 0 -0.28 18 18
Signaling events mediated by PTP1B

Figure S55.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S55.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.035 0.035 -10000 0 -0.47 1 1
Jak2/Leptin Receptor 0.031 0.14 0.29 4 -0.44 7 11
PTP1B/AKT1 0.023 0.11 0.23 2 -0.27 9 11
FYN 0.011 0.098 -10000 0 -0.32 15 15
p210 bcr-abl/PTP1B 0.015 0.11 0.21 6 -0.28 11 17
EGFR 0.012 0.088 -10000 0 -0.4 8 8
EGF/EGFR -0.012 0.15 -10000 0 -0.3 29 29
CSF1 0.035 0.017 -10000 0 -0.19 1 1
AKT1 0.031 0.029 -10000 0 -0.19 3 3
INSR 0.026 0.072 -10000 0 -0.38 6 6
PTP1B/N-cadherin 0.004 0.11 0.24 1 -0.31 12 13
Insulin Receptor/Insulin 0.04 0.11 0.26 1 -0.31 6 7
HCK -0.01 0.11 -10000 0 -0.35 17 17
CRK 0.03 0.015 -10000 0 -10000 0 0
TYK2 0.014 0.11 0.31 4 -0.28 9 13
EGF -0.085 0.18 -10000 0 -0.3 78 78
YES1 0.03 0.015 -10000 0 -10000 0 0
CAV1 0.025 0.14 0.25 13 -0.33 10 23
TXN 0.036 0.006 -10000 0 -10000 0 0
PTP1B/IRS1/GRB2 0.032 0.13 0.26 1 -0.3 11 12
cell migration -0.015 0.11 0.28 11 -0.21 6 17
STAT3 0.037 0.006 -10000 0 -10000 0 0
PRLR 0.01 0.12 -10000 0 -0.43 14 14
ITGA2B 0.035 0.007 -10000 0 -10000 0 0
CSF1R 0.021 0.086 -10000 0 -0.4 8 8
Prolactin Receptor/Prolactin 0.037 0.096 -10000 0 -0.34 12 12
FGR 0.027 0.041 -10000 0 -0.19 7 7
PTP1B/p130 Cas 0.026 0.11 0.23 2 -0.28 9 11
Crk/p130 Cas 0.026 0.11 -10000 0 -0.27 9 9
DOK1 0.019 0.11 0.23 3 -0.3 7 10
JAK2 0.021 0.13 0.29 1 -0.42 8 9
Jak2/Leptin Receptor/Leptin 0.022 0.14 -10000 0 -0.31 9 9
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
PTPN1 0.015 0.11 0.21 6 -0.28 11 17
LYN 0.032 0.013 -10000 0 -10000 0 0
CDH2 0.002 0.09 -10000 0 -0.27 18 18
SRC 0.016 0.13 -10000 0 -0.5 9 9
ITGB3 0.034 0.017 -10000 0 -0.19 1 1
CAT1/PTP1B 0.013 0.2 0.26 30 -0.43 18 48
CAPN1 0.021 0.076 -10000 0 -0.32 9 9
CSK 0.035 0.01 -10000 0 -10000 0 0
PI3K 0.048 0.11 -10000 0 -0.35 5 5
mol:H2O2 -0.001 0.005 -10000 0 -10000 0 0
STAT3 (dimer) 0.02 0.13 -10000 0 -0.3 8 8
negative regulation of transcription 0.021 0.13 0.29 1 -0.42 8 9
FCGR2A -0.026 0.15 -10000 0 -0.34 36 36
FER 0.024 0.05 -10000 0 -0.19 11 11
alphaIIb/beta3 Integrin 0.05 0.017 -10000 0 -10000 0 0
BLK 0.01 0.085 -10000 0 -0.3 12 12
Insulin Receptor/Insulin/Shc 0.062 0.051 -10000 0 -0.29 3 3
RHOA 0.036 0.005 -10000 0 -10000 0 0
LEPR 0.027 0.059 -10000 0 -0.27 7 7
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
p210 bcr-abl/Grb2 0.036 0.007 -10000 0 -10000 0 0
mol:NADPH -0.001 0.003 -10000 0 -10000 0 0
TRPV6 -0.053 0.23 0.23 6 -0.51 29 35
PRL 0.039 0.023 -10000 0 -0.18 2 2
SOCS3 -0.058 0.32 -10000 0 -1.3 14 14
SPRY2 0 0.11 -10000 0 -0.43 12 12
Insulin Receptor/Insulin/IRS1 0.049 0.089 -10000 0 -0.35 8 8
CSF1/CSF1R 0.032 0.13 0.26 2 -0.3 13 15
Ras protein signal transduction -0.008 0.065 0.45 3 -10000 0 3
IRS1 0.017 0.094 -10000 0 -0.37 11 11
INS 0.036 0.009 -10000 0 -10000 0 0
LEP 0.024 0.063 -10000 0 -0.25 9 9
STAT5B 0.025 0.11 0.22 5 -0.27 9 14
STAT5A 0.024 0.12 0.22 5 -0.28 11 16
GRB2 0.036 0.007 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.028 0.12 0.23 3 -0.29 10 13
CSN2 0.013 0.056 -10000 0 -10000 0 0
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
LAT -0.012 0.17 -10000 0 -0.49 22 22
YBX1 0.045 0.04 -10000 0 -0.36 2 2
LCK -0.013 0.14 -10000 0 -0.34 28 28
SHC1 0.037 0.006 -10000 0 -10000 0 0
NOX4 -0.036 0.15 -10000 0 -0.29 47 47
Arf6 downstream pathway

Figure S56.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S56.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PLAUR -0.019 0.19 -10000 0 -1.1 6 6
regulation of axonogenesis 0.003 0.07 0.31 8 -10000 0 8
myoblast fusion -0.013 0.08 0.37 8 -10000 0 8
mol:GTP 0.001 0.077 -10000 0 -0.2 25 25
regulation of calcium-dependent cell-cell adhesion -0.036 0.086 0.26 10 -10000 0 10
ARF1/GTP 0.023 0.069 -10000 0 -0.2 9 9
mol:GM1 -0.006 0.055 -10000 0 -0.2 9 9
mol:Choline 0.001 0.051 -10000 0 -0.25 6 6
lamellipodium assembly -0.023 0.13 -10000 0 -0.37 24 24
MAPK3 -0.001 0.087 -10000 0 -0.31 12 12
ARF6/GTP/NME1/Tiam1 0.037 0.087 -10000 0 -0.26 10 10
ARF1 0.036 0.007 -10000 0 -10000 0 0
ARF6/GDP 0.013 0.08 -10000 0 -0.37 8 8
ARF1/GDP 0.003 0.1 -10000 0 -0.3 14 14
ARF6 0.029 0.067 -10000 0 -0.57 2 2
RAB11A 0.032 0.039 -10000 0 -0.33 2 2
TIAM1 0.028 0.053 -10000 0 -0.37 3 3
fibronectin binding 0 0 -10000 0 -10000 0 0
MAPK1 0.008 0.076 -10000 0 -0.32 8 8
actin filament bundle formation -0.01 0.1 0.3 14 -10000 0 14
KALRN 0.007 0.062 -10000 0 -0.31 7 7
RAB11FIP3/RAB11A 0.043 0.058 -10000 0 -0.36 4 4
RhoA/GDP 0.01 0.11 -10000 0 -0.3 14 14
NME1 0.031 0.038 -10000 0 -0.47 1 1
Rac1/GDP 0.007 0.1 -10000 0 -0.3 13 13
substrate adhesion-dependent cell spreading 0.001 0.076 -10000 0 -0.2 25 25
cortical actin cytoskeleton organization -0.024 0.13 -10000 0 -0.38 24 24
RAC1 0.034 0.012 -10000 0 -10000 0 0
liver development 0.001 0.076 -10000 0 -0.2 25 25
ARF6/GTP 0.001 0.077 -10000 0 -0.2 25 25
RhoA/GTP 0.024 0.069 -10000 0 -0.2 9 9
mol:GDP -0.017 0.1 -10000 0 -0.32 15 15
ARF6/GTP/RAB11FIP3/RAB11A 0.038 0.085 -10000 0 -0.31 6 6
RHOA 0.037 0.005 -10000 0 -10000 0 0
PLD1 0 0.072 -10000 0 -0.23 12 12
RAB11FIP3 0.029 0.06 -10000 0 -0.47 3 3
tube morphogenesis -0.023 0.13 -10000 0 -0.37 24 24
ruffle organization -0.003 0.07 -10000 0 -0.31 8 8
regulation of epithelial cell migration 0.001 0.076 -10000 0 -0.2 25 25
PLD2 0.014 0.043 -10000 0 -0.21 5 5
PIP5K1A -0.003 0.07 -10000 0 -0.31 8 8
mol:Phosphatidic acid 0.001 0.051 -10000 0 -0.25 6 6
Rac1/GTP -0.024 0.13 -10000 0 -0.38 24 24
E-cadherin signaling in the nascent adherens junction

Figure S57.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S57.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CTTN -0.007 0.14 -10000 0 -0.49 16 16
KLHL20 0.031 0.12 0.22 14 -0.24 19 33
CYFIP2 0.012 0.11 -10000 0 -0.44 11 11
Rac1/GDP 0.047 0.14 0.29 6 -0.36 11 17
ENAH -0.016 0.15 -10000 0 -0.5 16 16
AP1M1 0.035 0.035 -10000 0 -0.47 1 1
RAP1B 0.035 0.035 -10000 0 -0.47 1 1
RAP1A 0.036 0.009 -10000 0 -10000 0 0
CTNNB1 0.018 0.081 -10000 0 -0.27 13 13
CDC42/GTP 0.047 0.1 -10000 0 -0.36 6 6
ABI1/Sra1/Nap1 -0.028 0.058 -10000 0 -0.18 23 23
E-cadherin/beta catenin/alpha catenin/beta7/alphaE Integrin 0.021 0.12 -10000 0 -0.26 28 28
RAPGEF1 0.036 0.16 0.3 5 -0.49 11 16
CTNND1 0.037 0.006 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion 0.002 0.15 -10000 0 -0.5 16 16
CRK 0.032 0.16 -10000 0 -0.53 11 11
E-cadherin/gamma catenin/alpha catenin 0.053 0.079 -10000 0 -0.29 10 10
alphaE/beta7 Integrin 0.017 0.097 -10000 0 -0.33 14 14
IQGAP1 0.035 0.01 -10000 0 -10000 0 0
NCKAP1 0.025 0.064 -10000 0 -0.24 10 10
Rap1/GTP/I-afadin 0.056 0.059 -10000 0 -0.26 6 6
DLG1 -0.008 0.14 -10000 0 -0.49 16 16
ChemicalAbstracts:7440-70-2 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 -0.01 0.055 -10000 0 -0.27 6 6
MLLT4 0.024 0.077 -10000 0 -0.47 5 5
ARF6/GTP/NME1/Tiam1 0.05 0.059 -10000 0 -0.27 5 5
PI3K -0.01 0.074 -10000 0 -0.36 6 6
ARF6 0.029 0.05 -10000 0 -0.47 2 2
mol:Ca2+ 0 0 -10000 0 -10000 0 0
E-cadherin/gamma catenin 0.034 0.084 -10000 0 -0.34 10 10
TIAM1 0.03 0.051 -10000 0 -0.38 3 3
E-cadherin(dimer)/Ca2+ 0.055 0.091 -10000 0 -0.25 14 14
AKT1 0.028 0.068 0.18 5 -0.2 5 10
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
CDH1 0.013 0.11 -10000 0 -0.47 10 10
RhoA/GDP 0.064 0.15 0.32 7 -0.36 11 18
actin cytoskeleton organization 0.033 0.097 0.21 17 -0.18 18 35
CDC42/GDP 0.06 0.15 0.32 8 -0.36 11 19
E-cadherin/Ca2+/gamma catenin/alpha catenin/p120 catenin 0.016 0.055 -10000 0 -0.23 10 10
ITGB7 0.004 0.12 -10000 0 -0.47 14 14
RAC1 0.034 0.012 -10000 0 -10000 0 0
E-cadherin/beta catenin/alpha catenin/p120 catenin 0.06 0.097 -10000 0 -0.27 14 14
E-cadherin/Ca2+/beta catenin/alpha catenin 0.037 0.083 -10000 0 -0.25 14 14
mol:GDP 0.049 0.16 0.32 8 -0.42 11 19
CDC42/GTP/IQGAP1 0.043 0.02 -10000 0 -10000 0 0
JUP 0.035 0.017 -10000 0 -0.19 1 1
p120 catenin/RhoA/GDP 0.072 0.15 0.34 6 -0.37 11 17
RAC1/GTP/IQGAP1 0.042 0.019 -10000 0 -10000 0 0
PIP5K1C/AP1M1 0.052 0.028 -10000 0 -0.34 1 1
RHOA 0.037 0.005 -10000 0 -10000 0 0
CDC42 0.034 0.018 -10000 0 -0.19 1 1
CTNNA1 0.037 0.005 -10000 0 -10000 0 0
positive regulation of S phase of mitotic cell cycle 0.03 0.077 0.17 20 -0.17 5 25
NME1 0.033 0.036 -10000 0 -0.47 1 1
clathrin coat assembly 0 0 -10000 0 -10000 0 0
TJP1 -0.01 0.14 -10000 0 -0.49 16 16
regulation of cell-cell adhesion -0.002 0.068 -10000 0 -0.31 6 6
WASF2 0.012 0.053 0.11 13 -0.13 5 18
Rap1/GTP 0.071 0.13 0.31 4 -0.41 6 10
E-cadherin/gamma catenin/alpha catenin/beta7/alphaE Integrin 0.046 0.11 -10000 0 -0.25 23 23
CCND1 0.033 0.09 0.19 20 -0.21 5 25
VAV2 0.006 0.29 0.42 1 -0.72 23 24
RAP1/GDP 0.073 0.14 0.33 5 -0.43 6 11
adherens junction assembly -0.009 0.14 -10000 0 -0.48 16 16
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
ABI1 0.037 0.004 -10000 0 -10000 0 0
PIP5K1C 0.037 0.006 -10000 0 -10000 0 0
regulation of heterotypic cell-cell adhesion 0.019 0.11 -10000 0 -0.24 26 26
E-cadherin/beta catenin -0.002 0.079 -10000 0 -0.33 11 11
mol:GTP 0 0 -10000 0 -10000 0 0
SRC -0.018 0.14 -10000 0 -0.57 11 11
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
Rac1/GTP -0.042 0.13 -10000 0 -0.39 23 23
E-cadherin/beta catenin/alpha catenin 0.041 0.097 -10000 0 -0.29 14 14
ITGAE 0.028 0.026 -10000 0 -0.19 2 2
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin 0.001 0.15 -10000 0 -0.52 16 16
E-cadherin signaling events

Figure S58.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S58.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
E-cadherin/beta catenin-gamma catenin 0.039 0.097 -9999 0 -0.29 14 14
E-cadherin/beta catenin 0.021 0.1 -9999 0 -0.34 14 14
CTNNB1 0.018 0.081 -9999 0 -0.27 13 13
JUP 0.035 0.017 -9999 0 -0.19 1 1
CDH1 0.013 0.11 -9999 0 -0.47 10 10
Sphingosine 1-phosphate (S1P) pathway

Figure S59.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S59.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 0.024 0.078 -9999 0 -0.42 6 6
SPHK1 -0.031 0.15 -9999 0 -0.31 42 42
GNAI2 0.027 0.07 -9999 0 -0.41 5 5
mol:S1P -0.017 0.096 -9999 0 -0.28 22 22
GNAO1 0.037 0.005 -9999 0 -10000 0 0
mol:Sphinganine-1-P -0.034 0.12 -9999 0 -0.36 22 22
growth factor activity 0 0 -9999 0 -10000 0 0
S1P/S1P2/G12/G13 0.018 0.088 -9999 0 -0.22 22 22
GNAI3 0.034 0.035 -9999 0 -0.47 1 1
G12/G13 0.048 0.02 -9999 0 -10000 0 0
S1PR3 0 0 -9999 0 -10000 0 0
S1PR2 0 0 -9999 0 -10000 0 0
EDG1 0 0 -9999 0 -10000 0 0
S1P1/S1P -0.02 0.083 -9999 0 -0.24 22 22
S1PR5 0 0 -9999 0 -10000 0 0
S1PR4 0 0 -9999 0 -10000 0 0
GNAI1 -0.005 0.13 -9999 0 -0.38 21 21
S1P/S1P5/G12 -0.002 0.086 -9999 0 -0.23 22 22
S1P/S1P3/Gq -0.017 0.1 -9999 0 -0.3 18 18
S1P/S1P4/Gi -0.016 0.11 -9999 0 -0.38 13 13
GNAQ 0 0 -9999 0 -10000 0 0
GNAZ 0.024 0.061 -9999 0 -0.26 8 8
GNA14 -0.016 0.14 -9999 0 -0.35 29 29
GNA15 0.024 0.064 -9999 0 -0.24 10 10
GNA12 0.034 0.011 -9999 0 -10000 0 0
GNA13 0.036 0.009 -9999 0 -10000 0 0
GNA11 0.031 0.051 -9999 0 -0.38 3 3
ABCC1 0.032 0.041 -9999 0 -0.28 3 3
Visual signal transduction: Cones

Figure S60.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S60.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Cone Metarhodopsin II/Cone Transducin 0.04 0.069 -10000 0 -0.24 9 9
RGS9BP 0.007 0.1 -10000 0 -0.29 19 19
mol:GTP 0 0 -10000 0 -10000 0 0
GRK1 0 0 -10000 0 -10000 0 0
mol:Na + 0.014 0.077 -10000 0 -0.27 10 10
mol:ADP 0.01 0.009 -10000 0 -0.12 1 1
GNAT2 0.012 0.1 -10000 0 -0.4 12 12
RGS9-1/Gbeta5/R9AP 0.014 0.11 -10000 0 -0.3 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
PDE6H/GNAT2/GTP 0.021 0.092 -10000 0 -0.3 15 15
GRK7 0.036 0.016 -10000 0 -0.19 1 1
CNGB3 0.002 0.095 -10000 0 -0.25 22 22
Cone Metarhodopsin II/X-Arrestin 0.028 0.002 -10000 0 -10000 0 0
mol:Ca2+ 0.02 0.095 0.19 28 -0.24 12 40
Cone PDE6 0.025 0.13 -10000 0 -0.28 23 23
Cone Metarhodopsin II 0.023 0.008 -10000 0 -0.087 1 1
Na + (4 Units) 0.027 0.083 -10000 0 -0.24 12 12
GNAT2/GDP 0.015 0.12 -10000 0 -0.29 23 23
GNB5 -0.002 0.12 -10000 0 -0.36 20 20
mol:GMP (4 units) -0.003 0.085 0.19 4 -0.27 16 20
Cone Transducin 0.044 0.074 -10000 0 -0.26 9 9
SLC24A2 0.031 0.044 -10000 0 -0.26 4 4
GNB3/GNGT2 0.047 0.029 -10000 0 -10000 0 0
GNB3 0.035 0.017 -10000 0 -0.19 1 1
GNAT2/GTP 0.009 0.074 -10000 0 -0.28 12 12
CNGA3 0.021 0.074 -10000 0 -0.26 12 12
ARR3 0.038 0.003 -10000 0 -10000 0 0
absorption of light 0 0 -10000 0 -10000 0 0
cGMP/Cone CNG Channel 0.014 0.077 -10000 0 -0.27 10 10
mol:Pi 0.013 0.11 -10000 0 -0.29 20 20
Cone CNG Channel 0.014 0.12 -10000 0 -0.28 19 19
mol:all-trans-retinal 0 0 -10000 0 -10000 0 0
mol:K + 0.031 0.044 -10000 0 -0.26 4 4
RGS9 0.028 0.049 -10000 0 -0.23 6 6
PDE6C 0.027 0.051 -10000 0 -0.23 7 7
GNGT2 0.03 0.044 -10000 0 -0.26 4 4
mol:cGMP (4 units) 0 0 -10000 0 -10000 0 0
PDE6H 0.02 0.09 -10000 0 -0.47 7 7
p75(NTR)-mediated signaling

Figure S61.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S61.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Sortilin/TRAF6 0.05 0.032 -10000 0 -0.34 1 1
Necdin/E2F1 0.003 0.088 -10000 0 -0.34 11 11
proNGF (dimer)/p75(NTR)/Sortilin/NADE/14-3-3 E 0.013 0.12 -10000 0 -0.24 34 34
NGF (dimer)/p75(NTR)/BEX1 0.047 0.019 -10000 0 -10000 0 0
NT-4/5 (dimer)/p75(NTR) 0.026 0.012 -10000 0 -0.12 1 1
IKBKB 0.032 0.013 -10000 0 -10000 0 0
AKT1 0.017 0.045 -10000 0 -0.25 3 3
IKBKG 0.036 0.016 -10000 0 -0.19 1 1
BDNF 0.019 0.08 -10000 0 -0.28 12 12
MGDIs/NGR/p75(NTR)/LINGO1 0.046 0.068 -10000 0 -0.25 5 5
FURIN 0.029 0.046 -10000 0 -0.24 5 5
proBDNF (dimer)/p75(NTR)/Sortilin 0.053 0.072 -10000 0 -0.32 5 5
LINGO1 0.026 0.046 -10000 0 -0.19 9 9
Sortilin/TRAF6/NRIF 0.009 0.082 -10000 0 -0.29 2 2
proBDNF (dimer) 0.019 0.08 -10000 0 -0.28 12 12
NTRK1 0.036 0.016 -10000 0 -0.19 1 1
RTN4R 0.022 0.07 -10000 0 -0.28 9 9
neuron apoptosis -0.037 0.15 0.3 1 -0.51 10 11
IRAK1 0.035 0.022 -10000 0 -0.19 2 2
SHC1 0.019 0.01 -10000 0 -10000 0 0
ARHGDIA 0.036 0.007 -10000 0 -10000 0 0
RhoA/GTP 0.027 0.004 -10000 0 -10000 0 0
Gamma Secretase 0.055 0.098 -10000 0 -0.26 10 10
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-H1 0.023 0.099 -10000 0 -0.26 19 19
MAGEH1 -0.026 0.15 -10000 0 -0.32 38 38
proNGF (dimer)/p75(NTR)/Sortilin/Necdin 0.025 0.098 -10000 0 -0.28 15 15
Mammalian IAPs/DIABLO 0.04 0.083 -10000 0 -0.25 11 11
proNGF (dimer) 0 0 -10000 0 -10000 0 0
MAGED1 0.026 0.072 -10000 0 -0.38 6 6
APP 0.018 0.083 -10000 0 -0.33 10 10
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
ZNF274 0.026 0.07 -10000 0 -0.41 5 5
RhoA/GDP/RHOGDI 0.052 0.023 -10000 0 -10000 0 0
NGF 0 0 -10000 0 -10000 0 0
cell cycle arrest -0.009 0.042 0.2 6 -0.26 1 7
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK 0.025 0.039 -10000 0 -0.27 3 3
NT-4/5 (dimer)/p75(NTR)/TRAF6 0.047 0.016 -10000 0 -10000 0 0
NCSTN 0.037 0.006 -10000 0 -10000 0 0
mol:GTP 0.005 0.1 -10000 0 -0.29 22 22
PSENEN 0.033 0.038 -10000 0 -0.33 2 2
mol:ceramide 0.022 0.035 0.19 5 -0.26 1 6
NGF (dimer)/p75(NTR)/TRAF6/RIP2/IRAK/p62/Atypical PKCs 0.02 0.036 -10000 0 -0.22 4 4
p75(NTR)/beta APP 0.038 0.062 -10000 0 -0.34 4 4
BEX1 0.036 0.016 -10000 0 -0.19 1 1
mol:GDP 0.003 0.007 -10000 0 -10000 0 0
NGF (dimer) -0.04 0.14 -10000 0 -0.27 52 52
MGDIs/NGR/p75(NTR)/LINGO1/RHOGDI 0.063 0.071 -10000 0 -0.26 3 3
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
RAC1/GTP 0.038 0.018 -10000 0 -10000 0 0
MYD88 0.037 0.004 -10000 0 -10000 0 0
CHUK 0.031 0.049 -10000 0 -0.47 2 2
NGF (dimer)/p75(NTR)/PKA 0.006 0.1 -10000 0 -0.29 22 22
RHOB 0.023 0.071 -10000 0 -0.27 10 10
RHOA 0.037 0.005 -10000 0 -10000 0 0
MAGE-G1/E2F1 0.023 0.052 -10000 0 -0.34 3 3
NT3 (dimer) 0.013 0.092 -10000 0 -0.31 14 14
TP53 -0.033 0.11 0.32 1 -0.26 34 35
PRDM4 0.023 0.037 0.19 6 -0.26 1 7
BDNF (dimer) -0.13 0.21 -10000 0 -0.34 90 90
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
SORT1 0.033 0.038 -10000 0 -0.33 2 2
activation of caspase activity 0.009 0.12 -10000 0 -0.24 34 34
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6 0.062 0.035 -10000 0 -0.22 2 2
RHOC 0.036 0.008 -10000 0 -10000 0 0
XIAP 0 0 -10000 0 -10000 0 0
MAPK10 0 0.094 0.28 4 -0.34 3 7
DIABLO 0.037 0.004 -10000 0 -10000 0 0
SMPD2 0.022 0.035 0.19 5 -0.26 1 6
APH1B 0.022 0.07 -10000 0 -0.28 9 9
APH1A 0.008 0.098 -10000 0 -0.27 20 20
proNGF (dimer)/p75(NTR)/Sortilin 0.043 0.031 -10000 0 -0.24 2 2
PSEN1 0.034 0.011 -10000 0 -10000 0 0
APAF-1/Pro-Caspase 9 0.032 0.081 -10000 0 -0.32 9 9
NT3 (dimer)/p75(NTR) 0.032 0.074 -10000 0 -0.32 7 7
MAPK8 0.009 0.085 0.28 4 -0.33 3 7
MAPK9 0.007 0.084 0.3 3 -0.34 2 5
APAF1 0.012 0.1 -10000 0 -0.35 14 14
NTF3 0.013 0.092 -10000 0 -0.31 14 14
NTF4 0 0 -10000 0 -10000 0 0
NDN -0.016 0.14 -10000 0 -0.34 29 29
RAC1/GDP 0.025 0.009 -10000 0 -10000 0 0
RhoA-B-C/GDP 0.028 0.1 -10000 0 -0.23 24 24
p75 CTF/Sortilin/TRAF6/NRIF 0.078 0.065 -10000 0 -0.26 6 6
RhoA-B-C/GTP 0.005 0.1 -10000 0 -0.29 22 22
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.075 0.09 -10000 0 -0.28 8 8
proBDNF (dimer)/p75(NTR)/Sortilin/TRAF6 0.07 0.074 -10000 0 -0.32 4 4
PRKACB -0.025 0.16 -10000 0 -0.39 31 31
proBDNF (dimer)/p75 ECD 0.039 0.068 -10000 0 -0.34 5 5
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
BIRC3 -0.006 0.12 -10000 0 -0.29 28 28
BIRC2 0.035 0.017 -10000 0 -0.19 1 1
neuron projection morphogenesis -0.058 0.097 -10000 0 -0.31 17 17
BAD -0.001 0.1 0.35 4 -0.35 2 6
RIPK2 0.025 0.06 -10000 0 -0.47 3 3
NGFR 0.035 0.017 -10000 0 -0.19 1 1
CYCS 0.009 0.055 0.19 3 -0.24 7 10
ADAM17 0.035 0.035 -10000 0 -0.47 1 1
NGF (dimer)/p75(NTR)/TRAF6/RIP2 0.052 0.05 -10000 0 -0.28 3 3
BCL2L11 0 0.099 0.35 4 -0.35 2 6
BDNF (dimer)/p75(NTR) 0.037 0.064 -10000 0 -0.34 4 4
PI3K 0.061 0.045 -10000 0 -0.26 3 3
proNGF (dimer)/p75(NTR)/Sortilin/MAGE-G1 0.057 0.045 -10000 0 -0.23 3 3
NDNL2 0.031 0.039 -10000 0 -0.33 2 2
YWHAE 0.03 0.015 -10000 0 -10000 0 0
PRKCI 0.03 0.053 -10000 0 -0.33 4 4
NGF (dimer)/p75(NTR) 0.026 0.012 -10000 0 -0.12 1 1
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
proNGF (dimer)/p75(NTR)/Sortilin/NRAGE 0.055 0.058 -10000 0 -0.25 6 6
TRAF6 0.037 0.005 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
PLG 0.033 0.035 -10000 0 -0.47 1 1
oligodendrocyte cell fate commitment 0 0 -10000 0 -10000 0 0
CASP6 0.013 0.062 -10000 0 -0.29 7 7
SQSTM1 0.036 0.016 -10000 0 -0.19 1 1
NGFRAP1 -0.056 0.19 -10000 0 -0.43 43 43
CASP3 -0.001 0.097 0.39 3 -0.32 2 5
E2F1 0.016 0.051 -10000 0 -0.47 2 2
CASP9 0.035 0.01 -10000 0 -10000 0 0
IKK complex 0.058 0.062 -10000 0 -0.41 1 1
NGF (dimer)/TRKA 0.026 0.011 -10000 0 -0.12 1 1
MMP7 -0.11 0.21 -10000 0 -0.38 78 78
proNGF (dimer)/p75(NTR)/Sortilin/TRAF6/NRIF 0.07 0.06 -10000 0 -0.25 5 5
MMP3 -0.13 0.22 -10000 0 -0.37 88 88
APAF-1/Caspase 9 -0.018 0.083 -10000 0 -0.36 4 4
Ceramide signaling pathway

Figure S62.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S62.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SPHK2 -0.013 0.09 -10000 0 -0.33 14 14
MAP4K4 0.002 0.084 -10000 0 -0.38 5 5
BAG4 0.031 0.036 -10000 0 -0.47 1 1
PKC zeta/ceramide -0.024 0.091 0.14 2 -0.23 23 25
NFKBIA 0.029 0.042 -10000 0 -0.28 3 3
BIRC3 -0.006 0.12 -10000 0 -0.29 28 28
BAX 0.005 0.05 -10000 0 -0.34 2 2
RIPK1 0.037 0.006 -10000 0 -10000 0 0
AKT1 -0.002 0.023 -10000 0 -10000 0 0
BAD -0.026 0.092 0.15 1 -0.23 23 24
SMPD1 0.021 0.063 0.26 3 -0.24 5 8
RB1 0.024 0.11 0.2 36 -0.24 13 49
FADD/Caspase 8 0.015 0.084 -10000 0 -0.43 4 4
MAP2K4 -0.028 0.091 -10000 0 -0.3 11 11
NSMAF 0.029 0.039 -10000 0 -0.33 2 2
response to UV 0 0 -10000 0 -10000 0 0
RAF1 -0.02 0.087 0.19 3 -0.29 8 11
EGF -0.087 0.18 -10000 0 -0.3 78 78
mol:ceramide -0.025 0.098 0.14 9 -0.24 23 32
MADD 0.037 0.004 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
mol:Free Fatty acid -0.001 0.061 -10000 0 -0.32 6 6
ASAH1 0.028 0.016 -10000 0 -10000 0 0
negative regulation of cell cycle 0.024 0.11 0.2 36 -0.24 13 49
cell proliferation 0.006 0.094 -10000 0 -0.3 5 5
BID -0.012 0.19 -10000 0 -0.65 15 15
MAP3K1 -0.027 0.094 0.15 1 -0.24 23 24
EIF2A -0.027 0.084 -10000 0 -0.47 3 3
TRADD 0.037 0.005 -10000 0 -10000 0 0
CRADD 0.028 0.069 -10000 0 -0.47 4 4
MAPK3 -0.016 0.084 0.2 1 -0.42 3 4
response to heat 0 0 -10000 0 -10000 0 0
MAPK1 -0.022 0.085 0.2 1 -0.38 4 5
Cathepsin D/ceramide -0.011 0.11 -10000 0 -0.24 23 23
FADD 0.01 0.069 -10000 0 -0.42 2 2
KSR1 -0.02 0.09 0.19 4 -0.22 21 25
MAPK8 -0.023 0.092 -10000 0 -0.35 6 6
PRKRA -0.026 0.092 0.15 1 -0.23 23 24
PDGFA 0.002 0.11 -10000 0 -0.3 21 21
TRAF2 0.036 0.016 -10000 0 -0.19 1 1
IGF1 0.018 0.078 -10000 0 -0.24 15 15
mol:GD3 0 0 -10000 0 -10000 0 0
ganglioside biosynthetic process -0.024 0.097 0.14 9 -0.24 23 32
CTSD 0.033 0.041 -10000 0 -0.28 3 3
regulation of nitric oxide biosynthetic process 0.053 0.012 -10000 0 -10000 0 0
response to radiation 0 0 -10000 0 -10000 0 0
ERK1/PKC delta 0.008 0.1 -10000 0 -0.33 5 5
PRKCD 0.037 0.005 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
mol:GW4869 0 0 -10000 0 -10000 0 0
mol:sphingosine -0.001 0.061 -10000 0 -0.32 6 6
RelA/NF kappa B1 0.053 0.012 -10000 0 -10000 0 0
mol:glutathione 0 0 -10000 0 -10000 0 0
PAWR 0.037 0.005 -10000 0 -10000 0 0
TNF-alpha/TNFR1A/TRADD/MADD/cIAP2/RIP1/TRAF2/RAIDD 0.015 0.077 -10000 0 -0.33 5 5
TNFR1A/BAG4/TNF-alpha 0.052 0.058 -10000 0 -0.28 3 3
mol:Sphingosine-1-phosphate -0.013 0.09 -10000 0 -0.33 14 14
MAP2K1 -0.021 0.082 0.19 1 -0.42 3 4
mol:C11AG 0 0 -10000 0 -10000 0 0
RELA 0.037 0.006 -10000 0 -10000 0 0
CYCS 0.034 0.068 0.17 8 -0.22 2 10
TNFRSF1A 0.036 0.008 -10000 0 -10000 0 0
NFKB1 0.037 0.006 -10000 0 -10000 0 0
TNFR1A/BAG4 0.045 0.033 -10000 0 -0.34 1 1
EIF2AK2 -0.027 0.088 -10000 0 -0.28 10 10
TNF-alpha/TNFR1A/FAN 0.052 0.055 -10000 0 -0.29 2 2
response to hydrogen peroxide 0 0 -10000 0 -10000 0 0
CASP8 0.023 0.1 -10000 0 -0.46 7 7
MAP2K2 -0.021 0.082 -10000 0 -0.42 3 3
SMPD3 -0.001 0.1 -10000 0 -0.31 17 17
TNF 0.025 0.062 -10000 0 -0.25 9 9
PKC zeta/PAR4 0.027 0.004 -10000 0 -10000 0 0
mol:PHOSPHOCHOLINE 0.04 0.095 0.21 38 -0.14 3 41
NF kappa B1/RelA/I kappa B alpha 0.074 0.042 -10000 0 -0.25 1 1
AIFM1 0.028 0.076 0.18 7 -0.25 3 10
BCL2 0.001 0.093 -10000 0 -0.29 16 16
IL2 signaling events mediated by PI3K

Figure S63.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S63.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.054 0.14 -10000 0 -0.6 1 1
UGCG 0.009 0.087 -10000 0 -0.66 3 3
AKT1/mTOR/p70S6K/Hsp90/TERT -0.04 0.2 -10000 0 -0.52 23 23
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucosylceramide 0.009 0.086 -10000 0 -0.65 3 3
mol:DAG -0.021 0.18 -10000 0 -0.94 8 8
CaM/Ca2+/Calcineurin A alpha-beta B1 -0.036 0.21 -10000 0 -0.53 22 22
FRAP1 -0.056 0.24 -10000 0 -0.61 24 24
FOXO3 -0.043 0.2 -10000 0 -0.5 24 24
AKT1 -0.046 0.21 -10000 0 -0.52 25 25
GAB2 0.037 0.005 -10000 0 -10000 0 0
SMPD1 0.005 0.11 -10000 0 -0.78 4 4
SGMS1 -0.008 0.15 -10000 0 -0.72 8 8
positive regulation of NF-kappaB transcription factor activity 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
mol:GDP 0.004 0.036 -10000 0 -0.28 3 3
CALM1 0.033 0.012 -10000 0 -10000 0 0
cell proliferation 0.004 0.14 -10000 0 -0.55 5 5
EIF3A 0.034 0.035 -10000 0 -0.47 1 1
PI3K 0.051 0.049 -10000 0 -0.34 3 3
RPS6KB1 -0.006 0.14 -10000 0 -0.8 5 5
mol:sphingomyelin -0.021 0.18 -10000 0 -0.94 8 8
natural killer cell activation 0 0.003 -10000 0 -0.012 8 8
JAK3 0.039 0.006 -10000 0 -10000 0 0
PIK3R1 0.031 0.06 -10000 0 -0.47 3 3
JAK1 0.036 0.035 -10000 0 -0.47 1 1
NFKB1 0.037 0.006 -10000 0 -10000 0 0
MYC -0.03 0.27 -10000 0 -0.88 14 14
MYB -0.069 0.35 -10000 0 -1.3 16 16
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K -0.028 0.18 -10000 0 -0.48 17 17
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.03 0.14 -10000 0 -0.74 5 5
mol:PI-3-4-5-P3 -0.027 0.17 -10000 0 -0.47 17 17
Rac1/GDP 0.023 0.039 -10000 0 -0.26 3 3
T cell proliferation -0.026 0.16 0.26 1 -0.44 17 18
SHC1 0.036 0.007 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
positive regulation of cyclin-dependent protein kinase activity -0.001 0.019 -10000 0 -0.066 16 16
PRKCZ -0.028 0.17 0.26 1 -0.45 17 18
NF kappa B1 p50/RelA -0.023 0.22 -10000 0 -0.55 20 20
IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K -0.006 0.13 -10000 0 -0.43 12 12
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
RELA 0.037 0.006 -10000 0 -10000 0 0
IL2RA -0.033 0.16 -10000 0 -0.34 40 40
IL2RB 0.02 0.087 -10000 0 -0.37 9 9
TERT 0.027 0.063 -10000 0 -0.36 5 5
E2F1 -0.02 0.13 -10000 0 -0.42 18 18
SOS1 0.037 0.004 -10000 0 -10000 0 0
RPS6 0.034 0.023 -10000 0 -0.19 2 2
mol:cAMP 0 0.009 0.032 16 -10000 0 16
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
IL2RG -0.017 0.16 -10000 0 -0.42 26 26
actin cytoskeleton organization -0.026 0.16 0.26 1 -0.44 17 18
GRB2 0.036 0.008 -10000 0 -10000 0 0
IL2 0.038 0.007 -10000 0 -10000 0 0
PIK3CA 0.039 0.006 -10000 0 -10000 0 0
Rac1/GTP 0.054 0.05 -10000 0 -0.24 3 3
LCK -0.011 0.14 -10000 0 -0.34 28 28
BCL2 -0.066 0.27 -10000 0 -0.82 19 19
Integrins in angiogenesis

Figure S64.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S64.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR2 homodimer/VEGFA homodimer 0.051 0.03 -10000 0 -0.34 1 1
alphaV beta3 Integrin 0.037 0.093 -10000 0 -0.28 12 12
PTK2 0.051 0.12 0.35 8 -0.35 5 13
IGF1R 0.032 0.039 -10000 0 -0.33 2 2
PI4KB 0.037 0.006 -10000 0 -10000 0 0
MFGE8 0.018 0.083 -10000 0 -0.33 10 10
SRC 0.013 0.06 -10000 0 -0.47 3 3
CDKN1B 0.016 0.059 -10000 0 -0.39 3 3
VEGFA 0.037 0.006 -10000 0 -10000 0 0
ILK 0.023 0.033 -10000 0 -10000 0 0
ROCK1 0.029 0.016 -10000 0 -10000 0 0
AKT1 0.013 0.03 -10000 0 -10000 0 0
PTK2B 0.013 0.055 0.36 1 -0.24 5 6
alphaV/beta3 Integrin/JAM-A 0.041 0.1 -10000 0 -0.26 16 16
CBL 0.037 0.006 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
alphaV beta3 Integrin/ANGPTL3 0.052 0.078 -10000 0 -0.3 8 8
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.052 0.1 -10000 0 -0.28 12 12
VEGF/Rho/ROCK/alphaV/beta3 Integrin 0.009 0.077 -10000 0 -0.36 4 4
alphaV/beta3 Integrin/Syndecan-1 0.062 0.062 -10000 0 -0.3 5 5
PI4KA 0.035 0.01 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 -0.005 0.14 -10000 0 -0.41 8 8
PI4 Kinase 0.051 0.016 -10000 0 -10000 0 0
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Osteopontin -0.083 0.16 -10000 0 -0.29 65 65
RPS6KB1 -0.061 0.097 -10000 0 -0.43 6 6
TLN1 0.037 0.006 -10000 0 -10000 0 0
MAPK3 -0.024 0.14 -10000 0 -0.49 14 14
GPR124 0.021 0.061 -10000 0 -0.26 8 8
MAPK1 -0.024 0.15 -10000 0 -0.49 15 15
PXN 0.037 0.004 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
alphaV/beta3 Integrin/Tumstatin 0.06 0.059 -10000 0 -0.29 4 4
cell adhesion 0.026 0.1 -10000 0 -0.28 17 17
ANGPTL3 0.024 0.073 -10000 0 -0.35 7 7
VEGFR2 homodimer/VEGFA homodimer/Src 0.035 0.055 -10000 0 -0.29 3 3
IGF-1R heterotetramer 0.032 0.039 -10000 0 -0.33 2 2
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
TGFBR2 0.033 0.049 -10000 0 -0.47 2 2
ITGB3 0.035 0.017 -10000 0 -0.19 1 1
IGF1 0.018 0.078 -10000 0 -0.24 15 15
RAC1 0.034 0.012 -10000 0 -10000 0 0
regulation of cell-matrix adhesion 0.045 0.072 -10000 0 -0.3 6 6
apoptosis 0.024 0.079 -10000 0 -0.39 7 7
CD47 0.024 0.078 -10000 0 -0.42 6 6
alphaV/beta3 Integrin/CD47 0.053 0.081 -10000 0 -0.32 8 8
VCL 0.034 0.035 -10000 0 -0.47 1 1
alphaV/beta3 Integrin/Del1 0.015 0.13 -10000 0 -0.3 27 27
CSF1 0.035 0.017 -10000 0 -0.19 1 1
PIK3C2A 0.016 0.065 -10000 0 -0.46 3 3
PI4 Kinase/Pyk2 0.017 0.073 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.076 0.064 -10000 0 -0.26 5 5
FAK1/Vinculin 0.061 0.11 0.33 7 -0.29 4 11
alphaV beta3/Integrin/ppsTEM5 0.046 0.073 -10000 0 -0.3 6 6
RHOA 0.037 0.005 -10000 0 -10000 0 0
VTN 0.036 0.008 -10000 0 -10000 0 0
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
FGF2 0.001 0.11 -10000 0 -0.28 24 24
F11R -0.013 0.092 -10000 0 -0.35 13 13
alphaV/beta3 Integrin/Lactadherin 0.046 0.082 -10000 0 -0.28 10 10
alphaV/beta3 Integrin/TGFBR2 0.059 0.066 -10000 0 -0.29 6 6
alphaV/beta3 Integrin/c-FMS/Cbl/Cas 0.077 0.064 -10000 0 -0.26 5 5
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Talin 0.058 0.052 -10000 0 -0.26 4 4
mol:GDP 0 0 -10000 0 -10000 0 0
FN1 -0.014 0.13 -10000 0 -0.28 35 35
alphaV/beta3 Integrin/Pyk2 0.045 0.06 -10000 0 -0.24 5 5
SDC1 0.035 0.035 -10000 0 -0.47 1 1
VAV3 -0.043 0.11 -10000 0 -0.26 44 44
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
IRS1 0.017 0.094 -10000 0 -0.37 11 11
FAK1/Paxillin 0.063 0.11 0.33 6 -0.3 3 9
cell migration 0.052 0.11 0.29 8 -0.28 1 9
ITGAV 0.024 0.079 -10000 0 -0.39 7 7
PI3K 0.049 0.11 -10000 0 -0.3 3 3
SPP1 -0.16 0.22 -10000 0 -0.34 112 112
KDR 0.033 0.038 -10000 0 -0.33 2 2
mol:PI-4-5-P2 0 0 -10000 0 -10000 0 0
alphaV/beta3 Integrin/Caspase 8 0.024 0.079 -10000 0 -0.39 7 7
COL4A3 0.034 0.027 -10000 0 -0.19 3 3
angiogenesis -0.022 0.15 -10000 0 -0.51 14 14
Rac1/GTP -0.028 0.11 -10000 0 -0.24 42 42
EDIL3 -0.029 0.16 -10000 0 -0.38 34 34
cell proliferation 0.058 0.065 -10000 0 -0.29 6 6
HIV-1 Nef: Negative effector of Fas and TNF-alpha

Figure S65.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S65.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BAG4 0.031 0.036 -10000 0 -0.47 1 1
Caspase 8 (4 units) -0.016 0.16 -10000 0 -0.44 17 17
NEF -0.011 0.037 -10000 0 -0.17 7 7
NFKBIA 0.018 0.054 -10000 0 -0.29 3 3
BIRC3 -0.017 0.13 -10000 0 -0.52 10 10
CYCS -0.034 0.15 -10000 0 -0.51 12 12
RIPK1 0.037 0.006 -10000 0 -10000 0 0
CD247 -0.03 0.16 -10000 0 -0.44 23 23
MAP2K7 -0.017 0.17 -10000 0 -0.63 9 9
protein ubiquitination 0.021 0.082 0.46 2 -0.32 1 3
CRADD 0.028 0.069 -10000 0 -0.47 4 4
DAXX 0.037 0.006 -10000 0 -10000 0 0
FAS -0.034 0.16 -10000 0 -0.39 35 35
BID -0.041 0.15 -10000 0 -0.48 16 16
NF-kappa-B/RelA/I kappa B alpha 0.04 0.094 -10000 0 -0.27 11 11
TRADD 0.037 0.005 -10000 0 -10000 0 0
MAP3K5 0.015 0.09 -10000 0 -0.33 12 12
CFLAR 0.038 0.003 -10000 0 -10000 0 0
FADD 0.037 0.004 -10000 0 -10000 0 0
NF-kappa-B/RelA/I kappa B alpha/ubiquitin 0.04 0.094 -10000 0 -0.27 11 11
MAPK8 -0.014 0.16 0.42 1 -0.58 9 10
APAF1 0.012 0.1 -10000 0 -0.35 14 14
TRAF1 0.036 0.016 -10000 0 -0.19 1 1
TRAF2 0.036 0.016 -10000 0 -0.19 1 1
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8/FASLG -0.039 0.16 -10000 0 -0.44 21 21
TNFR1A/Caspase 2/TNF-alpha/FADD/TRADD/RIP1/cIAP2/TRAF1/TRAF2/Ask1/RAIDD 0.024 0.074 -10000 0 -0.36 1 1
CHUK 0.02 0.078 0.52 1 -0.35 1 2
FAS/FADD/DAXX/Ask1/Caspase 8/Caspase 8 0.035 0.14 -10000 0 -0.3 28 28
TCRz/NEF -0.031 0.15 -10000 0 -0.36 30 30
TNF 0.025 0.062 -10000 0 -0.25 9 9
FASLG -0.057 0.19 -10000 0 -0.47 30 30
NFKB1 0.025 0.037 -10000 0 -10000 0 0
TNFR1A/BAG4/TNF-alpha 0.052 0.058 -10000 0 -0.28 3 3
CASP6 -0.008 0.18 -10000 0 -0.61 11 11
CASP7 -0.046 0.18 0.44 1 -0.5 18 19
RELA 0.025 0.037 -10000 0 -10000 0 0
CASP2 0.036 0.008 -10000 0 -10000 0 0
CASP3 -0.048 0.18 0.44 1 -0.53 17 18
TNFRSF1A 0.036 0.008 -10000 0 -10000 0 0
TNFR1A/BAG4 0.045 0.033 -10000 0 -0.34 1 1
CASP8 0.03 0.06 -10000 0 -0.47 3 3
CASP9 0.035 0.01 -10000 0 -10000 0 0
MAP3K14 0.022 0.075 -10000 0 -0.32 1 1
APAF-1/Caspase 9 -0.042 0.15 -10000 0 -0.4 21 21
BCL2 -0.028 0.15 0.4 1 -0.55 10 11
Regulation of p38-alpha and p38-beta

Figure S66.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S66.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
RIP1/MEKK3 0.047 0.013 -10000 0 -10000 0 0
response to insulin stimulus 0 0 -10000 0 -10000 0 0
RIPK1 0.037 0.006 -10000 0 -10000 0 0
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0.011 0.1 -10000 0 -0.4 12 12
mol:GTP 0 0 -10000 0 -10000 0 0
MAP2K4 0.026 0.037 -10000 0 -0.47 1 1
RAC1-CDC42/GTP/PAK family 0.019 0.03 -10000 0 -0.24 2 2
response to UV 0 0 -10000 0 -10000 0 0
YES1 0.03 0.015 -10000 0 -10000 0 0
interleukin-1 receptor activity 0 0 -10000 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
MAP3K3 0.036 0.009 -10000 0 -10000 0 0
FYN 0.011 0.098 -10000 0 -0.32 15 15
MAP3K12 0.037 0.004 -10000 0 -10000 0 0
FGR 0.027 0.041 -10000 0 -0.19 7 7
p38 alpha/TAB1 -0.084 0.15 -10000 0 -0.36 40 40
PRKG1 0.036 0.007 -10000 0 -10000 0 0
DUSP8 0.023 0.079 -10000 0 -0.39 7 7
PGK/cGMP/p38 alpha -0.027 0.19 0.21 4 -0.39 32 36
apoptosis -0.08 0.15 -10000 0 -0.35 40 40
RAL/GTP 0.037 0.052 -10000 0 -0.29 5 5
LYN 0.032 0.013 -10000 0 -10000 0 0
DUSP1 0.004 0.098 -10000 0 -0.24 25 25
PAK1 0.032 0.049 -10000 0 -0.47 2 2
SRC 0.013 0.06 -10000 0 -0.47 3 3
RAC1/OSM/MEKK3/MKK3 0.068 0.044 -10000 0 -10000 0 0
TRAF6 0.037 0.005 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
epidermal growth factor receptor activity 0 0 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
mol:cGMP 0 0 -10000 0 -10000 0 0
CCM2 0.034 0.011 -10000 0 -10000 0 0
RAC1-CDC42/GTP 0.041 0.022 -10000 0 -10000 0 0
MAPK11 -0.014 0.2 0.31 8 -0.44 22 30
BLK 0.01 0.085 -10000 0 -0.3 12 12
HCK -0.01 0.11 -10000 0 -0.35 17 17
MAP2K3 0.031 0.015 -10000 0 -10000 0 0
DUSP16 0.027 0.063 -10000 0 -0.36 5 5
DUSP10 0.015 0.095 -10000 0 -0.35 12 12
TRAF6/MEKK3 0.045 0.013 -10000 0 -10000 0 0
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 -0.034 0.21 0.24 11 -0.41 37 48
positive regulation of innate immune response -0.031 0.23 0.32 9 -0.5 27 36
LCK -0.013 0.14 -10000 0 -0.34 28 28
p38alpha-beta/MKP7 -0.024 0.23 0.33 7 -0.5 25 32
p38alpha-beta/MKP5 -0.026 0.23 0.34 6 -0.49 26 32
PGK/cGMP 0.027 0.005 -10000 0 -10000 0 0
PAK2 0.037 0.005 -10000 0 -10000 0 0
p38alpha-beta/MKP1 -0.027 0.23 0.33 9 -0.47 31 40
CDC42 0.034 0.018 -10000 0 -0.19 1 1
RALB 0.026 0.076 -10000 0 -0.47 5 5
RALA 0.033 0.012 -10000 0 -10000 0 0
PAK3 0.036 0.016 -10000 0 -0.19 1 1
Nongenotropic Androgen signaling

Figure S67.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S67.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.008 0.004 -10000 0 -10000 0 0
GNB1/GNG2 0.05 0.053 -10000 0 -0.25 3 3
regulation of S phase of mitotic cell cycle 0.005 0.056 -10000 0 -0.27 6 6
GNAO1 0.037 0.005 -10000 0 -10000 0 0
HRAS 0.033 0.038 -10000 0 -0.33 2 2
SHBG/T-DHT 0.02 0.01 -10000 0 -10000 0 0
PELP1 0.03 0.015 -10000 0 -10000 0 0
AKT1 0.008 0.016 -10000 0 -0.12 3 3
MAP2K1 0.038 0.1 0.28 1 -0.28 1 2
T-DHT/AR 0.015 0.052 -10000 0 -0.18 12 12
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
mol:GTP -0.002 0.003 -10000 0 -0.008 40 40
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
GNAI3 0.034 0.035 -10000 0 -0.47 1 1
GNAI1 -0.005 0.13 -10000 0 -0.38 21 21
mol:GDP -0.006 0.05 -10000 0 -0.29 5 5
cell proliferation -0.01 0.18 0.29 3 -0.4 19 22
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
FOS -0.096 0.32 -10000 0 -0.8 34 34
mol:Ca2+ -0.007 0.025 -10000 0 -0.074 19 19
MAPK3 0.014 0.14 0.28 5 -0.32 14 19
MAPK1 -0.011 0.13 -10000 0 -0.41 11 11
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:IP3 -0.001 0.002 -10000 0 -0.005 34 34
cAMP biosynthetic process 0.001 0.019 -10000 0 -10000 0 0
GNG2 0.034 0.011 -10000 0 -10000 0 0
potassium channel inhibitor activity -0.001 0.002 -10000 0 -0.005 34 34
HRAS/GTP 0.014 0.061 -10000 0 -0.25 5 5
actin cytoskeleton reorganization 0.042 0.042 -10000 0 -0.23 3 3
SRC 0.013 0.06 -10000 0 -0.47 3 3
voltage-gated calcium channel activity -0.001 0.002 -10000 0 -0.005 34 34
PI3K 0.044 0.04 -10000 0 -0.29 3 3
apoptosis 0.015 0.17 0.36 32 -10000 0 32
T-DHT/AR/PELP1 0.028 0.051 -10000 0 -0.28 3 3
HRAS/GDP 0.048 0.076 -10000 0 -0.3 5 5
CREB1 -0.018 0.18 -10000 0 -0.38 32 32
RAC1-CDC42/GTP 0.053 0.047 -10000 0 -0.24 3 3
AR 0.02 0.074 -10000 0 -0.26 12 12
GNB1 0.035 0.009 -10000 0 -10000 0 0
RAF1 0.054 0.11 0.29 1 -0.24 5 6
RAC1-CDC42/GDP 0.055 0.076 -10000 0 -0.29 4 4
T-DHT/AR/PELP1/Src 0.019 0.06 -10000 0 -0.26 5 5
MAP2K2 0.04 0.1 -10000 0 -0.28 1 1
T-DHT/AR/PELP1/Src/PI3K 0.005 0.056 -10000 0 -0.27 6 6
GNAZ 0.024 0.061 -10000 0 -0.26 8 8
SHBG 0.03 0.015 -10000 0 -10000 0 0
Gi family/GNB1/GNG2/GDP 0.004 0.11 -10000 0 -0.46 6 6
mol:T-DHT -0.001 0.002 0.002 1 -0.004 30 31
RAC1 0.034 0.012 -10000 0 -10000 0 0
GNRH1 0.002 0.037 -10000 0 -0.21 5 5
Gi family/GTP -0.013 0.092 -10000 0 -0.26 20 20
CDC42 0.034 0.018 -10000 0 -0.19 1 1
IL2 signaling events mediated by STAT5

Figure S68.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S68.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GAB2 0.038 0.005 -10000 0 -10000 0 0
ELF1 -0.005 0.1 -10000 0 -0.36 15 15
CCNA2 0.02 0.09 -10000 0 -0.47 7 7
PIK3CA 0.038 0.005 -10000 0 -10000 0 0
JAK3 0.038 0.005 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
JAK1 0.035 0.035 -10000 0 -0.47 1 1
IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K 0 0.16 -10000 0 -0.55 10 10
SHC1 0.037 0.006 -10000 0 -10000 0 0
SP1 -0.012 0.13 -10000 0 -0.34 28 28
IL2RA -0.044 0.19 -10000 0 -0.69 15 15
IL2RB 0.018 0.087 -10000 0 -0.38 9 9
SOS1 0.038 0.003 -10000 0 -10000 0 0
IL2RG -0.018 0.16 -10000 0 -0.43 26 26
G1/S transition of mitotic cell cycle -0.078 0.26 0.43 1 -0.65 33 34
PTPN11 0.032 0.051 -10000 0 -0.38 3 3
CCND2 -0.081 0.26 -10000 0 -0.75 27 27
LCK -0.012 0.14 -10000 0 -0.34 28 28
GRB2 0.037 0.007 -10000 0 -10000 0 0
IL2 0.037 0.006 -10000 0 -10000 0 0
CDK6 0.026 0.063 -10000 0 -0.36 5 5
CCND3 0.007 0.14 -10000 0 -0.56 6 6
Aurora B signaling

Figure S69.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S69.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Condensin I complex -0.002 0.096 -9999 0 -0.41 5 5
STMN1 0.01 0.051 -9999 0 -0.48 2 2
Aurora B/RasGAP/Survivin 0.042 0.084 -9999 0 -0.34 8 8
Chromosomal passenger complex/Cul3 protein complex -0.041 0.12 -9999 0 -0.32 21 21
BIRC5 0.026 0.074 -9999 0 -0.44 5 5
DES -0.14 0.33 -9999 0 -0.68 56 56
Aurora C/Aurora B/INCENP 0.039 0.071 -9999 0 -0.25 9 9
Aurora B/TACC1 0.019 0.067 -9999 0 -0.27 8 8
Aurora B/PP2A 0.04 0.037 -9999 0 -0.35 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
CBX5 0.006 0.033 -9999 0 -0.2 5 5
mitotic metaphase/anaphase transition 0.001 0.004 -9999 0 -10000 0 0
NDC80 0.002 0.069 -9999 0 -0.42 5 5
Cul3 protein complex -0.023 0.13 -9999 0 -0.29 30 30
KIF2C -0.002 0.13 -9999 0 -0.54 8 8
PEBP1 0.033 0.05 -9999 0 -0.48 2 2
KIF20A 0.029 0.069 -9999 0 -0.47 4 4
mol:GDP 0 0 -9999 0 -10000 0 0
Aurora B/RasGAP 0.032 0.064 -9999 0 -0.34 5 5
SEPT1 0.036 0.016 -9999 0 -0.19 1 1
SMC2 0.025 0.077 -9999 0 -0.47 5 5
SMC4 0.035 0.035 -9999 0 -0.47 1 1
NSUN2/NPM1/Nucleolin -0.087 0.24 -9999 0 -0.52 46 46
PSMA3 0.03 0.039 -9999 0 -0.33 2 2
G2/M transition of mitotic cell cycle -0.001 0.004 -9999 0 -10000 0 0
H3F3B 0.012 0.039 -9999 0 -0.31 3 3
AURKB 0.026 0.039 -9999 0 -0.5 1 1
AURKC 0.035 0.022 -9999 0 -0.19 2 2
CDCA8 0.035 0.038 -9999 0 -0.5 1 1
cytokinesis -0.009 0.16 -9999 0 -0.48 14 14
Aurora B/Septin1 -0.009 0.17 -9999 0 -0.48 12 12
AURKA 0.011 0.069 -9999 0 -0.47 4 4
INCENP 0.017 0.096 -9999 0 -0.39 10 10
KLHL13 -0.088 0.17 -9999 0 -0.28 86 86
BUB1 0.028 0.078 -9999 0 -0.48 5 5
hSgo1/Aurora B/Survivin 0.038 0.077 -9999 0 -0.32 7 7
EVI5 0.031 0.051 -9999 0 -0.38 3 3
RhoA/GTP 0.028 0.15 -9999 0 -0.49 9 9
SGOL1 0.025 0.066 -9999 0 -0.31 7 7
CENPA 0.009 0.15 -9999 0 -0.5 10 10
NCAPG 0 0 -9999 0 -10000 0 0
Aurora B/HC8 Proteasome 0.038 0.045 -9999 0 -0.35 2 2
NCAPD2 0.036 0.009 -9999 0 -10000 0 0
Aurora B/PP1-gamma 0.041 0.037 -9999 0 -0.35 1 1
RHOA 0.037 0.005 -9999 0 -10000 0 0
NCAPH 0.033 0.049 -9999 0 -0.47 2 2
NPM1 -0.049 0.17 -9999 0 -0.32 43 43
RASA1 0.026 0.07 -9999 0 -0.41 5 5
KLHL9 0.034 0.035 -9999 0 -0.47 1 1
mitotic prometaphase 0 0.003 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.038 0.045 -9999 0 -0.35 2 2
PPP1CC 0.037 0.004 -9999 0 -10000 0 0
Centraspindlin 0.018 0.16 -9999 0 -0.55 9 9
RhoA/GDP 0.027 0.004 -9999 0 -10000 0 0
NSUN2 -0.042 0.14 -9999 0 -0.3 44 44
MYLK 0.009 0.043 -9999 0 -0.28 4 4
KIF23 0.031 0.051 -9999 0 -0.48 2 2
VIM -0.011 0.089 -9999 0 -0.36 11 11
RACGAP1 0.035 0.036 -9999 0 -0.48 1 1
mitosis 0 0 -9999 0 -10000 0 0
NCL -0.054 0.17 -9999 0 -0.36 33 33
Chromosomal passenger complex -0.008 0.14 -9999 0 -0.47 11 11
Chromosomal passenger complex/EVI5 0.055 0.11 -9999 0 -0.31 13 13
TACC1 0.011 0.091 -9999 0 -0.32 13 13
PPP2R5D 0.036 0.016 -9999 0 -0.19 1 1
CUL3 0.032 0.034 -9999 0 -0.19 5 5
response to DNA damage stimulus 0 0 -9999 0 -10000 0 0
PDGFR-alpha signaling pathway

Figure S70.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S70.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA 0.012 0.091 -10000 0 -0.4 8 8
PDGF/PDGFRA/CRKL 0.034 0.077 -10000 0 -0.33 8 8
positive regulation of JUN kinase activity 0.073 0.065 -10000 0 -0.25 6 6
CRKL 0.03 0.049 -10000 0 -0.47 2 2
PDGF/PDGFRA/Caveolin-3 0.04 0.068 -10000 0 -0.3 7 7
AP1 -0.11 0.29 -10000 0 -0.75 29 29
mol:IP3 -0.011 0.054 -10000 0 -0.31 5 5
PLCG1 -0.011 0.054 -10000 0 -0.31 5 5
PDGF/PDGFRA/alphaV Integrin 0.031 0.094 -10000 0 -0.37 10 10
RAPGEF1 0.036 0.016 -10000 0 -0.19 1 1
CRK 0.03 0.015 -10000 0 -10000 0 0
mol:Ca2+ -0.011 0.054 -10000 0 -0.31 5 5
CAV3 0.036 0.016 -10000 0 -0.19 1 1
CAV1 0.025 0.061 -10000 0 -0.26 8 8
SHC/Grb2/SOS1 0.076 0.066 -10000 0 -0.25 6 6
PDGF/PDGFRA/Shf -0.022 0.13 -10000 0 -0.33 26 26
FOS -0.12 0.28 0.31 5 -0.74 29 34
JUN -0.047 0.096 -10000 0 -0.36 16 16
oligodendrocyte development 0.03 0.094 -10000 0 -0.36 10 10
GRB2 0.036 0.007 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:DAG -0.011 0.054 -10000 0 -0.31 5 5
PDGF/PDGFRA 0.012 0.091 -10000 0 -0.4 8 8
actin cytoskeleton reorganization 0.038 0.07 -10000 0 -0.28 8 8
SRF 0.011 0.03 -10000 0 -0.34 1 1
SHC1 0.037 0.006 -10000 0 -10000 0 0
PI3K 0.057 0.072 -10000 0 -0.28 8 8
PDGF/PDGFRA/Crk/C3G 0.046 0.067 -10000 0 -0.28 6 6
JAK1 -0.003 0.066 -10000 0 -0.34 7 7
ELK1/SRF 0.028 0.092 0.27 4 -0.27 5 9
SHB 0.035 0.022 -10000 0 -0.19 2 2
SHF -0.041 0.15 -10000 0 -0.28 51 51
CSNK2A1 0.027 0.032 -10000 0 -10000 0 0
GO:0007205 -0.009 0.064 0.24 4 -0.37 4 8
SOS1 0.038 0.003 -10000 0 -10000 0 0
Ras protein signal transduction 0.073 0.065 -10000 0 -0.25 6 6
PDGF/PDGFRA/SHB 0.039 0.07 -10000 0 -0.28 8 8
PDGF/PDGFRA/Caveolin-1 0.03 0.086 -10000 0 -0.37 7 7
ITGAV 0.024 0.079 -10000 0 -0.39 7 7
ELK1 -0.013 0.07 0.23 7 -0.28 6 13
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
PDGF/PDGFRA/Crk 0.031 0.068 -10000 0 -0.33 6 6
JAK-STAT cascade -0.003 0.066 -10000 0 -0.33 7 7
cell proliferation -0.022 0.13 -10000 0 -0.33 26 26
Signaling mediated by p38-gamma and p38-delta

Figure S71.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S71.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EEF2K -0.011 0.036 0.21 1 -0.29 3 4
SNTA1 0.013 0.062 -10000 0 -0.4 4 4
response to hypoxia 0 0 -10000 0 -10000 0 0
STMN1 -0.012 0.041 0.21 1 -0.29 4 5
MAPK12 -0.021 0.083 0.21 5 -0.26 18 23
CCND1 -0.001 0.059 -10000 0 -0.38 3 3
p38 gamma/SNTA1 -0.014 0.089 -10000 0 -0.27 18 18
MAP2K3 0.031 0.015 -10000 0 -10000 0 0
PKN1 0.03 0.06 -10000 0 -0.47 3 3
G2/M transition checkpoint -0.021 0.083 0.21 5 -0.26 18 23
MAP2K6 -0.011 0.089 0.24 5 -0.26 20 25
MAPT -0.005 0.063 0.25 4 -0.23 5 9
MAPK13 0.013 0.035 -10000 0 -0.34 2 2
hyperosmotic response 0 0 -10000 0 -10000 0 0
ZAK 0.003 0.071 -10000 0 -0.3 11 11
Class I PI3K signaling events

Figure S72.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S72.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ARF5/GTP -0.022 0.052 0.21 2 -0.23 7 9
DAPP1 -0.044 0.21 0.24 5 -0.47 27 32
Src family/SYK family/BLNK-LAT/BTK-ITK -0.064 0.24 0.3 1 -0.54 31 32
mol:DAG 0.014 0.11 0.19 31 -0.25 13 44
HRAS 0.033 0.037 -10000 0 -0.31 2 2
RAP1A 0.035 0.014 -10000 0 -10000 0 0
ARF5/GDP 0.043 0.11 -10000 0 -0.3 10 10
PLCG2 -0.004 0.12 -10000 0 -0.31 25 25
PLCG1 0.02 0.019 -10000 0 -10000 0 0
ARF5 0.031 0.049 -10000 0 -0.47 2 2
mol:GTP -0.02 0.049 0.18 2 -0.24 5 7
ARF1/GTP -0.011 0.044 0.18 2 -0.23 5 7
RHOA 0.037 0.005 -10000 0 -10000 0 0
YES1 0.03 0.015 -10000 0 -10000 0 0
RAP1A/GTP -0.015 0.057 0.17 12 -0.24 5 17
ADAP1 -0.019 0.046 0.18 2 -0.23 5 7
ARAP3 -0.02 0.048 0.18 2 -0.24 5 7
INPPL1 0.034 0.038 -10000 0 -0.33 2 2
PREX1 -0.002 0.097 -10000 0 -0.39 11 11
ARHGEF6 0.031 0.051 -10000 0 -0.38 3 3
ARHGEF7 0.027 0.017 -10000 0 -10000 0 0
ARF1 0.036 0.007 -10000 0 -10000 0 0
NRAS 0.022 0.077 -10000 0 -0.32 9 9
FYN 0.011 0.098 -10000 0 -0.32 15 15
ARF6 0.029 0.05 -10000 0 -0.47 2 2
FGR 0.027 0.041 -10000 0 -0.19 7 7
mol:Ca2+ 0.012 0.064 0.16 8 -0.13 6 14
mol:IP4 0 0 -10000 0 -10000 0 0
TIAM1 0.03 0.051 -10000 0 -0.38 3 3
ZAP70 0.032 0.051 -10000 0 -0.38 3 3
mol:IP3 0.008 0.08 0.19 7 -0.18 11 18
LYN 0.032 0.013 -10000 0 -10000 0 0
ARF1/GDP 0.044 0.1 -10000 0 -0.3 10 10
RhoA/GDP 0.047 0.083 0.24 3 -0.23 3 6
PDK1/Src/Hsp90 0.032 0.058 -10000 0 -0.28 4 4
BLNK 0.005 0.12 -10000 0 -0.43 14 14
actin cytoskeleton reorganization 0.031 0.11 0.24 3 -0.38 6 9
SRC 0.013 0.06 -10000 0 -0.47 3 3
PLEKHA2 -0.007 0.019 -10000 0 -0.28 1 1
RAC1 0.034 0.012 -10000 0 -10000 0 0
PTEN 0.031 0.048 -10000 0 -0.44 2 2
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
ARF6/GTP -0.02 0.054 0.21 2 -0.23 7 9
RhoA/GTP -0.016 0.055 0.2 2 -0.23 5 7
Src family/SYK family/BLNK-LAT -0.039 0.14 -10000 0 -0.46 16 16
BLK 0.01 0.085 -10000 0 -0.3 12 12
PDPK1 0.033 0.038 -10000 0 -0.33 2 2
CYTH1 -0.019 0.046 0.18 2 -0.23 5 7
HCK -0.01 0.11 -10000 0 -0.35 17 17
CYTH3 -0.019 0.046 0.18 2 -0.23 5 7
CYTH2 -0.019 0.046 0.18 2 -0.23 5 7
KRAS 0.033 0.04 -10000 0 -0.33 2 2
GO:0030676 0 0 -10000 0 -10000 0 0
FOXO3 -0.004 0.062 0.18 1 -0.33 5 6
SGK1 0 0.057 0.19 1 -0.29 5 6
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.031 0.1 -10000 0 -0.31 10 10
SOS1 0.038 0.003 -10000 0 -10000 0 0
SYK 0.031 0.051 -10000 0 -0.38 3 3
ARF6/GDP 0.023 0.08 0.22 3 -0.28 3 6
mol:PI-3-4-5-P3 -0.019 0.05 0.23 2 -0.24 5 7
ARAP3/RAP1A/GTP -0.015 0.057 0.17 11 -0.24 5 16
VAV1 0 0.13 -10000 0 -0.41 18 18
mol:PI-3-4-P2 0.008 0.025 -10000 0 -0.34 1 1
RAS family/GTP/PI3K Class I 0.05 0.069 -10000 0 -0.24 5 5
PLEKHA1 -0.008 0.02 -10000 0 -0.28 1 1
Rac1/GDP 0.04 0.1 -10000 0 -0.3 9 9
LAT 0.025 0.061 -10000 0 -0.26 8 8
Rac1/GTP -0.002 0.085 -10000 0 -0.42 6 6
ITK -0.028 0.054 0.18 1 -0.24 9 10
Src family/SYK family/BLNK-LAT/BTK-ITK/PLC-gamma 0.003 0.14 0.25 7 -0.36 13 20
LCK -0.013 0.14 -10000 0 -0.34 28 28
BTK -0.037 0.071 0.18 2 -0.25 16 18
Plasma membrane estrogen receptor signaling

Figure S73.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S73.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GNB1/GNG2 0.067 0.055 -10000 0 -0.24 4 4
ER alpha/Gai/GDP/Gbeta gamma -0.014 0.14 -10000 0 -0.48 12 12
AKT1 0.004 0.2 -10000 0 -0.76 12 12
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
E2/ER alpha (dimer)/PELP1/Src/PI3K 0.01 0.2 -10000 0 -0.76 12 12
mol:Ca2+ -0.032 0.14 -10000 0 -0.37 19 19
IGF1R 0.032 0.039 -10000 0 -0.33 2 2
E2/ER alpha (dimer)/Striatin 0.039 0.053 -10000 0 -0.29 5 5
SHC1 0.037 0.006 -10000 0 -10000 0 0
apoptosis -0.006 0.19 0.72 12 -10000 0 12
RhoA/GTP 0.018 0.058 -10000 0 -0.22 9 9
E2/ER alpha (dimer)/PELP1/Src/p130 Cas 0.057 0.14 0.27 3 -0.36 10 13
regulation of stress fiber formation 0.026 0.081 0.29 3 -0.3 2 5
E2/ERA-ERB (dimer) 0.037 0.048 -10000 0 -0.28 4 4
KRAS 0.033 0.038 -10000 0 -0.33 2 2
G13/GTP 0.038 0.043 -10000 0 -0.26 4 4
pseudopodium formation -0.026 0.081 0.3 2 -0.29 3 5
E2/ER alpha (dimer)/PELP1 0.034 0.048 -10000 0 -0.28 4 4
GRB2 0.036 0.007 -10000 0 -10000 0 0
GNG2 0.034 0.011 -10000 0 -10000 0 0
GNAO1 0.037 0.005 -10000 0 -10000 0 0
HRAS 0.034 0.038 -10000 0 -0.33 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
mol:NO 0 0.16 0.29 1 -0.48 15 16
E2/ER beta (dimer) 0.024 0.013 -10000 0 -0.12 1 1
mol:GDP 0.007 0.074 -10000 0 -0.34 5 5
mol:NADP 0 0.16 0.29 1 -0.48 15 16
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:IP3 -0.044 0.13 0.17 3 -0.38 19 22
IGF-1R heterotetramer 0.032 0.039 -10000 0 -0.33 2 2
PLCB1 -0.047 0.13 -10000 0 -0.3 37 37
PLCB2 -0.024 0.12 -10000 0 -0.39 18 18
IGF1 0.018 0.078 -10000 0 -0.24 15 15
mol:L-citrulline 0 0.16 0.29 1 -0.48 15 16
RHOA 0.037 0.005 -10000 0 -10000 0 0
Gai/GDP 0.009 0.16 -10000 0 -0.74 8 8
JNK cascade 0.024 0.013 -10000 0 -0.12 1 1
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
ESR2 0.033 0.019 -10000 0 -0.19 1 1
GNAQ 0 0 -10000 0 -10000 0 0
ESR1 0.026 0.069 -10000 0 -0.47 4 4
Gq family/GDP/Gbeta gamma -0.012 0.14 -10000 0 -0.58 9 9
E2/ER alpha (dimer)/PELP1/Src/p52 SHC/GRB2/SOS1 0.042 0.1 -10000 0 -0.52 4 4
E2/ER alpha (dimer)/PELP1/Src/p52 SHC 0.054 0.14 0.27 3 -0.37 10 13
GNAZ 0.024 0.061 -10000 0 -0.26 8 8
E2/ER alpha (dimer) 0.02 0.049 -10000 0 -0.34 4 4
STRN 0.033 0.041 -10000 0 -0.28 3 3
GNAL 0.025 0.033 -10000 0 -0.19 4 4
PELP1 0.03 0.015 -10000 0 -10000 0 0
MAPK11 0.016 0.014 -10000 0 -10000 0 0
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
GNAI3 0.034 0.035 -10000 0 -0.47 1 1
GNAI1 -0.005 0.13 -10000 0 -0.38 21 21
HBEGF 0.085 0.2 0.34 57 -0.41 10 67
cAMP biosynthetic process 0.025 0.043 -10000 0 -0.22 4 4
SRC 0.049 0.14 -10000 0 -0.4 7 7
PI3K 0.048 0.047 -10000 0 -0.34 3 3
GNB1 0.035 0.009 -10000 0 -10000 0 0
G13/GDP/Gbeta gamma 0.042 0.08 -10000 0 -0.33 4 4
SOS1 0.038 0.003 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1 -0.016 0.09 -10000 0 -0.33 11 11
Gs family/GTP 0.032 0.047 -10000 0 -0.22 4 4
EntrezGene:2778 0 0 -10000 0 -10000 0 0
RAS family/GTP 0.052 0.061 -10000 0 -0.25 6 6
vasodilation 0.002 0.15 0.29 1 -0.46 15 16
mol:DAG -0.044 0.13 0.17 3 -0.38 19 22
Gs family/GDP/Gbeta gamma 0.01 0.069 -10000 0 -0.32 4 4
MSN -0.028 0.086 0.3 2 -0.31 3 5
Gq family/GTP -0.02 0.12 -10000 0 -0.4 19 19
mol:PI-3-4-5-P3 0.011 0.19 -10000 0 -0.73 12 12
NRAS 0.021 0.076 -10000 0 -0.31 9 9
mol:E2 0 0 -10000 0 -10000 0 0
cell adhesion -0.002 0.15 0.46 15 -0.29 1 16
GRB2/SOS1 0.054 0.011 -10000 0 -10000 0 0
RhoA/GDP 0.024 0.08 -10000 0 -0.36 4 4
NOS3 -0.002 0.16 0.29 1 -0.5 15 16
GNA11 0.031 0.051 -10000 0 -0.38 3 3
MAPKKK cascade 0.034 0.16 0.3 1 -0.5 12 13
E2/ER alpha (dimer)/PELP1/Src 0.055 0.15 0.28 3 -0.37 11 14
ruffle organization -0.026 0.081 0.3 2 -0.29 3 5
ROCK2 -0.023 0.086 0.32 2 -0.27 1 3
GNA14 -0.016 0.14 -10000 0 -0.35 29 29
GNA15 0.024 0.064 -10000 0 -0.24 10 10
GNA13 0.036 0.009 -10000 0 -10000 0 0
MMP9 0.083 0.2 0.39 53 -0.44 7 60
MMP2 0.038 0.16 0.28 4 -0.44 10 14
Regulation of Androgen receptor activity

Figure S74.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S74.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.019 0.005 -10000 0 -10000 0 0
SMARCC1 0.016 0.06 -10000 0 -0.73 1 1
REL 0.027 0.069 -10000 0 -0.47 4 4
HDAC7 -0.021 0.1 -10000 0 -0.42 8 8
JUN -0.015 0.15 -10000 0 -0.39 26 26
EP300 0.017 0.091 -10000 0 -0.43 8 8
KAT2B 0 0 -10000 0 -10000 0 0
KAT5 0 0 -10000 0 -10000 0 0
MAPK14 -0.001 0.079 -10000 0 -0.36 9 9
FOXO1 0.008 0.093 -10000 0 -0.38 10 10
T-DHT/AR 0.02 0.12 -10000 0 -0.46 7 7
MAP2K6 0.011 0.11 -10000 0 -0.41 12 12
BRM/BAF57 0.05 0.031 -10000 0 -0.34 1 1
MAP2K4 0.026 0.038 -10000 0 -0.47 1 1
SMARCA2 0.032 0.049 -10000 0 -0.47 2 2
PDE9A -0.098 0.36 -10000 0 -1 26 26
NCOA2 0.028 0.05 -10000 0 -0.47 2 2
CEBPA 0.017 0.088 -10000 0 -0.36 10 10
EHMT2 0.037 0.005 -10000 0 -10000 0 0
cell proliferation 0.073 0.17 0.42 13 -0.4 7 20
NR0B1 0.025 0.062 -10000 0 -0.25 9 9
EGR1 -0.05 0.16 -10000 0 -0.3 55 55
RXRs/9cRA 0.061 0.05 -10000 0 -0.26 4 4
AR/RACK1/Src 0.071 0.13 0.32 5 -0.37 7 12
AR/GR 0.002 0.083 -10000 0 -0.26 10 10
GNB2L1 0.035 0.035 -10000 0 -0.47 1 1
PKN1 0.03 0.06 -10000 0 -0.47 3 3
RCHY1 0.029 0.055 -10000 0 -0.3 5 5
epidermal growth factor receptor activity 0.001 0 -10000 0 -10000 0 0
MAPK8 0.011 0.03 -10000 0 -0.33 1 1
T-DHT/AR/TIF2/CARM1 0.015 0.097 -10000 0 -0.36 8 8
SRC 0.03 0.12 0.19 56 -0.33 10 66
NR3C1 0.022 0.085 -10000 0 -0.43 7 7
KLK3 -0.049 0.11 -10000 0 -0.49 1 1
APPBP2 0.032 0.019 -10000 0 -10000 0 0
TRIM24 0.032 0.049 -10000 0 -0.47 2 2
T-DHT/AR/TIP60 -0.022 0.075 -10000 0 -0.32 10 10
TMPRSS2 -0.025 0.21 -10000 0 -0.78 11 11
RXRG 0.024 0.073 -10000 0 -0.35 7 7
mol:9cRA 0 0 -10000 0 -10000 0 0
RXRA 0.037 0.005 -10000 0 -10000 0 0
RXRB 0.037 0.006 -10000 0 -10000 0 0
CARM1 0.037 0.005 -10000 0 -10000 0 0
NR2C2 0.037 0.006 -10000 0 -10000 0 0
KLK2 0.045 0.098 0.3 1 -0.45 2 3
AR 0 0.062 -10000 0 -0.23 11 11
SENP1 0.037 0.005 -10000 0 -10000 0 0
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
MDM2 0.035 0.016 -10000 0 -0.19 1 1
SRY -0.001 0.001 -10000 0 -10000 0 0
GATA2 0.031 0.051 -10000 0 -0.38 3 3
MYST2 0 0 -10000 0 -10000 0 0
HOXB13 -0.1 0.2 -10000 0 -0.32 84 84
T-DHT/AR/RACK1/Src 0.075 0.14 0.36 7 -0.39 7 14
positive regulation of transcription 0.031 0.051 -10000 0 -0.38 3 3
DNAJA1 0.032 0.024 -10000 0 -0.21 1 1
proteasomal ubiquitin-dependent protein catabolic process 0.022 0.034 -10000 0 -0.31 2 2
NCOA1 0.031 0.077 -10000 0 -0.52 4 4
SPDEF -0.064 0.17 -10000 0 -0.3 65 65
T-DHT/AR/TIF2 -0.001 0.1 0.3 5 -0.41 6 11
T-DHT/AR/Hsp90 0.001 0.09 0.38 1 -0.34 8 9
GSK3B 0.035 0.035 -10000 0 -0.47 1 1
NR2C1 0.036 0.016 -10000 0 -0.19 1 1
mol:T-DHT -0.017 0.073 0.21 3 -0.31 10 13
SIRT1 0.033 0.038 -10000 0 -0.33 2 2
ZMIZ2 0.031 0.036 -10000 0 -0.47 1 1
POU2F1 0.023 0.077 -10000 0 -0.32 6 6
T-DHT/AR/DAX-1 -0.005 0.1 0.38 1 -0.35 11 12
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
SMARCE1 0.036 0.008 -10000 0 -10000 0 0
Regulation of nuclear SMAD2/3 signaling

Figure S75.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S75.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.016 0.092 -10000 0 -0.44 8 8
HSPA8 0.037 0.006 -10000 0 -10000 0 0
SMAD3/SMAD4/ER alpha 0.026 0.092 -10000 0 -0.27 6 6
AKT1 0.029 0.034 -10000 0 -0.18 4 4
GSC -0.02 0.17 -10000 0 -1.1 2 2
NKX2-5 0.029 0.033 -10000 0 -0.18 1 1
muscle cell differentiation 0.042 0.16 0.52 10 -10000 0 10
SMAD2-3/SMAD4/SP1 0.032 0.12 -10000 0 -0.36 4 4
SMAD4 0.008 0.061 -10000 0 -0.32 2 2
CBFB 0.037 0.005 -10000 0 -10000 0 0
SAP18 0.028 0.017 -10000 0 -10000 0 0
Cbp/p300/MSG1 0.021 0.11 -10000 0 -0.31 14 14
SMAD3/SMAD4/VDR 0.034 0.12 -10000 0 -0.28 9 9
MYC 0.007 0.11 -10000 0 -0.47 10 10
CDKN2B -0.032 0.24 -10000 0 -1.5 5 5
AP1 -0.058 0.17 -10000 0 -0.48 21 21
SMAD2/SMAD2/SMAD4/SnoN/SIN3/HDAC complex/NCoR1 -0.03 0.16 -10000 0 -0.39 23 23
SMAD2-3/SMAD4/FOXO1-3a-4/FOXG1 -0.044 0.13 -10000 0 -0.4 14 14
SP3 0.037 0.015 -10000 0 -10000 0 0
CREB1 0.038 0.003 -10000 0 -10000 0 0
FOXH1 0.021 0.048 -10000 0 -0.34 2 2
SMAD3/SMAD4/GR 0.017 0.1 -10000 0 -0.32 10 10
GATA3 0.03 0.056 -10000 0 -0.46 2 2
SKI/SIN3/HDAC complex/NCoR1 0.019 0.087 -10000 0 -0.3 8 8
MEF2C/TIF2 0.01 0.13 0.32 1 -0.46 11 12
endothelial cell migration 0.003 0.17 1.4 3 -10000 0 3
MAX 0.033 0.012 -10000 0 -10000 0 0
RBBP7 0.035 0.022 -10000 0 -0.19 2 2
RBBP4 0.03 0.044 -10000 0 -0.26 4 4
RUNX2 0.036 0.016 -10000 0 -0.19 1 1
RUNX3 -0.017 0.14 -10000 0 -0.33 30 30
RUNX1 0.014 0.091 -10000 0 -0.32 13 13
CTBP1 0.036 0.007 -10000 0 -10000 0 0
NR3C1 0.022 0.085 -10000 0 -0.43 7 7
VDR 0.024 0.078 -10000 0 -0.42 6 6
CDKN1A -0.034 0.22 -10000 0 -1.2 6 6
KAT2B 0 0.003 -10000 0 -10000 0 0
SMAD2/SMAD2/SMAD4/FOXH1 0.029 0.081 -10000 0 -0.35 3 3
DCP1A 0.037 0.005 -10000 0 -10000 0 0
SKI 0.035 0.009 -10000 0 -10000 0 0
SERPINE1 -0.004 0.17 -10000 0 -1.4 3 3
SMAD3/SMAD4/ATF2 0.025 0.083 -10000 0 -0.25 4 4
SMAD3/SMAD4/ATF3 0.012 0.095 -10000 0 -0.3 6 6
SAP30 0.033 0.035 -10000 0 -0.47 1 1
Cbp/p300/PIAS3 0.048 0.077 -10000 0 -0.29 8 8
JUN -0.071 0.16 -10000 0 -0.48 21 21
SMAD3/SMAD4/IRF7 0.029 0.09 -10000 0 -0.28 5 5
TFE3 0.037 0.026 -10000 0 -10000 0 0
COL1A2 -0.061 0.24 -10000 0 -0.84 18 18
mesenchymal cell differentiation -0.024 0.083 0.25 4 -10000 0 4
DLX1 0.029 0.043 -10000 0 -0.19 8 8
TCF3 0.029 0.06 -10000 0 -0.47 3 3
FOS -0.066 0.16 -10000 0 -0.31 56 56
SMAD3/SMAD4/Max 0.026 0.081 -10000 0 -0.25 4 4
Cbp/p300/SNIP1 0.051 0.074 -10000 0 -0.29 8 8
ZBTB17 0.035 0.013 -10000 0 -10000 0 0
LAMC1 -0.002 0.078 -10000 0 -0.5 2 2
TGIF2/HDAC complex/SMAD3/SMAD4 -0.007 0.1 -10000 0 -0.33 14 14
IRF7 0.037 0.022 -10000 0 -10000 0 0
ESR1 0.031 0.063 -10000 0 -0.41 4 4
HNF4A 0.01 0.069 -10000 0 -0.47 4 4
MEF2C 0.015 0.14 0.32 1 -0.48 11 12
SMAD2-3/SMAD4 0.023 0.093 -10000 0 -0.27 5 5
Cbp/p300/Src-1 0.046 0.085 -10000 0 -0.29 11 11
IGHV3OR16-13 0.006 0.026 -10000 0 -10000 0 0
TGIF2/HDAC complex -0.01 0.12 -10000 0 -0.47 13 13
CREBBP 0.033 0.036 -10000 0 -0.47 1 1
SKIL 0.006 0.12 -10000 0 -0.38 16 16
HDAC1 0.036 0.008 -10000 0 -10000 0 0
HDAC2 0.034 0.035 -10000 0 -0.47 1 1
SNIP1 0.037 0.006 -10000 0 -10000 0 0
GCN5L2 0 0.005 -10000 0 -10000 0 0
SMAD3/SMAD4/TFE3 0.029 0.093 -10000 0 -0.28 4 4
MSG1/HSC70 0.021 0.085 -10000 0 -0.33 6 6
SMAD2 0.02 0.049 -10000 0 -0.53 1 1
SMAD3 0.009 0.071 -10000 0 -0.37 3 3
SMAD3/E2F4-5/DP1/p107/SMAD4 -0.015 0.081 -10000 0 -0.33 5 5
SMAD2/SMAD2/SMAD4 -0.062 0.086 -10000 0 -0.2 54 54
NCOR1 0.029 0.016 -10000 0 -10000 0 0
NCOA2 0.028 0.05 -10000 0 -0.47 2 2
NCOA1 0.028 0.069 -10000 0 -0.47 4 4
MYOD/E2A 0.032 0.075 -10000 0 -0.35 5 5
SMAD2-3/SMAD4/SP1/MIZ-1 0.044 0.13 -10000 0 -0.37 3 3
IFNB1 -0.008 0.088 -10000 0 -0.52 4 4
SMAD3/SMAD4/MEF2C 0.019 0.15 -10000 0 -0.48 11 11
CITED1 -0.006 0.11 -10000 0 -0.24 34 34
SMAD2-3/SMAD4/ARC105 0.041 0.093 -10000 0 -0.28 2 2
RBL1 0.014 0.06 -10000 0 -0.47 3 3
SMAD2-3/SMAD4/FOXO1-3a-4/CEBPB -0.009 0.13 -10000 0 -0.6 6 6
RUNX1-3/PEBPB2 0.014 0.11 -10000 0 -0.29 20 20
SMAD7 -0.056 0.18 -10000 0 -0.59 8 8
MYC/MIZ-1 0.023 0.085 0.22 1 -0.34 10 11
SMAD3/SMAD4 -0.064 0.14 0.31 1 -0.41 20 21
IL10 -0.002 0.068 -10000 0 -0.36 1 1
PIASy/HDAC complex 0.033 0.039 -10000 0 -0.32 2 2
PIAS3 0.034 0.023 -10000 0 -0.19 2 2
CDK2 0.021 0.073 -10000 0 -0.26 11 11
IL5 -0.008 0.078 -10000 0 -0.36 1 1
CDK4 0.036 0.01 -10000 0 -10000 0 0
PIAS4 0.033 0.039 -10000 0 -0.32 2 2
ATF3 0.015 0.08 -10000 0 -0.24 17 17
SMAD3/SMAD4/SP1 0.017 0.12 -10000 0 -0.32 9 9
FOXG1 0.004 0.084 -10000 0 -0.21 26 26
FOXO3 0.008 0.041 -10000 0 -0.34 1 1
FOXO1 -0.002 0.068 -10000 0 -0.35 7 7
FOXO4 0.013 0.028 -10000 0 -0.21 1 1
heart looping 0.015 0.14 0.32 1 -0.47 11 12
CEBPB 0.017 0.039 -10000 0 -0.47 1 1
SMAD3/SMAD4/DLX1 0.021 0.087 -10000 0 -0.25 4 4
MYOD1 0.017 0.074 -10000 0 -0.22 17 17
SMAD3/SMAD4/HNF4 0.005 0.08 -10000 0 -0.34 5 5
SMAD3/SMAD4/GATA3 0.025 0.096 -10000 0 -0.32 3 3
SnoN/SIN3/HDAC complex/NCoR1 0.006 0.12 -10000 0 -0.38 16 16
SMAD3/SMAD4/RUNX1-3/PEBPB2 0.016 0.13 -10000 0 -0.28 20 20
SMAD3/SMAD4/SP1-3 0.034 0.12 -10000 0 -0.37 5 5
MED15 0.035 0.01 -10000 0 -10000 0 0
SP1 0.015 0.063 -10000 0 -0.22 5 5
SIN3B 0.037 0.005 -10000 0 -10000 0 0
SIN3A 0.034 0.018 -10000 0 -0.19 1 1
SMAD2/SMAD2/SMAD4/FOXH1/NKX2-5 0.034 0.1 -10000 0 -0.31 9 9
ITGB5 -0.013 0.1 -10000 0 -0.44 6 6
TGIF/SIN3/HDAC complex/CtBP 0.026 0.077 -10000 0 -0.35 4 4
SMAD3/SMAD4/AR 0.014 0.093 -10000 0 -0.26 7 7
AR 0.021 0.074 -10000 0 -0.26 12 12
negative regulation of cell growth -0.018 0.096 -10000 0 -0.46 3 3
SMAD3/SMAD4/MYOD 0.014 0.096 -10000 0 -0.28 7 7
E2F5 0.009 0.1 -10000 0 -0.42 11 11
E2F4 0.036 0.016 -10000 0 -0.19 1 1
SMAD2/SMAD2/SMAD4/FOXH1/SMIF 0.041 0.099 -10000 0 -0.29 6 6
SMAD2-3/SMAD4/FOXO1-3a-4 0.002 0.12 -10000 0 -0.44 8 8
TFDP1 0.023 0.051 -10000 0 -0.47 2 2
SMAD3/SMAD4/AP1 -0.042 0.19 -10000 0 -0.48 21 21
SMAD3/SMAD4/RUNX2 0.025 0.083 -10000 0 -0.25 4 4
TGIF2 -0.01 0.12 -10000 0 -0.47 13 13
TGIF1 0.021 0.056 -10000 0 -0.3 5 5
ATF2 0.038 0.003 -10000 0 -10000 0 0
Hedgehog signaling events mediated by Gli proteins

Figure S76.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S76.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.036 0.008 -10000 0 -10000 0 0
HDAC2 0.034 0.035 -10000 0 -0.47 1 1
GNB1/GNG2 0.026 0.094 -10000 0 -0.28 12 12
forebrain development -0.048 0.26 -10000 0 -0.85 15 15
GNAO1 0.037 0.005 -10000 0 -10000 0 0
SMO/beta Arrestin2 0.002 0.1 -10000 0 -0.33 13 13
SMO -0.015 0.13 -10000 0 -0.29 33 33
ARRB2 0.027 0.038 -10000 0 -0.47 1 1
GLI3/SPOP 0.04 0.13 0.28 2 -0.4 6 8
mol:GTP 0 0.002 -10000 0 -10000 0 0
GSK3B 0.035 0.035 -10000 0 -0.47 1 1
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
SIN3/HDAC complex 0.061 0.052 -10000 0 -0.26 1 1
GNAI1 -0.005 0.13 -10000 0 -0.38 21 21
XPO1 0.036 0.016 -10000 0 -10000 0 0
GLI1/Su(fu) -0.052 0.24 -10000 0 -0.96 11 11
SAP30 0.033 0.035 -10000 0 -0.47 1 1
mol:GDP -0.015 0.13 -10000 0 -0.29 33 33
MIM/GLI2A -0.009 0.13 -10000 0 -0.4 17 17
IFT88 0.006 0.1 -10000 0 -0.47 9 9
GNAI3 0.034 0.036 -10000 0 -0.47 1 1
GLI2 0.014 0.077 -10000 0 -0.34 4 4
GLI3 0.028 0.13 0.28 5 -0.42 6 11
CSNK1D 0.036 0.007 -10000 0 -10000 0 0
CSNK1E 0.027 0.062 -10000 0 -0.4 4 4
SAP18 0.027 0.017 -10000 0 -10000 0 0
embryonic digit morphogenesis 0.006 0.1 -10000 0 -0.47 9 9
GNG2 0.034 0.011 -10000 0 -10000 0 0
Gi family/GTP -0.022 0.13 -10000 0 -0.32 22 22
SIN3B 0.037 0.005 -10000 0 -10000 0 0
SIN3A 0.034 0.018 -10000 0 -0.19 1 1
GLI3/Su(fu) 0.029 0.13 0.3 2 -0.39 7 9
GLI2/Su(fu) 0.007 0.1 -10000 0 -0.42 5 5
FOXA2 -0.11 0.35 -10000 0 -0.99 27 27
neural tube patterning -0.048 0.26 -10000 0 -0.85 15 15
SPOP 0.036 0.008 -10000 0 -10000 0 0
Su(fu)/PIAS1 0.012 0.083 -10000 0 -0.62 1 1
GNB1 0.035 0.009 -10000 0 -10000 0 0
CSNK1G2 0.037 0.006 -10000 0 -10000 0 0
CSNK1G3 0.037 0.006 -10000 0 -10000 0 0
MTSS1 -0.009 0.13 -10000 0 -0.4 17 17
embryonic limb morphogenesis -0.048 0.26 -10000 0 -0.85 15 15
SUFU 0.004 0.07 -10000 0 -0.45 2 2
LGALS3 0.024 0.065 -10000 0 -0.33 6 6
catabolic process 0.041 0.14 0.34 1 -0.38 8 9
GLI3A/CBP 0.007 0.11 -10000 0 -0.36 17 17
KIF3A 0.032 0.049 -10000 0 -0.47 2 2
GLI1 -0.051 0.27 -10000 0 -0.89 15 15
RAB23 0.025 0.068 -10000 0 -0.29 8 8
CSNK1A1 0.037 0.005 -10000 0 -10000 0 0
IFT172 0.007 0.12 -10000 0 -0.47 13 13
RBBP7 0.035 0.022 -10000 0 -0.19 2 2
Su(fu)/Galectin3 0.009 0.093 -10000 0 -0.33 6 6
GNAZ 0.024 0.061 -10000 0 -0.26 8 8
RBBP4 0.03 0.044 -10000 0 -0.26 4 4
CSNK1G1 0.035 0.009 -10000 0 -10000 0 0
PIAS1 0.035 0.009 -10000 0 -10000 0 0
PRKACA 0.037 0.006 -10000 0 -10000 0 0
GLI2/SPOP 0.029 0.083 -10000 0 -0.34 5 5
STK36 0.031 0.043 -10000 0 -0.28 3 3
Gi family/GNB1/GNG2/GDP -0.016 0.12 -10000 0 -0.42 12 12
PTCH1 -0.049 0.26 -10000 0 -0.99 12 12
MIM/GLI1 -0.065 0.28 -10000 0 -0.72 24 24
CREBBP 0.007 0.11 -10000 0 -0.36 17 17
Su(fu)/SIN3/HDAC complex 0.023 0.1 -10000 0 -0.36 9 9
PLK1 signaling events

Figure S77.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S77.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
regulation of centriole-centriole cohesion -0.007 0.038 0.16 8 -0.11 1 9
BUB1B 0.006 0.074 0.13 1 -0.26 8 9
PLK1 0.021 0.042 0.1 5 -0.13 7 12
PLK1S1 0.01 0.022 0.058 5 -0.062 8 13
KIF2A 0.015 0.043 -10000 0 -0.2 4 4
regulation of mitotic centrosome separation 0.02 0.042 0.1 5 -0.13 7 12
GOLGA2 0.035 0.035 -10000 0 -0.47 1 1
Hec1/SPC24 0.021 0.06 -10000 0 -0.25 6 6
WEE1 0.02 0.087 -10000 0 -0.44 5 5
cytokinesis 0.01 0.09 -10000 0 -0.44 4 4
PP2A-alpha B56 0.023 0.23 -10000 0 -0.73 17 17
AURKA 0.017 0.05 -10000 0 -0.3 4 4
PICH/PLK1 0.012 0.12 0.18 22 -0.32 16 38
CENPE 0.015 0.037 -10000 0 -0.16 2 2
RhoA/GTP 0.027 0.004 -10000 0 -10000 0 0
positive regulation of microtubule depolymerization 0.014 0.043 -10000 0 -0.2 4 4
PPP2CA 0.037 0.005 -10000 0 -10000 0 0
FZR1 0.037 0.006 -10000 0 -10000 0 0
TPX2 0.035 0.052 0.12 3 -0.33 2 5
PAK1 0.033 0.05 -10000 0 -0.48 2 2
SPC24 0 0 -10000 0 -10000 0 0
FBXW11 0.037 0.004 -10000 0 -10000 0 0
CLSPN 0.013 0.057 -10000 0 -0.25 8 8
GORASP1 0.037 0.004 -10000 0 -10000 0 0
metaphase 0 0.004 0.017 6 -0.016 2 8
mol:GTP 0 0 -10000 0 -10000 0 0
NLP 0.01 0.022 0.058 5 -0.062 8 13
G2 phase of mitotic cell cycle 0.001 0.004 0.014 7 -0.012 3 10
STAG2 0.027 0.07 -10000 0 -0.41 5 5
GRASP65/GM130/RAB1/GTP 0.016 0.063 -10000 0 -0.47 3 3
spindle elongation 0.02 0.042 0.1 5 -0.13 7 12
ODF2 0.034 0.05 -10000 0 -0.48 2 2
BUB1 -0.026 0.24 -10000 0 -0.8 17 17
TPT1 0.028 0.038 0.13 2 -0.18 2 4
CDC25C 0.014 0.075 -10000 0 -0.36 7 7
CDC25B 0.013 0.088 -10000 0 -0.41 8 8
SGOL1 0.007 0.038 0.11 1 -0.16 8 9
RHOA 0.037 0.005 -10000 0 -10000 0 0
CCNB1/CDK1 0.016 0.11 -10000 0 -0.37 11 11
CDC14B 0.009 0.024 -10000 0 -0.34 1 1
CDC20 0.031 0.051 -10000 0 -0.38 3 3
PLK1/PBIP1 0.003 0.066 0.11 1 -0.22 13 14
mitosis -0.001 0.005 0.034 4 -10000 0 4
FBXO5 0.009 0.06 0.22 2 -0.21 8 10
CDC2 0.001 0.005 -10000 0 -0.014 21 21
NDC80 0.015 0.079 -10000 0 -0.39 7 7
metaphase plate congression 0.002 0.081 -10000 0 -0.24 20 20
ERCC6L -0.01 0.12 -10000 0 -0.35 16 16
NLP/gamma Tubulin 0.012 0.024 0.085 4 -0.086 2 6
microtubule cytoskeleton organization 0.029 0.038 0.13 2 -0.18 2 4
G2/M transition DNA damage checkpoint 0 0.003 0.016 4 -10000 0 4
PPP1R12A 0.038 0.005 -10000 0 -10000 0 0
interphase 0 0.003 0.016 4 -10000 0 4
PLK1/PRC1-2 0.051 0.071 -10000 0 -0.32 4 4
GRASP65/GM130/RAB1/GTP/PLK1 0.07 0.05 -10000 0 -0.19 2 2
RAB1A 0.038 0 -10000 0 -10000 0 0
prophase 0 0 -10000 0 -10000 0 0
Aurora A/BORA 0.024 0.042 0.079 28 -0.13 6 34
mitotic prometaphase 0.001 0.006 0.018 20 -0.012 1 21
proteasomal ubiquitin-dependent protein catabolic process 0.03 0.051 -10000 0 -0.29 1 1
microtubule-based process 0.033 0.062 -10000 0 -0.25 6 6
Golgi organization 0.02 0.042 0.1 5 -0.13 7 12
Cohesin/SA2 0.032 0.052 -10000 0 -0.21 6 6
PPP1CB/MYPT1 0.054 0.028 -10000 0 -0.34 1 1
KIF20A 0.028 0.069 -10000 0 -0.47 4 4
APC/C/CDC20 0.036 0.054 -10000 0 -0.21 5 5
PPP2R1A 0.037 0.006 -10000 0 -10000 0 0
chromosome segregation 0.003 0.065 0.1 1 -0.22 13 14
PRC1 0.033 0.036 -10000 0 -0.47 1 1
ECT2 0.012 0.06 0.24 2 -0.24 6 8
C13orf34 0.019 0.037 0.088 5 -0.11 8 13
NUDC 0.002 0.081 -10000 0 -0.24 20 20
regulation of attachment of spindle microtubules to kinetochore 0.006 0.074 0.13 1 -0.26 8 9
spindle assembly 0.017 0.035 0.11 6 -0.11 6 12
spindle stabilization 0.01 0.022 0.058 5 -0.061 8 13
APC/C/HCDH1 0.033 0.023 -10000 0 -0.29 1 1
MKLP2/PLK1 0.033 0.062 -10000 0 -0.25 6 6
CCNB1 0.019 0.092 -10000 0 -0.48 7 7
PPP1CB 0.036 0.035 -10000 0 -0.47 1 1
BTRC 0.036 0.008 -10000 0 -10000 0 0
ROCK2 0.005 0.11 -10000 0 -0.39 13 13
TUBG1 0.02 0.026 0.12 1 -0.15 1 2
G2/M transition of mitotic cell cycle -0.012 0.096 -10000 0 -0.37 11 11
MLF1IP -0.01 0.078 -10000 0 -0.34 11 11
INCENP 0.017 0.094 -10000 0 -0.39 10 10
mTOR signaling pathway

Figure S78.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S78.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
GBL 0 0 -10000 0 -10000 0 0
MKNK1 0.037 0.005 -10000 0 -10000 0 0
mol:PIP3 -0.004 0.062 0.24 1 -0.28 8 9
FRAP1 -0.027 0.15 -10000 0 -0.47 20 20
AKT1 -0.009 0.074 0.2 1 -0.28 9 10
INSR 0.025 0.072 -10000 0 -0.38 6 6
Insulin Receptor/Insulin 0.041 0.044 -10000 0 -0.29 3 3
mol:GTP 0.026 0.079 0.27 1 -0.3 3 4
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA/eIF3/40s Ribosomal subunit -0.002 0.063 -10000 0 -0.22 9 9
TSC2 0.037 0.007 -10000 0 -10000 0 0
RHEB/GDP 0.014 0.063 -10000 0 -0.26 3 3
TSC1 0.035 0.035 -10000 0 -0.47 1 1
Insulin Receptor/IRS1 0.013 0.086 -10000 0 -0.33 11 11
eIF4E/eIF4G1/eIF4A1/eIF4B/RNA 0.01 0.076 -10000 0 -0.25 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
EIF3A 0.034 0.035 -10000 0 -0.47 1 1
RPS6KB1 0 0.1 0.24 4 -0.34 11 15
MAP3K5 -0.007 0.072 0.18 2 -0.26 14 16
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
apoptosis -0.007 0.072 0.18 2 -0.26 14 16
mol:LY294002 0 0 0.001 3 -0.001 8 11
EIF4B 0 0.1 0.29 4 -0.34 8 12
40S S6 ribosomal protein /40s Ribosomal subunit/eIF3 0.023 0.1 0.25 3 -0.32 8 11
eIF4E/eIF4G1/eIF4A1 -0.006 0.094 -10000 0 -0.29 18 18
KIAA1303 0 0 -10000 0 -10000 0 0
PI3K 0.035 0.078 -10000 0 -0.28 11 11
mTOR/RHEB/GTP/Raptor/GBL 0.009 0.055 0.22 6 -0.18 1 7
FKBP1A 0.027 0.038 -10000 0 -0.47 1 1
RHEB/GTP 0.035 0.073 0.24 1 -0.26 3 4
mol:Amino Acids 0 0 0.001 3 -0.001 8 11
FKBP12/Rapamycin 0.02 0.027 -10000 0 -0.34 1 1
PDPK1 -0.017 0.062 0.2 3 -0.26 9 12
EIF4E 0.037 0.006 -10000 0 -10000 0 0
ASK1/PP5C -0.025 0.2 -10000 0 -0.56 20 20
mTOR/RHEB/GTP/Raptor/GBL/eIF4E 0.018 0.036 -10000 0 -10000 0 0
TSC1/TSC2 0.029 0.085 0.29 1 -0.32 3 4
tumor necrosis factor receptor activity 0 0 0.001 8 -0.001 3 11
RPS6 0.034 0.023 -10000 0 -0.19 2 2
PPP5C 0.036 0.016 -10000 0 -0.19 1 1
EIF4G1 0.029 0.055 -10000 0 -0.3 5 5
IRS1 -0.005 0.069 -10000 0 -0.32 9 9
INS 0.036 0.009 -10000 0 -10000 0 0
PTEN 0.03 0.049 -10000 0 -0.47 2 2
PDK2 -0.016 0.058 0.18 2 -0.26 8 10
EIF4EBP1 -0.078 0.34 -10000 0 -1.1 21 21
PIK3CA 0.037 0.005 -10000 0 -10000 0 0
PPP2R5D -0.02 0.14 0.26 2 -0.43 19 21
peptide biosynthetic process 0.011 0.081 0.19 8 -0.3 10 18
RHEB 0.036 0.008 -10000 0 -10000 0 0
EIF4A1 0.03 0.015 -10000 0 -10000 0 0
mol:Rapamycin 0 0.001 0.003 7 -0.003 4 11
EEF2 0.011 0.081 0.19 8 -0.31 10 18
eIF4E/4E-BP1 -0.055 0.32 -10000 0 -1 21 21
Paxillin-independent events mediated by a4b1 and a4b7

Figure S79.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S79.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 -0.005 0.099 -9999 0 -0.3 21 21
CRKL 0.03 0.049 -9999 0 -0.47 2 2
Rac1/GDP 0.025 0.009 -9999 0 -10000 0 0
DOCK1 0.024 0.078 -9999 0 -0.42 6 6
ITGA4 0.011 0.11 -9999 0 -0.45 12 12
alpha4/beta7 Integrin/MAdCAM1 0.033 0.13 -9999 0 -0.27 27 27
EPO 0.034 0.023 -9999 0 -0.19 2 2
alpha4/beta7 Integrin 0.009 0.13 -9999 0 -0.35 24 24
mol:GTP 0 0 -9999 0 -10000 0 0
CRK 0.03 0.015 -9999 0 -10000 0 0
alpha4/beta1 Integrin 0.035 0.085 -9999 0 -0.34 10 10
EPO/EPOR (dimer) 0.048 0.03 -9999 0 -10000 0 0
lamellipodium assembly -0.005 0.11 -9999 0 -0.38 9 9
PIK3CA 0.037 0.004 -9999 0 -10000 0 0
PI3K 0.048 0.047 -9999 0 -0.34 3 3
ARF6 0.029 0.05 -9999 0 -0.47 2 2
JAK2 0.013 0.082 -9999 0 -0.3 11 11
PXN 0.037 0.004 -9999 0 -10000 0 0
PIK3R1 0.03 0.06 -9999 0 -0.47 3 3
MADCAM1 0.016 0.079 -9999 0 -0.24 16 16
cell adhesion 0.03 0.12 -9999 0 -0.27 27 27
CRKL/CBL 0.048 0.04 -9999 0 -0.34 2 2
ITGB1 0.036 0.016 -9999 0 -0.19 1 1
SRC -0.008 0.081 -9999 0 -0.33 11 11
ITGB7 0.004 0.12 -9999 0 -0.47 14 14
RAC1 0.034 0.012 -9999 0 -10000 0 0
alpha4/beta1 Integrin/VCAM1 0.039 0.12 -9999 0 -0.35 15 15
p130Cas/Crk/Dock1 0.046 0.11 -9999 0 -0.4 4 4
VCAM1 0.013 0.1 -9999 0 -0.38 12 12
RHOA 0.037 0.005 -9999 0 -10000 0 0
alpha4/beta1 Integrin/Paxillin/GIT1 0.072 0.081 -9999 0 -0.26 10 10
BCAR1 -0.024 0.072 -9999 0 -0.31 11 11
EPOR 0.034 0.027 -9999 0 -0.19 3 3
mol:GDP 0 0 -9999 0 -10000 0 0
CBL 0.037 0.006 -9999 0 -10000 0 0
GIT1 0.035 0.017 -9999 0 -0.19 1 1
Rac1/GTP -0.005 0.12 -9999 0 -0.39 9 9
RXR and RAR heterodimerization with other nuclear receptor

Figure S80.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S80.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TGFB1 0.015 0.057 -10000 0 -10000 0 0
VDR 0.024 0.078 -10000 0 -0.42 6 6
FAM120B 0.036 0.008 -10000 0 -10000 0 0
RXRs/LXRs/DNA/9cRA 0.036 0.083 -10000 0 -0.48 2 2
RXRs/LXRs/DNA/Oxysterols 0.037 0.1 -10000 0 -0.43 7 7
MED1 0.024 0.077 -10000 0 -0.47 5 5
mol:9cRA 0.003 0.01 -10000 0 -10000 0 0
RARs/THRs/DNA/Src-1 0.015 0.082 -10000 0 -0.44 2 2
RXRs/NUR77 0.068 0.082 -10000 0 -0.26 4 4
RXRs/PPAR 0.007 0.095 -10000 0 -0.28 11 11
NCOR2 0.034 0.038 -10000 0 -0.33 2 2
VDR/VDR/Vit D3 0.018 0.056 -10000 0 -0.3 6 6
RARs/VDR/DNA/Vit D3 0.06 0.08 -10000 0 -0.25 11 11
RARA 0.035 0.009 -10000 0 -10000 0 0
NCOA1 0.028 0.069 -10000 0 -0.47 4 4
VDR/VDR/DNA 0.024 0.078 -10000 0 -0.42 6 6
RARs/RARs/DNA/9cRA 0.051 0.058 -10000 0 -0.24 6 6
RARG 0.03 0.053 -10000 0 -0.33 4 4
RPS6KB1 0.023 0.082 0.55 5 -10000 0 5
RARs/THRs/DNA/SMRT 0.015 0.084 -10000 0 -0.51 2 2
THRA 0.018 0.087 -10000 0 -0.38 9 9
mol:Bile acids 0 0 -10000 0 -10000 0 0
VDR/Vit D3/DNA 0.018 0.056 -10000 0 -0.3 6 6
RXRs/PPAR/9cRA/PGJ2/DNA 0.062 0.07 -10000 0 -0.25 4 4
NR1H4 -0.071 0.18 -10000 0 -0.3 70 70
RXRs/LXRs/DNA 0.098 0.1 -10000 0 -0.37 3 3
NR1H2 0.038 0.019 -10000 0 -10000 0 0
NR1H3 0.031 0.067 -10000 0 -0.42 4 4
RXRs/VDR/DNA/Vit D3 0.069 0.08 -10000 0 -0.24 9 9
NR4A1 0.019 0.061 -10000 0 -0.19 17 17
mol:ATRA 0 0 -10000 0 -10000 0 0
RXRs/FXR/9cRA/MED1 -0.014 0.1 -10000 0 -0.24 27 27
RXRG 0.025 0.075 -10000 0 -0.34 7 7
RXR alpha/CCPG 0.053 0.02 -10000 0 -10000 0 0
RXRA 0.038 0.018 -10000 0 -10000 0 0
RXRB 0.038 0.02 -10000 0 -10000 0 0
THRB 0.025 0.062 -10000 0 -0.25 9 9
PPARG -0.018 0.16 -10000 0 -0.44 25 25
PPARD 0.037 0.004 -10000 0 -10000 0 0
TNF 0.023 0.14 -10000 0 -0.91 3 3
mol:Oxysterols 0.003 0.009 -10000 0 -10000 0 0
cholesterol transport 0.037 0.1 -10000 0 -0.43 7 7
PPARA 0.031 0.039 -10000 0 -0.33 2 2
mol:Vit D3 0 0 -10000 0 -10000 0 0
RARB 0.024 0.074 -10000 0 -0.33 8 8
RXRs/NUR77/BCL2 -0.007 0.082 -10000 0 -0.28 10 10
SREBF1 0.017 0.12 -10000 0 -0.72 4 4
RXRs/RXRs/DNA/9cRA 0.062 0.07 -10000 0 -0.25 4 4
ABCA1 0.019 0.15 -10000 0 -0.95 4 4
RARs/THRs 0.067 0.1 -10000 0 -0.25 13 13
RXRs/FXR 0.004 0.14 -10000 0 -0.27 29 29
BCL2 0.001 0.093 -10000 0 -0.29 16 16
Effects of Botulinum toxin

Figure S81.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S81.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
STX1A 0.008 0.016 -10000 0 -0.12 3 3
UniProt:P19321 0 0 -10000 0 -10000 0 0
RIMS1/UNC13B 0.048 0.035 -10000 0 -0.34 1 1
STXBP1 0.027 0.059 -10000 0 -0.27 7 7
ACh/CHRNA1 0.018 0.045 -10000 0 -0.14 1 1
RAB3GAP2/RIMS1/UNC13B 0.063 0.05 -10000 0 -0.29 3 3
mol:Ca2+ 0 0 -10000 0 -10000 0 0
UniProt:P30996 0 0 -10000 0 -10000 0 0
UniProt:Q60393 0 0 -10000 0 -10000 0 0
CST086 0 0 -10000 0 -10000 0 0
RIMS1 0.034 0.023 -10000 0 -0.19 2 2
mol:ACh 0 0.046 0.077 31 -0.12 11 42
RAB3GAP2 0.032 0.049 -10000 0 -0.47 2 2
STX1A/SNAP25/VAMP2 0.032 0.082 -10000 0 -0.23 4 4
UniProt:P10844 0 0 -10000 0 -10000 0 0
muscle contraction 0.018 0.045 -10000 0 -0.14 1 1
UNC13B 0.033 0.038 -10000 0 -0.33 2 2
CHRNA1 0.034 0.026 -10000 0 -0.19 3 3
UniProt:P10845 0 0 -10000 0 -10000 0 0
ACh/Synaptotagmin 1 -0.058 0.12 -10000 0 -0.27 44 44
SNAP25 0.002 0.028 -10000 0 -0.28 2 2
VAMP2 0.006 0.003 -10000 0 -10000 0 0
SYT1 -0.089 0.19 -10000 0 -0.33 74 74
UniProt:Q00496 0 0 -10000 0 -10000 0 0
STXIA/STXBP1 0.025 0.041 -10000 0 -0.29 2 2
STX1A/SNAP25 fragment 1/VAMP2 0.032 0.082 -10000 0 -0.23 4 4
Regulation of Telomerase

Figure S82.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S82.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Telomerase catalytic core complex -0.05 0.2 -10000 0 -0.88 7 7
RAD9A 0.037 0.005 -10000 0 -10000 0 0
AP1 -0.058 0.16 -10000 0 -0.34 45 45
IFNAR2 0.035 0.019 -10000 0 -0.19 1 1
AKT1 0.022 0.05 -10000 0 -0.42 2 2
ER alpha/Oestrogen 0.02 0.05 -10000 0 -0.34 4 4
NFX1/SIN3/HDAC complex 0.042 0.065 -10000 0 -0.26 2 2
EGF -0.086 0.18 -10000 0 -0.3 78 78
SMG5 0.036 0.016 -10000 0 -0.19 1 1
SMG6 0.03 0.015 -10000 0 -10000 0 0
SP3/HDAC2 0.053 0.032 -10000 0 -0.34 1 1
TERT/c-Abl -0.039 0.2 -10000 0 -0.83 7 7
SAP18 0.028 0.017 -10000 0 -10000 0 0
MRN complex 0.058 0.046 -10000 0 -0.29 2 2
WT1 -0.19 0.22 -10000 0 -0.34 127 127
WRN 0.029 0.016 -10000 0 -10000 0 0
SP1 0.037 0.02 -10000 0 -0.18 1 1
SP3 0.038 0.003 -10000 0 -10000 0 0
TERF2IP 0.037 0.006 -10000 0 -10000 0 0
Telomerase/Nucleolin -0.025 0.19 -10000 0 -0.75 7 7
Mad/Max 0.044 0.044 -10000 0 -0.34 1 1
TERT -0.052 0.21 -10000 0 -0.93 7 7
CCND1 -0.051 0.2 -10000 0 -1.1 5 5
MAX 0.034 0.012 -10000 0 -10000 0 0
RBBP7 0.035 0.022 -10000 0 -0.19 2 2
RBBP4 0.031 0.044 -10000 0 -0.26 4 4
TERF2 0.032 0.033 -10000 0 -0.41 1 1
PTGES3 0.037 0.004 -10000 0 -10000 0 0
SIN3A 0.034 0.018 -10000 0 -0.19 1 1
Telomerase/911 0.046 0.055 -10000 0 -0.32 1 1
CDKN1B -0.074 0.15 -10000 0 -0.32 41 41
RAD1 0.033 0.038 -10000 0 -0.33 2 2
XRCC5 0.038 0.003 -10000 0 -10000 0 0
XRCC6 0.035 0.01 -10000 0 -10000 0 0
SAP30 0.034 0.035 -10000 0 -0.47 1 1
TRF2/PARP2 0.044 0.043 -10000 0 -0.32 2 2
UBE3A 0.035 0.01 -10000 0 -10000 0 0
JUN -0.015 0.15 -10000 0 -0.39 26 26
E6 0 0.002 -10000 0 -10000 0 0
HPV-16 E6/E6AP 0.027 0.01 -10000 0 -10000 0 0
FOS -0.054 0.16 -10000 0 -0.3 56 56
IFN-gamma/IRF1 -0.067 0.17 -10000 0 -0.33 54 54
PARP2 0.031 0.039 -10000 0 -0.33 2 2
BLM 0.023 0.077 -10000 0 -0.47 5 5
Telomerase 0.008 0.12 -10000 0 -0.51 5 5
IRF1 0.005 0.11 -10000 0 -0.27 24 24
ESR1 0.027 0.069 -10000 0 -0.47 4 4
KU/TER 0.052 0.015 -10000 0 -10000 0 0
ATM/TRF2 0.046 0.043 -10000 0 -0.27 2 2
ubiquitin-dependent protein catabolic process 0.036 0.074 -10000 0 -0.3 2 2
HPV-16 E6/E6AP/NFX1/SIN3/HDAC complex 0.036 0.075 -10000 0 -0.31 2 2
HDAC1 0.036 0.008 -10000 0 -10000 0 0
HDAC2 0.034 0.037 -10000 0 -0.47 1 1
ATM 0.012 0.032 0.2 1 -0.38 1 2
SMAD3 0.012 0.039 -10000 0 -0.3 3 3
ABL1 0.037 0.005 -10000 0 -10000 0 0
MXD1 0.029 0.052 -10000 0 -0.22 8 8
MRE11A 0.037 0.006 -10000 0 -10000 0 0
HUS1 0.032 0.024 -10000 0 -0.19 2 2
RPS6KB1 0.035 0.009 -10000 0 -10000 0 0
TERT/NF kappa B1/14-3-3 -0.017 0.2 -10000 0 -0.94 5 5
NR2F2 0.033 0.018 -10000 0 -0.18 1 1
MAPK3 0.012 0.051 -10000 0 -0.34 4 4
MAPK1 0.018 0.009 -10000 0 -10000 0 0
TGFB1/TGF beta receptor Type II 0.035 0.017 -10000 0 -0.19 1 1
NFKB1 0.037 0.006 -10000 0 -10000 0 0
HNRNPC 0.032 0.036 -10000 0 -0.47 1 1
DNA damage response signal transduction by p53 class mediator resulting in induction of apoptosis 0.012 0.032 0.2 1 -0.38 1 2
NBN 0.03 0.037 -10000 0 -0.47 1 1
EGFR 0.018 0.086 -10000 0 -0.4 8 8
mol:Oestrogen 0 0.001 -10000 0 -10000 0 0
EGF/EGFR -0.048 0.14 -10000 0 -0.34 34 34
MYC 0.007 0.11 -10000 0 -0.47 10 10
IL2 0.038 0.013 -10000 0 -10000 0 0
KU 0.052 0.015 -10000 0 -10000 0 0
RAD50 0.032 0.049 -10000 0 -0.47 2 2
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
TGFB1 0.035 0.017 -10000 0 -0.19 1 1
TRF2/BLM 0.04 0.064 -10000 0 -0.32 6 6
FRAP1 0 0 -10000 0 -10000 0 0
KU/TERT -0.027 0.2 -10000 0 -0.82 7 7
SP1/HDAC2 0.053 0.036 -10000 0 -0.34 1 1
PINX1 0.025 0.04 -10000 0 -0.33 2 2
Telomerase/EST1A -0.026 0.18 -10000 0 -0.72 7 7
Smad3/Myc 0.012 0.077 -10000 0 -0.3 11 11
911 complex 0.061 0.041 -10000 0 -0.29 1 1
IFNG -0.096 0.19 -10000 0 -0.3 85 85
Telomerase/PinX1 -0.032 0.18 -10000 0 -0.73 7 7
Telomerase/AKT1/mTOR/p70S6K 0.002 0.13 0.29 1 -0.53 6 7
SIN3B 0.037 0.005 -10000 0 -10000 0 0
YWHAE 0.03 0.015 -10000 0 -10000 0 0
Telomerase/EST1B -0.02 0.18 -10000 0 -0.72 7 7
response to DNA damage stimulus 0.002 0.025 -10000 0 -0.13 1 1
MRN complex/TRF2/Rap1 0.082 0.06 -10000 0 -0.25 3 3
TRF2/WRN 0.04 0.035 -10000 0 -0.32 1 1
Telomerase/hnRNP C1/C2 -0.021 0.18 -10000 0 -0.72 7 7
E2F1 0.017 0.051 -10000 0 -0.47 2 2
ZNFX1 0.02 0.019 -10000 0 -10000 0 0
PIF1 0.033 0.036 -10000 0 -0.47 1 1
NCL 0.028 0.069 -10000 0 -0.47 4 4
DKC1 0.036 0.016 -10000 0 -0.19 1 1
telomeric DNA binding 0 0 -10000 0 -10000 0 0
Insulin Pathway

Figure S83.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S83.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CBL/APS/CAP 0.027 0.11 -10000 0 -0.27 22 22
TC10/GTP 0.014 0.082 -10000 0 -0.23 17 17
Insulin Receptor/Insulin/IRS1/Shp2 0.08 0.11 -10000 0 -0.37 8 8
HRAS 0.034 0.038 -10000 0 -0.33 2 2
APS homodimer 0 0 -10000 0 -10000 0 0
GRB14 -0.16 0.21 -10000 0 -0.34 114 114
FOXO3 -0.029 0.16 -10000 0 -0.73 9 9
AKT1 -0.077 0.12 -10000 0 -0.4 8 8
INSR 0.038 0.075 -10000 0 -0.37 6 6
Insulin Receptor/Insulin 0.086 0.11 -10000 0 -0.42 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
GRB10 -0.003 0.13 -10000 0 -0.41 18 18
SORBS1 -0.016 0.14 -10000 0 -0.34 29 29
CRK 0.03 0.015 -10000 0 -10000 0 0
PTPN1 0.002 0.065 -10000 0 -0.47 3 3
CAV1 0.02 0.085 0.2 2 -0.28 10 12
CBL/APS/CAP/Crk-II/C3G 0.033 0.095 -10000 0 -0.25 16 16
Insulin Receptor/Insulin/IRS1/NCK2 0.084 0.096 -10000 0 -0.31 8 8
mol:GDP 0 0 -10000 0 -10000 0 0
mol:PI-3-4-5-P3 0.059 0.091 -10000 0 -0.29 10 10
Insulin Receptor/Insuli/IRS1/GRB2/SHC/PTP1B 0.063 0.12 -10000 0 -0.51 5 5
RPS6KB1 -0.075 0.11 -10000 0 -0.37 8 8
PARD6A 0.011 0.11 -10000 0 -0.37 14 14
CBL 0.037 0.006 -10000 0 -10000 0 0
tumor necrosis factor-mediated signaling pathway 0 0 -10000 0 -10000 0 0
DOK1 0.026 0.061 -10000 0 -0.82 1 1
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
Insulin Receptor/Insuli/IRS1/GRB2/Shc -0.051 0.13 -10000 0 -0.37 8 8
HRAS/GTP 0.013 0.062 -10000 0 -0.3 5 5
Insulin Receptor 0.038 0.075 -10000 0 -0.37 6 6
Insulin Receptor/Insuli/IRS1/GRB2/SHC 0.095 0.095 -10000 0 -0.29 8 8
PRKCI 0.009 0.1 -10000 0 -0.56 4 4
Insulin Receptor/Insulin/GRB14/PDK1 -0.066 0.14 -10000 0 -0.27 41 41
SHC1 0.037 0.006 -10000 0 -10000 0 0
negative regulation of MAPKKK cascade 0.049 0.087 -10000 0 -0.54 3 3
PI3K 0.077 0.097 -10000 0 -0.3 10 10
NCK2 0.038 0 -10000 0 -10000 0 0
RHOQ 0.033 0.041 -10000 0 -0.28 3 3
mol:H2O2 0.001 0.009 -10000 0 -10000 0 0
HRAS/GDP 0.025 0.027 -10000 0 -0.23 2 2
AKT2 -0.074 0.12 -10000 0 -0.4 8 8
PRKCZ -0.005 0.076 -10000 0 -0.42 4 4
SH2B2 0 0 -10000 0 -10000 0 0
SHC/SHIP 0.027 0.073 0.18 1 -0.28 8 9
F2RL2 0.016 0.1 -10000 0 -0.47 9 9
TRIP10 0.037 0.004 -10000 0 -10000 0 0
Insulin Receptor/Insulin/Shc 0.074 0.055 -10000 0 -0.24 3 3
TC10/GTP/CIP4/Exocyst 0.046 0.028 -10000 0 -0.29 1 1
Insulin Receptor/Insulin/SHC/GRB2/Sos1 0.11 0.062 -10000 0 -0.25 2 2
RAPGEF1 0.036 0.016 -10000 0 -0.19 1 1
RASA1 0.026 0.07 -10000 0 -0.41 5 5
NCK1 0.028 0.069 -10000 0 -0.47 4 4
CBL/APS/CAP/Crk-II 0.022 0.092 -10000 0 -0.26 16 16
TC10/GDP 0.024 0.029 -10000 0 -0.19 3 3
Insulin Receptor/Insulin/SHC/GRB10 0.061 0.11 -10000 0 -0.27 14 14
INPP5D -0.003 0.065 -10000 0 -0.29 8 8
SOS1 0.038 0.003 -10000 0 -10000 0 0
SGK1 -0.01 0.011 -10000 0 -10000 0 0
mol:cAMP 0 0 -10000 0 -10000 0 0
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
IRS1 0.017 0.094 -10000 0 -0.37 11 11
p62DOK/RasGAP 0.05 0.088 -10000 0 -0.55 3 3
INS 0.046 0.023 -10000 0 -10000 0 0
mol:PI-3-4-P2 -0.003 0.064 -10000 0 -0.29 8 8
GRB2 0.036 0.007 -10000 0 -10000 0 0
EIF4EBP1 -0.075 0.11 -10000 0 -0.37 9 9
PTPRA 0.033 0.044 -10000 0 -0.5 1 1
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
TC10/GTP/CIP4 0.046 0.028 -10000 0 -0.29 1 1
PDPK1 0.033 0.038 -10000 0 -0.33 2 2
Insulin Receptor/Insuli/IRS1/GRB2/SHC/Sos 0.036 0.072 -10000 0 -0.33 5 5
Insulin Receptor/Insulin/IRS1 0.063 0.088 -10000 0 -0.31 8 8
Insulin Receptor/Insulin/IRS3 0.064 0.061 -10000 0 -0.34 3 3
Par3/Par6 0.048 0.1 -10000 0 -0.25 19 19
VEGFR1 specific signals

Figure S84.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S84.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
VEGFR1 homodimer/VEGFB homodimer 0.009 0.095 -10000 0 -0.57 4 4
VEGFR1 homodimer/NRP1 -0.005 0.087 -10000 0 -0.49 5 5
mol:DAG 0.008 0.098 -10000 0 -0.53 4 4
VEGFR1 homodimer/NRP1/VEGFR 121 0.011 0.085 -10000 0 -0.62 3 3
CaM/Ca2+ 0.017 0.097 -10000 0 -0.51 4 4
HIF1A 0.025 0.067 -10000 0 -0.31 5 5
GAB1 0.03 0.053 -10000 0 -0.33 4 4
AKT1 0.027 0.12 0.33 1 -0.48 5 6
PLCG1 0.008 0.098 -10000 0 -0.54 4 4
NOS3 0.075 0.14 0.3 25 -0.48 5 30
CBL 0.037 0.006 -10000 0 -10000 0 0
mol:NO 0.081 0.14 0.31 28 -0.46 5 33
FLT1 -0.004 0.1 -10000 0 -0.56 5 5
PGF 0.025 0.043 -10000 0 -0.19 8 8
VEGFR1 homodimer/NRP2/VEGFR121 0.024 0.096 -10000 0 -0.48 5 5
CALM1 0.033 0.012 -10000 0 -10000 0 0
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
eNOS/Hsp90 0.095 0.14 0.32 27 -0.48 4 31
endothelial cell proliferation 0.075 0.15 0.33 27 -0.62 3 30
mol:Ca2+ 0.008 0.097 -10000 0 -0.53 4 4
MAPK3 -0.004 0.1 0.29 3 -0.57 3 6
MAPK1 -0.003 0.092 0.3 2 -0.55 3 5
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
PLGF homodimer 0.025 0.043 -10000 0 -0.19 8 8
PRKACA 0.037 0.006 -10000 0 -10000 0 0
RP11-342D11.1 0 0 -10000 0 -10000 0 0
CAV1 0.025 0.061 -10000 0 -0.26 8 8
VEGFA homodimer 0.037 0.006 -10000 0 -10000 0 0
VEGFR1 homodimer/VEGFA homodimer 0.012 0.092 -10000 0 -0.67 3 3
platelet activating factor biosynthetic process 0.058 0.15 0.33 25 -0.56 3 28
PI3K 0.07 0.12 -10000 0 -0.51 4 4
PRKCA 0.001 0.093 -10000 0 -0.5 4 4
PRKCB 0.002 0.09 -10000 0 -0.5 4 4
VEGFR1 homodimer/PLGF homodimer 0.01 0.096 -10000 0 -0.58 4 4
VEGFA 0.037 0.006 -10000 0 -10000 0 0
VEGFB 0.034 0.035 -10000 0 -0.47 1 1
mol:IP3 0.008 0.098 -10000 0 -0.53 4 4
RASA1 0.035 0.13 -10000 0 -0.43 7 7
NRP2 0.031 0.046 -10000 0 -0.24 5 5
VEGFR1 homodimer -0.004 0.1 -10000 0 -0.56 5 5
VEGFB homodimer 0.034 0.035 -10000 0 -0.47 1 1
NCK1 0.028 0.069 -10000 0 -0.47 4 4
eNOS/Caveolin-1 0.081 0.14 0.3 22 -0.44 6 28
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
mol:PI-3-4-5-P3 0.067 0.12 -10000 0 -0.5 4 4
mol:L-citrulline 0.081 0.14 0.31 28 -0.46 5 33
VEGFR1 homodimer/VEGFA homodimer/CBL/CD2AP 0.08 0.11 -10000 0 -0.59 3 3
VEGFR1 homodimer/VEGFA homodimer/NCK1 0.022 0.097 -10000 0 -0.48 5 5
CD2AP 0.035 0.035 -10000 0 -0.47 1 1
PI3K/GAB1 0.078 0.13 -10000 0 -0.55 4 4
PDPK1 0.03 0.12 0.35 1 -0.5 4 5
VEGFR1 homodimer/VEGFA homodimer/SHP2 0.024 0.096 -10000 0 -0.48 5 5
mol:NADP 0.081 0.14 0.31 28 -0.46 5 33
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
ubiquitin-dependent protein catabolic process 0.077 0.11 -10000 0 -0.58 3 3
VEGFR1 homodimer/NRP2 0.009 0.097 -10000 0 -0.52 5 5
PDGFR-beta signaling pathway

Figure S85.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S85.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
S1P1/Sphingosine-1-phosphate 0.055 0.15 0.26 6 -0.33 10 16
PDGFB-D/PDGFRB/SLAP 0.031 0.066 -10000 0 -0.19 13 13
PDGFB-D/PDGFRB/APS/CBL 0.048 0.025 -10000 0 -0.28 1 1
AKT1 0.038 0.12 0.32 5 -10000 0 5
mol:PI-4-5-P2 0 0.001 -10000 0 -10000 0 0
mol:Sphingosine-1-phosphate 0.058 0.15 0.27 3 -0.36 10 13
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
FGR -0.003 0.16 0.3 1 -0.58 11 12
mol:Ca2+ 0.054 0.13 0.26 1 -0.35 5 6
MYC 0.047 0.26 0.39 26 -0.72 13 39
SHC1 0.037 0.006 -10000 0 -10000 0 0
HRAS/GDP 0.066 0.084 -10000 0 -0.24 2 2
LRP1/PDGFRB/PDGFB 0.066 0.037 -10000 0 -0.28 1 1
GRB10 -0.003 0.13 -10000 0 -0.41 18 18
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
GO:0007205 0.053 0.14 0.26 1 -0.36 5 6
PTEN 0.031 0.049 -10000 0 -0.47 2 2
GRB2 0.036 0.007 -10000 0 -10000 0 0
GRB7 0.03 0.049 -10000 0 -0.47 2 2
PDGFB-D/PDGFRB/SHP2 0.048 0.049 -10000 0 -0.34 3 3
PDGFB-D/PDGFRB/GRB10 0.019 0.1 -10000 0 -0.34 15 15
cell cycle arrest 0.031 0.066 -10000 0 -0.19 13 13
HRAS 0.034 0.038 -10000 0 -0.33 2 2
HIF1A 0.03 0.11 0.3 5 -0.26 1 6
GAB1 0.022 0.16 -10000 0 -0.39 14 14
mol:GTP 0 0 -10000 0 -10000 0 0
DNM2 0.038 0.16 0.27 4 -0.4 8 12
PDGFB-D/PDGFRB 0.027 0.051 -10000 0 -0.29 2 2
mol:GDP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/LMW-PTP 0.054 0.028 -10000 0 -0.34 1 1
S1P1/Sphingosine-1-phosphate/PDGFB-D/PDGFRB -0.014 0.1 -10000 0 -0.34 11 11
positive regulation of MAPKKK cascade 0.048 0.049 -10000 0 -0.34 3 3
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:IP3 0.054 0.14 0.26 1 -0.36 5 6
E5 -0.001 0.001 -10000 0 -10000 0 0
CSK 0.033 0.01 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/GRB7 0.046 0.049 -10000 0 -0.34 3 3
SHB 0.035 0.022 -10000 0 -0.19 2 2
BLK -0.052 0.19 0.32 1 -0.46 34 35
PTPN2 0.031 0.017 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/SNX15 0.052 0.031 -10000 0 -0.34 1 1
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
VAV2 0.023 0.19 0.29 6 -0.45 12 18
CBL 0.037 0.006 -10000 0 -10000 0 0
PDGFB-D/PDGFRB/DEP1 0.05 0.041 -10000 0 -0.34 2 2
LCK -0.029 0.19 0.3 1 -0.53 22 23
PDGFRB 0.036 0.035 -10000 0 -0.47 1 1
ACP1 0.038 0 -10000 0 -10000 0 0
HCK -0.038 0.18 -10000 0 -0.63 15 15
ABL1 0.023 0.17 0.27 1 -0.39 15 16
PDGFB-D/PDGFRB/CBL 0.011 0.17 -10000 0 -0.43 14 14
PTPN1 0.015 0.051 -10000 0 -0.47 2 2
SNX15 0.036 0.016 -10000 0 -0.19 1 1
STAT3 0.037 0.006 -10000 0 -10000 0 0
STAT1 0.019 0.062 -10000 0 -0.19 18 18
cell proliferation 0.052 0.24 0.38 28 -0.63 13 41
SLA 0.015 0.074 -10000 0 -0.26 12 12
actin cytoskeleton reorganization 0.094 0.097 0.35 4 -10000 0 4
SRC -0.001 0.096 -10000 0 -0.69 3 3
PI3K -0.014 0.062 -10000 0 -0.23 12 12
PDGFB-D/PDGFRB/GRB7/SHC 0.063 0.048 -10000 0 -0.29 3 3
SH2B2 0 0 -10000 0 -10000 0 0
PLCgamma1/SPHK1 0.059 0.16 0.27 2 -0.37 10 12
LYN 0.015 0.097 0.3 1 -0.56 3 4
LRP1 0.037 0.004 -10000 0 -10000 0 0
SOS1 0.038 0.003 -10000 0 -10000 0 0
STAT5B 0.036 0.007 -10000 0 -10000 0 0
STAT5A 0.03 0.046 -10000 0 -0.24 5 5
NCK1-2/p130 Cas 0.043 0.066 -10000 0 -0.24 2 2
SPHK1 -0.028 0.15 -10000 0 -0.31 42 42
EDG1 0.003 0.005 -10000 0 -10000 0 0
mol:DAG 0.054 0.14 0.26 1 -0.36 5 6
PLCG1 0.054 0.14 0.26 1 -0.37 5 6
NHERF/PDGFRB 0.042 0.094 -10000 0 -0.29 14 14
YES1 -0.036 0.22 0.3 1 -0.57 26 27
cell migration 0.041 0.094 -10000 0 -0.29 14 14
SHC/Grb2/SOS1 0.043 0.064 -10000 0 -0.24 2 2
SLC9A3R2 0.008 0.11 -10000 0 -0.39 14 14
SLC9A3R1 0.028 0.062 -10000 0 -0.4 4 4
NHERF1-2/PDGFRB/PTEN 0.052 0.1 -10000 0 -0.26 16 16
FYN -0.017 0.17 0.29 1 -0.6 14 15
DOK1 0.061 0.09 -10000 0 -0.26 3 3
HRAS/GTP 0.025 0.027 -10000 0 -0.23 2 2
PDGFB 0.033 0.024 -10000 0 -0.19 2 2
RAC1 0.033 0.21 0.36 17 -0.44 18 35
PRKCD 0.063 0.089 -10000 0 -0.26 2 2
FER 0.058 0.092 -10000 0 -0.26 2 2
MAPKKK cascade 0.072 0.11 0.3 11 -10000 0 11
RASA1 0.061 0.089 -10000 0 -0.26 2 2
NCK1 0.028 0.069 -10000 0 -0.47 4 4
NCK2 0.038 0 -10000 0 -10000 0 0
p62DOK/Csk 0.076 0.086 0.34 1 -0.25 3 4
PDGFB-D/PDGFRB/SHB 0.051 0.034 -10000 0 -0.34 1 1
chemotaxis 0.023 0.16 0.24 4 -0.38 15 19
STAT1-3-5/STAT1-3-5 0.02 0.067 -10000 0 -0.24 1 1
Bovine Papilomavirus E5/PDGFRB 0.025 0.026 -10000 0 -0.33 1 1
PTPRJ 0.034 0.038 -10000 0 -0.33 2 2
ErbB4 signaling events

Figure S86.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S86.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ErbB4/ErbB4/HBEGF/HBEGF 0.043 0.097 -10000 0 -0.61 1 1
epithelial cell differentiation 0.012 0.12 -10000 0 -0.49 3 3
ITCH 0.024 0.023 -10000 0 -10000 0 0
WWP1 0.006 0.1 -10000 0 -1.3 1 1
FYN 0.011 0.098 -10000 0 -0.32 15 15
EGFR 0.018 0.086 -10000 0 -0.4 8 8
PRL 0.035 0.022 -10000 0 -0.19 2 2
neuron projection morphogenesis 0.028 0.075 0.28 1 -0.44 1 2
PTPRZ1 0.009 0.1 -10000 0 -0.33 16 16
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/GRB2/SHC 0.06 0.083 -10000 0 -0.47 1 1
ErbB4 CYT2/ErbB4 CYT2/neuregulin 1 beta/neuregulin 1 beta 0.033 0.068 -10000 0 -0.43 2 2
ADAM17 0.032 0.038 -10000 0 -0.47 1 1
ErbB4/ErbB4 0.009 0.064 -10000 0 -0.67 1 1
ErbB4/ErbB4/neuregulin 3/neuregulin 3 0.057 0.084 -10000 0 -0.61 1 1
NCOR1 0.029 0.016 -10000 0 -10000 0 0
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta/Fyn 0.034 0.088 -10000 0 -0.42 3 3
GRIN2B 0.014 0.086 -10000 0 -0.38 4 4
ErbB4/ErbB2/betacellulin 0.038 0.1 -10000 0 -0.52 2 2
STAT1 0.019 0.062 -10000 0 -0.19 18 18
HBEGF -0.003 0.12 -10000 0 -0.3 26 26
PRLR 0.006 0.12 -10000 0 -0.43 14 14
E4ICDs/ETO2 0.011 0.12 -10000 0 -0.61 1 1
axon guidance -0.001 0.086 -10000 0 -0.57 2 2
NEDD4 0.004 0.1 -10000 0 -0.38 13 13
Prolactin receptor/Prolactin receptor/Prolactin 0.028 0.094 -10000 0 -0.35 12 12
CBFA2T3 -0.061 0.17 -10000 0 -0.3 62 62
ErbB4/ErbB2/HBEGF 0.041 0.092 -10000 0 -0.37 3 3
MAPK3 0.029 0.075 0.27 1 -0.45 1 2
STAT1 (dimer) 0.055 0.082 -10000 0 -0.6 1 1
MAPK1 0.034 0.067 -10000 0 -0.45 1 1
JAK2 0.019 0.075 -10000 0 -0.25 13 13
ErbB4/ErbB2/neuregulin 1 beta 0.029 0.074 -10000 0 -0.37 3 3
NRG1 0.009 0.044 -10000 0 -0.34 3 3
NRG3 0.026 0.07 -10000 0 -0.41 5 5
NRG2 0.03 0.053 -10000 0 -0.33 4 4
NRG4 0.019 0.069 -10000 0 -0.23 13 13
heart development -0.001 0.086 -10000 0 -0.57 2 2
neural crest cell migration 0.029 0.073 -10000 0 -0.37 3 3
ERBB2 0.013 0.043 -10000 0 -0.34 3 3
WWOX/E4ICDs 0.059 0.077 -10000 0 -0.61 1 1
SHC1 0.037 0.006 -10000 0 -10000 0 0
ErbB4/EGFR/neuregulin 4 0.051 0.1 -10000 0 -0.86 1 1
apoptosis -0.012 0.11 0.41 4 -10000 0 4
ErbB4/ErbB4/neuregulin 2 beta/neuregulin 2 beta 0.059 0.08 -10000 0 -0.61 1 1
ErbB4/ErbB2/epiregulin -0.038 0.15 -10000 0 -0.34 10 10
ErbB4/ErbB4/betacellulin/betacellulin 0.042 0.1 -10000 0 -0.58 2 2
ErbB4/ErbB4/HBEGF/HBEGF/Prolactin receptor/Prolactin receptor/Prolactin/JAK2 0.059 0.13 -10000 0 -0.39 4 4
MDM2 0.004 0.056 -10000 0 -0.61 1 1
ErbB4 JM-B/ErbB4 JM-B/neuregulin 1 beta/neuregulin 1 beta 0.014 0.054 -10000 0 -0.35 2 2
STAT5A 0.009 0.09 -10000 0 -0.76 1 1
ErbB4/EGFR/neuregulin 1 beta 0.032 0.089 -10000 0 -0.52 2 2
DLG4 0.03 0.015 -10000 0 -10000 0 0
GRB2/SHC 0.052 0.014 -10000 0 -10000 0 0
E4ICDs/TAB2/NCoR1 0.043 0.068 -10000 0 -0.56 1 1
STAT5A (dimer) 0.024 0.14 -10000 0 -0.53 3 3
MAP3K7IP2 0 0 -10000 0 -10000 0 0
STAT5B (dimer) 0.034 0.096 -10000 0 -0.76 1 1
LRIG1 -0.015 0.15 -10000 0 -0.44 23 23
EREG -0.17 0.22 -10000 0 -0.36 113 113
BTC -0.001 0.12 -10000 0 -0.37 20 20
ErbB4/ErbB4/neuregulin 1 beta/neuregulin 1 beta -0.003 0.084 -10000 0 -0.58 2 2
ERBB4 0.009 0.064 -10000 0 -0.67 1 1
STAT5B 0.036 0.007 -10000 0 -10000 0 0
YAP1 0.005 0.079 -10000 0 -0.47 5 5
GRB2 0.036 0.007 -10000 0 -10000 0 0
ErbB4/ErbB2/neuregulin 4 0.048 0.082 -10000 0 -0.44 2 2
glial cell differentiation -0.042 0.067 0.55 1 -10000 0 1
WWOX 0.034 0.035 -10000 0 -0.47 1 1
cell proliferation 0.002 0.12 -10000 0 -0.62 2 2
Lissencephaly gene (LIS1) in neuronal migration and development

Figure S87.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S87.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
DYNC1H1 0.033 0.012 -10000 0 -10000 0 0
VLDLR -0.076 0.19 -10000 0 -0.36 61 61
LRPAP1 0.036 0.007 -10000 0 -10000 0 0
NUDC 0.034 0.011 -10000 0 -10000 0 0
RELN/LRP8 0.051 0.075 -10000 0 -0.29 8 8
CaM/Ca2+ 0.024 0.009 -10000 0 -10000 0 0
KATNA1 0.036 0.008 -10000 0 -10000 0 0
GO:0030286 0 0 -10000 0 -10000 0 0
ABL1 0.016 0.068 -10000 0 -0.26 8 8
IQGAP1/CaM 0.046 0.021 -10000 0 -10000 0 0
DAB1 0.037 0.006 -10000 0 -10000 0 0
IQGAP1 0.035 0.01 -10000 0 -10000 0 0
PLA2G7 -0.041 0.17 -10000 0 -0.36 42 42
CALM1 0.033 0.012 -10000 0 -10000 0 0
DYNLT1 0.036 0.008 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
LRPAP1/LRP8 0.036 0.077 -10000 0 -0.34 8 8
UniProt:Q4QZ09 0 0 -10000 0 -10000 0 0
CLIP1 0.029 0.061 -10000 0 -0.4 4 4
CDK5R1 0.036 0.008 -10000 0 -10000 0 0
LIS1/Poliovirus Protein 3A 0.01 0.007 -10000 0 -10000 0 0
CDK5R2 0.038 0.003 -10000 0 -10000 0 0
mol:PP1 0 0 -10000 0 -10000 0 0
RELN/VLDLR/DAB1 -0.01 0.13 -10000 0 -0.29 33 33
YWHAE 0.03 0.015 -10000 0 -10000 0 0
NDEL1/14-3-3 E 0.033 0.082 0.33 8 -10000 0 8
MAP1B 0.005 0.016 0.17 1 -10000 0 1
RAC1 0.012 0.011 -10000 0 -10000 0 0
p35/CDK5 0.017 0.054 -10000 0 -0.24 8 8
RELN 0.035 0.017 -10000 0 -0.19 1 1
PAFAH/LIS1 -0.013 0.099 -10000 0 -0.28 22 22
LIS1/CLIP170 0.025 0.036 -10000 0 -0.27 2 2
LIS1/NDEL1/Katanin 60/Dynein Light chain/Dynein heavy chain 0.019 0.061 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1/PAFAH1B2/PAFAH1B3 -0.016 0.12 -10000 0 -0.32 9 9
GO:0005869 0 0 -10000 0 -10000 0 0
NDEL1 0.016 0.078 0.33 7 -0.28 3 10
LIS1/IQGAP1 0.027 0.02 -10000 0 -10000 0 0
RHOA 0.014 0.01 -10000 0 -10000 0 0
PAFAH1B1 0.013 0.009 -10000 0 -10000 0 0
PAFAH1B3 0.034 0.035 -10000 0 -0.47 1 1
PAFAH1B2 0.032 0.041 -10000 0 -0.28 3 3
MAP1B/LIS1/Dynein heavy chain 0.018 0.041 -10000 0 -0.22 1 1
NDEL1/Katanin 60/Dynein heavy chain 0.032 0.087 0.34 5 -10000 0 5
LRP8 0.015 0.099 -10000 0 -0.39 11 11
NDEL1/Katanin 60 0.02 0.086 0.34 6 -10000 0 6
P39/CDK5 0.019 0.056 -10000 0 -10000 0 0
LIS1/NudC/Dynein intermediate chain/microtubule organizing center 0.027 0.02 -10000 0 -10000 0 0
CDK5 -0.02 0.05 0.19 2 -0.25 8 10
PPP2R5D 0.036 0.016 -10000 0 -0.19 1 1
LIS1/CLIP170/Dynein Complex/Dynactin Complex 0.021 0.032 -10000 0 -0.23 2 2
CSNK2A1 0.029 0.016 -10000 0 -10000 0 0
RELN/VLDLR/DAB1/LIS1 0.004 0.12 -10000 0 -0.25 30 30
RELN/VLDLR -0.009 0.14 -10000 0 -0.26 41 41
CDC42 0.013 0.013 -10000 0 -10000 0 0
Class I PI3K signaling events mediated by Akt

Figure S88.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S88.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.011 0.01 -10000 0 -10000 0 0
BAD/BCL-XL/YWHAZ 0.033 0.035 -10000 0 -10000 0 0
CDKN1B 0.024 0.087 0.26 1 -0.37 6 7
CDKN1A 0.021 0.087 -10000 0 -0.37 6 6
FRAP1 0 0 -10000 0 -10000 0 0
PRKDC 0.032 0.02 -10000 0 -0.19 1 1
FOXO3 0.024 0.086 -10000 0 -0.39 6 6
AKT1 0.026 0.086 -10000 0 -0.39 6 6
BAD 0.036 0.016 -10000 0 -0.19 1 1
AKT3 0.014 0.037 -10000 0 -0.27 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
FOXO4 0.025 0.083 -10000 0 -0.37 6 6
AKT1/ASK1 0.032 0.12 -10000 0 -0.38 9 9
BAD/YWHAZ 0.059 0.033 -10000 0 -10000 0 0
RICTOR 0.035 0.017 -10000 0 -0.19 1 1
RAF1 0.037 0.006 -10000 0 -10000 0 0
JNK cascade -0.031 0.12 0.36 9 -10000 0 9
TSC1 0.024 0.084 -10000 0 -0.37 6 6
YWHAZ 0.031 0.014 -10000 0 -10000 0 0
AKT1/RAF1 0.047 0.12 -10000 0 -0.37 6 6
EP300 0.017 0.091 -10000 0 -0.43 8 8
mol:GDP 0.026 0.085 -10000 0 -0.38 6 6
mol:PI-3-4-5-P3 0 0 -10000 0 -10000 0 0
TSC2 0.025 0.083 -10000 0 -0.37 6 6
YWHAQ 0.038 0 -10000 0 -10000 0 0
TBC1D4 0.059 0.12 0.24 54 -0.27 7 61
MAP3K5 0.015 0.09 -10000 0 -0.33 12 12
MAPKAP1 0.031 0.043 -10000 0 -0.26 4 4
negative regulation of cell cycle -0.047 0.11 0.32 6 -0.23 14 20
YWHAH 0.033 0.036 -10000 0 -0.47 1 1
AKT1S1 0.028 0.083 0.27 2 -0.39 5 7
CASP9 0.027 0.074 -10000 0 -0.41 4 4
YWHAB 0.015 0.051 -10000 0 -0.47 2 2
p27Kip1/KPNA1 0.044 0.12 0.36 3 -0.5 2 5
GBL 0 0 -10000 0 -10000 0 0
PDK1/Src/Hsp90 0.032 0.058 -10000 0 -0.28 4 4
YWHAE 0.03 0.015 -10000 0 -10000 0 0
SRC 0.013 0.06 -10000 0 -0.47 3 3
AKT2/p21CIP1 0.011 0.095 -10000 0 -0.54 2 2
KIAA1303 0 0 -10000 0 -10000 0 0
mTOR/RHEB/GTP/Raptor/GBL 0.021 0.032 -10000 0 -10000 0 0
CHUK 0.026 0.073 -10000 0 -0.34 5 5
BAD/BCL-XL 0.018 0.086 -10000 0 -0.5 2 2
mTORC2 0.041 0.03 -10000 0 -0.26 1 1
AKT2 0.018 0.023 -10000 0 -0.31 1 1
FOXO1-3a-4/14-3-3 family 0.054 0.15 0.34 10 -0.46 6 16
PDPK1 0.033 0.038 -10000 0 -0.33 2 2
MDM2 0.026 0.084 0.27 1 -0.37 6 7
MAPKKK cascade -0.047 0.11 0.36 6 -10000 0 6
MDM2/Cbp/p300 0.042 0.13 0.29 1 -0.42 4 5
TSC1/TSC2 0.019 0.08 -10000 0 -0.52 2 2
proteasomal ubiquitin-dependent protein catabolic process 0.039 0.12 0.28 1 -0.4 4 5
glucose import 0.026 0.1 0.21 37 -0.32 7 44
mTOR/RHEB/GDP/Raptor/GBL/PRAS40 0.028 0.055 0.19 2 -0.29 2 4
response to stress 0 0 -10000 0 -10000 0 0
SLC2A4 0.026 0.1 0.21 37 -0.32 7 44
GSK3A 0.029 0.084 0.27 2 -0.39 5 7
FOXO1 0.043 0.12 0.27 19 -0.39 5 24
GSK3B 0.027 0.085 0.27 1 -0.37 6 7
SFN 0.021 0.07 -10000 0 -0.28 9 9
G1/S transition of mitotic cell cycle 0.027 0.11 0.3 4 -0.52 2 6
p27Kip1/14-3-3 family 0.045 0.079 0.28 1 -0.38 2 3
PRKACA 0.037 0.006 -10000 0 -10000 0 0
KPNA1 0.037 0.006 -10000 0 -10000 0 0
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
YWHAG 0.036 0.008 -10000 0 -10000 0 0
RHEB 0.036 0.008 -10000 0 -10000 0 0
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
Signaling events mediated by HDAC Class III

Figure S89.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S89.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
EP300 0.017 0.091 -10000 0 -0.43 8 8
HDAC4 0.034 0.038 -10000 0 -0.33 2 2
induction of apoptosis 0 0 -10000 0 -10000 0 0
regulation of S phase of mitotic cell cycle -0.008 0.028 0.23 2 -0.12 2 4
CDKN1A -0.004 0.099 0.28 1 -0.61 4 5
KAT2B 0 0 -10000 0 -10000 0 0
BAX 0.034 0.027 -10000 0 -0.19 3 3
FOXO3 0.003 0.074 0.39 7 -0.22 1 8
FOXO1 0.008 0.093 -10000 0 -0.38 10 10
FOXO4 0.01 0.053 -10000 0 -0.26 8 8
response to UV 0 0 -10000 0 -10000 0 0
XRCC6 0.035 0.01 -10000 0 -10000 0 0
TAT 0.037 0.006 -10000 0 -10000 0 0
mol:Lysophosphatidic acid 0 0 -10000 0 -10000 0 0
MYOD1 -0.002 0.047 -10000 0 -0.34 2 2
PPARGC1A -0.032 0.16 -10000 0 -0.32 41 41
FHL2 0.02 0.087 -10000 0 -0.38 9 9
response to nutrient levels 0 0 -10000 0 -10000 0 0
KU70/SIRT1 0.047 0.035 -10000 0 -0.34 1 1
HIST2H4A 0.008 0.029 0.12 2 -0.23 2 4
SIRT1/FOXO3a 0.03 0.055 0.29 6 -0.16 1 7
SIRT1 0.033 0.042 0.22 1 -0.33 2 3
response to hypoxia 0 0 -10000 0 -10000 0 0
SIRT1/MEF2D/HDAC4 0.066 0.045 -10000 0 -0.29 2 2
SIRT1/Histone H1b 0.014 0.081 -10000 0 -0.26 12 12
apoptosis -0.061 0.043 0.29 1 -10000 0 1
SIRT1/PGC1A 0.001 0.1 -10000 0 -0.28 22 22
p53/SIRT1 -0.014 0.13 0.41 1 -0.34 28 29
SIRT1/FOXO4 0.021 0.07 0.21 1 -0.26 8 9
FOXO1/FHL2/SIRT1 0.028 0.084 -10000 0 -0.28 11 11
HIST1H1E 0.003 0.069 -10000 0 -0.27 12 12
SIRT1/p300 0.036 0.078 -10000 0 -0.38 6 6
muscle cell differentiation -0.01 0.047 0.26 3 -10000 0 3
TP53 -0.038 0.17 0.22 2 -0.45 30 32
KU70/SIRT1/BAX 0.061 0.043 -10000 0 -0.29 1 1
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
MEF2D 0.037 0.006 -10000 0 -10000 0 0
HIV-1 Tat/SIRT1 0.05 0.034 -10000 0 -0.34 1 1
ACSS2 0.003 0.06 0.36 1 -0.34 5 6
SIRT1/PCAF/MYOD 0.01 0.048 -10000 0 -0.26 3 3
TRAIL signaling pathway

Figure S90.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S90.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TNFSF10 0.017 0.09 -9999 0 -0.33 12 12
positive regulation of NF-kappaB transcription factor activity 0.019 0.081 -9999 0 -0.34 8 8
MAP2K4 0.011 0.057 -9999 0 -0.3 3 3
IKBKB 0.032 0.013 -9999 0 -10000 0 0
TNFRSF10B 0.019 0.058 -9999 0 -0.28 6 6
TNFRSF10A 0.02 0.056 -9999 0 -0.3 5 5
SMPD1 0.002 0.048 -9999 0 -0.2 8 8
IKBKG 0.036 0.016 -9999 0 -0.19 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
TNFRSF10D 0.02 0.051 -9999 0 -0.23 7 7
TRAIL/TRAILR2 0.018 0.083 -9999 0 -0.32 9 9
TRAIL/TRAILR3 -0.01 0.1 -9999 0 -0.33 14 14
TRAIL/TRAILR1 0.02 0.085 -9999 0 -0.38 7 7
TRAIL/TRAILR4 0.019 0.082 -9999 0 -0.34 8 8
TRAIL/TRAILR1/DAP3/GTP 0.032 0.077 -9999 0 -0.3 7 7
IKK complex 0.011 0.086 -9999 0 -0.47 3 3
RIPK1 0.037 0.006 -9999 0 -10000 0 0
response to oxidative stress 0 0 -9999 0 -10000 0 0
DAP3/GTP 0.027 0.005 -9999 0 -10000 0 0
MAPK3 -0.001 0.081 -9999 0 -0.36 9 9
MAP3K1 0.02 0.056 -9999 0 -0.35 2 2
TRAILR4 (trimer) 0.02 0.051 -9999 0 -0.23 7 7
TRADD 0.037 0.005 -9999 0 -10000 0 0
TRAILR1 (trimer) 0.02 0.056 -9999 0 -0.3 5 5
TRAIL/TRAILR1/FADD/TRADD/RIP/TRAF2 0.016 0.063 -9999 0 -0.27 6 6
CFLAR 0.038 0.003 -9999 0 -10000 0 0
MAPK1 0.006 0.058 -9999 0 -0.34 5 5
TRAIL/TRAILR1/FADD/TRADD/RIP 0.059 0.087 -9999 0 -0.29 6 6
mol:ceramide 0.002 0.048 -9999 0 -0.2 8 8
FADD 0.037 0.004 -9999 0 -10000 0 0
MAPK8 0.006 0.056 -9999 0 -0.32 1 1
TRAF2 0.036 0.016 -9999 0 -0.19 1 1
TRAILR3 (trimer) -0.018 0.11 -9999 0 -0.24 35 35
CHUK 0.031 0.049 -9999 0 -0.47 2 2
TRAIL/TRAILR1/FADD 0.035 0.083 -9999 0 -0.32 7 7
DAP3 0.037 0.006 -9999 0 -10000 0 0
CASP10 -0.005 0.072 -9999 0 -0.38 6 6
JNK cascade 0.019 0.081 -9999 0 -0.34 8 8
TRAIL (trimer) 0.017 0.09 -9999 0 -0.33 12 12
TNFRSF10C -0.018 0.11 -9999 0 -0.24 35 35
TRAIL/TRAILR1/DAP3/GTP/FADD 0.044 0.08 -9999 0 -0.28 7 7
TRAIL/TRAILR2/FADD 0.033 0.081 -9999 0 -0.27 9 9
cell death 0.002 0.048 -9999 0 -0.2 8 8
TRAIL/TRAILR2/FADD/TRADD/RIP/TRAF2 0.015 0.06 -9999 0 -0.23 7 7
TRAILR2 (trimer) 0.019 0.058 -9999 0 -0.28 6 6
CASP8 0.01 0.099 -9999 0 -0.8 3 3
negative regulation of caspase activity 0 0 -9999 0 -10000 0 0
TRAIL/TRAILR2/FADD/TRADD/RIP 0.057 0.086 -9999 0 -0.25 7 7
FoxO family signaling

Figure S91.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S91.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G6PC 0.016 0.17 0.54 1 -1.4 2 3
PLK1 0 0.2 -10000 0 -0.92 4 4
CDKN1B 0.041 0.17 0.47 2 -0.41 7 9
FOXO3 0.004 0.19 -10000 0 -0.58 13 13
KAT2B 0.003 0.017 -10000 0 -0.054 5 5
FOXO1/SIRT1 0.035 0.11 0.35 2 -0.39 4 6
CAT -0.011 0.23 -10000 0 -1 6 6
CTNNB1 0.018 0.081 -10000 0 -0.27 13 13
AKT1 0.029 0.041 -10000 0 -0.17 3 3
FOXO1 0.026 0.11 0.36 4 -0.39 3 7
MAPK10 0.026 0.088 0.2 21 -0.25 12 33
mol:GTP 0.001 0.002 -10000 0 -10000 0 0
FOXO4 0.036 0.12 0.33 5 -0.42 3 8
response to oxidative stress 0.006 0.018 -10000 0 -0.052 5 5
FOXO3A/SIRT1 0.026 0.18 -10000 0 -0.54 12 12
XPO1 0.038 0.001 -10000 0 -10000 0 0
EP300 0.019 0.092 -10000 0 -0.43 8 8
BCL2L11 0.038 0.03 -10000 0 -10000 0 0
FOXO1/SKP2 0.033 0.1 0.29 1 -0.36 2 3
mol:GDP 0.006 0.018 -10000 0 -0.052 5 5
RAN 0.038 0.004 -10000 0 -10000 0 0
GADD45A 0.02 0.23 -10000 0 -0.8 12 12
YWHAQ 0.038 0 -10000 0 -10000 0 0
FOXO1/14-3-3 family 0.043 0.15 0.32 4 -0.51 6 10
MST1 0.014 0.079 -10000 0 -0.22 16 16
CSNK1D 0.036 0.007 -10000 0 -10000 0 0
CSNK1E 0.027 0.062 -10000 0 -0.4 4 4
FOXO4/14-3-3 family -0.025 0.13 -10000 0 -0.4 15 15
YWHAB 0.015 0.051 -10000 0 -0.47 2 2
MAPK8 0.037 0.072 0.2 20 -0.26 5 25
MAPK9 0.037 0.078 0.2 21 -0.3 5 26
YWHAG 0.036 0.008 -10000 0 -10000 0 0
YWHAE 0.03 0.015 -10000 0 -10000 0 0
YWHAZ 0.031 0.014 -10000 0 -10000 0 0
SIRT1 0.033 0.041 -10000 0 -0.32 2 2
SOD2 0.03 0.2 0.57 1 -0.72 7 8
RBL2 0.037 0.15 -10000 0 -0.64 2 2
RAL/GDP 0.042 0.059 -10000 0 -0.3 5 5
CHUK 0.028 0.059 -10000 0 -0.48 2 2
Ran/GTP 0.029 0.008 -10000 0 -10000 0 0
CSNK1G2 0.037 0.006 -10000 0 -10000 0 0
RAL/GTP 0.044 0.057 -10000 0 -0.27 5 5
CSNK1G1 0.035 0.009 -10000 0 -10000 0 0
FASLG -0.076 0.38 -10000 0 -1.4 15 15
SKP2 0.024 0.068 -10000 0 -0.29 8 8
USP7 0.023 0.079 -10000 0 -0.39 7 7
IKBKB 0.029 0.032 -10000 0 -10000 0 0
CCNB1 -0.027 0.28 -10000 0 -1.1 10 10
FOXO1-3a-4/beta catenin 0.047 0.18 0.46 4 -0.41 9 13
proteasomal ubiquitin-dependent protein catabolic process 0.033 0.099 0.29 1 -0.35 2 3
CSNK1A1 0.037 0.005 -10000 0 -10000 0 0
SGK1 0.003 0.017 -10000 0 -0.054 5 5
CSNK1G3 0.037 0.006 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.054 0.01 -10000 0 -10000 0 0
ZFAND5 0.036 0.1 0.35 1 -10000 0 1
SFN 0.021 0.07 -10000 0 -0.28 9 9
CDK2 0.023 0.073 -10000 0 -0.26 11 11
FOXO3A/14-3-3 -0.018 0.12 -10000 0 -0.45 7 7
CREBBP 0.035 0.038 -10000 0 -0.47 1 1
FBXO32 0.001 0.31 -10000 0 -1.2 11 11
BCL6 0.003 0.26 -10000 0 -1.3 7 7
RALB 0.027 0.077 -10000 0 -0.47 5 5
RALA 0.034 0.012 -10000 0 -10000 0 0
YWHAH 0.033 0.036 -10000 0 -0.47 1 1
Retinoic acid receptors-mediated signaling

Figure S92.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S92.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.036 0.008 -10000 0 -10000 0 0
HDAC3 0.037 0.005 -10000 0 -10000 0 0
VDR 0.024 0.078 -10000 0 -0.42 6 6
Cbp/p300/PCAF 0.032 0.066 -10000 0 -0.29 8 8
EP300 0.017 0.091 -10000 0 -0.43 8 8
RARs/AIB1/Cbp/p300/PCAF/9cRA 0.003 0.064 -10000 0 -0.32 3 3
KAT2B 0 0 -10000 0 -10000 0 0
MAPK14 0.037 0.005 -10000 0 -10000 0 0
AKT1 0.041 0.09 0.21 27 -0.24 2 29
RAR alpha/9cRA/Cyclin H 0.054 0.077 -10000 0 -0.27 2 2
mol:9cRA 0 0 -10000 0 -10000 0 0
RARs/Src-1/Cbp/p300/PCAF/9cRA 0.015 0.077 0.2 2 -0.28 5 7
CDC2 0 0.001 -10000 0 -10000 0 0
response to UV 0.001 0.002 -10000 0 -10000 0 0
RAR alpha/Jnk1 0.037 0.049 -10000 0 -0.33 1 1
NCOR2 0.034 0.038 -10000 0 -0.33 2 2
VDR/VDR/Vit D3 0.018 0.056 -10000 0 -0.3 6 6
RXRs/RARs/NRIP1/9cRA 0.03 0.11 0.38 1 -0.5 4 5
NCOA2 0.028 0.05 -10000 0 -0.47 2 2
NCOA3 0.015 0.051 -10000 0 -0.47 2 2
NCOA1 0.028 0.069 -10000 0 -0.47 4 4
VDR/VDR/DNA 0.024 0.078 -10000 0 -0.42 6 6
RARG 0.031 0.053 -10000 0 -0.33 4 4
RAR gamma1/9cRA 0.045 0.036 -10000 0 -0.29 2 2
MAPK3 0.026 0.072 -10000 0 -0.38 6 6
MAPK1 0.035 0.01 -10000 0 -10000 0 0
MAPK8 0.037 0.009 -10000 0 -10000 0 0
mol:Vit D3 0 0 -10000 0 -10000 0 0
RXRs/VDR/DNA/Vit D3 0.037 0.092 -10000 0 -0.39 5 5
RARA 0.021 0.034 -10000 0 -0.22 3 3
negative regulation of phosphoinositide 3-kinase cascade 0 0 -10000 0 -10000 0 0
RARs/TIF2/Cbp/p300/PCAF/9cRA 0.012 0.076 0.2 2 -0.34 4 6
PRKCA 0.034 0.039 -10000 0 -0.33 2 2
RXRs/RARs/NRIP1/9cRA/HDAC1 0.032 0.11 0.35 3 -0.52 4 7
RXRG 0.017 0.067 -10000 0 -0.32 7 7
RXRA 0.018 0.05 -10000 0 -0.21 5 5
RXRB 0.024 0.043 -10000 0 -0.3 3 3
VDR/Vit D3/DNA 0.018 0.056 -10000 0 -0.3 6 6
RBP1 -0.097 0.19 -10000 0 -0.31 83 83
CRBP1/9-cic-RA -0.066 0.14 -10000 0 -0.21 83 83
RARB 0.025 0.075 -10000 0 -0.33 8 8
PRKCG 0.026 0.065 -10000 0 -0.24 10 10
MNAT1 0.034 0.011 -10000 0 -10000 0 0
RAR alpha/RXRs 0.041 0.11 -10000 0 -0.42 5 5
RXRs/RARs/SMRT(N-CoR2)/9cRA 0.035 0.094 -10000 0 -0.37 5 5
proteasomal ubiquitin-dependent protein catabolic process 0.048 0.088 0.3 5 -0.32 3 8
RXRs/RARs/NRIP1/9cRA/HDAC3 0.033 0.11 0.35 3 -0.52 4 7
positive regulation of DNA binding 0.043 0.069 -10000 0 -0.26 2 2
NRIP1 0.033 0.13 -10000 0 -0.96 2 2
RXRs/RARs 0.033 0.099 -10000 0 -0.44 5 5
RXRs/RXRs/DNA/9cRA 0.019 0.081 -10000 0 -0.4 5 5
PRKACA 0.037 0.006 -10000 0 -10000 0 0
CDK7 0.034 0.035 -10000 0 -0.47 1 1
TFIIH 0.065 0.035 -10000 0 -0.29 1 1
RAR alpha/9cRA 0.069 0.065 -10000 0 -0.28 1 1
CCNH 0.037 0.005 -10000 0 -10000 0 0
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
RAR gamma2/9cRA 0.06 0.047 -10000 0 -0.23 3 3
Paxillin-dependent events mediated by a4b1

Figure S93.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S93.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.03 0.049 -10000 0 -0.47 2 2
Rac1/GDP 0.034 0.016 -10000 0 -10000 0 0
DOCK1 0.024 0.078 -10000 0 -0.42 6 6
ITGA4 0.011 0.11 -10000 0 -0.45 12 12
RAC1 0.034 0.012 -10000 0 -10000 0 0
alpha4/beta7 Integrin 0.009 0.13 -10000 0 -0.35 24 24
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.03 0.015 -10000 0 -10000 0 0
alpha4/beta1 Integrin 0.055 0.08 -10000 0 -0.29 10 10
alpha4/beta7 Integrin/Paxillin 0.024 0.11 -10000 0 -0.27 24 24
lamellipodium assembly 0.007 0.1 -10000 0 -0.42 7 7
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
PI3K 0.048 0.047 -10000 0 -0.34 3 3
ARF6 0.029 0.05 -10000 0 -0.47 2 2
TLN1 0.037 0.006 -10000 0 -10000 0 0
PXN 0.019 0.003 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
ARF6/GTP 0.053 0.079 -10000 0 -0.23 12 12
cell adhesion 0.062 0.074 -10000 0 -0.25 10 10
CRKL/CBL 0.048 0.04 -10000 0 -0.34 2 2
alpha4/beta1 Integrin/Paxillin 0.045 0.071 -10000 0 -0.26 10 10
ITGB1 0.036 0.016 -10000 0 -0.19 1 1
ITGB7 0.004 0.12 -10000 0 -0.47 14 14
ARF6/GDP 0.029 0.05 -10000 0 -0.46 2 2
alpha4/beta1 Integrin/Paxillin/VCAM1 0.05 0.11 -10000 0 -0.32 14 14
p130Cas/Crk/Dock1 0.048 0.065 -10000 0 -0.3 5 5
VCAM1 0.013 0.1 -10000 0 -0.38 12 12
alpha4/beta1 Integrin/Paxillin/Talin 0.065 0.076 -10000 0 -0.25 10 10
alpha4/beta1 Integrin/Paxillin/GIT1 0.064 0.076 -10000 0 -0.25 10 10
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
mol:GDP -0.061 0.075 0.25 10 -10000 0 10
CBL 0.037 0.006 -10000 0 -10000 0 0
PRKACA 0.037 0.006 -10000 0 -10000 0 0
GIT1 0.035 0.017 -10000 0 -0.19 1 1
alpha4/beta1 Integrin/Paxillin/Talin/Actin Cytoskeleton 0.065 0.076 -10000 0 -0.25 10 10
Rac1/GTP 0.005 0.11 -10000 0 -0.47 7 7
Arf6 trafficking events

Figure S94.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S94.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SLC2A4 0.007 0.092 -10000 0 -0.31 14 14
CLTC -0.011 0.14 -10000 0 -0.42 20 20
calcium ion-dependent exocytosis 0.004 0.072 -10000 0 -0.3 5 5
Dynamin 2/GTP 0.028 0.039 -10000 0 -0.26 3 3
EXOC4 0.036 0.008 -10000 0 -10000 0 0
CD59 -0.012 0.12 -10000 0 -0.38 19 19
CPE -0.045 0.11 -10000 0 -0.29 31 31
CTNNB1 0.018 0.081 -10000 0 -0.27 13 13
membrane fusion 0.019 0.038 -10000 0 -0.27 1 1
CTNND1 0.015 0.042 0.19 5 -0.24 3 8
DNM2 0.037 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 -0.002 0.084 -10000 0 -0.33 7 7
TSHR 0.014 0.036 -10000 0 -0.28 3 3
INS 0.015 0.058 -10000 0 -0.5 2 2
BIN1 0.016 0.1 -10000 0 -0.47 9 9
mol:Choline 0.019 0.038 -10000 0 -0.27 1 1
growth hormone secretagogue receptor activity 0 0 -10000 0 -10000 0 0
mol:GDP 0.012 0.038 -10000 0 -0.28 3 3
membrane depolarization 0 0 -10000 0 -10000 0 0
ARF6 0.029 0.05 -10000 0 -0.47 2 2
mol:Ca2+ 0.027 0.038 -10000 0 -0.26 3 3
JUP -0.011 0.12 -10000 0 -0.38 18 18
ASAP2/amphiphysin II 0.027 0.069 -10000 0 -0.26 11 11
ARF6/GTP 0.022 0.036 -10000 0 -0.34 2 2
CDH1 -0.021 0.12 -10000 0 -0.36 21 21
clathrin-independent pinocytosis 0.022 0.036 -10000 0 -0.34 2 2
MAPK8IP3 0.029 0.06 -10000 0 -0.47 3 3
positive regulation of endocytosis 0.022 0.036 -10000 0 -0.34 2 2
EXOC2 0.034 0.035 -10000 0 -0.47 1 1
substrate adhesion-dependent cell spreading 0.019 0.07 -10000 0 -0.35 3 3
insulin receptor binding 0 0 -10000 0 -10000 0 0
SPAG9 0.035 0.009 -10000 0 -10000 0 0
regulation of calcium-dependent cell-cell adhesion 0 0.14 0.36 19 -10000 0 19
positive regulation of phagocytosis 0.013 0.032 -10000 0 -0.28 2 2
ARF6/GTP/JIP3 0.036 0.053 -10000 0 -0.29 5 5
ACAP1 0.014 0.046 -10000 0 -0.19 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
CHRM2 -0.039 0.14 -10000 0 -0.4 20 20
clathrin heavy chain/ACAP1 -0.006 0.12 0.24 2 -0.35 18 20
JIP4/KLC1 0.056 0.043 -10000 0 -0.26 2 2
EXOC1 0.037 0.006 -10000 0 -10000 0 0
exocyst 0.019 0.07 -10000 0 -0.36 3 3
RALA/GTP 0.025 0.009 -10000 0 -10000 0 0
ARF6/GTP/ARF6/GTP/JIP4/Dynactin Complex 0.039 0.039 -10000 0 -0.29 2 2
receptor recycling 0.022 0.036 -10000 0 -0.34 2 2
CTNNA1 0.015 0.042 0.19 5 -0.24 3 8
NME1 0.012 0.038 -10000 0 -0.28 3 3
clathrin coat assembly -0.012 0.14 -10000 0 -0.41 20 20
IL2RA -0.034 0.13 -10000 0 -0.38 20 20
VAMP3 0.013 0.032 -10000 0 -0.28 2 2
GLUT4/clathrin heavy chain/ACAP1 -0.004 0.12 -10000 0 -0.34 17 17
EXOC6 0.034 0.035 -10000 0 -0.47 1 1
PLD1 0.011 0.033 -10000 0 -0.26 2 2
PLD2 0.013 0.027 -10000 0 -0.34 1 1
EXOC5 0.034 0.011 -10000 0 -10000 0 0
PIP5K1C 0 0.084 -10000 0 -0.26 16 16
SDC1 -0.011 0.12 -10000 0 -0.38 18 18
ARF6/GDP 0.026 0.039 -10000 0 -0.28 3 3
EXOC7 0.036 0.008 -10000 0 -10000 0 0
E-cadherin/beta catenin 0.001 0.14 -10000 0 -0.37 19 19
mol:Phosphatidic acid 0.019 0.038 -10000 0 -0.27 1 1
endocytosis -0.026 0.068 0.26 11 -10000 0 11
SCAMP2 0.035 0.01 -10000 0 -10000 0 0
ADRB2 -0.026 0.14 0.38 1 -0.42 20 21
EXOC3 0.036 0.008 -10000 0 -10000 0 0
ASAP2 0 0 -10000 0 -10000 0 0
Dynamin 2/GDP 0.032 0.04 -10000 0 -0.26 3 3
KLC1 0.033 0.012 -10000 0 -10000 0 0
AVPR2 -0.011 0.14 0.31 4 -0.4 20 24
RALA 0.033 0.012 -10000 0 -10000 0 0
E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin -0.002 0.13 -10000 0 -0.36 17 17
S1P3 pathway

Figure S95.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S95.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRB 0.035 0.035 -10000 0 -0.47 1 1
mol:S1P 0.001 0.003 -10000 0 -0.037 1 1
S1P1/S1P/Gi 0.002 0.088 -10000 0 -0.27 17 17
GNAO1 0.038 0.008 -10000 0 -10000 0 0
S1P/S1P3/G12/G13 0.042 0.019 -10000 0 -10000 0 0
AKT1 -0.014 0.15 -10000 0 -0.4 25 25
AKT3 0.027 0.11 -10000 0 -1.2 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
PDGFB-D/PDGFRB 0.035 0.035 -10000 0 -0.47 1 1
GNAI2 0.028 0.07 -10000 0 -0.41 5 5
GNAI3 0.034 0.036 -10000 0 -0.47 1 1
GNAI1 -0.004 0.13 -10000 0 -0.38 21 21
mol:GDP 0 0 -10000 0 -10000 0 0
S1PR3 0.001 0.003 -10000 0 -0.042 1 1
S1PR2 0 0 -10000 0 -10000 0 0
EDG1 0 0 -10000 0 -10000 0 0
mol:Ca2+ 0.001 0.097 -10000 0 -0.32 12 12
MAPK3 -0.01 0.097 -10000 0 -0.29 15 15
MAPK1 0 0.088 -10000 0 -0.32 10 10
JAK2 0.03 0.12 0.23 3 -0.38 8 11
CXCR4 -0.029 0.12 -10000 0 -0.31 22 22
FLT1 0.013 0.073 -10000 0 -0.26 11 11
RhoA/GDP 0.027 0.004 -10000 0 -10000 0 0
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
SRC -0.004 0.071 -10000 0 -0.33 6 6
S1P/S1P3/Gi 0.001 0.098 -10000 0 -0.32 12 12
RAC1 0.034 0.012 -10000 0 -10000 0 0
RhoA/GTP 0.017 0.097 -10000 0 -0.3 11 11
VEGFA 0.038 0.01 -10000 0 -10000 0 0
S1P/S1P2/Gi -0.001 0.095 -10000 0 -0.26 19 19
VEGFR1 homodimer/VEGFA homodimer 0.033 0.06 -10000 0 -0.34 3 3
RHOA 0.037 0.005 -10000 0 -10000 0 0
S1P/S1P3/Gq -0.008 0.084 -10000 0 -0.25 20 20
GNAQ 0 0 -10000 0 -10000 0 0
GNAZ 0.025 0.061 -10000 0 -0.26 8 8
G12/G13 0.048 0.02 -10000 0 -10000 0 0
GNA14 -0.016 0.14 -10000 0 -0.35 29 29
GNA15 0.024 0.064 -10000 0 -0.24 10 10
GNA12 0.034 0.011 -10000 0 -10000 0 0
GNA13 0.036 0.009 -10000 0 -10000 0 0
GNA11 0.031 0.051 -10000 0 -0.38 3 3
Rac1/GTP 0.012 0.095 -10000 0 -0.31 10 10
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha

Figure S96.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S96.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HIF3A 0.036 0.016 -10000 0 -0.19 1 1
oxygen homeostasis 0 0 -10000 0 -10000 0 0
TCEB2 0.034 0.035 -10000 0 -0.47 1 1
TCEB1 0.031 0.02 -10000 0 -0.19 1 1
HIF1A/p53 -0.027 0.11 0.27 1 -0.32 12 13
HIF1A -0.008 0.066 -10000 0 -0.31 8 8
COPS5 0.03 0.037 -10000 0 -0.47 1 1
VHL/Elongin B/Elongin C/RBX1/CUL2 0.079 0.063 -10000 0 -0.25 2 2
FIH (dimer) 0.035 0.017 -10000 0 -0.19 1 1
CDKN2A -0.03 0.14 -10000 0 -0.29 43 43
ARNT/IPAS 0.051 0.031 -10000 0 -0.34 1 1
HIF1AN 0.035 0.017 -10000 0 -0.19 1 1
GNB2L1 0.035 0.035 -10000 0 -0.47 1 1
HIF1A/ARNT -0.001 0.083 -10000 0 -0.3 11 11
CUL2 0.037 0.004 -10000 0 -10000 0 0
OS9 0.036 0.016 -10000 0 -0.19 1 1
RACK1/Elongin B/Elongin C 0.059 0.047 -10000 0 -0.29 2 2
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF1A/Hsp90 0.01 0.079 0.27 1 -0.3 9 10
PHD1-3/OS9 0.032 0.11 -10000 0 -0.26 16 16
HIF1A/RACK1/Elongin B/Elongin C 0.024 0.09 -10000 0 -0.34 4 4
VHL 0.03 0.053 -10000 0 -0.33 4 4
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
HIF1A/JAB1 0.001 0.082 0.27 1 -0.3 10 11
EGLN3 -0.032 0.15 -10000 0 -0.31 40 40
EGLN2 0.036 0.007 -10000 0 -10000 0 0
EGLN1 0.036 0.008 -10000 0 -10000 0 0
TP53 -0.039 0.17 -10000 0 -0.45 30 30
VHL/Elongin B/Elongin C/RBX1/CUL2/HIF1A 0.027 0.11 -10000 0 -0.53 8 8
ARNT 0.034 0.035 -10000 0 -0.47 1 1
ARD1A 0 0 -10000 0 -10000 0 0
RBX1 0.034 0.018 -10000 0 -0.19 1 1
HIF1A/p19ARF -0.027 0.1 0.27 1 -0.31 13 14
S1P4 pathway

Figure S97.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S97.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
GNAO1 0.037 0.005 -10000 0 -10000 0 0
CDC42/GTP 0.011 0.093 -10000 0 -0.31 9 9
PLCG1 -0.002 0.061 0.2 2 -0.25 9 11
mol:GTP 0 0 -10000 0 -10000 0 0
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
GNAI3 0.034 0.035 -10000 0 -0.47 1 1
G12/G13 0.048 0.02 -10000 0 -10000 0 0
cell migration 0.011 0.091 -10000 0 -0.31 9 9
S1PR5 0 0 -10000 0 -10000 0 0
S1PR4 0 0 -10000 0 -10000 0 0
MAPK3 -0.015 0.093 -10000 0 -0.3 14 14
MAPK1 -0.004 0.083 -10000 0 -0.33 8 8
S1P/S1P5/Gi -0.004 0.093 -10000 0 -0.26 20 20
GNAI1 -0.005 0.13 -10000 0 -0.38 21 21
CDC42/GDP 0.025 0.013 -10000 0 -0.12 1 1
S1P/S1P5/G12 0.023 0.008 -10000 0 -10000 0 0
RHOA 0.043 0.062 0.2 26 -10000 0 26
S1P/S1P4/Gi -0.004 0.093 -10000 0 -0.26 20 20
mol:GDP 0 0 -10000 0 -10000 0 0
GNAZ 0.024 0.061 -10000 0 -0.26 8 8
S1P/S1P4/G12/G13 0.041 0.017 -10000 0 -10000 0 0
GNA12 0.034 0.011 -10000 0 -10000 0 0
GNA13 0.036 0.009 -10000 0 -10000 0 0
CDC42 0.034 0.018 -10000 0 -0.19 1 1
ErbB2/ErbB3 signaling events

Figure S98.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S98.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
USP8 -0.006 0.014 -10000 0 -10000 0 0
RAS family/GTP 0.018 0.1 -10000 0 -0.34 4 4
NFATC4 -0.016 0.057 0.24 1 -0.37 1 2
ERBB2IP 0.023 0.083 -10000 0 -0.46 6 6
HSP90 (dimer) 0.033 0.012 -10000 0 -10000 0 0
mammary gland morphogenesis 0.009 0.074 0.22 3 -0.29 5 8
JUN -0.001 0.077 0.25 1 -10000 0 1
HRAS 0.033 0.038 -10000 0 -0.33 2 2
DOCK7 -0.021 0.064 -10000 0 -0.46 1 1
ErbB2/ErbB3/neuregulin 1 beta/SHC 0.052 0.077 0.27 4 -0.32 5 9
AKT1 0.007 0.016 -10000 0 -0.12 3 3
BAD -0.007 0.014 -10000 0 -10000 0 0
MAPK10 -0.006 0.068 0.23 5 -0.21 4 9
mol:GTP -0.001 0.002 -10000 0 -10000 0 0
ErbB2/ErbB3/neuregulin 1 beta 0.012 0.08 0.24 3 -0.33 4 7
RAF1 -0.009 0.095 0.39 1 -0.34 4 5
ErbB2/ErbB3/neuregulin 2 0.045 0.076 0.26 6 -0.39 4 10
STAT3 0.004 0.15 -10000 0 -0.96 5 5
cell migration 0.003 0.067 0.28 3 -0.22 1 4
mol:PI-3-4-5-P3 -0.001 0.001 -10000 0 -10000 0 0
cell proliferation -0.088 0.24 -10000 0 -0.6 27 27
FOS -0.093 0.22 0.34 1 -0.44 52 53
NRAS 0.021 0.076 -10000 0 -0.31 9 9
mol:Ca2+ 0.009 0.074 0.22 3 -0.29 5 8
MAPK3 -0.054 0.19 0.37 1 -0.51 20 21
MAPK1 -0.07 0.22 0.4 1 -0.56 23 24
JAK2 -0.026 0.07 -10000 0 -0.32 3 3
NF2 0.009 0.064 -10000 0 -0.65 2 2
ErbB2/ErbB3/neuregulin 1 beta/SHC/GRB2/SOS1 0.016 0.055 -10000 0 -0.28 5 5
NRG1 0.024 0.053 -10000 0 -0.38 3 3
GRB2/SOS1 0.053 0.011 -10000 0 -10000 0 0
MAPK8 0 0.083 -10000 0 -0.29 5 5
MAPK9 -0.001 0.062 0.23 5 -0.23 1 6
ERBB2 -0.018 0.071 0.35 6 -0.36 2 8
ERBB3 0.032 0.049 -10000 0 -0.47 2 2
SHC1 0.036 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
apoptosis 0.001 0.014 -10000 0 -10000 0 0
STAT3 (dimer) 0.005 0.15 -10000 0 -0.93 5 5
RNF41 -0.008 0.012 -10000 0 -10000 0 0
FRAP1 -0.004 0.012 -10000 0 -0.099 3 3
RAC1-CDC42/GTP -0.012 0.043 -10000 0 -0.33 1 1
ErbB2/ErbB2/HSP90 (dimer) 0.011 0.057 0.26 6 -0.3 2 8
CHRNA1 -0.033 0.15 0.36 1 -0.41 5 6
myelination -0.011 0.063 0.3 2 -0.36 1 3
PPP3CB -0.018 0.061 -10000 0 -0.42 1 1
KRAS 0.033 0.038 -10000 0 -0.33 2 2
RAC1-CDC42/GDP 0.032 0.076 -10000 0 -0.31 2 2
NRG2 0.03 0.053 -10000 0 -0.33 4 4
mol:GDP 0.016 0.055 -10000 0 -0.28 5 5
SOS1 0.037 0.003 -10000 0 -10000 0 0
MAP2K2 -0.023 0.098 0.38 1 -0.32 5 6
SRC 0.013 0.06 -10000 0 -0.47 3 3
mol:cAMP -0.001 0.001 -10000 0 -10000 0 0
PTPN11 -0.022 0.071 -10000 0 -0.38 3 3
MAP2K1 -0.071 0.22 -10000 0 -0.63 18 18
heart morphogenesis 0.009 0.074 0.22 3 -0.29 5 8
RAS family/GDP 0.03 0.1 -10000 0 -0.34 4 4
GRB2 0.036 0.007 -10000 0 -10000 0 0
PRKACA 0.013 0.068 -10000 0 -0.69 2 2
CHRNE 0.008 0.019 -10000 0 -10000 0 0
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
activation of caspase activity -0.007 0.016 0.12 3 -10000 0 3
nervous system development 0.009 0.074 0.22 3 -0.29 5 8
CDC42 0.034 0.018 -10000 0 -0.19 1 1
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)

Figure S99.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S99.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MET/RANBP9 0.047 0.043 -10000 0 -0.34 2 2
CRKL 0.038 0.11 0.3 3 -0.52 4 7
mol:PIP3 0.005 0.05 0.41 2 -10000 0 2
AKT1 -0.002 0.047 0.28 2 -10000 0 2
PTK2B 0.028 0.016 -10000 0 -10000 0 0
RAPGEF1 0.04 0.1 0.29 4 -0.5 4 8
RANBP10 0.034 0.027 -10000 0 -0.19 3 3
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
HGF/MET/SHIP2 0.062 0.055 -10000 0 -0.32 3 3
MAP3K5 0.044 0.11 0.36 4 -0.5 4 8
HGF/MET/CIN85/CBL/ENDOPHILINS 0.062 0.092 -10000 0 -0.27 13 13
AP1 -0.053 0.15 -10000 0 -0.29 46 46
mol:SU11274 0 0 -10000 0 -10000 0 0
SHC1 0.037 0.006 -10000 0 -10000 0 0
apoptosis -0.18 0.36 -10000 0 -0.74 62 62
STAT3 (dimer) 0.041 0.071 -10000 0 -0.25 1 1
GAB1/CRKL/SHP2/PI3K 0.084 0.12 0.31 2 -0.55 4 6
INPP5D 0 0 -10000 0 -10000 0 0
CBL/CRK 0.066 0.1 0.29 3 -0.5 4 7
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
GO:0007205 0 0 -10000 0 -10000 0 0
PLCG1 0.02 0.019 -10000 0 -10000 0 0
PTEN 0.031 0.049 -10000 0 -0.47 2 2
ELK1 0.016 0.12 0.36 17 -10000 0 17
mol:SU5416 0 0 -10000 0 -10000 0 0
SHP2/GRB2/SOS1GAB1 0.014 0.045 -10000 0 -0.27 2 2
PAK1 -0.006 0.047 -10000 0 -10000 0 0
HGF/MET/RANBP10 0.063 0.053 -10000 0 -0.37 2 2
HRAS 0.03 0.081 -10000 0 -0.67 2 2
DOCK1 0.034 0.11 0.28 3 -0.5 4 7
GAB1 0.034 0.1 -10000 0 -0.5 5 5
CRK 0.034 0.1 0.29 3 -0.52 4 7
mol:PHA665752 0 0 -10000 0 -10000 0 0
mol:GDP 0.034 0.073 -10000 0 -0.62 2 2
JUN -0.015 0.15 -10000 0 -0.39 26 26
EntrezGene:200958 0 0 -10000 0 -10000 0 0
HGF/MET -0.009 0.041 -10000 0 -0.27 3 3
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
cell morphogenesis 0.061 0.12 0.4 5 -0.6 2 7
GRB2/SHC 0.02 0.062 -10000 0 -0.26 2 2
FOS -0.055 0.16 -10000 0 -0.3 56 56
GLMN 0.001 0.022 -10000 0 -0.32 1 1
cell motility 0.016 0.12 0.36 17 -10000 0 17
HGF/MET/MUC20 0.042 0.042 -10000 0 -0.33 2 2
cell migration 0.02 0.06 -10000 0 -0.25 2 2
GRB2 0.036 0.007 -10000 0 -10000 0 0
CBL 0.037 0.006 -10000 0 -10000 0 0
MET/RANBP10 0.045 0.05 -10000 0 -0.38 2 2
HGF/MET/Paxillin/FAK1/FAK12/RasGAP 0.02 0.046 -10000 0 -0.23 4 4
MET/MUC20 0.022 0.038 -10000 0 -0.23 4 4
RAP1B 0.038 0.1 0.33 4 -0.47 4 8
RAP1A 0.036 0.098 0.28 4 -0.47 4 8
HGF/MET/RANBP9 0.065 0.048 -10000 0 -0.33 2 2
RAF1 0.032 0.082 -10000 0 -0.63 2 2
STAT3 0.011 0.045 -10000 0 -0.25 1 1
cell proliferation 0.045 0.076 0.34 2 -0.39 1 3
RPS6KB1 0.002 0.051 -10000 0 -0.27 6 6
MAPK3 -0.001 0.14 0.62 8 -10000 0 8
MAPK1 0.03 0.2 0.64 18 -10000 0 18
RANBP9 0.037 0.005 -10000 0 -10000 0 0
MAPK8 0.047 0.12 0.38 3 -0.49 4 7
SRC 0.008 0.05 -10000 0 -0.25 1 1
PI3K 0.015 0.07 -10000 0 -0.24 6 6
MET/Glomulin -0.014 0.061 -10000 0 -0.2 10 10
SOS1 0.038 0.003 -10000 0 -10000 0 0
MAP2K1 0.031 0.077 0.3 1 -0.58 2 3
MET 0.029 0.054 -10000 0 -0.33 4 4
MAP4K1 0.054 0.11 0.3 3 -0.53 4 7
PTK2 0.031 0.015 -10000 0 -10000 0 0
MAP2K2 0.032 0.08 0.3 1 -0.58 2 3
BAD -0.004 0.045 -10000 0 -10000 0 0
MAP2K4 0.033 0.1 0.34 4 -0.51 3 7
SHP2/GRB2/SOS1/GAB1 0.067 0.097 -10000 0 -0.46 4 4
INPPL1 0.034 0.038 -10000 0 -0.33 2 2
PXN 0.037 0.004 -10000 0 -10000 0 0
SH3KBP1 0.008 0.12 -10000 0 -0.45 13 13
HGS -0.01 0.034 -10000 0 -0.27 2 2
PLCgamma1/PKC 0.015 0.014 -10000 0 -10000 0 0
HGF 0.034 0.023 -10000 0 -0.19 2 2
RASA1 0.026 0.07 -10000 0 -0.41 5 5
NCK1 0.028 0.069 -10000 0 -0.47 4 4
PTPRJ 0.034 0.038 -10000 0 -0.33 2 2
NCK/PLCgamma1 0.032 0.046 -10000 0 -0.24 2 2
PDPK1 0.001 0.052 0.32 2 -10000 0 2
HGF/MET/SHIP 0.042 0.042 -10000 0 -0.33 2 2
Signaling events regulated by Ret tyrosine kinase

Figure S100.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S100.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PTK2 0.021 0.05 -10000 0 -0.35 3 3
Crk/p130 Cas/Paxillin -0.023 0.077 -10000 0 -0.32 5 5
JUN -0.021 0.1 -10000 0 -0.39 5 5
HRAS 0.034 0.038 -10000 0 -0.33 2 2
RET51/GFRalpha1/GDNF/GRB10 0.025 0.12 -10000 0 -0.28 19 19
RAP1A 0.036 0.009 -10000 0 -10000 0 0
FRS2 0.035 0.022 -10000 0 -0.19 2 2
RAP1A/GDP 0.026 0.006 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/DOK1 0.048 0.099 -10000 0 -0.29 10 10
EntrezGene:5979 0 0 -10000 0 -10000 0 0
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.03 0.015 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Enigma 0.056 0.054 -10000 0 -0.26 4 4
RHOA 0.037 0.005 -10000 0 -10000 0 0
RAP1A/GTP 0.036 0.1 -10000 0 -0.26 15 15
GRB7 0.03 0.049 -10000 0 -0.47 2 2
RET51/GFRalpha1/GDNF 0.049 0.096 -10000 0 -0.29 9 9
MAPKKK cascade 0.017 0.086 -10000 0 -0.3 4 4
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
RET9/GFRalpha1/GDNF/IRS1 0.045 0.08 -10000 0 -0.28 11 11
lamellipodium assembly -0.009 0.08 -10000 0 -0.3 5 5
RET51/GFRalpha1/GDNF/SHC 0.05 0.095 -10000 0 -0.29 9 9
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/SHC 0.057 0.051 -10000 0 -0.26 4 4
RET9/GFRalpha1/GDNF/Shank3 0.055 0.052 -10000 0 -0.26 4 4
MAPK3 -0.014 0.086 -10000 0 -0.29 5 5
DOK1 0.034 0.038 -10000 0 -0.33 2 2
DOK6 0.024 0.023 -10000 0 -0.19 1 1
PXN 0.037 0.004 -10000 0 -10000 0 0
neurite development 0.002 0.094 0.25 3 -0.36 5 8
DOK5 0.001 0.079 -10000 0 -0.27 13 13
GFRA1 0.032 0.041 -10000 0 -0.28 3 3
MAPK8 0.006 0.081 -10000 0 -0.36 4 4
HRAS/GTP 0.051 0.099 -10000 0 -0.29 12 12
tube development 0.053 0.048 0.23 2 -0.24 3 5
MAPK1 -0.007 0.086 0.35 2 -0.29 5 7
RET9/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.025 0.045 -10000 0 -0.24 5 5
Rac1/GDP 0.025 0.009 -10000 0 -10000 0 0
SRC 0.013 0.06 -10000 0 -0.47 3 3
PDLIM7 0.034 0.027 -10000 0 -0.19 3 3
RET51/GFRalpha1/GDNF/Dok6 0.017 0.081 -10000 0 -0.27 6 6
SHC1 0.037 0.006 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/Dok4 0.04 0.11 -10000 0 -0.29 15 15
RET51/GFRalpha1/GDNF/Dok5 0.01 0.088 -10000 0 -0.32 6 6
PRKCA 0.032 0.039 -10000 0 -0.33 2 2
HRAS/GDP 0.025 0.027 -10000 0 -0.34 1 1
CREB1 0.034 0.056 -10000 0 -0.28 1 1
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
RET9/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.024 0.045 -10000 0 -0.22 5 5
RET51/GFRalpha1/GDNF/Grb7 0.042 0.099 -10000 0 -0.29 10 10
mol:GDP 0 0 -10000 0 -10000 0 0
RET -0.002 0.1 -10000 0 -0.23 31 31
DOK4 0.018 0.096 -10000 0 -0.47 8 8
JNK cascade -0.021 0.099 -10000 0 -0.38 5 5
RET9/GFRalpha1/GDNF/FRS2 0.057 0.053 -10000 0 -0.26 4 4
SHANK3 0.034 0.011 -10000 0 -10000 0 0
RASA1 0.026 0.07 -10000 0 -0.41 5 5
NCK1 0.028 0.069 -10000 0 -0.47 4 4
RET9/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.028 0.036 -10000 0 -0.22 3 3
RET51/GFRalpha1/GDNF/FRS2/SHP2/Grb2 0.014 0.069 -10000 0 -0.27 3 3
RET51/GFRalpha1/GDNF/DOK/RasGAP/NCK 0.009 0.086 -10000 0 -0.35 5 5
RET51/GFRalpha1/GDNF/SHC/Grb2/SOS1 0.019 0.06 -10000 0 -0.27 2 2
PI3K -0.016 0.11 -10000 0 -0.44 5 5
SOS1 0.038 0.003 -10000 0 -10000 0 0
RET9/GFRalpha1/GDNF/Shank3/Grb2 0.069 0.053 -10000 0 -0.24 3 3
GRB10 -0.003 0.13 -10000 0 -0.41 18 18
activation of MAPKK activity 0.018 0.069 -10000 0 -0.29 4 4
RET51/GFRalpha1/GDNF/FRS2 0.049 0.097 -10000 0 -0.29 9 9
GAB1 0.03 0.053 -10000 0 -0.33 4 4
IRS1 0.017 0.094 -10000 0 -0.37 11 11
IRS2 -0.006 0.12 -10000 0 -0.43 15 15
RET51/GFRalpha1/GDNF/SHC/GAB1/Grb2 0.016 0.065 -10000 0 -0.27 2 2
RET51/GFRalpha1/GDNF/PKC alpha 0.046 0.094 -10000 0 -0.28 8 8
GRB2 0.036 0.007 -10000 0 -10000 0 0
PRKACA 0.037 0.006 -10000 0 -10000 0 0
GDNF 0.029 0.06 -10000 0 -0.47 3 3
RAC1 0.034 0.012 -10000 0 -10000 0 0
RET51/GFRalpha1/GDNF/IRS1 0.036 0.11 -10000 0 -0.29 16 16
Rac1/GTP -0.008 0.095 -10000 0 -0.36 5 5
RET9/GFRalpha1/GDNF 0.039 0.049 -10000 0 -0.29 4 4
GFRalpha1/GDNF 0.042 0.057 -10000 0 -0.34 4 4
S1P5 pathway

Figure S101.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S101.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
mol:S1P 0 0 -10000 0 -10000 0 0
telencephalon oligodendrocyte cell migration -0.013 0.091 0.31 9 -10000 0 9
GNAI2 0.027 0.07 -10000 0 -0.41 5 5
S1P/S1P5/G12 0.023 0.008 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
GNAO1 0.037 0.005 -10000 0 -10000 0 0
RhoA/GTP 0.013 0.093 -10000 0 -0.32 9 9
negative regulation of cAMP metabolic process -0.004 0.093 -10000 0 -0.26 20 20
GNAZ 0.024 0.061 -10000 0 -0.26 8 8
GNAI3 0.034 0.035 -10000 0 -0.47 1 1
GNA12 0.034 0.011 -10000 0 -10000 0 0
S1PR5 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
S1P/S1P5/Gi -0.004 0.093 -10000 0 -0.26 20 20
RhoA/GDP 0.027 0.004 -10000 0 -10000 0 0
RHOA 0.037 0.005 -10000 0 -10000 0 0
GNAI1 -0.005 0.13 -10000 0 -0.38 21 21
ceramide signaling pathway

Figure S102.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S102.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAP4K4 0.01 0.1 -10000 0 -0.43 5 5
BAG4 0.031 0.036 -10000 0 -0.47 1 1
BAD 0.012 0.039 0.2 1 -0.19 1 2
NFKBIA 0.029 0.042 -10000 0 -0.28 3 3
BIRC3 -0.006 0.12 -10000 0 -0.29 28 28
BAX 0.014 0.053 0.26 4 -0.23 1 5
EnzymeConsortium:3.1.4.12 0.007 0.027 0.17 1 -0.096 3 4
IKBKB 0.023 0.1 0.34 1 -0.39 4 5
MAP2K2 0.015 0.054 0.21 7 -10000 0 7
MAP2K1 0.012 0.05 0.2 8 -10000 0 8
SMPD1 0.009 0.034 0.17 1 -0.16 4 5
GO:0005551 0 0 -10000 0 -10000 0 0
FADD/Caspase 8 0.018 0.099 -10000 0 -0.43 4 4
MAP2K4 0.006 0.037 0.2 1 -0.2 1 2
protein ubiquitination 0.018 0.1 0.38 1 -0.42 4 5
EnzymeConsortium:2.7.1.37 0.013 0.055 0.21 7 -10000 0 7
response to UV 0 0.001 0.003 7 -0.002 1 8
RAF1 0.015 0.051 0.2 8 -10000 0 8
CRADD 0.028 0.069 -10000 0 -0.47 4 4
mol:ceramide 0.014 0.041 0.17 2 -0.16 2 4
I-kappa-B-alpha/RELA/p50/ubiquitin 0.042 0.031 -10000 0 -0.29 1 1
MADD 0.037 0.004 -10000 0 -10000 0 0
MAP3K1 0.011 0.039 0.21 1 -0.17 1 2
TRADD 0.037 0.005 -10000 0 -10000 0 0
RELA/p50 0.037 0.006 -10000 0 -10000 0 0
MAPK3 0.017 0.054 0.2 9 -10000 0 9
MAPK1 0.013 0.06 0.2 8 -0.26 1 9
p50/RELA/I-kappa-B-alpha 0.046 0.036 -10000 0 -0.34 1 1
FADD 0.015 0.092 -10000 0 -0.49 2 2
KSR1 0.016 0.051 0.21 7 -0.19 1 8
MAPK8 0.006 0.042 0.2 2 -10000 0 2
TRAF2 0.036 0.016 -10000 0 -0.19 1 1
response to radiation 0 0 0.002 4 -10000 0 4
CHUK 0.004 0.097 -10000 0 -0.43 4 4
TNF R/SODD 0.045 0.033 -10000 0 -0.34 1 1
TNF 0.025 0.063 -10000 0 -0.25 9 9
CYCS 0.042 0.063 0.18 15 -10000 0 15
IKBKG 0.011 0.1 -10000 0 -0.43 4 4
TNF/TNF R/TRADD/MADD/cIAP/RIP/TRAF2/RAIDD 0.018 0.097 -10000 0 -0.41 4 4
RELA 0.037 0.006 -10000 0 -10000 0 0
RIPK1 0.037 0.006 -10000 0 -10000 0 0
AIFM1 0.037 0.058 0.17 12 -10000 0 12
TNF/TNF R/SODD 0.052 0.058 -10000 0 -0.28 3 3
TNFRSF1A 0.036 0.008 -10000 0 -10000 0 0
response to heat 0 0 0.002 4 -10000 0 4
CASP8 0.024 0.13 -10000 0 -0.64 8 8
NSMAF 0.033 0.1 0.26 4 -0.48 2 6
response to hydrogen peroxide 0 0.001 0.003 7 -0.002 1 8
BCL2 0.001 0.093 -10000 0 -0.29 16 16
HIF-2-alpha transcription factor network

Figure S103.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S103.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MMP14 -0.003 0.2 -10000 0 -0.7 13 13
oxygen homeostasis 0.003 0.011 -10000 0 -10000 0 0
TCEB2 0.034 0.035 -10000 0 -0.47 1 1
TCEB1 0.031 0.02 -10000 0 -0.19 1 1
VHL/Elongin B/Elongin C/HIF2A 0.025 0.12 -10000 0 -0.32 4 4
EPO 0.024 0.18 -10000 0 -0.55 4 4
FIH (dimer) 0.033 0.029 -10000 0 -0.2 1 1
APEX1 0.034 0.026 -10000 0 -10000 0 0
SERPINE1 0.008 0.2 0.4 1 -0.59 6 7
FLT1 0.01 0.16 -10000 0 -0.94 5 5
ADORA2A 0.003 0.18 0.39 3 -0.52 6 9
germ cell development 0.01 0.21 0.39 1 -0.57 9 10
SLC11A2 0.011 0.2 -10000 0 -0.62 5 5
BHLHE40 0.004 0.18 -10000 0 -0.51 7 7
HIF1AN 0.034 0.029 -10000 0 -0.2 1 1
HIF2A/ARNT/SIRT1 0.031 0.15 -10000 0 -0.46 4 4
ETS1 0.036 0.056 -10000 0 -0.22 7 7
CITED2 0.031 0.11 -10000 0 -0.59 4 4
KDR 0.034 0.15 -10000 0 -0.76 6 6
PGK1 0.013 0.2 0.4 1 -0.55 7 8
SIRT1 0.033 0.038 -10000 0 -0.33 2 2
response to hypoxia 0 0 -10000 0 -10000 0 0
HIF2A/ARNT 0.048 0.23 -10000 0 -0.61 6 6
EPAS1 0 0.11 0.23 1 -0.31 8 9
SP1 0.039 0.022 -10000 0 -0.18 1 1
ABCG2 -0.003 0.22 -10000 0 -0.59 14 14
EFNA1 0.006 0.2 -10000 0 -0.63 6 6
FXN 0.008 0.18 0.39 3 -0.57 4 7
POU5F1 0.009 0.21 -10000 0 -0.6 9 9
neuron apoptosis -0.047 0.22 0.59 6 -10000 0 6
EP300 0.017 0.091 -10000 0 -0.43 8 8
EGLN3 -0.031 0.15 -10000 0 -0.31 40 40
EGLN2 0.036 0.021 -10000 0 -10000 0 0
EGLN1 0.035 0.023 -10000 0 -10000 0 0
VHL/Elongin B/Elongin C 0.056 0.05 -10000 0 -0.29 2 2
VHL 0.03 0.053 -10000 0 -0.33 4 4
ARNT 0.033 0.043 -10000 0 -0.47 1 1
SLC2A1 -0.012 0.2 0.39 3 -0.56 11 14
TWIST1 -0.012 0.19 0.38 2 -0.54 10 12
ELK1 0.04 0.028 -10000 0 -0.18 3 3
HIF2A/ARNT/Cbp/p300 0.026 0.17 -10000 0 -0.43 5 5
VEGFA 0.019 0.19 0.4 1 -0.53 5 6
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
Signaling events mediated by VEGFR1 and VEGFR2

Figure S104.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S104.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
alphaV beta3 Integrin 0.043 0.058 -10000 0 -0.34 4 4
AKT1 0.058 0.16 0.39 8 -0.49 5 13
PTK2B 0.002 0.083 0.28 1 -0.44 3 4
VEGFR2 homodimer/Frs2 0.024 0.081 -10000 0 -0.38 5 5
CAV1 0.025 0.061 -10000 0 -0.26 8 8
CALM1 0.033 0.012 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2 0.04 0.092 -10000 0 -0.54 2 2
endothelial cell proliferation 0.1 0.18 0.37 31 -0.45 5 36
mol:Ca2+ -0.02 0.095 -10000 0 -0.46 4 4
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Rac 0.048 0.093 -10000 0 -0.51 2 2
RP11-342D11.1 -0.026 0.11 -10000 0 -0.47 5 5
CDH5 0.036 0.016 -10000 0 -0.19 1 1
VEGFA homodimer 0.07 0.067 -10000 0 -0.31 3 3
SHC1 0.037 0.006 -10000 0 -10000 0 0
SHC2 -0.017 0.13 -10000 0 -0.28 36 36
HRAS/GDP 0.017 0.12 -10000 0 -0.41 7 7
SH2D2A 0.023 0.079 -10000 0 -0.39 7 7
VEGFR2 homodimer/VEGFA homodimer/SHP1/eNOS 0.075 0.15 0.34 1 -0.53 4 5
VEGFR2 homodimer/VEGFA homodimer/TsAd 0.034 0.1 -10000 0 -0.54 3 3
VEGFR1 homodimer 0.011 0.072 -10000 0 -0.26 11 11
SHC/GRB2/SOS1 0.046 0.14 -10000 0 -0.46 5 5
GRB10 -0.032 0.16 -10000 0 -0.57 15 15
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
GRB2 0.036 0.007 -10000 0 -10000 0 0
PAK1 0.032 0.049 -10000 0 -0.47 2 2
VEGFR2 homodimer/VEGFA homodimer/IQGAP1/Cadherin/beta catenin 0.06 0.11 -10000 0 -0.43 3 3
HRAS 0.034 0.038 -10000 0 -0.33 2 2
VEGF/Rho/ROCK1/Integrin Complex -0.012 0.11 -10000 0 -0.36 8 8
HIF1A 0.026 0.041 -10000 0 -0.19 7 7
FRS2 0.035 0.022 -10000 0 -0.19 2 2
oxygen and reactive oxygen species metabolic process 0.046 0.091 -10000 0 -0.5 2 2
mol:GTP 0 0 -10000 0 -10000 0 0
FLT4 0.037 0.004 -10000 0 -10000 0 0
Nck/Pak 0.043 0.065 -10000 0 -0.34 6 6
VEGFR2 homodimer/VEGFA homodimer/Fyn 0.025 0.11 -10000 0 -0.31 9 9
mol:GDP 0.03 0.13 -10000 0 -0.45 5 5
mol:NADP 0.067 0.14 0.36 5 -0.49 4 9
eNOS/Hsp90 0.071 0.14 0.36 5 -0.5 3 8
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
mol:IP3 -0.02 0.096 -10000 0 -0.47 4 4
HIF1A/ARNT 0.041 0.044 -10000 0 -0.32 1 1
SHB 0.035 0.022 -10000 0 -0.19 2 2
VEGFA 0.029 0.03 -10000 0 -10000 0 0
VEGFC 0.004 0.12 -10000 0 -0.37 17 17
FAK1/Vinculin 0.043 0.12 0.32 2 -0.43 4 6
mol:Ca ++ 0 0 -10000 0 -10000 0 0
RHOA 0.037 0.005 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/alphaV beta3 Integrin 0.049 0.1 -10000 0 -0.46 3 3
PTPN6 0.036 0.007 -10000 0 -10000 0 0
EPAS1 0.022 0.093 -10000 0 -0.52 5 5
mol:L-citrulline 0.067 0.14 0.36 5 -0.49 4 9
ITGAV 0.024 0.079 -10000 0 -0.39 7 7
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/Frs2/GRB2 0.056 0.096 -10000 0 -0.51 2 2
VEGFR2 homodimer/VEGFA homodimer 0.017 0.14 -10000 0 -0.36 14 14
VEGFR2/3 heterodimer 0.025 0.08 -10000 0 -0.38 5 5
VEGFB 0.034 0.035 -10000 0 -0.47 1 1
MAPK11 -0.036 0.12 -10000 0 -0.44 10 10
VEGFR2 homodimer 0.007 0.084 -10000 0 -0.44 5 5
FLT1 0.011 0.072 -10000 0 -0.26 11 11
NEDD4 0.002 0.11 -10000 0 -0.39 13 13
MAPK3 0.025 0.13 0.32 4 -0.44 4 8
MAPK1 0.025 0.13 0.32 4 -0.44 4 8
VEGFA145/NRP2 0.044 0.045 -10000 0 -0.26 2 2
VEGFR1/2 heterodimer 0.009 0.086 -10000 0 -0.35 8 8
KDR 0.007 0.084 -10000 0 -0.44 5 5
VEGFA165/NRP1/VEGFR2 homodimer 0.018 0.13 -10000 0 -0.48 6 6
SRC 0.013 0.06 -10000 0 -0.47 3 3
platelet activating factor biosynthetic process 0.037 0.14 0.32 6 -0.45 4 10
PI3K 0.017 0.14 -10000 0 -0.53 6 6
VEGFR2 homodimer/VEGFA homodimer/NCK1 0.036 0.098 -10000 0 -0.49 3 3
FES -0.02 0.13 -10000 0 -0.52 6 6
GAB1 0.002 0.11 -10000 0 -0.55 4 4
VEGFR2 homodimer/VEGFA homodimer/Src 0.016 0.085 -10000 0 -0.44 4 4
CTNNB1 0.018 0.081 -10000 0 -0.27 13 13
SOS1 0.038 0.003 -10000 0 -10000 0 0
ARNT 0.034 0.035 -10000 0 -0.47 1 1
eNOS/Caveolin-1 0.067 0.14 0.33 3 -0.5 4 7
VEGFR2 homodimer/VEGFA homodimer/Yes 0.027 0.09 -10000 0 -0.54 2 2
PI3K/GAB1 0.02 0.13 -10000 0 -0.5 6 6
VEGFR2 homodimer/VEGFA homodimer/Frs2/Nck/Pak 0.066 0.11 -10000 0 -0.45 3 3
PRKACA 0.037 0.006 -10000 0 -10000 0 0
VEGFR2/3 heterodimer/VEGFC homodimer 0.023 0.11 -10000 0 -0.43 3 3
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
CDC42 -0.013 0.12 -10000 0 -0.46 6 6
actin cytoskeleton reorganization 0.033 0.1 -10000 0 -0.54 3 3
PTK2 0.015 0.099 0.28 1 -0.45 4 5
EDG1 -0.026 0.11 -10000 0 -0.47 5 5
mol:DAG -0.02 0.096 -10000 0 -0.47 4 4
CaM/Ca2+ -0.011 0.094 -10000 0 -0.44 4 4
MAP2K3 -0.025 0.11 -10000 0 -0.44 7 7
VEGFR2 homodimer/VEGFA homodimer/GRB10/NEDD4 0.014 0.19 -10000 0 -0.58 15 15
PLCG1 -0.02 0.097 -10000 0 -0.48 4 4
VEGFR2 homodimer/VEGFA homodimer/Src/Shb 0.023 0.089 -10000 0 -0.42 4 4
IQGAP1 0.035 0.01 -10000 0 -10000 0 0
YES1 0.03 0.015 -10000 0 -10000 0 0
VEGFR2 homodimer/VEGFA homodimer/SHP2 0.038 0.097 -10000 0 -0.49 3 3
VEGFR2 homodimer/VEGFA homodimer/SHP1 0.041 0.09 -10000 0 -0.54 2 2
cell migration 0.048 0.12 0.43 1 -0.45 2 3
mol:PI-3-4-5-P3 0.018 0.13 -10000 0 -0.49 6 6
FYN 0.011 0.098 -10000 0 -0.32 15 15
VEGFB/NRP1 -0.005 0.11 -10000 0 -0.42 6 6
mol:NO 0.067 0.14 0.36 5 -0.49 4 9
PXN 0.037 0.004 -10000 0 -10000 0 0
HRAS/GTP -0.005 0.11 -10000 0 -0.41 7 7
VEGFR2 homodimer/VEGFA homodimer/GRB10 -0.011 0.17 -10000 0 -0.58 15 15
VHL 0.03 0.053 -10000 0 -0.33 4 4
ITGB3 0.035 0.017 -10000 0 -0.19 1 1
NOS3 0.067 0.15 0.37 5 -0.57 4 9
VEGFR2 homodimer/VEGFA homodimer/Sck 0.008 0.12 -10000 0 -0.42 6 6
RAC1 0.034 0.012 -10000 0 -10000 0 0
PRKCA -0.025 0.088 -10000 0 -0.44 4 4
PRKCB -0.026 0.086 -10000 0 -0.44 4 4
VCL 0.034 0.035 -10000 0 -0.47 1 1
VEGFA165/NRP1 -0.005 0.12 -10000 0 -0.48 5 5
VEGFR1/2 heterodimer/VEGFA homodimer 0.022 0.092 -10000 0 -0.46 3 3
VEGFA165/NRP2 0.044 0.045 -10000 0 -0.26 2 2
MAPKKK cascade -0.003 0.16 -10000 0 -0.52 15 15
NRP2 0.031 0.046 -10000 0 -0.24 5 5
VEGFC homodimer 0.004 0.12 -10000 0 -0.37 17 17
NCK1 0.028 0.069 -10000 0 -0.47 4 4
ROCK1 0.029 0.016 -10000 0 -10000 0 0
FAK1/Paxillin 0.044 0.12 0.32 2 -0.43 4 6
MAP3K13 -0.014 0.12 -10000 0 -0.47 7 7
PDPK1 0.043 0.15 0.26 26 -0.44 7 33
TCGA08_rtk_signaling

Figure S105.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S105.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
PDGFRA 0.02 0.086 -10000 0 -0.4 8 8
HRAS 0.034 0.038 -10000 0 -0.33 2 2
EGFR 0.018 0.086 -10000 0 -0.4 8 8
AKT 0.056 0.088 0.31 6 -0.29 2 8
FOXO3 0.027 0.051 -10000 0 -0.23 7 7
AKT1 0.03 0.028 -10000 0 -0.19 3 3
FOXO1 0.008 0.093 -10000 0 -0.38 10 10
AKT3 0.028 0.051 -10000 0 -0.23 7 7
FOXO4 0.038 0.003 -10000 0 -10000 0 0
MET 0.029 0.054 -10000 0 -0.33 4 4
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
PIK3CB 0.034 0.035 -10000 0 -0.47 1 1
NRAS 0.021 0.076 -10000 0 -0.31 9 9
PIK3CG 0.026 0.065 -10000 0 -0.33 6 6
PIK3R3 0.029 0.055 -10000 0 -0.3 5 5
PIK3R2 0.037 0.004 -10000 0 -10000 0 0
NF1 0.036 0.008 -10000 0 -10000 0 0
RAS 0.014 0.064 -10000 0 -0.26 5 5
ERBB2 0.031 0.049 -10000 0 -0.47 2 2
proliferation/survival/translation -0.042 0.079 0.27 4 -0.25 3 7
PI3K 0.042 0.087 0.25 16 -0.21 6 22
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
KRAS 0.033 0.038 -10000 0 -0.33 2 2
FOXO 0.075 0.08 0.27 9 -0.2 4 13
AKT2 0.036 0.008 -10000 0 -10000 0 0
PTEN 0.031 0.049 -10000 0 -0.47 2 2
E-cadherin signaling in keratinocytes

Figure S106.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S106.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
keratinocyte differentiation 0.004 0.055 -10000 0 -0.33 3 3
adherens junction organization 0.027 0.083 -10000 0 -0.25 11 11
mol:GTP 0 0 -10000 0 -10000 0 0
Rac1/GDP 0.01 0.07 -10000 0 -0.34 3 3
FMN1 0.029 0.078 -10000 0 -0.25 11 11
mol:IP3 0.004 0.05 -10000 0 -0.25 4 4
E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.033 0.082 -10000 0 -0.26 11 11
CTNNB1 0.019 0.081 -10000 0 -0.27 13 13
AKT1 0.047 0.082 0.2 6 -0.3 2 8
E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin 0.04 0.16 -10000 0 -0.47 13 13
CTNND1 0.04 0.007 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.029 0.079 -10000 0 -0.24 11 11
VASP 0.024 0.084 -10000 0 -0.25 11 11
ZYX 0.027 0.079 -10000 0 -0.25 11 11
JUB 0.029 0.078 -10000 0 -0.25 11 11
EGFR(dimer) 0.036 0.1 -10000 0 -0.36 6 6
E-cadherin/beta catenin-gamma catenin 0.037 0.093 -10000 0 -0.28 14 14
mol:PI-3-4-5-P3 0.091 0.098 0.23 7 -0.32 2 9
PIK3CA 0.041 0.007 -10000 0 -10000 0 0
PI3K 0.093 0.1 0.24 7 -0.32 2 9
FYN -0.004 0.075 -10000 0 -0.37 6 6
mol:Ca2+ 0.004 0.049 -10000 0 -0.24 4 4
JUP 0.037 0.017 -10000 0 -0.19 1 1
PIK3R1 0.034 0.061 -10000 0 -0.47 3 3
mol:DAG 0.004 0.05 -10000 0 -0.25 4 4
CDH1 0.014 0.11 -10000 0 -0.47 10 10
RhoA/GDP 0.012 0.072 -10000 0 -0.34 3 3
establishment of polarity of embryonic epithelium 0.023 0.083 -10000 0 -0.24 11 11
SRC 0.013 0.06 -10000 0 -0.47 3 3
RAC1 0.034 0.012 -10000 0 -10000 0 0
RHOA 0.037 0.005 -10000 0 -10000 0 0
EGFR 0.018 0.086 -10000 0 -0.4 8 8
CASR -0.001 0.054 -10000 0 -0.54 1 1
RhoA/GTP 0.014 0.053 -10000 0 -0.32 1 1
AKT2 0.054 0.08 0.19 5 -0.37 1 6
actin cable formation 0.021 0.081 -10000 0 -0.24 11 11
apoptosis -0.044 0.075 0.38 1 -0.24 1 2
CTNNA1 0.04 0.007 -10000 0 -10000 0 0
mol:GDP -0.002 0.065 -10000 0 -0.36 3 3
PIP5K1A 0.03 0.08 -10000 0 -0.25 11 11
PLCG1 0.004 0.051 -10000 0 -0.25 4 4
Rac1/GTP 0.045 0.099 -10000 0 -0.35 5 5
homophilic cell adhesion 0.003 0.004 -10000 0 -10000 0 0
Class IB PI3K non-lipid kinase events

Figure S107.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S107.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
cAMP biosynthetic process -0.026 0.07 0.41 5 -10000 0 5
PI3K Class IB/PDE3B 0.026 0.07 -10000 0 -0.41 5 5
PDE3B 0.026 0.07 -10000 0 -0.41 5 5
Coregulation of Androgen receptor activity

Figure S108.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S108.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NRIP1 0.033 0.036 -9999 0 -0.47 1 1
SVIL 0.026 0.068 -9999 0 -0.29 8 8
ZNF318 0.034 0.006 -9999 0 -10000 0 0
JMJD2C 0.007 0 -9999 0 -10000 0 0
T-DHT/AR/Ubc9 0.042 0.058 -9999 0 -0.23 5 5
CARM1 0.037 0.005 -9999 0 -10000 0 0
PRDX1 0.037 0.005 -9999 0 -10000 0 0
PELP1 0.03 0.015 -9999 0 -10000 0 0
CTNNB1 0.019 0.081 -9999 0 -0.27 13 13
AKT1 0.03 0.028 -9999 0 -0.19 3 3
PTK2B 0.029 0.017 -9999 0 -10000 0 0
MED1 0.023 0.077 -9999 0 -0.47 5 5
MAK 0.03 0.031 -9999 0 -0.19 4 4
response to oxidative stress 0 0 -9999 0 -10000 0 0
HIP1 0.036 0.017 -9999 0 -0.19 1 1
GSN 0.018 0.082 -9999 0 -0.27 14 14
NCOA2 0.028 0.05 -9999 0 -0.47 2 2
NCOA6 0.008 0.083 -9999 0 -0.47 6 6
DNA-PK 0.059 0.031 -9999 0 -10000 0 0
NCOA4 0.035 0.035 -9999 0 -0.47 1 1
PIAS3 0.036 0.022 -9999 0 -0.19 2 2
cell proliferation 0.018 0.043 -9999 0 -0.38 2 2
XRCC5 0.037 0.003 -9999 0 -10000 0 0
UBE3A 0.036 0.01 -9999 0 -10000 0 0
T-DHT/AR/SNURF 0.021 0.05 -9999 0 -0.25 4 4
FHL2 0.01 0.17 -9999 0 -0.89 7 7
RANBP9 0.038 0.005 -9999 0 -10000 0 0
JMJD1A 0.005 0.017 -9999 0 -0.14 3 3
CDK6 0.026 0.063 -9999 0 -0.36 5 5
TGFB1I1 0.025 0.073 -9999 0 -0.35 7 7
T-DHT/AR/CyclinD1 0.039 0.066 -9999 0 -0.26 5 5
XRCC6 0.034 0.01 -9999 0 -10000 0 0
T-DHT/AR 0.052 0.071 -9999 0 -0.27 4 4
CTDSP1 0.038 0.003 -9999 0 -10000 0 0
CTDSP2 0.028 0.053 -9999 0 -0.33 4 4
BRCA1 0.038 0.007 -9999 0 -10000 0 0
TCF4 0.021 0.03 -9999 0 -0.19 3 3
CDKN2A -0.031 0.14 -9999 0 -0.29 43 43
SRF 0.033 0.051 -9999 0 -0.2 8 8
NKX3-1 0.005 0.036 -9999 0 -0.16 7 7
KLK3 0.026 0.047 -9999 0 -10000 0 0
TMF1 0.037 0.006 -9999 0 -10000 0 0
HNRNPA1 0.036 0.004 -9999 0 -10000 0 0
AOF2 0.001 0.001 -9999 0 -10000 0 0
APPL1 0.009 0.045 -9999 0 -0.34 3 3
T-DHT/AR/Caspase 8 0.038 0.068 -9999 0 -0.26 7 7
AR 0.022 0.076 -9999 0 -0.26 12 12
UBA3 0 0 -9999 0 -10000 0 0
PATZ1 0.027 0.06 -9999 0 -0.47 3 3
PAWR 0.037 0.005 -9999 0 -10000 0 0
PRKDC 0.031 0.02 -9999 0 -0.19 1 1
PA2G4 0.036 0.004 -9999 0 -10000 0 0
UBE2I 0.036 0.008 -9999 0 -10000 0 0
T-DHT/AR/Cyclin D3/CDK11 p58 0.04 0.053 -9999 0 -0.23 4 4
RPS6KA3 0.036 0.035 -9999 0 -0.47 1 1
T-DHT/AR/ARA70 0.042 0.061 -9999 0 -0.26 5 5
LATS2 0.008 0.088 -9999 0 -0.36 10 10
T-DHT/AR/PRX1 0.04 0.052 -9999 0 -0.23 4 4
Cyclin D3/CDK11 p58 0.026 0.011 -9999 0 -0.12 1 1
VAV3 -0.071 0.2 -9999 0 -0.4 53 53
KLK2 0.024 0.026 -9999 0 -10000 0 0
CASP8 0.03 0.06 -9999 0 -0.47 3 3
T-DHT/AR/TIF2/CARM1 0.051 0.068 -9999 0 -0.25 5 5
TMPRSS2 0.009 0.12 -9999 0 -0.7 5 5
CCND1 0.029 0.05 -9999 0 -0.23 7 7
PIAS1 0.037 0.01 -9999 0 -10000 0 0
mol:T-DHT 0.002 0.013 -9999 0 -0.06 9 9
CDC2L1 0 0 -9999 0 -10000 0 0
PIAS4 0.035 0.039 -9999 0 -0.33 2 2
T-DHT/AR/CDK6 0.035 0.07 -9999 0 -0.25 8 8
CMTM2 0.031 0.034 -9999 0 -0.19 5 5
SNURF 0 0 -9999 0 -10000 0 0
ZMIZ1 0.036 0.024 -9999 0 -10000 0 0
CCND3 0.035 0.016 -9999 0 -0.19 1 1
TGIF1 0.02 0.056 -9999 0 -0.3 5 5
FKBP4 0.035 0.035 -9999 0 -0.47 1 1
BARD1 signaling events

Figure S109.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S109.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BARD1/CSTF1 0.028 0.037 -10000 0 -0.34 1 1
ATM 0.032 0.041 -10000 0 -0.28 3 3
UBE2D3 0.034 0.035 -10000 0 -0.47 1 1
PRKDC 0.032 0.02 -10000 0 -0.19 1 1
ATR 0.036 0.016 -10000 0 -0.19 1 1
UBE2L3 0.035 0.01 -10000 0 -10000 0 0
FANCD2 0.027 0.027 -10000 0 -0.3 1 1
protein ubiquitination 0.069 0.079 -10000 0 -0.25 7 7
XRCC5 0.038 0.003 -10000 0 -10000 0 0
XRCC6 0.035 0.01 -10000 0 -10000 0 0
M/R/N Complex 0.058 0.046 -10000 0 -0.29 2 2
MRE11A 0.037 0.006 -10000 0 -10000 0 0
DNA-PK 0.061 0.032 -10000 0 -10000 0 0
FA complex/FANCD2/Ubiquitin 0.023 0.08 -10000 0 -0.37 4 4
FANCF 0.023 0.084 -10000 0 -0.47 6 6
BRCA1 0.036 0.007 -10000 0 -10000 0 0
CCNE1 0.028 0.055 -10000 0 -0.3 5 5
CDK2/Cyclin E1 0.035 0.071 -10000 0 -0.32 6 6
FANCG 0.034 0.035 -10000 0 -0.47 1 1
BRCA1/BACH1/BARD1 0.052 0.028 -10000 0 -0.34 1 1
FANCE 0.036 0.016 -10000 0 -0.19 1 1
FANCC 0.032 0.041 -10000 0 -0.28 3 3
NBN 0.03 0.037 -10000 0 -0.47 1 1
FANCA 0.02 0.082 -10000 0 -0.34 9 9
DNA repair 0.025 0.11 0.32 3 -0.36 3 6
BRCA1/BARD1/ubiquitin 0.052 0.028 -10000 0 -0.34 1 1
BARD1/DNA-PK 0.076 0.046 -10000 0 -0.26 1 1
FANCL 0.038 0 -10000 0 -10000 0 0
mRNA polyadenylation -0.028 0.037 0.34 1 -10000 0 1
BRCA1/BARD1/CTIP/M/R/N Complex 0.019 0.071 -10000 0 -0.3 4 4
BRCA1/BACH1/BARD1/TopBP1 0.071 0.03 -10000 0 -0.29 1 1
BRCA1/BARD1/P53 0.02 0.12 -10000 0 -0.26 29 29
BARD1/CSTF1/BRCA1 0.039 0.044 -10000 0 -0.29 1 1
BRCA1/BACH1 0.036 0.007 -10000 0 -10000 0 0
BARD1 0.035 0.035 -10000 0 -0.47 1 1
PCNA 0.013 0.085 -10000 0 -0.43 7 7
BRCA1/BARD1/UbcH5C 0.069 0.039 -10000 0 -0.29 2 2
BRCA1/BARD1/UbcH7 0.068 0.033 -10000 0 -0.29 1 1
BRCA1/BARD1/RAD51/PCNA 0.046 0.092 -10000 0 -0.32 8 8
BARD1/DNA-PK/P53 0.032 0.12 -10000 0 -0.25 23 23
BRCA1/BARD1/Ubiquitin 0.052 0.028 -10000 0 -0.34 1 1
BRCA1/BARD1/CTIP 0.036 0.057 -10000 0 -0.26 5 5
FA complex 0.024 0.063 -10000 0 -10000 0 0
BARD1/EWS 0.048 0.036 -10000 0 -0.34 1 1
RBBP8 0.006 0.05 -10000 0 -0.34 4 4
TP53 -0.039 0.17 -10000 0 -0.45 30 30
TOPBP1 0.037 0.005 -10000 0 -10000 0 0
G1/S transition of mitotic cell cycle -0.018 0.12 0.26 29 -10000 0 29
BRCA1/BARD1 0.077 0.083 -10000 0 -0.25 7 7
CSTF1 0.02 0.019 -10000 0 -10000 0 0
BARD1/EWS-Fli1 0.026 0.025 -10000 0 -0.34 1 1
CDK2 0.022 0.072 -10000 0 -0.26 11 11
UniProt:Q9BZD1 0 0 -10000 0 -10000 0 0
RAD51 0.022 0.078 -10000 0 -0.42 6 6
RAD50 0.032 0.049 -10000 0 -0.47 2 2
BRCA1/BARD1/DNA-directed RNA polymerase II holoenzyme 0.052 0.028 -10000 0 -0.34 1 1
EWSR1 0.032 0.028 -10000 0 -0.19 3 3
EPO signaling pathway

Figure S110.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S110.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.018 0.078 -10000 0 -10000 0 0
CRKL 0.02 0.078 0.32 3 -0.26 3 6
mol:DAG 0.019 0.045 -10000 0 -10000 0 0
HRAS 0.016 0.085 0.32 5 -0.4 1 6
MAPK8 0.046 0.073 0.31 3 -10000 0 3
RAP1A 0.022 0.07 0.32 3 -0.23 2 5
GAB1 0.018 0.075 0.33 2 -0.23 3 5
MAPK14 0.044 0.069 0.29 2 -10000 0 2
EPO 0.034 0.027 -10000 0 -0.19 2 2
PLCG1 0.019 0.046 -10000 0 -10000 0 0
EPOR/TRPC2/IP3 Receptors 0.034 0.031 -10000 0 -0.19 3 3
RAPGEF1 0.036 0.016 -10000 0 -0.19 1 1
EPO/EPOR (dimer)/SOCS3 0.047 0.075 -10000 0 -0.3 5 5
GAB1/SHC/GRB2/SOS1 0.051 0.078 -10000 0 -10000 0 0
EPO/EPOR (dimer) 0.047 0.038 -10000 0 -10000 0 0
IRS2 -0.001 0.079 0.23 1 -0.24 13 14
STAT1 0.042 0.079 -10000 0 -0.3 1 1
STAT5B 0.044 0.068 -10000 0 -10000 0 0
cell proliferation 0.026 0.072 0.2 18 -10000 0 18
GAB1/SHIP/PIK3R1/SHP2/SHC 0.026 0.079 -10000 0 -0.37 2 2
TEC 0.022 0.073 0.32 3 -0.24 1 4
SOCS3 0.013 0.092 -10000 0 -0.31 14 14
STAT1 (dimer) 0.044 0.078 -10000 0 -0.29 1 1
JAK2 0.021 0.076 -10000 0 -0.25 13 13
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
EPO/EPOR (dimer)/JAK2 0.078 0.074 -10000 0 -0.24 3 3
EPO/EPOR 0.047 0.038 -10000 0 -10000 0 0
LYN 0.031 0.017 -10000 0 -10000 0 0
TEC/VAV2 0.012 0.1 0.27 1 -0.29 3 4
elevation of cytosolic calcium ion concentration 0.034 0.031 -10000 0 -0.19 3 3
SHC1 0.037 0.006 -10000 0 -10000 0 0
EPO/EPOR (dimer)/LYN 0.058 0.048 -10000 0 -10000 0 0
mol:IP3 0.019 0.045 -10000 0 -10000 0 0
PI3K regualtory subunit polypeptide 1/IRS2/SHIP 0.005 0.09 0.22 1 -0.4 3 4
SH2B3 0.035 0.03 -10000 0 -0.19 3 3
NFKB1 0.044 0.069 0.28 2 -10000 0 2
EPO/EPOR (dimer)/JAK2/SOCS3 0.003 0.056 -10000 0 -0.22 8 8
PTPN6 0.019 0.068 0.28 2 -0.23 3 5
TEC/VAV2/GRB2 0.029 0.11 0.34 2 -0.3 2 4
EPOR 0.035 0.031 -10000 0 -0.19 3 3
INPP5D 0 0 -10000 0 -10000 0 0
mol:GDP 0.05 0.078 -10000 0 -10000 0 0
SOS1 0.038 0.003 -10000 0 -10000 0 0
PLCG2 -0.004 0.12 -10000 0 -0.31 25 25
CRKL/CBL/C3G 0.049 0.083 0.34 2 -0.31 1 3
VAV2 0 0.1 0.32 3 -0.24 19 22
CBL 0.021 0.072 0.32 3 -0.24 1 4
SHC/Grb2/SOS1 0.046 0.059 -10000 0 -10000 0 0
STAT5A 0.041 0.08 -10000 0 -0.55 1 1
GRB2 0.036 0.007 -10000 0 -10000 0 0
STAT5 (dimer) 0.056 0.1 -10000 0 -0.52 1 1
LYN/PLCgamma2 0.024 0.08 -10000 0 -0.34 7 7
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
BTK 0.003 0.088 0.26 2 -0.25 9 11
BCL2 -0.02 0.23 -10000 0 -0.76 16 16
Role of Calcineurin-dependent NFAT signaling in lymphocytes

Figure S111.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S111.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL2L1 0.022 0.019 -10000 0 -10000 0 0
NFATC1 -0.032 0.15 0.42 1 -0.43 18 19
NFATC2 0.037 0.054 0.17 3 -0.16 1 4
NFATC3 0.014 0.026 -10000 0 -0.36 1 1
YWHAE 0.03 0.015 -10000 0 -10000 0 0
Calcineurin A alpha-beta B1/CABIN1 -0.012 0.099 0.26 1 -0.35 8 9
Exportin 1/Ran/NUP214 0.073 0.021 -10000 0 -10000 0 0
mol:DAG 0 0.001 -10000 0 -10000 0 0
CABIN1/MEF2D/CaM/Ca2+/CAMK IV 0.023 0.1 0.24 1 -0.36 5 6
BCL2/BAX 0.015 0.076 -10000 0 -0.34 6 6
CaM/Ca2+/Calcineurin A alpha-beta B1 0.025 0.01 -10000 0 -10000 0 0
CaM/Ca2+ 0.025 0.01 -10000 0 -10000 0 0
BAX 0.034 0.027 -10000 0 -0.19 3 3
MAPK14 0.037 0.005 -10000 0 -10000 0 0
BAD 0.036 0.016 -10000 0 -0.19 1 1
CABIN1/MEF2D 0.004 0.1 0.25 1 -0.37 6 7
Calcineurin A alpha-beta B1/BCL2 0.001 0.093 -10000 0 -0.29 16 16
FKBP8 0.037 0.004 -10000 0 -10000 0 0
activation-induced cell death of T cells -0.004 0.1 0.37 6 -0.25 1 7
KPNB1 0.025 0.061 -10000 0 -0.26 8 8
KPNA2 0.033 0.035 -10000 0 -0.47 1 1
XPO1 0.038 0 -10000 0 -10000 0 0
SFN 0.021 0.07 -10000 0 -0.28 9 9
MAP3K8 0.009 0.1 -10000 0 -0.3 18 18
NFAT4/CK1 alpha 0.031 0.038 0.18 1 -0.21 1 2
MEF2D/NFAT1/Cbp/p300 0.069 0.092 -10000 0 -0.29 2 2
CABIN1 -0.012 0.099 0.26 1 -0.36 8 9
CALM1 0.033 0.012 -10000 0 -10000 0 0
RAN 0.037 0.004 -10000 0 -10000 0 0
MAP3K1 0.033 0.031 -10000 0 -0.19 4 4
CAMK4 0.037 0.006 -10000 0 -10000 0 0
mol:Ca2+ 0 0.002 -10000 0 -10000 0 0
MAPK3 0.025 0.072 -10000 0 -0.38 6 6
YWHAH 0.033 0.036 -10000 0 -0.47 1 1
Calcineurin A alpha-beta B1/AKAP79/PKA 0.018 0.1 -10000 0 -0.34 14 14
YWHAB 0.015 0.051 -10000 0 -0.47 2 2
MAPK8 0.036 0.007 -10000 0 -10000 0 0
MAPK9 0.035 0.035 -10000 0 -0.47 1 1
YWHAG 0.036 0.008 -10000 0 -10000 0 0
FKBP1A 0.027 0.037 -10000 0 -0.47 1 1
NFAT1-c-4/YWHAQ -0.001 0.14 0.43 1 -0.39 13 14
PRKCH 0.02 0.084 -10000 0 -0.47 6 6
CABIN1/Cbp/p300 0.035 0.076 -10000 0 -0.34 8 8
CASP3 0.033 0.036 -10000 0 -0.47 1 1
PIM1 0.032 0.041 -10000 0 -0.28 3 3
Calcineurin A alpha-beta B1/FKBP12/FK506 0.018 0.024 -10000 0 -0.28 1 1
apoptosis 0.008 0.025 -10000 0 -10000 0 0
14-3-3 family/BAD/CaM/Ca2+/Calcineurin A alpha-beta B1 0.029 0.075 -10000 0 -0.34 4 4
PRKCB 0 0 -10000 0 -10000 0 0
PRKCE 0.035 0.035 -10000 0 -0.47 1 1
JNK2/NFAT4 0.027 0.041 -10000 0 -0.29 2 2
BAD/BCL-XL 0.031 0.03 -10000 0 -10000 0 0
PRKCD 0.037 0.005 -10000 0 -10000 0 0
NUP214 0.035 0.022 -10000 0 -0.19 2 2
PRKCZ 0 0.001 -10000 0 -10000 0 0
PRKCA 0.032 0.039 -10000 0 -0.33 2 2
PRKCG 0.024 0.064 -10000 0 -0.24 10 10
PRKCQ -0.009 0.14 -10000 0 -0.36 25 25
FKBP38/BCL2 0.018 0.075 -10000 0 -0.31 7 7
EP300 0.018 0.091 -10000 0 -0.43 8 8
PRKCB1 0 0 -10000 0 -10000 0 0
CSNK2A1 0.029 0.016 -10000 0 -10000 0 0
NFATc/JNK1 -0.012 0.15 0.42 1 -0.4 18 19
CaM/Ca2+/FKBP38 0.044 0.018 -10000 0 -10000 0 0
FKBP12/FK506 0.02 0.027 -10000 0 -0.34 1 1
CSNK1A1 0.016 0.012 -10000 0 -10000 0 0
CaM/Ca2+/CAMK IV 0.043 0.018 -10000 0 -10000 0 0
NFATc/ERK1 -0.021 0.15 0.42 1 -0.41 17 18
CABIN1/YWHAQ/CaM/Ca2+/CAMK IV 0.026 0.1 0.24 1 -0.36 5 6
NR4A1 0.029 0.087 0.28 3 -0.29 1 4
GSK3B 0.035 0.035 -10000 0 -0.47 1 1
positive T cell selection 0.014 0.026 -10000 0 -0.36 1 1
NFAT1/CK1 alpha 0.035 0.042 0.16 1 -10000 0 1
RCH1/ KPNB1 0.042 0.056 -10000 0 -0.34 3 3
YWHAQ 0.038 0 -10000 0 -10000 0 0
PRKACA 0.037 0.006 -10000 0 -10000 0 0
AKAP5 -0.007 0.13 -10000 0 -0.38 21 21
MEF2D 0.037 0.006 -10000 0 -10000 0 0
mol:FK506 0 0 -10000 0 -10000 0 0
YWHAZ 0.031 0.014 -10000 0 -10000 0 0
NFATc/p38 alpha -0.016 0.15 0.42 1 -0.4 18 19
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
BCL2 0.001 0.093 -10000 0 -0.29 16 16
IGF1 pathway

Figure S112.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S112.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NCK2 0.038 0 -10000 0 -10000 0 0
PTK2 0.031 0.015 -10000 0 -10000 0 0
CRKL 0.001 0.057 -10000 0 -0.25 6 6
GRB2/SOS1/SHC 0.071 0.019 -10000 0 -10000 0 0
HRAS 0.034 0.038 -10000 0 -0.33 2 2
IRS1/Crk 0.012 0.056 -10000 0 -0.24 5 5
IGF-1R heterotetramer/IGF1/PTP1B 0.027 0.054 -10000 0 -0.32 2 2
AKT1 -0.024 0.052 0.23 1 -10000 0 1
BAD -0.024 0.05 0.22 1 -0.28 1 2
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.003 0.048 -10000 0 -0.24 5 5
IGF-1R heterotetramer/IGF1/IRS1/Shp2 0.02 0.068 -10000 0 -0.27 6 6
RAF1 -0.002 0.083 -10000 0 -0.46 4 4
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos 0.062 0.07 -10000 0 -0.24 4 4
YWHAZ 0.031 0.014 -10000 0 -10000 0 0
IGF-1R heterotetramer/IGF1/IRS1 0.025 0.064 -10000 0 -0.2 11 11
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
RPS6KB1 -0.025 0.054 0.23 1 -10000 0 1
GNB2L1 0.035 0.035 -10000 0 -0.47 1 1
positive regulation of MAPKKK cascade 0.015 0.082 -10000 0 -0.34 1 1
PXN 0.037 0.004 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
cell adhesion 0 0 -10000 0 -10000 0 0
GRB2/SOS1 0.054 0.011 -10000 0 -10000 0 0
HRAS/GTP 0.021 0.061 -10000 0 -0.22 4 4
IGF-1R heterotetramer/IGF1/GRB2/Sos/Shc 0.089 0.058 -10000 0 -0.22 4 4
IGF-1R heterotetramer 0.027 0.046 -10000 0 -0.34 2 2
IGF-1R heterotetramer/IGF1/IRS/Nck 0.041 0.07 -10000 0 -0.25 4 4
Crk/p130 Cas/Paxillin 0.061 0.069 -10000 0 -0.22 4 4
IGF1R 0.028 0.046 -10000 0 -0.34 2 2
IGF1 0.012 0.081 -10000 0 -0.25 14 14
IRS2/Crk -0.006 0.076 -10000 0 -0.25 15 15
PI3K 0.058 0.078 -10000 0 -0.24 7 7
apoptosis 0.001 0.052 0.25 1 -0.24 1 2
HRAS/GDP 0.025 0.027 -10000 0 -0.34 1 1
PRKCD 0.009 0.062 -10000 0 -0.33 3 3
RAF1/14-3-3 E 0.009 0.089 -10000 0 -0.4 5 5
BAD/14-3-3 -0.001 0.054 0.25 1 -0.27 1 2
PRKCZ -0.023 0.054 0.22 1 -0.22 8 9
Crk/p130 Cas/Paxillin/FAK1 0.016 0.062 -10000 0 -10000 0 0
PTPN1 0.015 0.051 -10000 0 -0.47 2 2
IGF-1R heterotetramer/IGF1/IRS1/GRB2/Sos/Shc/RACK1 0.011 0.065 -10000 0 -0.31 5 5
BCAR1 0.036 0.016 -10000 0 -0.19 1 1
IGF-1R heterotetramer/IGF1/SHC/GRB10 0.045 0.1 -10000 0 -0.27 17 17
mol:GDP 0 0 -10000 0 -10000 0 0
SOS1 0.038 0.003 -10000 0 -10000 0 0
IRS1/NCK2 0.023 0.063 -10000 0 -0.25 4 4
GRB10 -0.003 0.13 -10000 0 -0.41 18 18
PTPN11 0 0.061 -10000 0 -0.27 6 6
IRS1 0.003 0.059 -10000 0 -0.2 11 11
IRS2 -0.014 0.076 -10000 0 -0.27 14 14
IGF-1R heterotetramer/IGF1 0.027 0.072 -10000 0 -0.36 4 4
GRB2 0.036 0.007 -10000 0 -10000 0 0
PDPK1 -0.001 0.064 0.23 1 -0.23 8 9
YWHAE 0.03 0.015 -10000 0 -10000 0 0
PRKD1 -0.009 0.082 -10000 0 -0.32 7 7
SHC1 0.037 0.006 -10000 0 -10000 0 0
Angiopoietin receptor Tie2-mediated signaling

Figure S113.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S113.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
AKT1 0.065 0.12 -10000 0 -0.74 2 2
NCK1/PAK1/Dok-R -0.014 0.048 -10000 0 -0.36 2 2
NCK1/Dok-R 0.061 0.11 -10000 0 -1 1 1
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
mol:beta2-estradiol -0.009 0.019 0.24 1 -10000 0 1
RELA 0.037 0.006 -10000 0 -10000 0 0
SHC1 0.038 0.007 -10000 0 -10000 0 0
Rac/GDP 0.025 0.009 -10000 0 -10000 0 0
F2 -0.001 0.074 0.28 1 -0.4 5 6
TNIP2 0.035 0.017 -10000 0 -0.19 1 1
NF kappa B/RelA 0.11 0.094 -10000 0 -0.98 1 1
FN1 -0.014 0.13 -10000 0 -0.28 35 35
PLD2 0.022 0.084 -10000 0 -1.1 1 1
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
GRB14 -0.16 0.21 -10000 0 -0.34 114 114
ELK1 0.052 0.092 -10000 0 -0.96 1 1
GRB7 0.03 0.049 -10000 0 -0.47 2 2
PAK1 0.032 0.049 -10000 0 -0.47 2 2
Tie2/Ang1/alpha5/beta1 Integrin 0.09 0.12 -10000 0 -1 1 1
CDKN1A 0.051 0.17 0.52 1 -0.76 6 7
ITGA5 0.028 0.045 -10000 0 -0.19 9 9
mol:GTP 0 0 -10000 0 -10000 0 0
RasGAP/Dok-R 0.058 0.11 -10000 0 -1 1 1
CRK 0.03 0.015 -10000 0 -10000 0 0
mol:NO 0.078 0.12 0.56 1 -0.57 2 3
PLG 0.024 0.086 -10000 0 -1.1 1 1
mol:GDP 0 0 -10000 0 -10000 0 0
chemokinesis 0.076 0.11 -10000 0 -0.81 1 1
GRB2 0.036 0.007 -10000 0 -10000 0 0
PIK3R1 0.031 0.06 -10000 0 -0.47 3 3
ANGPT2 0.009 0.14 -10000 0 -1 1 1
BMX 0.013 0.092 -10000 0 -1.1 1 1
ANGPT1 0.027 0.1 -10000 0 -1.3 1 1
tube development 0.047 0.13 0.51 1 -0.68 1 2
ANGPT4 0.023 0.061 -10000 0 -0.47 3 3
response to hypoxia 0.001 0.008 -10000 0 -10000 0 0
Tie2/Ang1/GRB14 0.005 0.15 -10000 0 -1.1 1 1
alpha5/beta1 Integrin 0.046 0.039 -10000 0 -10000 0 0
FGF2 0 0.11 -10000 0 -0.28 24 24
STAT5A (dimer) 0.064 0.15 -10000 0 -0.7 2 2
mol:L-citrulline 0.078 0.12 0.56 1 -0.57 2 3
AGTR1 0.01 0.082 -10000 0 -0.21 24 24
MAPK14 0.068 0.1 -10000 0 -0.94 1 1
Tie2/SHP2 0.062 0.06 -10000 0 -10000 0 0
TEK 0.035 0.055 -10000 0 -10000 0 0
RPS6KB1 0.074 0.12 0.51 1 -0.77 1 2
Angiotensin II/AT1 0.012 0.057 -10000 0 -0.14 24 24
Tie2/Ang1/GRB2 0.076 0.096 -10000 0 -1.1 1 1
MAPK3 0.024 0.089 -10000 0 -0.99 1 1
MAPK1 0.027 0.083 -10000 0 -0.99 1 1
Tie2/Ang1/GRB7 0.072 0.1 -10000 0 -1.1 1 1
NFKB1 0.037 0.006 -10000 0 -10000 0 0
MAPK8 0.026 0.084 -10000 0 -1.1 1 1
PI3K 0.07 0.12 -10000 0 -0.89 1 1
FES 0.036 0.14 -10000 0 -0.97 2 2
Crk/Dok-R 0.056 0.1 -10000 0 -1 1 1
Tie2/Ang1/ABIN2 0.076 0.096 -10000 0 -1.1 1 1
blood circulation 0 0 -10000 0 -10000 0 0
negative regulation of caspase activity 0.074 0.12 -10000 0 -0.67 2 2
STAT5A 0.03 0.046 -10000 0 -0.24 5 5
mol:ROS 0 0 -10000 0 -10000 0 0
PTK2 0.097 0.13 0.51 1 -0.77 1 2
Tie2/Ang2 0.03 0.12 -10000 0 -0.91 1 1
Tie2/Ang1 0.032 0.091 -10000 0 -1.1 1 1
FOXO1 0.088 0.14 -10000 0 -0.72 1 1
ELF1 0.028 0.052 -10000 0 -0.46 2 2
ELF2 0.03 0.084 -10000 0 -1 1 1
mol:Choline 0.022 0.081 -10000 0 -1 1 1
cell migration -0.004 0.039 -10000 0 -0.21 2 2
FYN 0.044 0.13 -10000 0 -0.77 1 1
DOK2 0.013 0.062 -10000 0 -0.21 13 13
negative regulation of cell cycle 0.055 0.16 0.51 1 -0.68 6 7
ETS1 0.035 0.056 -10000 0 -0.35 2 2
PXN 0.096 0.13 0.45 2 -0.65 1 3
ITGB1 0.036 0.016 -10000 0 -0.19 1 1
NOS3 0.075 0.13 -10000 0 -0.64 2 2
RAC1 0.034 0.012 -10000 0 -10000 0 0
TNF 0.033 0.068 -10000 0 -0.4 3 3
MAPKKK cascade 0.022 0.081 -10000 0 -1 1 1
RASA1 0.026 0.07 -10000 0 -0.41 5 5
Tie2/Ang1/Shc 0.078 0.098 -10000 0 -1.1 1 1
NCK1 0.028 0.069 -10000 0 -0.47 4 4
vasculogenesis 0.077 0.12 0.47 2 -0.51 2 4
mol:Phosphatidic acid 0.022 0.081 -10000 0 -1 1 1
mol:Angiotensin II 0.001 0.004 -10000 0 -10000 0 0
mol:NADP 0.078 0.12 0.56 1 -0.57 2 3
Rac1/GTP 0.07 0.11 -10000 0 -0.72 1 1
MMP2 0.02 0.099 -10000 0 -1.3 1 1
Neurotrophic factor-mediated Trk receptor signaling

Figure S114.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S114.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
CRKL 0.03 0.049 -10000 0 -0.47 2 2
RAS family/GTP/Tiam1 0.006 0.068 -10000 0 -0.27 4 4
NT3 (dimer)/TRKC 0.03 0.074 -10000 0 -0.34 6 6
NT3 (dimer)/TRKB 0.029 0.09 -10000 0 -0.3 7 7
SHC/Grb2/SOS1/GAB1/PI3K 0.033 0.046 -10000 0 -10000 0 0
RAPGEF1 0.036 0.016 -10000 0 -0.19 1 1
BDNF 0.019 0.08 -10000 0 -0.28 12 12
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
DYNLT1 0.036 0.008 -10000 0 -10000 0 0
NTRK1 0.036 0.016 -10000 0 -0.19 1 1
NTRK2 0.006 0.078 -10000 0 -0.19 30 30
NTRK3 0.033 0.023 -10000 0 -0.19 2 2
NT-4/5 (dimer)/TRKB 0.026 0.054 -10000 0 -0.19 1 1
neuron apoptosis 0.013 0.15 0.36 25 -10000 0 25
SHC 2-3/Grb2 -0.015 0.16 -10000 0 -0.39 25 25
SHC1 0.037 0.006 -10000 0 -10000 0 0
SHC2 -0.017 0.15 -10000 0 -0.52 15 15
SHC3 -0.018 0.15 -10000 0 -0.51 15 15
STAT3 (dimer) 0.037 0.041 -10000 0 -0.3 2 2
NT3 (dimer)/TRKA 0.05 0.072 -10000 0 -0.29 6 6
RIN/GDP 0.043 0.092 0.31 7 -0.28 2 9
GIPC1 0.031 0.051 -10000 0 -0.38 3 3
KRAS 0.033 0.038 -10000 0 -0.33 2 2
DNAJA3 0.009 0.047 0.21 4 -0.22 1 5
RIN/GTP 0.019 0.013 -10000 0 -10000 0 0
CCND1 0.016 0.069 -10000 0 -0.6 2 2
MAGED1 0.026 0.072 -10000 0 -0.38 6 6
PTPN11 0.031 0.051 -10000 0 -0.38 3 3
RICS 0 0 -10000 0 -10000 0 0
NT-4/5 (dimer) 0 0 -10000 0 -10000 0 0
SHC/GRB2/SOS1 0.071 0.019 -10000 0 -10000 0 0
GRB2 0.036 0.007 -10000 0 -10000 0 0
NGF (dimer)/TRKA/MATK 0.045 0.026 -10000 0 -0.19 1 1
TRKA/NEDD4-2 0.03 0.053 -10000 0 -0.34 3 3
ELMO1 0.033 0.012 -10000 0 -10000 0 0
RhoG/GTP/ELMO1/DOCK1 0.034 0.054 -10000 0 -0.29 5 5
NGF 0 0 -10000 0 -10000 0 0
HRAS 0.034 0.038 -10000 0 -0.33 2 2
DOCK1 0.024 0.078 -10000 0 -0.42 6 6
GAB2 0.037 0.004 -10000 0 -10000 0 0
RIT2 0.026 0.018 -10000 0 -10000 0 0
RIT1 0.036 0.016 -10000 0 -0.19 1 1
FRS2 0.035 0.022 -10000 0 -0.19 2 2
DNM1 0.033 0.031 -10000 0 -0.19 4 4
mol:GTP 0 0 -10000 0 -10000 0 0
CRK 0.03 0.015 -10000 0 -10000 0 0
SH2B1 (homopentamer) 0 0 -10000 0 -10000 0 0
RhoG/GTP 0.033 0.049 0.23 4 -10000 0 4
mol:GDP 0.052 0.12 0.35 8 -0.4 3 11
NGF (dimer) 0 0 -10000 0 -10000 0 0
RhoG/GDP 0.025 0.009 -10000 0 -10000 0 0
RIT1/GDP 0.048 0.085 0.22 6 -0.27 3 9
TIAM1 0.03 0.051 -10000 0 -0.38 3 3
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
BDNF (dimer)/TRKB 0.026 0.089 -10000 0 -0.26 8 8
KIDINS220/CRKL/C3G 0.047 0.042 -10000 0 -0.34 2 2
SHC/RasGAP 0.045 0.055 -10000 0 -0.34 4 4
FRS2 family/SHP2 0.068 0.045 -10000 0 -0.33 2 2
SHC/GRB2/SOS1/GAB1 0.084 0.047 -10000 0 -0.26 2 2
RIT1/GTP 0.026 0.011 -10000 0 -0.12 1 1
NT3 (dimer) 0.013 0.092 -10000 0 -0.31 14 14
RAP1/GDP 0.042 0.07 0.18 5 -0.24 2 7
KIDINS220/CRKL 0.03 0.049 -10000 0 -0.47 2 2
BDNF (dimer) 0.019 0.08 -10000 0 -0.28 12 12
ubiquitin-dependent protein catabolic process 0.027 0.046 -10000 0 -0.28 3 3
Schwann cell development -0.008 0.018 -10000 0 -10000 0 0
EHD4 0.029 0.052 -10000 0 -0.38 3 3
FRS2 family/GRB2/SOS1 0.087 0.032 -10000 0 -10000 0 0
FRS2 family/SHP2/CRK family/C3G/GAB2 0.01 0.078 -10000 0 -0.35 5 5
RAP1B 0.035 0.035 -10000 0 -0.47 1 1
RAP1A 0.036 0.009 -10000 0 -10000 0 0
CDC42/GTP 0 0.097 -10000 0 -0.37 7 7
ABL1 0.037 0.005 -10000 0 -10000 0 0
SH2B family/GRB2/SOS1 0.054 0.011 -10000 0 -10000 0 0
Rap1/GTP 0.01 0.11 -10000 0 -0.4 9 9
STAT3 0.037 0.041 -10000 0 -0.3 2 2
axon guidance -0.009 0.087 -10000 0 -0.35 7 7
MAPK3 0.019 0.056 0.22 6 -0.26 4 10
MAPK1 0.024 0.04 0.22 6 -10000 0 6
CDC42/GDP 0.056 0.097 0.29 9 -0.28 3 12
NTF3 0.013 0.092 -10000 0 -0.31 14 14
NTF4 0 0 -10000 0 -10000 0 0
NGF (dimer)/TRKA/FAIM 0.04 0.052 -10000 0 -0.29 5 5
PI3K 0.048 0.047 -10000 0 -0.34 3 3
FRS3 0.037 0.006 -10000 0 -10000 0 0
FAIM 0.024 0.078 -10000 0 -0.42 6 6
GAB1 0.03 0.053 -10000 0 -0.33 4 4
RASGRF1 0.002 0.051 0.21 4 -0.22 2 6
SOS1 0.038 0.003 -10000 0 -10000 0 0
MCF2L -0.001 0.063 -10000 0 -0.29 8 8
RGS19 0.013 0.049 -10000 0 -0.23 6 6
CDC42 0.034 0.018 -10000 0 -0.19 1 1
RAS family/GTP 0.048 0.093 0.48 2 -10000 0 2
Rac1/GDP 0.043 0.087 0.29 5 -0.26 3 8
NGF (dimer)/TRKA/GRIT 0.024 0.009 -10000 0 -10000 0 0
neuron projection morphogenesis 0.031 0.11 -10000 0 -0.87 2 2
NGF (dimer)/TRKA/NEDD4-2 0.028 0.046 -10000 0 -0.29 3 3
MAP2K1 0.022 0.042 -10000 0 -0.25 2 2
NGFR 0.035 0.017 -10000 0 -0.19 1 1
NGF (dimer)/TRKA/GIPC/GAIP 0.013 0.035 -10000 0 -0.22 3 3
RAS family/GTP/PI3K 0.021 0.056 -10000 0 -0.24 8 8
FRS2 family/SHP2/GRB2/SOS1 0.097 0.052 -10000 0 -0.29 2 2
NRAS 0.021 0.076 -10000 0 -0.31 9 9
GRB2/SOS1 0.054 0.011 -10000 0 -10000 0 0
PRKCI 0.03 0.053 -10000 0 -0.33 4 4
ChemicalAbstracts:146-91-8 0 0 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
PRKCZ 0 0 -10000 0 -10000 0 0
MAPKKK cascade -0.005 0.085 -10000 0 -0.49 4 4
RASA1 0.026 0.07 -10000 0 -0.41 5 5
TRKA/c-Abl 0.052 0.017 -10000 0 -10000 0 0
SQSTM1 0.036 0.016 -10000 0 -0.19 1 1
BDNF (dimer)/TRKB/GIPC 0.045 0.092 -10000 0 -0.26 7 7
NGF (dimer)/TRKA/p62/Atypical PKCs 0.059 0.039 -10000 0 -0.28 2 2
MATK 0.032 0.031 -10000 0 -0.19 4 4
NEDD4L 0.018 0.062 -10000 0 -0.4 4 4
RAS family/GDP -0.015 0.042 -10000 0 -0.22 3 3
NGF (dimer)/TRKA 0.017 0.044 0.23 4 -10000 0 4
Rac1/GTP -0.006 0.057 -10000 0 -0.24 2 2
FRS2 family/SHP2/CRK family 0.076 0.074 -10000 0 -0.34 3 3
LPA4-mediated signaling events

Figure S115.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S115.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
ADCY4 -0.023 0.065 -10000 0 -0.29 12 12
ADCY5 -0.008 0.021 -10000 0 -0.29 1 1
ADCY6 -0.008 0.019 -10000 0 -0.29 1 1
ADCY7 -0.01 0.028 -10000 0 -0.29 2 2
ADCY1 -0.007 0.019 -10000 0 -0.29 1 1
ADCY2 -0.008 0.02 -10000 0 -0.29 1 1
ADCY3 -0.021 0.062 -10000 0 -0.29 11 11
ADCY8 -0.011 0.039 -10000 0 -0.29 4 4
PRKCE 0.009 0.024 -10000 0 -0.34 1 1
ADCY9 -0.013 0.039 -10000 0 -0.29 4 4
mol:DAG 0 0 -10000 0 -10000 0 0
cAMP biosynthetic process 0.014 0.077 0.24 7 -0.34 1 8
Regulation of cytoplasmic and nuclear SMAD2/3 signaling

Figure S116.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S116.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
SMAD4 0.023 0.038 -9999 0 -0.47 1 1
SMAD2 0.006 0.065 -9999 0 -0.24 6 6
SMAD3 0 0.08 -9999 0 -0.41 4 4
SMAD3/SMAD4 0.007 0.12 -9999 0 -0.48 10 10
SMAD4/Ubc9/PIASy 0.042 0.055 -9999 0 -0.28 2 2
SMAD2/SMAD2/SMAD4 0.035 0.086 -9999 0 -0.32 1 1
PPM1A 0.034 0.012 -9999 0 -10000 0 0
CALM1 0.033 0.012 -9999 0 -10000 0 0
SMAD2/SMAD4 0.008 0.062 -9999 0 -0.24 3 3
MAP3K1 0.033 0.031 -9999 0 -0.19 4 4
TRAP-1/SMAD4 0.025 0.071 -9999 0 -0.33 7 7
MAPK3 0.025 0.072 -9999 0 -0.38 6 6
MAPK1 0.035 0.01 -9999 0 -10000 0 0
NUP214 0.035 0.022 -9999 0 -0.19 2 2
CTDSP1 0.038 0.003 -9999 0 -10000 0 0
CTDSP2 0.03 0.053 -9999 0 -0.33 4 4
CTDSPL 0.017 0.093 -9999 0 -0.38 10 10
KPNB1 0.025 0.061 -9999 0 -0.26 8 8
TGFBRAP1 0.024 0.084 -9999 0 -0.47 6 6
UBE2I 0.036 0.008 -9999 0 -10000 0 0
NUP153 0.034 0.035 -9999 0 -0.47 1 1
KPNA2 0.033 0.035 -9999 0 -0.47 1 1
PIAS4 0.033 0.038 -9999 0 -0.33 2 2
Ephrin A reverse signaling

Figure S117.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S117.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
MAPKKK cascade 0.04 0.045 -10000 0 -0.28 3 3
EFNA5 0.031 0.051 -10000 0 -0.38 3 3
FYN 0.003 0.062 0.19 1 -0.26 9 10
neuron projection morphogenesis 0.04 0.045 -10000 0 -0.28 3 3
cell-cell signaling 0 0 -10000 0 -10000 0 0
Ephrin A5/EPHA5 0.04 0.045 -10000 0 -0.29 3 3
EPHA5 0.031 0.044 -10000 0 -0.26 4 4
Aurora A signaling

Figure S118.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S118.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Aurora A/GADD45A 0.055 0.069 -10000 0 -0.27 4 4
BIRC5 0.025 0.07 -10000 0 -0.41 5 5
NFKBIA 0.001 0.04 0.19 1 -0.26 3 4
CPEB1 0.03 0.049 -10000 0 -0.47 2 2
AKT1 0.002 0.034 0.19 1 -0.26 2 3
NDEL1 0.03 0.015 -10000 0 -10000 0 0
Aurora A/BRCA1 0.047 0.048 -10000 0 -0.23 2 2
NDEL1/TACC3 0.053 0.063 -10000 0 -0.22 3 3
GADD45A 0.022 0.076 -10000 0 -0.31 9 9
GSK3B 0.033 0.035 -10000 0 -0.47 1 1
PAK1/Aurora A 0.062 0.061 -10000 0 -0.26 4 4
MDM2 0.036 0.016 -10000 0 -0.19 1 1
JUB 0 0 -10000 0 -10000 0 0
TPX2 0.008 0.035 -10000 0 -0.34 2 2
TP53 -0.024 0.1 -10000 0 -0.29 21 21
DLG7 0.004 0.034 0.19 1 -0.23 3 4
AURKAIP1 0.033 0.036 -10000 0 -0.47 1 1
ARHGEF7 0.027 0.017 -10000 0 -10000 0 0
G2 phase of mitotic cell cycle 0 0 -10000 0 -10000 0 0
Aurora A/NDEL1/TACC3 0.056 0.067 -10000 0 -0.23 3 3
G2/M transition of mitotic cell cycle 0.046 0.048 -10000 0 -0.22 2 2
AURKA 0.009 0.042 0.24 1 -0.27 3 4
AURKB -0.006 0.065 -10000 0 -0.18 19 19
CDC25B -0.001 0.07 -10000 0 -0.31 9 9
G2/M transition checkpoint 0.004 0.029 -10000 0 -0.23 2 2
mRNA polyadenylation 0.043 0.052 -10000 0 -0.23 2 2
Aurora A/CPEB 0.043 0.052 -10000 0 -0.23 2 2
Aurora A/TACC1/TRAP/chTOG 0.071 0.082 -10000 0 -0.23 6 6
BRCA1 0.036 0.007 -10000 0 -10000 0 0
centrosome duplication 0.062 0.061 -10000 0 -0.26 4 4
regulation of centrosome cycle 0.052 0.062 -10000 0 -0.22 3 3
spindle assembly 0.069 0.081 -10000 0 -0.23 6 6
TDRD7 0.035 0.035 -10000 0 -0.47 1 1
Aurora A/RasGAP/Survivin 0.077 0.078 -10000 0 -0.35 3 3
CENPA 0.007 0.058 -10000 0 -0.56 2 2
Aurora A/PP2A 0.064 0.051 -10000 0 -0.26 2 2
meiosis 0 0 -10000 0 -10000 0 0
protein catabolic process 0.02 0.06 -10000 0 -0.27 2 2
negative regulation of DNA binding -0.024 0.1 -10000 0 -0.29 21 21
prophase 0 0 -10000 0 -10000 0 0
GIT1/beta-PIX 0.04 0.025 -10000 0 -10000 0 0
RASA1 0.026 0.07 -10000 0 -0.41 5 5
Ajuba/Aurora A 0.004 0.029 -10000 0 -0.23 2 2
mitotic prometaphase 0.012 0.031 -10000 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0.009 0.042 0.24 1 -0.27 3 4
TACC1 0.011 0.091 -10000 0 -0.32 13 13
TACC3 0.025 0.072 -10000 0 -0.38 6 6
Aurora A/Antizyme1 0.075 0.057 -10000 0 -0.24 2 2
Aurora A/RasGAP 0.058 0.067 -10000 0 -0.3 3 3
OAZ1 0.037 0.006 -10000 0 -10000 0 0
RAN 0.037 0.004 -10000 0 -10000 0 0
mitosis 0 0 -10000 0 -10000 0 0
PRKACA 0.035 0.008 -10000 0 -10000 0 0
GIT1 0.035 0.017 -10000 0 -0.19 1 1
GIT1/beta-PIX/PAK1 0.05 0.048 -10000 0 -0.29 2 2
Importin alpha/Importin beta/TPX2 0.008 0.035 -10000 0 -0.34 2 2
PPP2R5D 0.036 0.016 -10000 0 -0.19 1 1
Aurora A/TPX2 0.016 0.053 -10000 0 -0.32 4 4
PAK1 0.032 0.049 -10000 0 -0.47 2 2
CKAP5 0.037 0.004 -10000 0 -10000 0 0
Aurora C signaling

Figure S119.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S119.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
INCENP 0.017 0.093 -9999 0 -0.38 10 10
Aurora C/Aurora B/INCENP 0.04 0.07 -9999 0 -0.25 9 9
metaphase 0 0 -9999 0 -10000 0 0
mitosis 0 0 -9999 0 -10000 0 0
H3F3B 0.005 0.064 -9999 0 -0.43 4 4
AURKB 0.027 0.037 -9999 0 -0.47 1 1
AURKC 0.035 0.022 -9999 0 -0.19 2 2
Insulin-mediated glucose transport

Figure S120.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S120.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Insulin responsive Vesicles 0.004 0.13 0.23 1 -0.29 17 18
CaM/Ca2+ 0.024 0.009 -10000 0 -10000 0 0
AKT1 0.03 0.028 -10000 0 -0.19 3 3
AKT2 0.036 0.008 -10000 0 -10000 0 0
STXBP4 0.036 0.008 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
mol:glucose -0.018 0.13 0.24 1 -0.28 24 25
YWHAZ 0.031 0.014 -10000 0 -10000 0 0
CALM1 0.033 0.012 -10000 0 -10000 0 0
YWHAQ 0.038 0 -10000 0 -10000 0 0
TBC1D4 0.002 0.056 -10000 0 -0.34 5 5
mol:Ca2+ 0 0 -10000 0 -10000 0 0
YWHAH 0.033 0.036 -10000 0 -0.47 1 1
YWHAB 0.015 0.051 -10000 0 -0.47 2 2
SNARE/Synip 0.056 0.04 -10000 0 -0.27 1 1
YWHAG 0.036 0.008 -10000 0 -10000 0 0
ASIP 0 0 -10000 0 -10000 0 0
PRKCI 0.03 0.053 -10000 0 -0.33 4 4
AS160/CaM/Ca2+ 0.024 0.009 -10000 0 -10000 0 0
RHOQ 0.033 0.041 -10000 0 -0.28 3 3
GYS1 0.013 0.021 -10000 0 -0.26 1 1
PRKCZ 0 0 -10000 0 -10000 0 0
TRIP10 0.037 0.004 -10000 0 -10000 0 0
TC10/GTP/CIP4/Exocyst 0.046 0.028 -10000 0 -0.29 1 1
AS160/14-3-3 0.001 0.07 -10000 0 -0.29 4 4
VAMP2 0.03 0.015 -10000 0 -10000 0 0
SLC2A4 -0.021 0.14 0.24 1 -0.3 26 27
STX4 0.034 0.035 -10000 0 -0.47 1 1
GSK3B 0.024 0.026 -10000 0 -0.3 1 1
SFN 0.021 0.07 -10000 0 -0.28 9 9
LNPEP 0.036 0.007 -10000 0 -10000 0 0
YWHAE 0.03 0.015 -10000 0 -10000 0 0
Signaling events mediated by HDAC Class I

Figure S121.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S121.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
NF kappa B/RelA 0.067 0.077 -10000 0 -0.29 3 3
Ran/GTP/Exportin 1/HDAC1 0.009 0.017 -10000 0 -0.22 1 1
NF kappa B1 p50/RelA/I kappa B alpha 0.032 0.085 0.3 1 -0.3 4 5
SUMO1 0.038 0.003 -10000 0 -10000 0 0
ZFPM1 0.035 0.017 -10000 0 -0.19 1 1
NPC/RanGAP1/SUMO1/Ubc9 0.017 0.02 -10000 0 -0.2 1 1
FKBP3 0.034 0.012 -10000 0 -10000 0 0
Histones 0.081 0.05 -10000 0 -10000 0 0
YY1/LSF 0.004 0.085 -10000 0 -0.25 14 14
SMG5 0.036 0.016 -10000 0 -0.19 1 1
RAN 0.037 0.004 -10000 0 -10000 0 0
I kappa B alpha/HDAC3 0.028 0.037 -10000 0 -0.23 3 3
I kappa B alpha/HDAC1 0.025 0.071 -10000 0 -0.33 1 1
SAP18 0.028 0.017 -10000 0 -10000 0 0
RELA 0.022 0.055 -10000 0 -0.2 10 10
HDAC1/Smad7 0.049 0.043 -10000 0 -0.29 1 1
RANGAP1 0.032 0.028 -10000 0 -0.19 3 3
HDAC3/TR2 0.046 0.041 -10000 0 -10000 0 0
NuRD/MBD3 Complex 0.017 0.078 -10000 0 -0.39 4 4
NF kappa B1 p50/RelA 0.027 0.09 0.32 1 -0.3 6 7
EntrezGene:23225 0 0 -10000 0 -10000 0 0
GATA2 0.031 0.051 -10000 0 -0.38 3 3
GATA1 0.029 0.061 -10000 0 -0.4 4 4
Mad/Max 0.043 0.044 -10000 0 -0.34 1 1
NuRD/MBD3 Complex/GATA1/Fog1 0.012 0.098 -10000 0 -0.41 5 5
RBBP7 0.035 0.022 -10000 0 -0.19 2 2
NPC 0.021 0.019 -10000 0 -0.24 1 1
RBBP4 0.03 0.044 -10000 0 -0.26 4 4
MAX 0.034 0.011 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
FBXW11 0.037 0.004 -10000 0 -10000 0 0
NFKBIA 0.023 0.037 -10000 0 -0.36 1 1
KAT2B 0 0 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
SIN3/HDAC complex 0.041 0.061 -10000 0 -0.36 1 1
SIN3 complex 0.061 0.052 -10000 0 -0.26 1 1
SMURF1 0.036 0.008 -10000 0 -10000 0 0
CHD3 0.029 0.021 -10000 0 -0.19 1 1
SAP30 0.033 0.035 -10000 0 -0.47 1 1
EntrezGene:23636 0 0 -10000 0 -10000 0 0
NCOR1 0.029 0.016 -10000 0 -10000 0 0
YY1/HDAC3 0.01 0.068 -10000 0 -0.26 4 4
YY1/HDAC2 0.006 0.081 -10000 0 -0.24 13 13
YY1/HDAC1 0.007 0.08 -10000 0 -0.24 12 12
NuRD/MBD2 Complex (MeCP1) 0.007 0.088 -10000 0 -0.31 9 9
PPARG -0.013 0.12 -10000 0 -0.32 25 25
HDAC8/hEST1B 0.072 0.021 -10000 0 -10000 0 0
UBE2I 0.036 0.008 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.037 0.004 -10000 0 -10000 0 0
TNFRSF1A 0.036 0.008 -10000 0 -10000 0 0
HDAC3/SMRT (N-CoR2) 0.045 0.046 -10000 0 -0.24 1 1
MBD3L2 0.021 0.086 -10000 0 -0.4 8 8
ubiquitin-dependent protein catabolic process 0.049 0.042 -10000 0 -0.29 1 1
CREBBP 0.034 0.035 -10000 0 -0.47 1 1
NuRD/MBD3/MBD3L2 Complex 0.01 0.1 -10000 0 -0.38 5 5
HDAC1 0.036 0.008 -10000 0 -10000 0 0
HDAC3 0.028 0.024 -10000 0 -10000 0 0
HDAC2 0.034 0.035 -10000 0 -0.47 1 1
YY1 0.007 0.059 -10000 0 -0.27 9 9
HDAC8 0.038 0.003 -10000 0 -10000 0 0
SMAD7 0.024 0.038 -10000 0 -0.47 1 1
NCOR2 0.034 0.038 -10000 0 -0.33 2 2
MXD1 0.028 0.052 -10000 0 -0.22 8 8
STAT3 0.015 0.063 -10000 0 -0.3 8 8
NFKB1 0.037 0.006 -10000 0 -10000 0 0
EntrezGene:8021 0 0 -10000 0 -10000 0 0
RANBP2 0.034 0.038 -10000 0 -0.33 2 2
YY1/LSF/HDAC1 0.02 0.087 -10000 0 -0.23 14 14
YY1/SAP30/HDAC1 0.022 0.085 -10000 0 -0.23 13 13
EP300 0.017 0.091 -10000 0 -0.43 8 8
STAT3 (dimer non-phopshorylated) 0.015 0.063 -10000 0 -0.3 8 8
proteasomal ubiquitin-dependent protein catabolic process 0.023 0.037 -10000 0 -0.35 1 1
histone deacetylation 0.007 0.088 -10000 0 -0.31 9 9
STAT3 (dimer non-phopshorylated)/HDAC3 0.028 0.061 -10000 0 -0.24 1 1
nuclear export -0.071 0.021 -10000 0 -10000 0 0
PRKACA 0.037 0.006 -10000 0 -10000 0 0
GATAD2B 0.037 0.006 -10000 0 -10000 0 0
GATAD2A 0.035 0.035 -10000 0 -0.47 1 1
GATA2/HDAC3 0.043 0.05 -10000 0 -0.24 2 2
GATA1/HDAC1 0.046 0.049 -10000 0 -0.34 3 3
GATA1/HDAC3 0.041 0.053 -10000 0 -0.24 3 3
CHD4 0.036 0.008 -10000 0 -10000 0 0
TNF-alpha/TNFR1A 0.043 0.05 -10000 0 -0.34 2 2
SIN3/HDAC complex/Mad/Max 0.032 0.07 -10000 0 -0.31 4 4
NuRD Complex -0.015 0.12 -10000 0 -0.37 10 10
positive regulation of chromatin silencing 0.078 0.049 -10000 0 -10000 0 0
SIN3B 0.037 0.005 -10000 0 -10000 0 0
MTA2 0.032 0.049 -10000 0 -0.47 2 2
SIN3A 0.034 0.018 -10000 0 -0.19 1 1
XPO1 0.038 0 -10000 0 -10000 0 0
SUMO1/HDAC1 0.048 0.044 -10000 0 -10000 0 0
HDAC complex 0.08 0.051 -10000 0 -0.26 2 2
GATA1/Fog1 0.046 0.05 -10000 0 -0.34 3 3
FKBP25/HDAC1/HDAC2 0.06 0.04 -10000 0 -0.29 1 1
TNF 0.025 0.062 -10000 0 -0.25 9 9
negative regulation of cell growth 0.032 0.07 -10000 0 -0.31 4 4
NuRD/MBD2/PRMT5 Complex 0.007 0.088 -10000 0 -0.31 9 9
Ran/GTP/Exportin 1 0.05 0.045 -10000 0 -10000 0 0
NF kappa B/RelA/I kappa B alpha 0.014 0.072 -10000 0 -0.3 5 5
SIN3/HDAC complex/NCoR1 0.005 0.075 -10000 0 -0.32 6 6
TFCP2 0.032 0.049 -10000 0 -0.47 2 2
NR2C1 0.036 0.016 -10000 0 -0.19 1 1
MBD3 0.036 0.007 -10000 0 -10000 0 0
MBD2 0.026 0.018 -10000 0 -10000 0 0
Atypical NF-kappaB pathway

Figure S122.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S122.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
BCL3/RelA 0.044 0.061 -10000 0 -0.34 5 5
FBXW11 0.037 0.004 -10000 0 -10000 0 0
NF kappa B1 p50/c-Rel 0.032 0.035 -10000 0 -0.29 2 2
NF kappa B1 p50/RelA/I kappa B alpha 0.041 0.091 0.24 2 -0.34 2 4
NFKBIA 0.035 0.08 -10000 0 -0.31 4 4
MAPK14 0.037 0.005 -10000 0 -10000 0 0
NF kappa B1 p105/p50 0.035 0.016 -10000 0 -10000 0 0
ARRB2 0.015 0.024 -10000 0 -0.31 1 1
REL 0.028 0.069 -10000 0 -0.47 4 4
response to oxidative stress 0 0 -10000 0 -10000 0 0
BCL3/NF kappa B1 p50 0.028 0.048 -10000 0 -0.29 4 4
response to UV 0 0 -10000 0 -10000 0 0
NF kappa B1 p105/RelA 0.034 0.017 -10000 0 -10000 0 0
PIK3CA 0.037 0.004 -10000 0 -10000 0 0
NF kappa B1 p50 dimer 0.025 0.011 -10000 0 -10000 0 0
PIK3R1 0.03 0.06 -10000 0 -0.47 3 3
NFKB1 0.016 0.008 -10000 0 -10000 0 0
RELA 0.037 0.006 -10000 0 -10000 0 0
positive regulation of anti-apoptosis 0.026 0.074 -10000 0 -0.28 3 3
NF kappa B1 p50/RelA/I kappa B alpha/beta Arrestin2 0.036 0.088 0.23 1 -0.32 2 3
SRC 0.013 0.06 -10000 0 -0.47 3 3
PI3K 0.048 0.047 -10000 0 -0.34 3 3
NF kappa B1 p50/RelA 0.026 0.074 -10000 0 -0.28 3 3
IKBKB 0.032 0.013 -10000 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.037 0.004 -10000 0 -10000 0 0
SYK 0.031 0.051 -10000 0 -0.38 3 3
I kappa B alpha/PIK3R1 0.039 0.11 0.24 2 -0.33 8 10
cell death 0.035 0.085 0.22 1 -0.3 2 3
NF kappa B1 p105/c-Rel 0.032 0.035 -10000 0 -0.29 2 2
LCK -0.013 0.14 -10000 0 -0.34 28 28
BCL3 0.024 0.078 -10000 0 -0.42 6 6
p38 MAPK signaling pathway

Figure S123.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S123.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
TRAF6/ASK1 0.017 0.049 -10000 0 -0.22 7 7
TRAF2/ASK1 0.032 0.062 -10000 0 -0.29 6 6
ATM 0.032 0.041 -10000 0 -0.28 3 3
MAP2K3 0.007 0.1 0.36 2 -0.39 5 7
response to stress 0 0 -10000 0 -10000 0 0
MAP2K6 0 0.11 0.26 2 -0.36 8 10
hyperosmotic response 0 0 -10000 0 -10000 0 0
response to oxidative stress 0 0 -10000 0 -10000 0 0
GADD45G 0.017 0.082 -10000 0 -0.27 14 14
TXN 0.01 0.001 -10000 0 -10000 0 0
CALM1 0.033 0.012 -10000 0 -10000 0 0
GADD45A 0.022 0.076 -10000 0 -0.31 9 9
GADD45B 0.021 0.072 -10000 0 -0.26 11 11
MAP3K1 0.033 0.031 -10000 0 -0.19 4 4
MAP3K6 0.027 0.06 -10000 0 -0.47 3 3
MAP3K7 0.036 0.008 -10000 0 -10000 0 0
MAP3K4 0.036 0.009 -10000 0 -10000 0 0
mol:Ca2+ 0 0 -10000 0 -10000 0 0
ASK1/ASK2 0.03 0.084 -10000 0 -0.38 7 7
TAK1/TAB family 0 0.018 -10000 0 -10000 0 0
RAC1/OSM/MEKK3 0.061 0.026 -10000 0 -10000 0 0
TRAF2 0.036 0.016 -10000 0 -0.19 1 1
RAC1/OSM/MEKK3/MKK3 0.024 0.085 -10000 0 -0.35 3 3
TRAF6 0.01 0.001 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
mol:LPS 0 0 -10000 0 -10000 0 0
CAMK2B 0.029 0.035 -10000 0 -0.19 5 5
CCM2 0.034 0.011 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB 0.037 0.029 -10000 0 -10000 0 0
MAPK11 0.033 0.018 -10000 0 -0.19 1 1
response to DNA damage stimulus 0 0 -10000 0 -10000 0 0
CaM/Ca2+/CAMKIIB/ASK1 0.041 0.066 -10000 0 -0.27 5 5
OSM/MEKK3 0.048 0.019 -10000 0 -10000 0 0
TAOK1 0.012 0.045 -10000 0 -0.31 4 4
TAOK2 0.018 0.024 -10000 0 -0.31 1 1
TAOK3 0.018 0.024 -10000 0 -0.31 1 1
MAP3K7IP1 0 0 -10000 0 -10000 0 0
MAPK14 0.037 0.005 -10000 0 -10000 0 0
MAP3K7IP2 0 0 -10000 0 -10000 0 0
MAP3K5 0.015 0.09 -10000 0 -0.33 12 12
MAP3K10 0.031 0.035 -10000 0 -0.19 5 5
MAP3K3 0.036 0.009 -10000 0 -10000 0 0
TRX/ASK1 0.02 0.056 -10000 0 -0.26 7 7
GADD45/MTK1/MTK1 0.047 0.088 -10000 0 -0.24 10 10
Canonical NF-kappaB pathway

Figure S124.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S124.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
FBXW11 0.038 0.014 -10000 0 -10000 0 0
mol:GTP 0 0 -10000 0 -10000 0 0
NF kappa B1 p50/RelA/I kappa B alpha 0.044 0.1 0.38 3 -0.32 2 5
ERC1 0.035 0.017 -10000 0 -0.19 1 1
RIP2/NOD2 -0.004 0.12 -10000 0 -0.34 20 20
NFKBIA 0.013 0.042 -10000 0 -0.52 1 1
BIRC2 0.035 0.017 -10000 0 -0.19 1 1
IKBKB 0.032 0.013 -10000 0 -10000 0 0
RIPK2 0.025 0.06 -10000 0 -0.47 3 3
IKBKG 0.009 0.079 -10000 0 -0.31 1 1
IKK complex/A20 0.044 0.092 -10000 0 -10000 0 0
NEMO/A20/RIP2 0.025 0.06 -10000 0 -0.47 3 3
XPO1 0.038 0 -10000 0 -10000 0 0
NEMO/ATM 0.031 0.09 -10000 0 -10000 0 0
tumor necrosis factor receptor activity 0 0 -10000 0 -10000 0 0
RAN 0.037 0.004 -10000 0 -10000 0 0
Exportin 1/RanGTP 0.05 0.005 -10000 0 -10000 0 0
IKK complex/ELKS 0.034 0.086 -10000 0 -0.39 1 1
BCL10/MALT1/TRAF6 0.047 0.05 -10000 0 -0.29 2 2
NOD2 -0.036 0.16 -10000 0 -0.35 41 41
NFKB1 0.038 0.014 -10000 0 -10000 0 0
RELA 0.038 0.014 -10000 0 -10000 0 0
MALT1 0.023 0.038 -10000 0 -0.47 1 1
cIAP1/UbcH5C 0.05 0.032 -10000 0 -0.34 1 1
ATM 0.032 0.041 -10000 0 -0.28 3 3
TNF/TNFR1A 0.043 0.05 -10000 0 -0.34 2 2
TRAF6 0.037 0.005 -10000 0 -10000 0 0
PRKCA 0.032 0.039 -10000 0 -0.33 2 2
CHUK 0.031 0.049 -10000 0 -0.47 2 2
UBE2D3 0.034 0.035 -10000 0 -0.47 1 1
TNF 0.025 0.062 -10000 0 -0.25 9 9
NF kappa B1 p50/RelA 0.078 0.036 -10000 0 -0.27 1 1
BCL10 0.034 0.035 -10000 0 -0.47 1 1
proteasomal ubiquitin-dependent protein catabolic process 0.013 0.041 -10000 0 -0.52 1 1
beta TrCP1/SCF ubiquitin ligase complex 0.038 0.014 -10000 0 -10000 0 0
TNFRSF1A 0.036 0.008 -10000 0 -10000 0 0
IKK complex 0.035 0.093 -10000 0 -0.41 1 1
CYLD 0.037 0.004 -10000 0 -10000 0 0
IKK complex/PKC alpha 0.044 0.098 -10000 0 -0.4 1 1
Signaling events mediated by HDAC Class II

Figure S125.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S125.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
G beta1gamma2/HDAC5 0.078 0.041 -10000 0 -10000 0 0
HDAC3 0.037 0.005 -10000 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.008 0.023 -10000 0 -0.22 2 2
GATA1/HDAC4 0.045 0.056 -10000 0 -0.34 4 4
GATA1/HDAC5 0.045 0.053 -10000 0 -0.36 3 3
GATA2/HDAC5 0.046 0.045 -10000 0 -0.34 2 2
HDAC5/BCL6/BCoR 0.047 0.08 -10000 0 -0.29 8 8
HDAC9 0.03 0.039 -10000 0 -0.33 2 2
Glucocorticoid receptor/Hsp90/HDAC6 0.054 0.066 -10000 0 -0.29 6 6
HDAC4/ANKRA2 0.051 0.033 -10000 0 -0.34 1 1
HDAC5/YWHAB 0.025 0.045 -10000 0 -0.34 2 2
NPC/RanGAP1/SUMO1/Ubc9 0.017 0.02 -10000 0 -0.2 1 1
GATA2 0.031 0.051 -10000 0 -0.38 3 3
HDAC4/RFXANK 0.052 0.031 -10000 0 -0.34 1 1
BCOR 0.035 0.035 -10000 0 -0.47 1 1
mol:GTP 0 0 -10000 0 -10000 0 0
HDAC10 0.03 0.042 -10000 0 -0.28 3 3
HDAC5 0.034 0.023 -10000 0 -0.19 2 2
GNB1/GNG2 0.047 0.02 -10000 0 -10000 0 0
Histones 0.027 0.054 -10000 0 -0.25 3 3
ADRBK1 0.037 0.004 -10000 0 -10000 0 0
HDAC4 0.034 0.038 -10000 0 -0.33 2 2
XPO1 0.038 0 -10000 0 -10000 0 0
HDAC5/ANKRA2 0.05 0.025 -10000 0 -10000 0 0
HDAC4/Ubc9 0.05 0.032 -10000 0 -0.34 1 1
HDAC7 0 0 -10000 0 -10000 0 0
HDAC5/14-3-3 E 0.042 0.028 -10000 0 -10000 0 0
TUBA1B 0.034 0.038 -10000 0 -0.33 2 2
HDAC6 0.036 0.016 -10000 0 -0.19 1 1
HDAC5/RFXANK 0.051 0.021 -10000 0 -10000 0 0
CAMK4 0.037 0.006 -10000 0 -10000 0 0
Tubulin/HDAC6 0.063 0.053 -10000 0 -0.29 3 3
SUMO1 0.038 0.003 -10000 0 -10000 0 0
EntrezGene:9972 0 0 -10000 0 -10000 0 0
YWHAB 0.015 0.051 -10000 0 -0.47 2 2
GATA1 0.029 0.061 -10000 0 -0.4 4 4
EntrezGene:8021 0 0 -10000 0 -10000 0 0
YWHAE 0.03 0.015 -10000 0 -10000 0 0
NR3C1 0.022 0.085 -10000 0 -0.43 7 7
SUMO1/HDAC4 0.047 0.049 -10000 0 -0.22 1 1
SRF 0.033 0.038 -10000 0 -0.33 2 2
HDAC4/YWHAB 0.023 0.052 -10000 0 -0.34 3 3
Tubulin 0.044 0.054 -10000 0 -0.34 3 3
HDAC4/14-3-3 E 0.041 0.037 -10000 0 -0.34 1 1
GNB1 0.035 0.009 -10000 0 -10000 0 0
RANGAP1 0.032 0.028 -10000 0 -0.19 3 3
BCL6/BCoR 0.031 0.082 -10000 0 -0.34 8 8
HDAC4/HDAC3/SMRT (N-CoR2) 0.067 0.042 -10000 0 -0.29 2 2
HDAC4/SRF 0.067 0.049 -10000 0 -0.54 1 1
HDAC4/ER alpha 0.042 0.061 -10000 0 -0.34 5 5
EntrezGene:23225 0 0 -10000 0 -10000 0 0
positive regulation of chromatin silencing 0.027 0.054 -10000 0 -0.25 3 3
cell motility 0.062 0.053 -10000 0 -0.29 3 3
EntrezGene:23636 0 0 -10000 0 -10000 0 0
UBE2I 0.036 0.008 -10000 0 -10000 0 0
HDAC7/HDAC3 0.027 0.004 -10000 0 -10000 0 0
BCL6 0.01 0.1 -10000 0 -0.3 17 17
HDAC4/CaMK II delta B 0.034 0.038 -10000 0 -0.33 2 2
Hsp90/HDAC6 0.048 0.021 -10000 0 -10000 0 0
ESR1 0.026 0.069 -10000 0 -0.47 4 4
HDAC6/HDAC11 0.051 0.024 -10000 0 -10000 0 0
Ran/GTP/Exportin 1 0.05 0.045 -10000 0 -10000 0 0
NPC 0.021 0.019 -10000 0 -0.24 1 1
MEF2C 0 0.12 -10000 0 -0.34 21 21
RAN 0.037 0.004 -10000 0 -10000 0 0
HDAC4/MEF2C 0.071 0.095 -10000 0 -0.25 12 12
GNG2 0.034 0.011 -10000 0 -10000 0 0
NCOR2 0.034 0.038 -10000 0 -0.33 2 2
TUBB2A 0.028 0.057 -10000 0 -0.28 6 6
HDAC11 0.035 0.022 -10000 0 -0.19 2 2
HSP90AA1 0.033 0.012 -10000 0 -10000 0 0
RANBP2 0.034 0.038 -10000 0 -0.33 2 2
ANKRA2 0.036 0.016 -10000 0 -0.19 1 1
RFXANK 0.037 0.004 -10000 0 -10000 0 0
nuclear import -0.016 0.045 0.28 3 -10000 0 3
Arf1 pathway

Figure S126.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S126.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
coatomer protein complex 0.065 0.067 0.17 1 -10000 0 1
EntrezGene:79658 0 0 -10000 0 -10000 0 0
ARF1/GDP/Membrin/GBF1/p115/Brefeldin A 0.011 0.044 -10000 0 -0.29 1 1
AP2 0.051 0.031 -10000 0 -0.34 1 1
mol:DAG 0 0 -10000 0 -10000 0 0
Arfaptin 2/Rac/GTP 0.043 0.018 -10000 0 -10000 0 0
CLTB 0.037 0.004 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ER cargo protein 0.027 0.009 -10000 0 -10000 0 0
CD4 0.036 0.008 -10000 0 -10000 0 0
CLTA 0.037 0.006 -10000 0 -10000 0 0
mol:GTP -0.001 0.003 -10000 0 -10000 0 0
ARFGAP1 0.006 0.005 -10000 0 -10000 0 0
mol:PI-4-5-P2 0.007 0.007 -10000 0 -10000 0 0
ARF1/GTP 0.024 0.008 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1/ER cargo protein 0.079 0.079 0.17 87 -10000 0 87
mol:Choline 0.007 0.007 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
ARF1 0.037 0.008 -10000 0 -10000 0 0
DDEF1 0.005 0.006 -10000 0 -10000 0 0
ARF1/GDP 0.003 0.009 -10000 0 -10000 0 0
AP2M1 0.034 0.038 -10000 0 -0.33 2 2
EntrezGene:1313 0 0 -10000 0 -10000 0 0
actin filament polymerization 0.016 0.007 -10000 0 -10000 0 0
Rac/GTP 0.026 0.009 -10000 0 -10000 0 0
ARF1/GTP/GGA3/ARF-GAP1 0.029 0.027 -10000 0 -10000 0 0
ARFIP2 0.022 0.027 -10000 0 -10000 0 0
COPA 0.037 0.006 -10000 0 -10000 0 0
RAC1 0.034 0.012 -10000 0 -10000 0 0
ARF1/GTP/coatomer protein complex 0.021 0.022 -10000 0 -10000 0 0
ARF1/GTP/ARHGAP10 0.025 0.006 -10000 0 -10000 0 0
GGA3 0.036 0.007 -10000 0 -10000 0 0
ARF1/GTP/Membrin 0.026 0.04 -10000 0 -0.25 4 4
AP2A1 0.037 0.006 -10000 0 -10000 0 0
coatomer protein complex/ARF1/GTP/ARF-GAP1 0.012 0.018 -10000 0 -10000 0 0
ARF1/GDP/Membrin 0.026 0.047 -10000 0 -0.29 4 4
Arfaptin 2/Rac/GDP 0.043 0.017 -10000 0 -10000 0 0
CYTH2 -0.001 0.003 -10000 0 -10000 0 0
ARF1/GTP/GGA3 0.047 0.013 -10000 0 -10000 0 0
mol:ATP 0 0 -10000 0 -10000 0 0
Rac/GDP 0.025 0.009 -10000 0 -10000 0 0
mol:Brefeldin A 0 0 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex/Coatomer protein complex/ARF1/GTP 0.032 0.025 -10000 0 -10000 0 0
PLD2 0.007 0.007 -10000 0 -10000 0 0
ARF-GAP1/v-SNARE 0.006 0.005 -10000 0 -10000 0 0
PIP5K1A 0.007 0.007 -10000 0 -10000 0 0
ARF1/GTP/Membrin/GBF1/p115 0.012 0.034 -10000 0 -0.14 1 1
mol:Phosphatic acid 0 0 -10000 0 -10000 0 0
mol:Phosphatidic acid 0.007 0.007 -10000 0 -10000 0 0
KDEL Receptor/Ligand/ARF-GAP1 0.006 0.005 -10000 0 -10000 0 0
GOSR2 0.013 0.024 -10000 0 -0.31 1 1
USO1 0.013 0.024 -10000 0 -0.31 1 1
GBF1 0.006 0.06 -10000 0 -0.37 5 5
ARF1/GTP/Arfaptin 2 0.047 0.012 -10000 0 -10000 0 0
CD4/HIV Nef/AP2/vacuolar proton-transporting V-type ATPase complex 0.069 0.032 -10000 0 -0.29 1 1
Nephrin/Neph1 signaling in the kidney podocyte

Figure S127.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S127.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
positive regulation of NF-kappaB transcription factor activity -0.046 0.037 -10000 0 -10000 0 0
KIRREL 0.036 0.018 -10000 0 -10000 0 0
Nephrin/NEPH1Par3/Par6/Atypical PKCs 0.046 0.037 -10000 0 -10000 0 0
PLCG1 0.02 0.019 -10000 0 -10000 0 0
ARRB2 0.028 0.037 -10000 0 -0.47 1 1
WASL 0.034 0.035 -10000 0 -0.47 1 1
Nephrin/NEPH1/podocin/CD2AP 0.08 0.049 -10000 0 -0.28 1 1
ChemicalAbstracts:57-88-5 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2/N-WASP 0.03 0.043 -10000 0 -10000 0 0
FYN 0.018 0.066 0.31 4 -0.19 7 11
mol:Ca2+ 0.043 0.05 -10000 0 -10000 0 0
mol:DAG 0.044 0.051 -10000 0 -10000 0 0
NPHS2 0.034 0.028 -10000 0 -0.2 2 2
mol:IP3 0.044 0.051 -10000 0 -10000 0 0
regulation of endocytosis 0.043 0.066 -10000 0 -0.24 1 1
Nephrin/NEPH1/podocin/Cholesterol 0.057 0.041 -10000 0 -10000 0 0
establishment of cell polarity 0.046 0.037 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/NCK1-2 0.096 0.061 -10000 0 -0.26 4 4
Nephrin/NEPH1/beta Arrestin2 0.045 0.067 -10000 0 -0.24 1 1
NPHS1 0.031 0.038 -10000 0 -0.19 5 5
Nephrin/NEPH1/podocin 0.05 0.06 -10000 0 -0.19 7 7
TJP1 0.033 0.036 -10000 0 -0.47 1 1
NCK1 0.028 0.069 -10000 0 -0.47 4 4
NCK2 0.038 0 -10000 0 -10000 0 0
heterophilic cell adhesion 0 0 -10000 0 -10000 0 0
Nephrin/NEPH1/podocin/PLCgamma1 0.045 0.052 -10000 0 -10000 0 0
CD2AP 0.035 0.035 -10000 0 -0.47 1 1
Nephrin/NEPH1/podocin/GRB2 0.08 0.044 -10000 0 -10000 0 0
GRB2 0.036 0.007 -10000 0 -10000 0 0
homophilic cell adhesion 0 0 -10000 0 -10000 0 0
TRPC6 0.016 0.08 0.32 6 -0.29 5 11
cytoskeleton organization 0.017 0.044 0.22 3 -10000 0 3
Nephrin/NEPH1 0.04 0.027 -10000 0 -10000 0 0
Nephrin/NEPH1/ZO-1 0.06 0.044 -10000 0 -0.31 1 1
Circadian rhythm pathway

Figure S128.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S128.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
chromatin modification 0.057 0.058 -9999 0 -10000 0 0
CLOCK 0.036 0.038 -9999 0 -0.32 2 2
TIMELESS/CRY2 0.05 0.026 -9999 0 -10000 0 0
DEC1/BMAL1 0.053 0.033 -9999 0 -0.34 1 1
ATR 0.036 0.016 -9999 0 -0.19 1 1
NR1D1 0.027 0.023 -9999 0 -10000 0 0
ARNTL 0.037 0.035 -9999 0 -0.47 1 1
TIMELESS 0.029 0.018 -9999 0 -10000 0 0
NPAS2 0.028 0.077 -9999 0 -0.47 5 5
CRY2 0.037 0.004 -9999 0 -10000 0 0
mol:CO -0.011 0.003 -9999 0 -10000 0 0
CHEK1 0.02 0.09 -9999 0 -0.47 7 7
mol:HEME 0.011 0.003 -9999 0 -10000 0 0
PER1 0.03 0.015 -9999 0 -10000 0 0
BMAL/CLOCK/NPAS2 0.074 0.069 -9999 0 -0.28 7 7
BMAL1/CLOCK 0.037 0.058 -9999 0 -10000 0 0
S phase of mitotic cell cycle 0.057 0.058 -9999 0 -10000 0 0
TIMELESS/CHEK1/ATR 0.058 0.059 -9999 0 -10000 0 0
mol:NADPH 0.011 0.003 -9999 0 -10000 0 0
PER1/TIMELESS 0.04 0.03 -9999 0 -10000 0 0
PER1-2 / CRY1-2 0 0 -9999 0 -10000 0 0
DEC1 0.036 0.016 -9999 0 -0.19 1 1
Sumoylation by RanBP2 regulates transcriptional repression

Figure S129.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S129.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
HDAC1 0.036 0.008 -9999 0 -10000 0 0
Ran/GTP/Exportin 1/HDAC4 0.003 0.028 -9999 0 -0.22 2 2
MDM2/SUMO1 0.048 0.045 -9999 0 -0.18 1 1
HDAC4 0.034 0.038 -9999 0 -0.33 2 2
Ran/GTP/Exportin 1/HDAC1 0.005 0.023 -9999 0 -0.24 1 1
SUMO1 0.038 0.003 -9999 0 -10000 0 0
NPC/RanGAP1/SUMO1 0.015 0.017 -9999 0 -0.2 1 1
mol:GTP 0 0 -9999 0 -10000 0 0
XPO1 0.007 0.029 -9999 0 -0.19 1 1
EntrezGene:23636 0 0 -9999 0 -10000 0 0
RAN 0.037 0.004 -9999 0 -10000 0 0
EntrezGene:8021 0 0 -9999 0 -10000 0 0
RANBP2 0.034 0.038 -9999 0 -0.33 2 2
SUMO1/HDAC4 0.047 0.049 -9999 0 -0.22 1 1
SUMO1/HDAC1 0.048 0.044 -9999 0 -10000 0 0
RANGAP1 0.032 0.028 -9999 0 -0.19 3 3
MDM2/SUMO1/SUMO1 0.056 0.062 -9999 0 -0.26 2 2
NPC/RanGAP1/SUMO1/RanBP2/Ubc9 0.017 0.02 -9999 0 -0.2 1 1
Ran/GTP 0.031 0.04 -9999 0 -0.18 2 2
EntrezGene:23225 0 0 -9999 0 -10000 0 0
MDM2 0.036 0.016 -9999 0 -0.19 1 1
UBE2I 0.036 0.008 -9999 0 -10000 0 0
Ran/GTP/Exportin 1 0.029 0.039 -9999 0 -10000 0 0
NPC 0.021 0.019 -9999 0 -0.24 1 1
PIAS2 0.015 0.061 -9999 0 -0.26 8 8
PIAS1 0.035 0.009 -9999 0 -10000 0 0
EntrezGene:9972 0 0 -9999 0 -10000 0 0
Rapid glucocorticoid signaling

Figure S130.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S130.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
Gs family/GDP/Gbeta gamma 0.046 0.035 -10000 0 -10000 0 0
MAPK9 0.009 0.022 -10000 0 -0.31 1 1
adrenocorticotropin secretion 0.008 0.01 -10000 0 -0.12 1 1
GNB1/GNG2 0.043 0.018 -10000 0 -10000 0 0
GNB1 0.035 0.009 -10000 0 -10000 0 0
regulation of calcium ion transport via voltage-gated calcium channel activity 0 0 -10000 0 -10000 0 0
mol:GDP 0 0 -10000 0 -10000 0 0
MAPK14 0.01 0.001 -10000 0 -10000 0 0
Gs family/GTP 0.016 0.018 -10000 0 -0.083 5 5
EntrezGene:2778 0 0 -10000 0 -10000 0 0
vasopressin secretion 0 0 -10000 0 -10000 0 0
G-protein coupled receptor activity 0 0 -10000 0 -10000 0 0
ChemicalAbstracts:86-01-1 0 0 -10000 0 -10000 0 0
glutamate secretion 0.001 0.004 0.027 4 -10000 0 4
GNAL 0.025 0.033 -10000 0 -0.19 4 4
GNG2 0.034 0.011 -10000 0 -10000 0 0
CRH 0.031 0.02 -10000 0 -0.19 1 1
mol:cortisol 0 0 -10000 0 -10000 0 0
MAPK8 0.01 0.002 -10000 0 -10000 0 0
MAPK11 0.009 0.006 -10000 0 -10000 0 0
Alternative NF-kappaB pathway

Figure S131.  Get High-res Image This plot shows pathway concept perturbations across all samples against a permutation model. The concepts along the x-axis are sorted by lowest to highest mean activity for the real patient samples. Mean inferred activities are plotted along the y-axis as a colored band showing the average level and one standard deviation range. Real samples are shown in red and permuted samples in black.

Table S131.  Get Full Table This table displays mean, standard deviation, and perturbation statistics for Inferred Pathway Levels (IPLs). A mean perturbation of -9999 implies that the IPLs across all the real samples did not differ enough from the IPLs generated by a background model of permuted samples (> 1 Std.Dev from the permuted sample IPLs).

Entity Mean Std.Dev Mean.of.Up.Perturbations Number.of.Up.Perturbations Mean.of.Down.Perturbations Number.of.Down.Perturbations Number.of.Total.Perturbations
IKK alpha homodimer 0.048 0.04 -9999 0 -0.34 2 2
FBXW11 0.037 0.004 -9999 0 -10000 0 0
proteasomal ubiquitin-dependent protein catabolic process 0 0 -9999 0 -10000 0 0
beta TrCP1/SCF ubiquitin ligase complex 0.037 0.004 -9999 0 -10000 0 0
CHUK 0.031 0.049 -9999 0 -0.47 2 2
NF kappa B2 p100/RelB 0.095 0.055 -9999 0 -0.25 3 3
NFKB1 0.037 0.006 -9999 0 -10000 0 0
MAP3K14 0.036 0.007 -9999 0 -10000 0 0
NF kappa B1 p50/RelB 0.052 0.029 -9999 0 -0.34 1 1
RELB 0.034 0.035 -9999 0 -0.47 1 1
NFKB2 0.035 0.017 -9999 0 -0.19 1 1
NF kappa B2 p52/RelB 0.045 0.028 -9999 0 -0.29 1 1
regulation of B cell activation 0.045 0.028 -9999 0 -0.28 1 1
Inferred Pathway Levels Matrix

Table 3.  Get Full Table First 10 out of 7202 rows and 4 out of 215 columns in the PARADIGM inferred pathway levels matrix.

pid_entity TCGA.AY.4071 TCGA.AY.4070 TCGA.AG.A032 TCGA.AG.A02X
109_MAP3K5 0.16 0.13 0.093 -0.06
47_PPARGC1A -0.19 0.038 -0.19 0.038
105_BMP4 -0.47 0.038 0.038 0.038
105_BMP6 0.038 -0.19 0.038 0.038
105_BMP7 0 0 0 -0.47
105_BMP2 0 0.038 0.038 0.038
131_RELN/VLDLR 0.097 0 0.097 -0.095
30_TGFB1/TGF beta receptor Type II 0.037 0.037 0.037 0.037
84_STAT5B 0.13 0.076 0.12 -0.091
84_STAT5A 0.13 0.076 0.12 -0.091
Methods & Data
Input

  • Expression Data Normalization = Tumor samples were used to median center the expression data used in this analysis.

  • mRNA Expression File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_MergeDataFilesPipeline/COADREAD-TP/4392266/GDAC_MergeDataFiles_3202301/COADREAD-TP.transcriptome__agilentg4502a_07_3__unc_edu__Level_3__unc_lowess_normalization_gene_level__data.data.txt

  • Copy Number File Used = /xchip/cga/gdac-prod/tcga-gdac/jobResults/GDAC_Gistic2/COADREAD-TP/4425377/GDAC_Gistic2Report_4428385/all_data_by_genes.txt

Data Sets and Pathway Interactions

Both copy number and expression data are incorporated into PARADIGM's inference. Whenever normal tissue controls are available for analysis in the expression data, each patient's gene-value is normalized by subtracting the gene's median level observed in the normal control. Copy number data is also normalized to reflect the difference in copy number between a gene's levels detected in tumor versus control (e.g. blood normal). The collection of pathways used by PARADIGM includes those from NCI-PID on September 15, 2009 containing 131 pathways, 11,563 interactions, and 7,204 entities. All gene identifiers were translated into HUGO standard identifiers wherever possible. We refer to molecular entities as "concepts," which include gene products such as proteins and miRNAs, small molecules, protein complexes, and abstract concepts. Each concept is represented as "node" in PARADIGM's graphical model. The abstract concepts correspond to general cellular processes (such as "apoptosis" or "DNA damage response") and families of genes that share functional activity such as the RAS family of signal transducers. Various types of concept-concept interactions are included in the pathways including protein-protein interactions, transcriptional regulatory interactions, and protein modifications such as phosphorylation and ubiquitinylation interactions.

Pathway Inference Method

The PARADIGM algorithm (described in PMID: 20529912) assigns an integrated pathway level (IPL) reflecting the activity of a concept determined through a belief propagation strategy. The belief propagation is given the copy number and gene expression measurements of all of the genes and iteratively updates hidden states reflecting the activities of all of the genes in a pathway so as to maximize the likelihood of the observed data given the interactions in the pathway. In the end, the inferred level of a concept reflects both the data observed for the concept and the neighborhood of activity surrounding the concept.

Determining significantly altered levels

The significance of the IPL obtained for each concept in each patient sample is assessed using a permutation analysis. Importantly, the permutation analysis preserves data tuples so as to preserve any implicit correlations between the different data modalities. For example, genes that are deleted have concomitantly lower expression levels. Preserving the copy number and expression pairs therefore retains this data property. The simulation therefore makes "null samples" by permuting data tuples across all of the genes in the genome so that each gene in a null sample is associated with a random tuple of another gene with equal probability. This approach has the added benefit of preserving the pathway structure so that every observed IPL can be compared to a distribution of random IPLs derived from exactly the same interaction context. PARADIGM inferences are then obtained for 1000 "null" patients and serve as a background distribution to contrast the observed IPLs against. Pathway concepts are excluded from further analysis if they did not obtain a minimum IPL of 0.5 in any patient sample both observed or simulated.

An IPL I(i,j) for concept i in sample j, is considered to be deviated if its absolute level is two standard deviations from the average level observed for concept i in the 1000 null samples. The degree to which a concept has significantly altered levels across a patient cohort is summarized in the proportion of deviated samples (PDS) score. For example, a protein with a PDS of 0.10 reflects that the protein's level of activity was inferred to be significantly higher or lower in tumors compared to normal in 10% of the patient samples. An average PDS for a pathway is also reported by computing the mean PDS over all concepts in the pathway.

Download Results

In addition to the links below, the full results of the analysis summarized in this report can also be downloaded programmatically using firehose_get, or interactively from either the Broad GDAC website or TCGA Data Coordination Center Portal.

References
[2] Charles J. Vaske, Stephen C. Benz, J. Zachary Sanborn, Dent Earl, Christopher Szeto, Jingchun Zhu, David Haussler, and Joshua M. Stuart, Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM, Bioinformatics 12(26):237-245 (2010)
Copyright © 2013 Broad Institute TCGA GDAC as part of the TCGA Research Network. All rights reserved.
Made with Nozzle